WO2012172482A1 - Metal complexes comprising azabenzimidazole carbene ligands and the use thereof in oleds - Google Patents
Metal complexes comprising azabenzimidazole carbene ligands and the use thereof in oleds Download PDFInfo
- Publication number
- WO2012172482A1 WO2012172482A1 PCT/IB2012/052963 IB2012052963W WO2012172482A1 WO 2012172482 A1 WO2012172482 A1 WO 2012172482A1 IB 2012052963 W IB2012052963 W IB 2012052963W WO 2012172482 A1 WO2012172482 A1 WO 2012172482A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- carbon atoms
- substituted
- radical
- optionally
- heteroatom
- Prior art date
Links
- 239000003446 ligand Substances 0.000 title claims description 185
- HZVOZRGWRWCICA-UHFFFAOYSA-N methanediyl Chemical compound [CH2] HZVOZRGWRWCICA-UHFFFAOYSA-N 0.000 title claims description 76
- 229910052751 metal Inorganic materials 0.000 title description 15
- 239000002184 metal Substances 0.000 title description 15
- GAMYYCRTACQSBR-UHFFFAOYSA-N 4-azabenzimidazole Chemical compound C1=CC=C2NC=NC2=N1 GAMYYCRTACQSBR-UHFFFAOYSA-N 0.000 title description 11
- 239000000463 material Substances 0.000 claims abstract description 86
- 239000011159 matrix material Substances 0.000 claims abstract description 37
- 229910052741 iridium Inorganic materials 0.000 claims abstract description 17
- 230000000007 visual effect Effects 0.000 claims abstract description 15
- 229910052697 platinum Inorganic materials 0.000 claims abstract description 7
- -1 alkyl radical Chemical class 0.000 claims description 362
- 125000004432 carbon atom Chemical group C* 0.000 claims description 349
- 125000005842 heteroatom Chemical group 0.000 claims description 304
- 150000001875 compounds Chemical class 0.000 claims description 163
- 125000003118 aryl group Chemical group 0.000 claims description 124
- 125000000524 functional group Chemical group 0.000 claims description 113
- 150000005840 aryl radicals Chemical class 0.000 claims description 84
- 230000009471 action Effects 0.000 claims description 80
- 150000003254 radicals Chemical class 0.000 claims description 77
- 125000000217 alkyl group Chemical group 0.000 claims description 70
- 125000001072 heteroaryl group Chemical group 0.000 claims description 68
- 229910052739 hydrogen Inorganic materials 0.000 claims description 55
- 239000001257 hydrogen Substances 0.000 claims description 54
- 125000001424 substituent group Chemical group 0.000 claims description 53
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 44
- 229920006395 saturated elastomer Polymers 0.000 claims description 44
- 150000002431 hydrogen Chemical group 0.000 claims description 40
- 229910052717 sulfur Inorganic materials 0.000 claims description 38
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 36
- 229910052760 oxygen Inorganic materials 0.000 claims description 36
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims description 35
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 28
- 229910052799 carbon Inorganic materials 0.000 claims description 24
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 23
- 229910052757 nitrogen Inorganic materials 0.000 claims description 20
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 19
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 19
- 229910052736 halogen Inorganic materials 0.000 claims description 19
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 19
- 125000006413 ring segment Chemical group 0.000 claims description 19
- 239000007787 solid Substances 0.000 claims description 16
- 125000000609 carbazolyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3NC12)* 0.000 claims description 15
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 14
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 13
- 125000004429 atom Chemical group 0.000 claims description 11
- 125000004987 dibenzofuryl group Chemical group C1(=CC=CC=2OC3=C(C21)C=CC=C3)* 0.000 claims description 11
- 125000000623 heterocyclic group Chemical group 0.000 claims description 11
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 10
- 125000005595 acetylacetonate group Chemical group 0.000 claims description 9
- 125000004988 dibenzothienyl group Chemical group C1(=CC=CC=2SC3=C(C21)C=CC=C3)* 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 8
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical class [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 claims description 6
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 claims description 6
- 229960001860 salicylate Drugs 0.000 claims description 6
- 229910052727 yttrium Inorganic materials 0.000 claims description 6
- 229910052794 bromium Inorganic materials 0.000 claims description 5
- 238000005286 illumination Methods 0.000 claims description 5
- 238000013086 organic photovoltaic Methods 0.000 claims description 5
- 239000003574 free electron Substances 0.000 claims description 4
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 4
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical group [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 3
- 125000003342 alkenyl group Chemical group 0.000 claims description 3
- 125000000304 alkynyl group Chemical group 0.000 claims description 3
- 125000000732 arylene group Chemical group 0.000 claims description 3
- 230000005669 field effect Effects 0.000 claims description 3
- 125000005549 heteroarylene group Chemical group 0.000 claims description 3
- 229910052740 iodine Inorganic materials 0.000 claims description 3
- 229910052700 potassium Inorganic materials 0.000 claims description 3
- 125000004450 alkenylene group Chemical group 0.000 claims description 2
- 125000002947 alkylene group Chemical group 0.000 claims description 2
- 125000004419 alkynylene group Chemical group 0.000 claims description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 abstract description 21
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 abstract description 9
- 239000010410 layer Substances 0.000 description 170
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 131
- 239000000203 mixture Substances 0.000 description 71
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 51
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 48
- 238000005160 1H NMR spectroscopy Methods 0.000 description 41
- 239000000243 solution Substances 0.000 description 41
- 238000001816 cooling Methods 0.000 description 34
- 238000000034 method Methods 0.000 description 32
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 30
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 25
- 239000000741 silica gel Substances 0.000 description 24
- 229910002027 silica gel Inorganic materials 0.000 description 24
- 230000032258 transport Effects 0.000 description 24
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 23
- 238000004440 column chromatography Methods 0.000 description 23
- 239000002585 base Substances 0.000 description 22
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 21
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 21
- 239000002904 solvent Substances 0.000 description 20
- 238000005424 photoluminescence Methods 0.000 description 19
- 239000002244 precipitate Substances 0.000 description 19
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 18
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 18
- 239000010408 film Substances 0.000 description 17
- 239000012074 organic phase Substances 0.000 description 17
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 17
- 239000004926 polymethyl methacrylate Substances 0.000 description 17
- 230000008569 process Effects 0.000 description 17
- 238000010992 reflux Methods 0.000 description 15
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 14
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 14
- 239000000706 filtrate Substances 0.000 description 14
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 13
- 239000000725 suspension Substances 0.000 description 13
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 12
- 0 CC(*1)N(C(C)=C(C)*(C)=**=I)c2c1c(*)c(*)c(*)n2 Chemical compound CC(*1)N(C(C)=C(C)*(C)=**=I)c2c1c(*)c(*)c(*)n2 0.000 description 12
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 12
- 230000005525 hole transport Effects 0.000 description 12
- 238000002360 preparation method Methods 0.000 description 12
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 12
- 229910052709 silver Inorganic materials 0.000 description 12
- 239000004332 silver Substances 0.000 description 12
- 125000001309 chloro group Chemical group Cl* 0.000 description 11
- 239000000178 monomer Substances 0.000 description 11
- 239000011541 reaction mixture Substances 0.000 description 11
- 238000001228 spectrum Methods 0.000 description 11
- GKASDNZWUGIAMG-UHFFFAOYSA-N triethyl orthoformate Chemical compound CCOC(OCC)OCC GKASDNZWUGIAMG-UHFFFAOYSA-N 0.000 description 11
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 10
- 150000001721 carbon Chemical group 0.000 description 10
- 229920001577 copolymer Polymers 0.000 description 10
- 239000004912 1,5-cyclooctadiene Substances 0.000 description 9
- XZXYQEHISUMZAT-UHFFFAOYSA-N 2-[(2-hydroxy-5-methylphenyl)methyl]-4-methylphenol Chemical compound CC1=CC=C(O)C(CC=2C(=CC=C(C)C=2)O)=C1 XZXYQEHISUMZAT-UHFFFAOYSA-N 0.000 description 9
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 9
- 229940107816 ammonium iodide Drugs 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- 239000008346 aqueous phase Substances 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 8
- 238000000576 coating method Methods 0.000 description 8
- 239000004020 conductor Substances 0.000 description 8
- 238000005401 electroluminescence Methods 0.000 description 8
- 229920000642 polymer Polymers 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 150000003624 transition metals Chemical class 0.000 description 8
- VYXHVRARDIDEHS-UHFFFAOYSA-N 1,5-cyclooctadiene Chemical compound C1CC=CCCC=C1 VYXHVRARDIDEHS-UHFFFAOYSA-N 0.000 description 7
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 7
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 7
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 7
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 7
- 239000003208 petroleum Substances 0.000 description 7
- 239000002243 precursor Substances 0.000 description 7
- 238000007740 vapor deposition Methods 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 6
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 6
- 229910052783 alkali metal Inorganic materials 0.000 description 6
- 150000001342 alkaline earth metals Chemical class 0.000 description 6
- 229910052731 fluorine Inorganic materials 0.000 description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- 238000002347 injection Methods 0.000 description 6
- 239000007924 injection Substances 0.000 description 6
- 150000002739 metals Chemical class 0.000 description 6
- 238000000746 purification Methods 0.000 description 6
- 150000003222 pyridines Chemical class 0.000 description 6
- 239000000758 substrate Substances 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- 229910052723 transition metal Inorganic materials 0.000 description 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 5
- 239000002800 charge carrier Substances 0.000 description 5
- 239000011248 coating agent Substances 0.000 description 5
- 239000003085 diluting agent Substances 0.000 description 5
- 230000001815 facial effect Effects 0.000 description 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 5
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 5
- 150000002825 nitriles Chemical class 0.000 description 5
- 239000012044 organic layer Substances 0.000 description 5
- 239000012071 phase Substances 0.000 description 5
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 5
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- JNCMHMUGTWEVOZ-UHFFFAOYSA-N F[CH]F Chemical compound F[CH]F JNCMHMUGTWEVOZ-UHFFFAOYSA-N 0.000 description 4
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 4
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 4
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 4
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 4
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 4
- 238000007792 addition Methods 0.000 description 4
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 4
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical compound C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 4
- 125000002619 bicyclic group Chemical group 0.000 description 4
- 239000012043 crude product Substances 0.000 description 4
- TXCDCPKCNAJMEE-UHFFFAOYSA-N dibenzofuran Chemical compound C1=CC=C2C3=CC=CC=C3OC2=C1 TXCDCPKCNAJMEE-UHFFFAOYSA-N 0.000 description 4
- IYYZUPMFVPLQIF-UHFFFAOYSA-N dibenzothiophene Chemical compound C1=CC=C2C3=CC=CC=C3SC2=C1 IYYZUPMFVPLQIF-UHFFFAOYSA-N 0.000 description 4
- 239000003480 eluent Substances 0.000 description 4
- 239000011737 fluorine Substances 0.000 description 4
- VUWZPRWSIVNGKG-UHFFFAOYSA-N fluoromethane Chemical compound F[CH2] VUWZPRWSIVNGKG-UHFFFAOYSA-N 0.000 description 4
- 125000005843 halogen group Chemical group 0.000 description 4
- 150000002367 halogens Chemical class 0.000 description 4
- 150000002390 heteroarenes Chemical class 0.000 description 4
- 239000002808 molecular sieve Substances 0.000 description 4
- 229940078552 o-xylene Drugs 0.000 description 4
- 125000005004 perfluoroethyl group Chemical group FC(F)(F)C(F)(F)* 0.000 description 4
- IUBQJLUDMLPAGT-UHFFFAOYSA-N potassium bis(trimethylsilyl)amide Chemical compound C[Si](C)(C)N([K])[Si](C)(C)C IUBQJLUDMLPAGT-UHFFFAOYSA-N 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 238000007639 printing Methods 0.000 description 4
- 125000002577 pseudohalo group Chemical group 0.000 description 4
- 150000003384 small molecules Chemical class 0.000 description 4
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 4
- MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 description 4
- 125000003944 tolyl group Chemical group 0.000 description 4
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 4
- CYPYTURSJDMMMP-WVCUSYJESA-N (1e,4e)-1,5-diphenylpenta-1,4-dien-3-one;palladium Chemical compound [Pd].[Pd].C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 CYPYTURSJDMMMP-WVCUSYJESA-N 0.000 description 3
- OZRQQVJZHUAPTI-UHFFFAOYSA-M 1,3-diphenylimidazo[4,5-b]pyridin-3-ium;chloride Chemical compound [Cl-].C12=NC=CC=C2[N+](C=2C=CC=CC=2)=CN1C1=CC=CC=C1 OZRQQVJZHUAPTI-UHFFFAOYSA-M 0.000 description 3
- NSMJMUQZRGZMQC-UHFFFAOYSA-N 2-naphthalen-1-yl-1H-imidazo[4,5-f][1,10]phenanthroline Chemical compound C12=CC=CN=C2C2=NC=CC=C2C2=C1NC(C=1C3=CC=CC=C3C=CC=1)=N2 NSMJMUQZRGZMQC-UHFFFAOYSA-N 0.000 description 3
- KJFSSYNBXWZUQE-UHFFFAOYSA-M 3-phenyl-1-propan-2-ylimidazo[4,5-b]pyridin-1-ium;iodide Chemical compound [I-].C12=NC=CC=C2[N+](C(C)C)=CN1C1=CC=CC=C1 KJFSSYNBXWZUQE-UHFFFAOYSA-M 0.000 description 3
- VFUDMQLBKNMONU-UHFFFAOYSA-N 9-[4-(4-carbazol-9-ylphenyl)phenyl]carbazole Chemical group C12=CC=CC=C2C2=CC=CC=C2N1C1=CC=C(C=2C=CC(=CC=2)N2C3=CC=CC=C3C3=CC=CC=C32)C=C1 VFUDMQLBKNMONU-UHFFFAOYSA-N 0.000 description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 3
- 229910015711 MoOx Inorganic materials 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 229960000583 acetic acid Drugs 0.000 description 3
- 150000001340 alkali metals Chemical class 0.000 description 3
- 125000003545 alkoxy group Chemical group 0.000 description 3
- 125000004618 benzofuryl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 3
- MCQRPQCQMGVWIQ-UHFFFAOYSA-N boron;methylsulfanylmethane Chemical compound [B].CSC MCQRPQCQMGVWIQ-UHFFFAOYSA-N 0.000 description 3
- 229910000024 caesium carbonate Inorganic materials 0.000 description 3
- 238000005266 casting Methods 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- URYYVOIYTNXXBN-UPHRSURJSA-N cyclooctene Chemical compound C1CCC\C=C/CC1 URYYVOIYTNXXBN-UPHRSURJSA-N 0.000 description 3
- 239000004913 cyclooctene Substances 0.000 description 3
- 125000004986 diarylamino group Chemical group 0.000 description 3
- 150000001993 dienes Chemical class 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 239000012362 glacial acetic acid Substances 0.000 description 3
- 238000004770 highest occupied molecular orbital Methods 0.000 description 3
- 238000007641 inkjet printing Methods 0.000 description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 3
- 235000019341 magnesium sulphate Nutrition 0.000 description 3
- 229910044991 metal oxide Inorganic materials 0.000 description 3
- 150000004706 metal oxides Chemical class 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 230000037230 mobility Effects 0.000 description 3
- 125000002950 monocyclic group Chemical group 0.000 description 3
- 125000001624 naphthyl group Chemical group 0.000 description 3
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 229910052763 palladium Inorganic materials 0.000 description 3
- 230000000737 periodic effect Effects 0.000 description 3
- 150000003003 phosphines Chemical class 0.000 description 3
- 125000004076 pyridyl group Chemical group 0.000 description 3
- 229910052705 radium Inorganic materials 0.000 description 3
- 229910052701 rubidium Inorganic materials 0.000 description 3
- 238000004528 spin coating Methods 0.000 description 3
- 239000008096 xylene Substances 0.000 description 3
- APPOKADJQUIAHP-GGWOSOGESA-N (2e,4e)-hexa-2,4-diene Chemical compound C\C=C\C=C\C APPOKADJQUIAHP-GGWOSOGESA-N 0.000 description 2
- BCMCBBGGLRIHSE-UHFFFAOYSA-N 1,3-benzoxazole Chemical compound C1=CC=C2OC=NC2=C1 BCMCBBGGLRIHSE-UHFFFAOYSA-N 0.000 description 2
- WQADWIOXOXRPLN-UHFFFAOYSA-N 1,3-dithiane Chemical compound C1CSCSC1 WQADWIOXOXRPLN-UHFFFAOYSA-N 0.000 description 2
- YBYIRNPNPLQARY-UHFFFAOYSA-N 1H-indene Natural products C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 description 2
- STTGYIUESPWXOW-UHFFFAOYSA-N 2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline Chemical compound C=12C=CC3=C(C=4C=CC=CC=4)C=C(C)N=C3C2=NC(C)=CC=1C1=CC=CC=C1 STTGYIUESPWXOW-UHFFFAOYSA-N 0.000 description 2
- IXHWGNYCZPISET-UHFFFAOYSA-N 2-[4-(dicyanomethylidene)-2,3,5,6-tetrafluorocyclohexa-2,5-dien-1-ylidene]propanedinitrile Chemical compound FC1=C(F)C(=C(C#N)C#N)C(F)=C(F)C1=C(C#N)C#N IXHWGNYCZPISET-UHFFFAOYSA-N 0.000 description 2
- HABKYPVMMHBOIW-UHFFFAOYSA-N 2-chloro-5-(trifluoromethyl)pyridin-3-amine Chemical compound NC1=CC(C(F)(F)F)=CN=C1Cl HABKYPVMMHBOIW-UHFFFAOYSA-N 0.000 description 2
- ZDAWFMCVTXSZTC-UHFFFAOYSA-N 2-n',7-n'-dinaphthalen-1-yl-2-n',7-n'-diphenyl-9,9'-spirobi[fluorene]-2',7'-diamine Chemical compound C1=CC=CC=C1N(C=1C2=CC=CC=C2C=CC=1)C1=CC=C(C=2C(=CC(=CC=2)N(C=2C=CC=CC=2)C=2C3=CC=CC=C3C=CC=2)C23C4=CC=CC=C4C4=CC=CC=C43)C2=C1 ZDAWFMCVTXSZTC-UHFFFAOYSA-N 0.000 description 2
- VQGHOUODWALEFC-UHFFFAOYSA-N 2-phenylpyridine Chemical compound C1=CC=CC=C1C1=CC=CC=N1 VQGHOUODWALEFC-UHFFFAOYSA-N 0.000 description 2
- ZVFQEOPUXVPSLB-UHFFFAOYSA-N 3-(4-tert-butylphenyl)-4-phenyl-5-(4-phenylphenyl)-1,2,4-triazole Chemical compound C1=CC(C(C)(C)C)=CC=C1C(N1C=2C=CC=CC=2)=NN=C1C1=CC=C(C=2C=CC=CC=2)C=C1 ZVFQEOPUXVPSLB-UHFFFAOYSA-N 0.000 description 2
- OOWFYDWAMOKVSF-UHFFFAOYSA-N 3-methoxypropanenitrile Chemical compound COCCC#N OOWFYDWAMOKVSF-UHFFFAOYSA-N 0.000 description 2
- DHDHJYNTEFLIHY-UHFFFAOYSA-N 4,7-diphenyl-1,10-phenanthroline Chemical compound C1=CC=CC=C1C1=CC=NC2=C1C=CC1=C(C=3C=CC=CC=3)C=CN=C21 DHDHJYNTEFLIHY-UHFFFAOYSA-N 0.000 description 2
- UQRONKZLYKUEMO-UHFFFAOYSA-N 4-methyl-1-(2,4,6-trimethylphenyl)pent-4-en-2-one Chemical group CC(=C)CC(=O)Cc1c(C)cc(C)cc1C UQRONKZLYKUEMO-UHFFFAOYSA-N 0.000 description 2
- UHBIKXOBLZWFKM-UHFFFAOYSA-N 8-hydroxy-2-quinolinecarboxylic acid Chemical group C1=CC=C(O)C2=NC(C(=O)O)=CC=C21 UHBIKXOBLZWFKM-UHFFFAOYSA-N 0.000 description 2
- HJCUTNIGJHJGCF-UHFFFAOYSA-N 9,10-dihydroacridine Chemical compound C1=CC=C2CC3=CC=CC=C3NC2=C1 HJCUTNIGJHJGCF-UHFFFAOYSA-N 0.000 description 2
- LTUJKAYZIMMJEP-UHFFFAOYSA-N 9-[4-(4-carbazol-9-yl-2-methylphenyl)-3-methylphenyl]carbazole Chemical group C12=CC=CC=C2C2=CC=CC=C2N1C1=CC=C(C=2C(=CC(=CC=2)N2C3=CC=CC=C3C3=CC=CC=C32)C)C(C)=C1 LTUJKAYZIMMJEP-UHFFFAOYSA-N 0.000 description 2
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 2
- DJHGAFSJWGLOIV-UHFFFAOYSA-K Arsenate3- Chemical class [O-][As]([O-])([O-])=O DJHGAFSJWGLOIV-UHFFFAOYSA-K 0.000 description 2
- 229940122361 Bisphosphonate Drugs 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical compound C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 2
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical class OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 2
- 229910052772 Samarium Inorganic materials 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 2
- BCRJHHFLBOQAMG-YNRRLODASA-N [(1e,3e)-penta-1,3-dienyl]benzene Chemical compound C\C=C\C=C\C1=CC=CC=C1 BCRJHHFLBOQAMG-YNRRLODASA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 229910000086 alane Inorganic materials 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 150000004703 alkoxides Chemical class 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 125000003368 amide group Chemical group 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 2
- 125000002178 anthracenyl group Chemical group C1(=CC=CC2=CC3=CC=CC=C3C=C12)* 0.000 description 2
- 125000001769 aryl amino group Chemical group 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- MUALRAIOVNYAIW-UHFFFAOYSA-N binap Chemical compound C1=CC=CC=C1P(C=1C(=C2C=CC=CC2=CC=1)C=1C2=CC=CC=C2C=CC=1P(C=1C=CC=CC=1)C=1C=CC=CC=1)C1=CC=CC=C1 MUALRAIOVNYAIW-UHFFFAOYSA-N 0.000 description 2
- 150000004663 bisphosphonates Chemical class 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 229910000085 borane Inorganic materials 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- XZCJVWCMJYNSQO-UHFFFAOYSA-N butyl pbd Chemical compound C1=CC(C(C)(C)C)=CC=C1C1=NN=C(C=2C=CC(=CC=2)C=2C=CC=CC=2)O1 XZCJVWCMJYNSQO-UHFFFAOYSA-N 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 125000005708 carbonyloxy group Chemical group [*:2]OC([*:1])=O 0.000 description 2
- 238000005229 chemical vapour deposition Methods 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 2
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 2
- 125000000664 diazo group Chemical group [N-]=[N+]=[*] 0.000 description 2
- 125000005509 dibenzothiophenyl group Chemical group 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 125000002541 furyl group Chemical group 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 150000004820 halides Chemical class 0.000 description 2
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N hydrazine Substances NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- 125000002883 imidazolyl group Chemical group 0.000 description 2
- 125000001841 imino group Chemical group [H]N=* 0.000 description 2
- 125000003454 indenyl group Chemical group C1(C=CC2=CC=CC=C12)* 0.000 description 2
- 125000001041 indolyl group Chemical group 0.000 description 2
- 230000001678 irradiating effect Effects 0.000 description 2
- QDLAGTHXVHQKRE-UHFFFAOYSA-N lichenxanthone Natural products COC1=CC(O)=C2C(=O)C3=C(C)C=C(OC)C=C3OC2=C1 QDLAGTHXVHQKRE-UHFFFAOYSA-N 0.000 description 2
- 238000004768 lowest unoccupied molecular orbital Methods 0.000 description 2
- AUHZEENZYGFFBQ-UHFFFAOYSA-N mesitylene Substances CC1=CC(C)=CC(C)=C1 AUHZEENZYGFFBQ-UHFFFAOYSA-N 0.000 description 2
- 125000001827 mesitylenyl group Chemical group [H]C1=C(C(*)=C(C([H])=C1C([H])([H])[H])C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- IBHBKWKFFTZAHE-UHFFFAOYSA-N n-[4-[4-(n-naphthalen-1-ylanilino)phenyl]phenyl]-n-phenylnaphthalen-1-amine Chemical group C1=CC=CC=C1N(C=1C2=CC=CC=C2C=CC=1)C1=CC=C(C=2C=CC(=CC=2)N(C=2C=CC=CC=2)C=2C3=CC=CC=C3C=CC=2)C=C1 IBHBKWKFFTZAHE-UHFFFAOYSA-N 0.000 description 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000000018 nitroso group Chemical group N(=O)* 0.000 description 2
- 239000011368 organic material Substances 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- AUONHKJOIZSQGR-UHFFFAOYSA-N oxophosphane Chemical compound P=O AUONHKJOIZSQGR-UHFFFAOYSA-N 0.000 description 2
- 125000005740 oxycarbonyl group Chemical group [*:1]OC([*:2])=O 0.000 description 2
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 2
- 125000001792 phenanthrenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3C=CC12)* 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- AQSJGOWTSHOLKH-UHFFFAOYSA-N phosphite(3-) Chemical class [O-]P([O-])[O-] AQSJGOWTSHOLKH-UHFFFAOYSA-N 0.000 description 2
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 2
- 229910000073 phosphorus hydride Inorganic materials 0.000 description 2
- 238000005240 physical vapour deposition Methods 0.000 description 2
- 150000003057 platinum Chemical class 0.000 description 2
- 229920003227 poly(N-vinyl carbazole) Polymers 0.000 description 2
- 229920000548 poly(silane) polymer Polymers 0.000 description 2
- 229920000767 polyaniline Polymers 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000011241 protective layer Substances 0.000 description 2
- 125000000168 pyrrolyl group Chemical group 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 238000005215 recombination Methods 0.000 description 2
- 230000006798 recombination Effects 0.000 description 2
- 238000010020 roller printing Methods 0.000 description 2
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- OLRJXMHANKMLTD-UHFFFAOYSA-N silyl Chemical compound [SiH3] OLRJXMHANKMLTD-UHFFFAOYSA-N 0.000 description 2
- 125000003808 silyl group Chemical group [H][Si]([H])([H])[*] 0.000 description 2
- 229940124530 sulfonamide Drugs 0.000 description 2
- 150000003456 sulfonamides Chemical class 0.000 description 2
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 2
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 2
- 150000003462 sulfoxides Chemical class 0.000 description 2
- 125000005555 sulfoximide group Chemical group 0.000 description 2
- 125000001544 thienyl group Chemical group 0.000 description 2
- 125000002813 thiocarbonyl group Chemical group *C(*)=S 0.000 description 2
- 229930192474 thiophene Natural products 0.000 description 2
- JFLKFZNIIQFQBS-FNCQTZNRSA-N trans,trans-1,4-Diphenyl-1,3-butadiene Chemical compound C=1C=CC=CC=1\C=C\C=C\C1=CC=CC=C1 JFLKFZNIIQFQBS-FNCQTZNRSA-N 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- UORVGPXVDQYIDP-UHFFFAOYSA-N trihydridoboron Substances B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 description 2
- ODHXBMXNKOYIBV-UHFFFAOYSA-N triphenylamine Chemical compound C1=CC=CC=C1N(C=1C=CC=CC=1)C1=CC=CC=C1 ODHXBMXNKOYIBV-UHFFFAOYSA-N 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 238000001291 vacuum drying Methods 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- RRKODOZNUZCUBN-CCAGOZQPSA-N (1z,3z)-cycloocta-1,3-diene Chemical class C1CC\C=C/C=C\C1 RRKODOZNUZCUBN-CCAGOZQPSA-N 0.000 description 1
- NSJVYHOPHZMZPN-UHFFFAOYSA-N (2-methylphenyl)boronic acid Chemical compound CC1=CC=CC=C1B(O)O NSJVYHOPHZMZPN-UHFFFAOYSA-N 0.000 description 1
- 125000006736 (C6-C20) aryl group Chemical group 0.000 description 1
- VEJOYRPGKZZTJW-FDGPNNRMSA-N (z)-4-hydroxypent-3-en-2-one;platinum Chemical compound [Pt].C\C(O)=C\C(C)=O.C\C(O)=C\C(C)=O VEJOYRPGKZZTJW-FDGPNNRMSA-N 0.000 description 1
- 125000001399 1,2,3-triazolyl group Chemical group N1N=NC(=C1)* 0.000 description 1
- 125000001376 1,2,4-triazolyl group Chemical group N1N=C(N=C1)* 0.000 description 1
- KGLYHHCCIBZMLN-UHFFFAOYSA-N 1-methyl-4-[4-(4-methylphenyl)buta-1,3-dienyl]benzene Chemical compound C1=CC(C)=CC=C1C=CC=CC1=CC=C(C)C=C1 KGLYHHCCIBZMLN-UHFFFAOYSA-N 0.000 description 1
- TZMSYXZUNZXBOL-UHFFFAOYSA-N 10H-phenoxazine Chemical compound C1=CC=C2NC3=CC=CC=C3OC2=C1 TZMSYXZUNZXBOL-UHFFFAOYSA-N 0.000 description 1
- VEPOHXYIFQMVHW-XOZOLZJESA-N 2,3-dihydroxybutanedioic acid (2S,3S)-3,4-dimethyl-2-phenylmorpholine Chemical compound OC(C(O)C(O)=O)C(O)=O.C[C@H]1[C@@H](OCCN1C)c1ccccc1 VEPOHXYIFQMVHW-XOZOLZJESA-N 0.000 description 1
- KTSGGWMVDAECFK-UHFFFAOYSA-N 2,4,7,9-tetraphenyl-1,10-phenanthroline Chemical compound C1=CC=CC=C1C1=CC(C=2C=CC=CC=2)=C(C=CC=2C3=NC(=CC=2C=2C=CC=CC=2)C=2C=CC=CC=2)C3=N1 KTSGGWMVDAECFK-UHFFFAOYSA-N 0.000 description 1
- MJVZSRZTBDMYLX-UHFFFAOYSA-N 2,6-dichloropyridin-3-amine Chemical compound NC1=CC=C(Cl)N=C1Cl MJVZSRZTBDMYLX-UHFFFAOYSA-N 0.000 description 1
- FLHLSYBCDKENMZ-UHFFFAOYSA-N 2-N,2-N,2-N',2-N',7-N,7-N,7-N',7-N'-octakis(2-methylphenyl)-9,9'-spirobi[fluorene]-2,2',7,7'-tetramine Chemical compound CC1=CC=CC=C1N(C=1C(=CC=CC=1)C)C1=CC=C(C=2C(=CC(=CC=2)N(C=2C(=CC=CC=2)C)C=2C(=CC=CC=2)C)C23C4=CC(=CC=C4C4=CC=C(C=C42)N(C=2C(=CC=CC=2)C)C=2C(=CC=CC=2)C)N(C=2C(=CC=CC=2)C)C=2C(=CC=CC=2)C)C3=C1 FLHLSYBCDKENMZ-UHFFFAOYSA-N 0.000 description 1
- RIKNNBBGYSDYAX-UHFFFAOYSA-N 2-[1-[2-(4-methyl-n-(4-methylphenyl)anilino)phenyl]cyclohexyl]-n,n-bis(4-methylphenyl)aniline Chemical compound C1=CC(C)=CC=C1N(C=1C(=CC=CC=1)C1(CCCCC1)C=1C(=CC=CC=1)N(C=1C=CC(C)=CC=1)C=1C=CC(C)=CC=1)C1=CC=C(C)C=C1 RIKNNBBGYSDYAX-UHFFFAOYSA-N 0.000 description 1
- RICKKZXCGCSLIU-UHFFFAOYSA-N 2-[2-[carboxymethyl-[[3-hydroxy-5-(hydroxymethyl)-2-methylpyridin-4-yl]methyl]amino]ethyl-[[3-hydroxy-5-(hydroxymethyl)-2-methylpyridin-4-yl]methyl]amino]acetic acid Chemical compound CC1=NC=C(CO)C(CN(CCN(CC(O)=O)CC=2C(=C(C)N=CC=2CO)O)CC(O)=O)=C1O RICKKZXCGCSLIU-UHFFFAOYSA-N 0.000 description 1
- PEBRIGBNSYOMPV-UHFFFAOYSA-N 2-[4-(dicyanomethylidene)-2,5-bis(2-hydroxyethoxy)cyclohexa-2,5-dien-1-ylidene]propanedinitrile Chemical compound OCCOC1=CC(=C(C#N)C#N)C(OCCO)=CC1=C(C#N)C#N PEBRIGBNSYOMPV-UHFFFAOYSA-N 0.000 description 1
- PFSDYUVXXQTNMX-UHFFFAOYSA-N 2-[4-(dicyanomethylidene)-2,5-difluorocyclohexa-2,5-dien-1-ylidene]propanedinitrile Chemical compound FC1=CC(=C(C#N)C#N)C(F)=CC1=C(C#N)C#N PFSDYUVXXQTNMX-UHFFFAOYSA-N 0.000 description 1
- DFJXWQJAMNCPII-UHFFFAOYSA-N 2-[4-(dicyanomethylidene)-2,5-dimethylcyclohexa-2,5-dien-1-ylidene]propanedinitrile Chemical compound CC1=CC(=C(C#N)C#N)C(C)=CC1=C(C#N)C#N DFJXWQJAMNCPII-UHFFFAOYSA-N 0.000 description 1
- BXPLEMMFZOKIHP-UHFFFAOYSA-N 2-[4-(dicyanomethylidene)-3-fluorocyclohexa-2,5-dien-1-ylidene]propanedinitrile Chemical compound FC1=CC(=C(C#N)C#N)C=CC1=C(C#N)C#N BXPLEMMFZOKIHP-UHFFFAOYSA-N 0.000 description 1
- DRPIKFKCAJGTJF-UHFFFAOYSA-N 2-chloro-3-nitro-5-(trifluoromethyl)pyridine Chemical compound [O-][N+](=O)C1=CC(C(F)(F)F)=CN=C1Cl DRPIKFKCAJGTJF-UHFFFAOYSA-N 0.000 description 1
- MEQBJJUWDCYIAB-UHFFFAOYSA-N 2-chloropyridin-3-amine Chemical compound NC1=CC=CN=C1Cl MEQBJJUWDCYIAB-UHFFFAOYSA-N 0.000 description 1
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 description 1
- SDTMFDGELKWGFT-UHFFFAOYSA-N 2-methylpropan-2-olate Chemical compound CC(C)(C)[O-] SDTMFDGELKWGFT-UHFFFAOYSA-N 0.000 description 1
- JWUJQDFVADABEY-UHFFFAOYSA-N 2-methyltetrahydrofuran Chemical compound CC1CCCO1 JWUJQDFVADABEY-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 125000000389 2-pyrrolyl group Chemical group [H]N1C([*])=C([H])C([H])=C1[H] 0.000 description 1
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 description 1
- VSKSSQACZWHPED-UHFFFAOYSA-N 3-(2-methylphenyl)aniline Chemical compound CC1=CC=CC=C1C1=CC=CC(N)=C1 VSKSSQACZWHPED-UHFFFAOYSA-N 0.000 description 1
- AQCGDYFRDPMZRI-UHFFFAOYSA-N 3-(2-methylphenyl)aniline;hydrochloride Chemical compound Cl.CC1=CC=CC=C1C1=CC=CC(N)=C1 AQCGDYFRDPMZRI-UHFFFAOYSA-N 0.000 description 1
- HHRZEERABYONLQ-UHFFFAOYSA-M 3-(4-tert-butylphenyl)-1-propan-2-ylimidazo[4,5-b]pyridin-1-ium;iodide Chemical compound [I-].C12=NC=CC=C2[N+](C(C)C)=CN1C1=CC=C(C(C)(C)C)C=C1 HHRZEERABYONLQ-UHFFFAOYSA-M 0.000 description 1
- 125000003682 3-furyl group Chemical group O1C([H])=C([*])C([H])=C1[H] 0.000 description 1
- OGGKVJMNFFSDEV-UHFFFAOYSA-N 3-methyl-n-[4-[4-(n-(3-methylphenyl)anilino)phenyl]phenyl]-n-phenylaniline Chemical compound CC1=CC=CC(N(C=2C=CC=CC=2)C=2C=CC(=CC=2)C=2C=CC(=CC=2)N(C=2C=CC=CC=2)C=2C=C(C)C=CC=2)=C1 OGGKVJMNFFSDEV-UHFFFAOYSA-N 0.000 description 1
- HRPPYQUWZQNQDR-UHFFFAOYSA-N 3-phenyl-1-propan-2-yl-6-(trifluoromethyl)-2H-imidazo[4,5-b]pyridine hydroiodide Chemical compound I.C12=NC=C(C(F)(F)F)C=C2N(C(C)C)CN1C1=CC=CC=C1 HRPPYQUWZQNQDR-UHFFFAOYSA-N 0.000 description 1
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 1
- 125000001397 3-pyrrolyl group Chemical group [H]N1C([H])=C([*])C([H])=C1[H] 0.000 description 1
- 125000001541 3-thienyl group Chemical group S1C([H])=C([*])C([H])=C1[H] 0.000 description 1
- YGBCLRRWZQSURU-UHFFFAOYSA-N 4-[(diphenylhydrazinylidene)methyl]-n,n-diethylaniline Chemical compound C1=CC(N(CC)CC)=CC=C1C=NN(C=1C=CC=CC=1)C1=CC=CC=C1 YGBCLRRWZQSURU-UHFFFAOYSA-N 0.000 description 1
- KBXXZTIBAVBLPP-UHFFFAOYSA-N 4-[[4-(diethylamino)-2-methylphenyl]-(4-methylphenyl)methyl]-n,n-diethyl-3-methylaniline Chemical compound CC1=CC(N(CC)CC)=CC=C1C(C=1C(=CC(=CC=1)N(CC)CC)C)C1=CC=C(C)C=C1 KBXXZTIBAVBLPP-UHFFFAOYSA-N 0.000 description 1
- ZOKIJILZFXPFTO-UHFFFAOYSA-N 4-methyl-n-[4-[1-[4-(4-methyl-n-(4-methylphenyl)anilino)phenyl]cyclohexyl]phenyl]-n-(4-methylphenyl)aniline Chemical compound C1=CC(C)=CC=C1N(C=1C=CC(=CC=1)C1(CCCCC1)C=1C=CC(=CC=1)N(C=1C=CC(C)=CC=1)C=1C=CC(C)=CC=1)C1=CC=C(C)C=C1 ZOKIJILZFXPFTO-UHFFFAOYSA-N 0.000 description 1
- MVIXNQZIMMIGEL-UHFFFAOYSA-N 4-methyl-n-[4-[4-(4-methyl-n-(4-methylphenyl)anilino)phenyl]phenyl]-n-(4-methylphenyl)aniline Chemical compound C1=CC(C)=CC=C1N(C=1C=CC(=CC=1)C=1C=CC(=CC=1)N(C=1C=CC(C)=CC=1)C=1C=CC(C)=CC=1)C1=CC=C(C)C=C1 MVIXNQZIMMIGEL-UHFFFAOYSA-N 0.000 description 1
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 1
- WRDWWAVNELMWAM-UHFFFAOYSA-N 4-tert-butylaniline Chemical compound CC(C)(C)C1=CC=C(N)C=C1 WRDWWAVNELMWAM-UHFFFAOYSA-N 0.000 description 1
- UCKZVZOUGQEQDW-UHFFFAOYSA-M 5-(2-methylphenyl)-3-phenyl-1-propan-2-ylimidazo[4,5-b]pyridin-1-ium;iodide Chemical compound [I-].C12=NC(C=3C(=CC=CC=3)C)=CC=C2[N+](C(C)C)=CN1C1=CC=CC=C1 UCKZVZOUGQEQDW-UHFFFAOYSA-M 0.000 description 1
- OEDUIFSDODUDRK-UHFFFAOYSA-N 5-phenyl-1h-pyrazole Chemical compound N1N=CC=C1C1=CC=CC=C1 OEDUIFSDODUDRK-UHFFFAOYSA-N 0.000 description 1
- MZYDBGLUVPLRKR-UHFFFAOYSA-N 9-(3-carbazol-9-ylphenyl)carbazole Chemical compound C12=CC=CC=C2C2=CC=CC=C2N1C1=CC(N2C3=CC=CC=C3C3=CC=CC=C32)=CC=C1 MZYDBGLUVPLRKR-UHFFFAOYSA-N 0.000 description 1
- FHIDQQRZRPITJG-UHFFFAOYSA-N 9-ethylcarbazol-4-amine Chemical compound C1=CC=C2N(CC)C3=CC=CC=C3C2=C1N FHIDQQRZRPITJG-UHFFFAOYSA-N 0.000 description 1
- PQJUJGAVDBINPI-UHFFFAOYSA-N 9H-thioxanthene Chemical compound C1=CC=C2CC3=CC=CC=C3SC2=C1 PQJUJGAVDBINPI-UHFFFAOYSA-N 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 229910015898 BF4 Inorganic materials 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- ZWGIJNFITOYEKI-UHFFFAOYSA-N CC(C)N(C(C(C)(C)C1(C)C)N2c3c1ccc(-c1c(C)cccc1)c3)c1c2nccc1 Chemical compound CC(C)N(C(C(C)(C)C1(C)C)N2c3c1ccc(-c1c(C)cccc1)c3)c1c2nccc1 ZWGIJNFITOYEKI-UHFFFAOYSA-N 0.000 description 1
- CHMKJYGGPKRFOX-UHFFFAOYSA-N CC(C)Nc1cc(C(F)(F)F)cnc1Nc1ccccc1 Chemical compound CC(C)Nc1cc(C(F)(F)F)cnc1Nc1ccccc1 CHMKJYGGPKRFOX-UHFFFAOYSA-N 0.000 description 1
- TWIKJCHPXAXCDO-UHFFFAOYSA-N CC(C)Nc1cccnc1Cl Chemical compound CC(C)Nc1cccnc1Cl TWIKJCHPXAXCDO-UHFFFAOYSA-N 0.000 description 1
- WHFDGIXQTUIJKK-UHFFFAOYSA-N CC(C)[n]1c(cc(C(F)(F)F)cn2)c2[n+](C2C=CC=CC2C)c1 Chemical compound CC(C)[n]1c(cc(C(F)(F)F)cn2)c2[n+](C2C=CC=CC2C)c1 WHFDGIXQTUIJKK-UHFFFAOYSA-N 0.000 description 1
- QCFSSIKVRKBHAV-UHFFFAOYSA-N CC(C)c1cccc(C(C)c2c3c(C45C)ccc2)c1NC3=NC4(C)C5=C1[ClH]C=C[ClH]1 Chemical compound CC(C)c1cccc(C(C)c2c3c(C45C)ccc2)c1NC3=NC4(C)C5=C1[ClH]C=C[ClH]1 QCFSSIKVRKBHAV-UHFFFAOYSA-N 0.000 description 1
- PUUUHGRNNLOVEO-UHFFFAOYSA-N CC[n](c1ccccc1c1c2)c1ccc2Nc1ncccc1NC(C)C Chemical compound CC[n](c1ccccc1c1c2)c1ccc2Nc1ncccc1NC(C)C PUUUHGRNNLOVEO-UHFFFAOYSA-N 0.000 description 1
- OSJLOPGPFMIKTH-UHFFFAOYSA-N C[n]1c(ccnc2)c2c2c1cccc2 Chemical compound C[n]1c(ccnc2)c2c2c1cccc2 OSJLOPGPFMIKTH-UHFFFAOYSA-N 0.000 description 1
- NVSXQUCPVQBLSB-UHFFFAOYSA-N C[n]1c(nccc2)c2c2c1cccc2 Chemical compound C[n]1c(nccc2)c2c2c1cccc2 NVSXQUCPVQBLSB-UHFFFAOYSA-N 0.000 description 1
- ZWDIMJBCSRTGFW-UHFFFAOYSA-N C[n]1c2ccncc2c2cnccc12 Chemical compound C[n]1c2ccncc2c2cnccc12 ZWDIMJBCSRTGFW-UHFFFAOYSA-N 0.000 description 1
- MABOIYXDALNSES-UHFFFAOYSA-N C[n]1c2cnccc2c2c1cccc2 Chemical compound C[n]1c2cnccc2c2c1cccc2 MABOIYXDALNSES-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229910052684 Cerium Inorganic materials 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 244000248349 Citrus limon Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 1
- 229910052691 Erbium Inorganic materials 0.000 description 1
- 229910052688 Gadolinium Inorganic materials 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- QCKWEMJOMGDCSA-UHFFFAOYSA-N N-[4-(9H-fluoren-1-yl)phenyl]-4-phenyl-N-(4-phenylphenyl)aniline Chemical compound C=12CC3=CC=CC=C3C2=CC=CC=1C(C=C1)=CC=C1N(C=1C=CC(=CC=1)C=1C=CC=CC=1)C(C=C1)=CC=C1C1=CC=CC=C1 QCKWEMJOMGDCSA-UHFFFAOYSA-N 0.000 description 1
- WYNCHZVNFNFDNH-UHFFFAOYSA-N Oxazolidine Chemical compound C1COCN1 WYNCHZVNFNFDNH-UHFFFAOYSA-N 0.000 description 1
- 229910021188 PF6 Inorganic materials 0.000 description 1
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- 239000002262 Schiff base Substances 0.000 description 1
- 150000004753 Schiff bases Chemical class 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 229910052771 Terbium Inorganic materials 0.000 description 1
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 description 1
- YPWFISCTZQNZAU-UHFFFAOYSA-N Thiane Chemical compound C1CCSCC1 YPWFISCTZQNZAU-UHFFFAOYSA-N 0.000 description 1
- 229910052775 Thulium Inorganic materials 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 229910052769 Ytterbium Inorganic materials 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 description 1
- LXGQHDUCNDGTDB-PAMNCVQHSA-N [2-[(8s,9r,10s,13s,14s,16s,17r)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate;[2-[(8s,9r,10s,13s,14s,16s,17r)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11, Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)COC(C)=O)(O)[C@@]1(C)CC2O.C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)COP(O)(O)=O)(O)[C@@]1(C)CC2O LXGQHDUCNDGTDB-PAMNCVQHSA-N 0.000 description 1
- CUJRVFIICFDLGR-UHFFFAOYSA-N acetylacetonate Chemical compound CC(=O)[CH-]C(C)=O CUJRVFIICFDLGR-UHFFFAOYSA-N 0.000 description 1
- 229910052768 actinide Inorganic materials 0.000 description 1
- 150000001255 actinides Chemical class 0.000 description 1
- 125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 125000003282 alkyl amino group Chemical group 0.000 description 1
- 125000004414 alkyl thio group Chemical group 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- YCOXTKKNXUZSKD-UHFFFAOYSA-N as-o-xylenol Natural products CC1=CC=C(O)C=C1C YCOXTKKNXUZSKD-UHFFFAOYSA-N 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 150000003851 azoles Chemical class 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 150000007514 bases Chemical class 0.000 description 1
- 229910052728 basic metal Inorganic materials 0.000 description 1
- HFACYLZERDEVSX-UHFFFAOYSA-N benzidine Chemical class C1=CC(N)=CC=C1C1=CC=C(N)C=C1 HFACYLZERDEVSX-UHFFFAOYSA-N 0.000 description 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000003354 benzotriazolyl group Chemical group N1N=NC2=C1C=CC=C2* 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- ZJNVNFNXBANKDD-UHFFFAOYSA-N c([n](c1c2cccn1)-c1ccccc1)[n+]2-c1ccccc1 Chemical compound c([n](c1c2cccn1)-c1ccccc1)[n+]2-c1ccccc1 ZJNVNFNXBANKDD-UHFFFAOYSA-N 0.000 description 1
- TZVZNQXIKZVETP-UHFFFAOYSA-N c(cc1)ccc1-c1nc(cccc2)c2[n]1-c(cc1)cc2c1[o]c(cc1)c2cc1-[n]1c2ccccc2c2c1cccc2 Chemical compound c(cc1)ccc1-c1nc(cccc2)c2[n]1-c(cc1)cc2c1[o]c(cc1)c2cc1-[n]1c2ccccc2c2c1cccc2 TZVZNQXIKZVETP-UHFFFAOYSA-N 0.000 description 1
- HMMISUCRJXCVFN-UHFFFAOYSA-N c(cc1)ccc1[SiH-](c1ccccc1)(c1ccccc1)c1ccc2[o]c(ccc([SiH-](c3ccccc3)(c3ccccc3)c3ccccc3)c3)c3c2c1 Chemical compound c(cc1)ccc1[SiH-](c1ccccc1)(c1ccccc1)c1ccc2[o]c(ccc([SiH-](c3ccccc3)(c3ccccc3)c3ccccc3)c3)c3c2c1 HMMISUCRJXCVFN-UHFFFAOYSA-N 0.000 description 1
- COHQQWZJNAJBJP-UHFFFAOYSA-N c(cc1)ccc1[Si](c1ccccc1)(c1ccccc1)c(cc1c2c3)ccc1[o]c2ccc3[Si](c1ccccc1)(c1ccccc1)c1ccccc1 Chemical compound c(cc1)ccc1[Si](c1ccccc1)(c1ccccc1)c(cc1c2c3)ccc1[o]c2ccc3[Si](c1ccccc1)(c1ccccc1)c1ccccc1 COHQQWZJNAJBJP-UHFFFAOYSA-N 0.000 description 1
- BHDKGJHLCKRHAA-UHFFFAOYSA-N c(cc1c2ccccc22)ccc1[n]2-c1ccc2[o]c(ccc(-c3cc(-[n]4c5ccccc5c5c4cccc5)ccc3)c3)c3c2c1 Chemical compound c(cc1c2ccccc22)ccc1[n]2-c1ccc2[o]c(ccc(-c3cc(-[n]4c5ccccc5c5c4cccc5)ccc3)c3)c3c2c1 BHDKGJHLCKRHAA-UHFFFAOYSA-N 0.000 description 1
- 150000001716 carbazoles Chemical class 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 229940126214 compound 3 Drugs 0.000 description 1
- 229920001940 conductive polymer Polymers 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000006547 cyclononyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- URYYVOIYTNXXBN-UHFFFAOYSA-N cyclooctene Chemical compound [CH]1[CH]CCCCCC1 URYYVOIYTNXXBN-UHFFFAOYSA-N 0.000 description 1
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000000058 cyclopentadienyl group Chemical group C1(=CC=CC1)* 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 125000004855 decalinyl group Chemical group C1(CCCC2CCCCC12)* 0.000 description 1
- 229940043397 deconex Drugs 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 229910052805 deuterium Inorganic materials 0.000 description 1
- 150000001470 diamides Chemical class 0.000 description 1
- ZFTFAPZRGNKQPU-UHFFFAOYSA-N dicarbonic acid Chemical class OC(=O)OC(O)=O ZFTFAPZRGNKQPU-UHFFFAOYSA-N 0.000 description 1
- 125000001664 diethylamino group Chemical group [H]C([H])([H])C([H])([H])N(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- HASCQPSFPAKVEK-UHFFFAOYSA-N dimethyl(phenyl)phosphine Chemical compound CP(C)C1=CC=CC=C1 HASCQPSFPAKVEK-UHFFFAOYSA-N 0.000 description 1
- 238000003618 dip coating Methods 0.000 description 1
- GPAYUJZHTULNBE-UHFFFAOYSA-N diphenylphosphine Chemical compound C=1C=CC=CC=1PC1=CC=CC=C1 GPAYUJZHTULNBE-UHFFFAOYSA-N 0.000 description 1
- GOMCKELMLXHYHH-UHFFFAOYSA-L dipotassium;phthalate Chemical compound [K+].[K+].[O-]C(=O)C1=CC=CC=C1C([O-])=O GOMCKELMLXHYHH-UHFFFAOYSA-L 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000001194 electroluminescence spectrum Methods 0.000 description 1
- 238000000295 emission spectrum Methods 0.000 description 1
- ZSWFCLXCOIISFI-UHFFFAOYSA-N endo-cyclopentadiene Natural products C1C=CC=C1 ZSWFCLXCOIISFI-UHFFFAOYSA-N 0.000 description 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- RMBPEFMHABBEKP-UHFFFAOYSA-N fluorene Chemical compound C1=CC=C2C3=C[CH]C=CC3=CC2=C1 RMBPEFMHABBEKP-UHFFFAOYSA-N 0.000 description 1
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- JVZRCNQLWOELDU-UHFFFAOYSA-N gamma-Phenylpyridine Natural products C1=CC=CC=C1C1=CC=NC=C1 JVZRCNQLWOELDU-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000009477 glass transition Effects 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 239000012456 homogeneous solution Substances 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- 125000003037 imidazol-2-yl group Chemical group [H]N1C([*])=NC([H])=C1[H] 0.000 description 1
- 125000002636 imidazolinyl group Chemical group 0.000 description 1
- 125000003392 indanyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 description 1
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 description 1
- 229910052738 indium Inorganic materials 0.000 description 1
- APFVFJFRJDLVQX-UHFFFAOYSA-N indium atom Chemical compound [In] APFVFJFRJDLVQX-UHFFFAOYSA-N 0.000 description 1
- AMGQUBHHOARCQH-UHFFFAOYSA-N indium;oxotin Chemical compound [In].[Sn]=O AMGQUBHHOARCQH-UHFFFAOYSA-N 0.000 description 1
- 125000003387 indolinyl group Chemical group N1(CCC2=CC=CC=C12)* 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- SNHMUERNLJLMHN-UHFFFAOYSA-N iodobenzene Chemical compound IC1=CC=CC=C1 SNHMUERNLJLMHN-UHFFFAOYSA-N 0.000 description 1
- 125000004594 isoindolinyl group Chemical group C1(NCC2=CC=CC=C12)* 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 229910052747 lanthanoid Inorganic materials 0.000 description 1
- 150000002602 lanthanoids Chemical class 0.000 description 1
- 238000007644 letterpress printing Methods 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- IDBFBDSKYCUNPW-UHFFFAOYSA-N lithium nitride Chemical compound [Li]N([Li])[Li] IDBFBDSKYCUNPW-UHFFFAOYSA-N 0.000 description 1
- 238000001459 lithography Methods 0.000 description 1
- 125000000040 m-tolyl group Chemical group [H]C1=C([H])C(*)=C([H])C(=C1[H])C([H])([H])[H] 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229910001092 metal group alloy Inorganic materials 0.000 description 1
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 1
- 229910003455 mixed metal oxide Inorganic materials 0.000 description 1
- 125000002757 morpholinyl group Chemical group 0.000 description 1
- JGOAZQAXRONCCI-SDNWHVSQSA-N n-[(e)-benzylideneamino]aniline Chemical compound C=1C=CC=CC=1N\N=C\C1=CC=CC=C1 JGOAZQAXRONCCI-SDNWHVSQSA-N 0.000 description 1
- GKTNLYAAZKKMTQ-UHFFFAOYSA-N n-[bis(dimethylamino)phosphinimyl]-n-methylmethanamine Chemical compound CN(C)P(=N)(N(C)C)N(C)C GKTNLYAAZKKMTQ-UHFFFAOYSA-N 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 229910052755 nonmetal Inorganic materials 0.000 description 1
- 125000002868 norbornyl group Chemical group C12(CCC(CC1)C2)* 0.000 description 1
- NIHNNTQXNPWCJQ-UHFFFAOYSA-N o-biphenylenemethane Natural products C1=CC=C2CC3=CC=CC=C3C2=C1 NIHNNTQXNPWCJQ-UHFFFAOYSA-N 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 150000002902 organometallic compounds Chemical class 0.000 description 1
- OOFGXDQWDNJDIS-UHFFFAOYSA-N oxathiolane Chemical compound C1COSC1 OOFGXDQWDNJDIS-UHFFFAOYSA-N 0.000 description 1
- 125000004287 oxazol-2-yl group Chemical group [H]C1=C([H])N=C(*)O1 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 1
- 238000007649 pad printing Methods 0.000 description 1
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 1
- CBHCDHNUZWWAPP-UHFFFAOYSA-N pecazine Chemical compound C1N(C)CCCC1CN1C2=CC=CC=C2SC2=CC=CC=C21 CBHCDHNUZWWAPP-UHFFFAOYSA-N 0.000 description 1
- 150000005041 phenanthrolines Chemical class 0.000 description 1
- 125000004625 phenanthrolinyl group Chemical group N1=C(C=CC2=CC=C3C=CC=NC3=C12)* 0.000 description 1
- 125000005936 piperidyl group Chemical group 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920006254 polymer film Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- DNXIASIHZYFFRO-UHFFFAOYSA-N pyrazoline Chemical compound C1CN=NC1 DNXIASIHZYFFRO-UHFFFAOYSA-N 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- ZZYXNRREDYWPLN-UHFFFAOYSA-N pyridine-2,3-diamine Chemical compound NC1=CC=CN=C1N ZZYXNRREDYWPLN-UHFFFAOYSA-N 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- 238000006862 quantum yield reaction Methods 0.000 description 1
- 150000004053 quinones Chemical class 0.000 description 1
- 229910052761 rare earth metal Inorganic materials 0.000 description 1
- 150000002910 rare earth metals Chemical class 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 229910000026 rubidium carbonate Inorganic materials 0.000 description 1
- KZUNJOHGWZRPMI-UHFFFAOYSA-N samarium atom Chemical compound [Sm] KZUNJOHGWZRPMI-UHFFFAOYSA-N 0.000 description 1
- 238000007650 screen-printing Methods 0.000 description 1
- FZHAPNGMFPVSLP-UHFFFAOYSA-N silanamine Chemical class [SiH3]N FZHAPNGMFPVSLP-UHFFFAOYSA-N 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 229910000080 stannane Inorganic materials 0.000 description 1
- 229940071182 stannate Drugs 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- 125000005504 styryl group Chemical group 0.000 description 1
- 125000003107 substituted aryl group Chemical group 0.000 description 1
- 150000003513 tertiary aromatic amines Chemical class 0.000 description 1
- DZLFLBLQUQXARW-UHFFFAOYSA-N tetrabutylammonium Chemical compound CCCC[N+](CCCC)(CCCC)CCCC DZLFLBLQUQXARW-UHFFFAOYSA-N 0.000 description 1
- NLDYACGHTUPAQU-UHFFFAOYSA-N tetracyanoethylene Chemical group N#CC(C#N)=C(C#N)C#N NLDYACGHTUPAQU-UHFFFAOYSA-N 0.000 description 1
- PCCVSPMFGIFTHU-UHFFFAOYSA-N tetracyanoquinodimethane Chemical compound N#CC(C#N)=C1C=CC(=C(C#N)C#N)C=C1 PCCVSPMFGIFTHU-UHFFFAOYSA-N 0.000 description 1
- RAOIDOHSFRTOEL-UHFFFAOYSA-N tetrahydrothiophene Chemical compound C1CCSC1 RAOIDOHSFRTOEL-UHFFFAOYSA-N 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 238000002207 thermal evaporation Methods 0.000 description 1
- 125000000437 thiazol-2-yl group Chemical group [H]C1=C([H])N=C(*)S1 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- TVIVIEFSHFOWTE-UHFFFAOYSA-K tri(quinolin-8-yloxy)alumane Chemical compound [Al+3].C1=CN=C2C([O-])=CC=CC2=C1.C1=CN=C2C([O-])=CC=CC2=C1.C1=CN=C2C([O-])=CC=CC2=C1 TVIVIEFSHFOWTE-UHFFFAOYSA-K 0.000 description 1
- 150000003852 triazoles Chemical class 0.000 description 1
- RXJKFRMDXUJTEX-UHFFFAOYSA-N triethylphosphine Chemical compound CCP(CC)CC RXJKFRMDXUJTEX-UHFFFAOYSA-N 0.000 description 1
- HVLLSGMXQDNUAL-UHFFFAOYSA-N triphenyl phosphite Chemical compound C=1C=CC=CC=1OP(OC=1C=CC=CC=1)OC1=CC=CC=C1 HVLLSGMXQDNUAL-UHFFFAOYSA-N 0.000 description 1
- BPLUKJNHPBNVQL-UHFFFAOYSA-N triphenylarsine Chemical compound C1=CC=CC=C1[As](C=1C=CC=CC=1)C1=CC=CC=C1 BPLUKJNHPBNVQL-UHFFFAOYSA-N 0.000 description 1
- 238000001429 visible spectrum Methods 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
- 150000003738 xylenes Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0033—Iridium compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0086—Platinum compounds
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- H—ELECTRICITY
- H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
- H05B—ELECTRIC HEATING; ELECTRIC LIGHT SOURCES NOT OTHERWISE PROVIDED FOR; CIRCUIT ARRANGEMENTS FOR ELECTRIC LIGHT SOURCES, IN GENERAL
- H05B33/00—Electroluminescent light sources
- H05B33/12—Light sources with substantially two-dimensional radiating surfaces
- H05B33/14—Light sources with substantially two-dimensional radiating surfaces characterised by the chemical or physical composition or the arrangement of the electroluminescent material, or by the simultaneous addition of the electroluminescent material in or onto the light source
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K50/00—Organic light-emitting devices
- H10K50/10—OLEDs or polymer light-emitting diodes [PLED]
- H10K50/14—Carrier transporting layers
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K50/00—Organic light-emitting devices
- H10K50/10—OLEDs or polymer light-emitting diodes [PLED]
- H10K50/14—Carrier transporting layers
- H10K50/16—Electron transporting layers
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K50/00—Organic light-emitting devices
- H10K50/10—OLEDs or polymer light-emitting diodes [PLED]
- H10K50/18—Carrier blocking layers
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/30—Coordination compounds
- H10K85/341—Transition metal complexes, e.g. Ru(II)polypyridine complexes
- H10K85/342—Transition metal complexes, e.g. Ru(II)polypyridine complexes comprising iridium
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/30—Coordination compounds
- H10K85/341—Transition metal complexes, e.g. Ru(II)polypyridine complexes
- H10K85/346—Transition metal complexes, e.g. Ru(II)polypyridine complexes comprising platinum
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1003—Carbocyclic compounds
- C09K2211/1007—Non-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1029—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1044—Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1088—Heterocyclic compounds characterised by ligands containing oxygen as the only heteroatom
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/18—Metal complexes
- C09K2211/185—Metal complexes of the platinum group, i.e. Os, Ir, Pt, Ru, Rh or Pd
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/40—Organosilicon compounds, e.g. TIPS pentacene
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/649—Aromatic compounds comprising a hetero atom
- H10K85/657—Polycyclic condensed heteroaromatic hydrocarbons
- H10K85/6572—Polycyclic condensed heteroaromatic hydrocarbons comprising only nitrogen in the heteroaromatic polycondensed ring system, e.g. phenanthroline or carbazole
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/649—Aromatic compounds comprising a hetero atom
- H10K85/657—Polycyclic condensed heteroaromatic hydrocarbons
- H10K85/6574—Polycyclic condensed heteroaromatic hydrocarbons comprising only oxygen in the heteroaromatic polycondensed ring system, e.g. cumarine dyes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E10/00—Energy generation through renewable energy sources
- Y02E10/50—Photovoltaic [PV] energy
- Y02E10/549—Organic PV cells
Definitions
- Metal complexes comprising azabenzimidazole carbene ligands and the use thereof in OLEDs
- the present invention relates to metal-carbene complexes comprising a central atom selected from iridium and platinum, and specific azabenzimidazole carbene ligands, to OLEDs (Organic Light-Emitting Diodes) which comprise such complexes, to a device selected from the group consisting of illuminating elements, stationary visual display units and mobile visual display units comprising such an OLED, to the use of such a metal-carbene complex in OLEDs, for example as emitter, matrix material, charge transport material and/or charge or exciton blocker.
- OLEDs Organic Light-Emitting Diodes
- OLEDs Organic light-emitting diodes
- OLEDs exploit the propensity of materials to emit light when they are excited by electrical current.
- OLEDs are of particular interest as an alternative to cathode ray tubes and liquid-crystal displays for production of flat visual display units.
- devices comprising OLEDs are suitable especially for mobile applications, for example for applications in cellphones, smartphones, digital cameras, mp3 players, laptops, etc.
- white OLEDs give great advantages over the illumination technologies known to date, especially a particularly high efficiency.
- the prior art proposes numerous materials which emit light on excitation by electrical current.
- WO 2005/019373 discloses the use of transition metal complexes comprising at least one carbene ligand in OLEDs. According to WO2005/019373, a new compound class has been found, which is suitable for electroluminescence in the blue, red and green region of the electromagnetic spectrum, which enables the production of full-color displays.
- WO 2006/056418 A2 discloses the use of transition metal-carbene complexes having at least one unsymmetrically substituted carbene ligand in organic light-emitting diodes.
- the transition metal-carbene complexes are suitable for electroluminescence in the blue, red and green region of the electromagnetic spectrum.
- a homoleptic carbene complex with a specific azabenzimidazole carbene ligand is mentioned, though it is not described as advantageous over the further carbene complexes disclosed.
- this carbene complex differs from the carbene complexes according to the present application.
- WO 2005/1 13704 A2 relates to luminescent compounds having carbene ligands.
- WO 2005/1 13704 A2 discloses numerous different types of carbene ligands.
- a homoleptic carbene complex with a specific azabenzimidazole carbene ligand is mentioned, though this is not described as advantageous over the further carbene complexes disclosed.
- this carbene complex differs from the carbene complexes according to the present application.
- WO 2009/046266 A1 discloses complexes with tridentate ligands.
- the tridentate ligands mentioned include tridentate carbene ligands, and these tridentate carbene ligands may bear, for example, two azabenzimidazole substituents.
- the carbene complexes according to the present application differ from the carbene complexes disclosed in WO 2009/046266 A1 especially in that they do not comprise any tridentate carbene ligands.
- iridium and platinum complexes which are suitable for use in organic electronic components. More particularly, the iridium and platinum complexes shall be suitable for use in OLEDs as emitters, matrix material, charge transport material, or charge blockers. The complexes shall be particularly suitable for electroluminescence in the blue region, more particularly in the deep blue region, of the electromagnetic spectrum, which enables, for example, the production of full-color displays and white OLEDs. It is a further object of the present invention to provide corresponding complexes which can be used as a mixture with a host compound (matrix material) or as a pure layer as a light-emitting layer in OLEDs. More particularly, it is desirable to provide transition metal complexes which exhibit a spectrum of properties improved over known transition metal complexes, for example improved efficiencies, improved CIE color coordinates and/or improved lifetime/stability.
- M is Ir or Pt, n is an integer selected from 1 , 2 and 3, where the ligand(s)
- Y is NR 1 , 0, S or C(R 10 ) 2 ,
- R 1 is a linear or branched alkyl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyi radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 3 to 20 carbon atoms, substituted or unsubstituted aryl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having a total of 5 to 18 carbon atoms and/or heteroatoms,
- R 2 , R 3 , R 4 are each independently hydrogen, a linear or branched alkyl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyi radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 3 to 20 carbon atoms, substituted or unsubstituted aryl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having a total of 5 to 18 carbon atoms and/or heteroatoms, group with donor or acceptor action, or
- R 2 and R 3 or R 3 and R 4 together with the carbon atoms to which they are bonded form an optionally substituted, saturated or unsaturated or aromatic ring optionally interrupted by at least one further heteroatom and having a total of 5 to 18 carbon atoms and/or heteroatoms, and may optionally be fused to at least one further optionally substituted saturated or unsaturated or aromatic ring optionally interrupted by at least one further heteroatom and having a total of 5 to 18 carbon atoms and/or heteroatoms,
- a 1 is CR 6 or N
- a 2 is CR 7 or N
- a 3 is CR 8 or N
- a 4 is CR 9 or N
- R 6 , R 7 , R 8 , R 9 are each independently hydrogen, a linear or branched alkyl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyi radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 3 to 20 carbon atoms, substituted or unsubstituted heterocycloalkyl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 3 to 20 carbon atoms and/or heteroatoms, substituted or unsubstituted aryl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having a total of 5 to 18 carbon atoms and/or heteroatoms,
- R 6 and R 7 , R 7 and R 8 or R 8 and R 9 together with the carbon atoms to which they are bonded, form a saturated, unsaturated or aromatic, optionally substituted ring which is optionally interrupted by at least one heteroatom, has a total of 5 to 18 carbon atoms and/or heteroatoms, and may optionally be fused to at least one further optionally substituted saturated or unsaturated or aromatic ring optionally interrupted by at least one further heteroatom and having a total of 5 to 18 carbon atoms and/or heteroatoms, p is O or l ;
- R 10 is independently a linear or branched alkyl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 3 to 20 carbon atoms, substituted or unsubstituted aryl radical optionally interrupted by at least one hetero
- the two R 10 radicals form, together with the carbon atom to which they are bonded, a saturated or unsaturated optionally substituted ring optionally interrupted by at least one heteroatom and having a total of 5 to 18 carbon atoms and/or heteroatoms;
- K is an uncharged mono- or bidentate ligand
- L is a mono- or dianionic ligand, preferably monoanionic ligand, which may be mono- or bidentate, m is 0, 1 or 2, where, when m is 2, the K ligands may be the same or different, o is 0, 1 or 2, where, when o is 2, the L ligands may be the same or different, excluding ligands L of the following general formula (A):
- Y' is NR 1 , O, S or C(R 10 ) 2 ,
- R 2' , R 3' , R 4' , R 5' if A 2' , A 3' , A 4' and/or A 5' is N, are each a free electron pair or, if A 2' , A 3' , A 4 and/or A 5 is C, are each independently hydrogen, a linear or branched alkyl radical optionally bearing at least one functional group, optionally interrupted by at least one heteroatom and having 1 to 20 carbon atoms, cycloalkyl radical having 3 to 20 carbon atoms, substituted or unsubstituted aryl radical having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical having a total of 5 to 18 carbon atoms and/or heteroatoms, group with donor or acceptor action or R 3 and R 4 form, together with A 3 and A 4 , an optionally substituted, unsaturated ring optionally interrupted by at least one further heteroatom and having a total of 5 to 18 carbon atoms and/or heteroatoms, R
- R 10 is independently a linear or branched alkyl radical optionally bearing at least one functional group, optionally interrupted by at least one heteroatom and having 1 to 20 carbon atoms, cycloalkyl radical having 3 to 20 carbon atoms, substituted or unsubstituted aryl radical having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical having a total of 5 to 18 carbon atoms and/or heteroatoms.
- p is 1 , which means that preferred metal-carbene complexes of the formula (I) have the following formula:
- n 3 in the case when M is Ir, and n is 2 in the case when M is Pt.
- the n carbene ligands in the metal-carbene complex of the general formula (I) may also be different.
- the complex is a heteroleptic pure carbene complex of the formula (I) when m and n are each 0.
- o is 1 or 2 and L is a carbene ligand, suitable carbene ligands having been specified above.
- the complex is likewise a heteroleptic pure carbene complex of the formula (I).
- aryl radical, unit or group, heteroaryl radical, unit or group, alkyl radical, unit or group, cycloalkyl radical, unit or group, cycloheteroalkyl radical, unit or group, and groups with donor or acceptor action are each defined as follows - unless stated otherwise:
- Aryl radicals or substituted or unsubstituted aryl radicals having 6 to 30 carbon atoms refer in the present invention to radicals which are derived from monocyclic, bicyclic or tricyclic aromatics which do not comprise any ring heteroatoms.
- aryl for the second ring also includes the saturated form (perhydro form) or the partly unsaturated form (for example the dihydro form or tetrahydro form), provided that the particular forms are known and stable.
- aryl in the present invention encompasses, for example, also bicyclic or tricyclic radicals in which either both or all three radicals are aromatic, and bicyclic or tricyclic radicals in which only one ring is aromatic, and also tricyclic radicals in which two rings are aromatic.
- aryl are: phenyl, naphthyl, indanyl, 1 ,2-dihydronaphthenyl, 1 ,4-dihydronaphthenyl, indenyl, anthracenyl, phenanthrenyl or 1 ,2,3,4-tetrahydronaphthyl.
- Particular preference is given to C 6 -Ci 0 - aryl radicals, for example phenyl or naphthyl, very particular preference to C 6 -aryl radicals, for example phenyl.
- the aryl radicals or C 6 -C 3 o-aryl radicals may be unsubstituted or substituted by one or more further radicals.
- Suitable further radicals are selected from the group consisting of CrC 2 o-alkyl, C 6 -C 3 o-aryl and substituents with donor or acceptor action, suitable substituents with donor or acceptor action having been specified above.
- the C 6 -C 30 - aryl radicals are preferably unsubstituted or substituted by one or more CrC 2 o-alkyl groups, CrC 2 o-alkoxy groups, CN, CF 3 , F or amino groups (NR 32 R 33 where suitable R 32 and R 33 radicals are specified below).
- Heteroaryl radicals or substituted or unsubstituted heteroaryl radicals having a total of 5 to 18 carbon atoms and/or heteroatoms are understood to mean monocyclic, bicyclic or tricyclic heteroaromatics, some of which can be derived from the aforementioned aryl, in which at least one carbon atom in the aryl base structure has been replaced by a heteroatom.
- Preferred heteroatoms are N, O and S.
- the heteroaryl radicals more preferably have 5 to 13 ring atoms.
- the base structure of the heteroaryl radicals is especially preferably selected from systems such as pyridine and five-membered heteroaromatics such as thiophene, pyrrole, imidazole, thiazole, oxazole or furan. These base structures may optionally be fused to one or two six-membered aromatic radicals. Suitable fused heteroaromatics are carbazolyl, benzimidazolyl, benzofuryl, benzothiazole, benzoxazole, dibenzofuryl or dibenzothiophenyl.
- the base structure may be substituted at one, more than one or all substitutable positions, suitable substituents being the same as those already specified under the definition of C 6 -C 3 o-aryl.
- heteroaryl radicals are preferably unsubstituted.
- Suitable heteroaryl radicals are, for example, pyridin-2-yl, pyridin-3-yl, pyridin-4-yl, thiophen-2-yl, thiophen-3-yl, pyrrol-2-yl, pyrrol-3-yl, furan-2-yl, furan-3-yl, thiazol-2-yl, oxazol-2-yl and imidazol-2-yl, and the corresponding benzofused radicals, especially carbazolyl, benzimidazolyl, benzofuryl, benzothiazole, benzoxazole, dibenzofuryl or dibenzothiophenyl.
- alkyl radical in the context of the present application is a linear or branched alkyl radical optionally bearing at least one functional group, optionally interrupted by at least one heteroatom and having 1 to 20 carbon atoms.
- C to Cio- alkyl radicals Preference is given to C to Cio- alkyl radicals, particular preference to C to C 6 -alkyl radicals.
- the alkyl radicals may be substituted by one or more functional groups, preferably selected from the group consisting of CrC 2 o-alkyl, CrC 2 o-alkoxy, halogen, preferably F, Ci-C 20 - haloalkyl, e.g. CF 3 , and C 6 -C 3 o-aryl which may in turn be substituted or unsubstituted.
- Suitable aryl substituents and suitable alkoxy and halogen substituents are specified below.
- suitable alkyl groups are methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl and octyl, and also CrC 2 o-alkyl-, CrC 20 -haloalkyl-, C 6 -C 3 o-aryl-, CrC 20 -alkoxy- and/or halogen-substituted, especially F-substituted, derivatives of the alkyl groups mentioned, for example CF 3 .
- This comprises both the n-isomers of the radicals mentioned and branched isomers such as isopropyl, isobutyl, isopentyl, sec-butyl, tert- butyl, neopentyl, 3,3-dimethylbutyl, 3-ethylhexyl, etc.
- Preferred alkyl groups are methyl, ethyl, isopropyl, tert-butyl and CF 3 .
- a cycloalkyi radical or a substituted or unsubstituted cycloalkyi radical having 3 to 20 carbon atoms is understood in the context of the present application to mean a substituted or unsubstituted C 3 -C 20 -cycloalkyl radical.
- Preferred are cycloalkyi radicals having 5 to 20, more preferably 5 to 10 and most preferably 5 to 8 carbon atoms in the base structure (ring) to understand.
- Suitable substituents are the substituents mentioned for the alkyl groups.
- Suitable cycloalkyi groups which may be unsubstituted or substituted by the radicals mentioned above for the alkyl groups, are cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, cyclononyl and cyclodecyl. They may also be polycyclic ring systems such as decalinyl, norbornyl, bornanyl or adamantyl.
- a heterocycloalkyl radical or a substituted or unsubstituted heterocycloalkyl radical having 3 to 20 carbon atoms and/or heteroatoms is understood to mean heterocycloalkyl radicals having 3 to 20, preferably 5 to 10 and more preferably 5 to 8 ring atoms, where at least one carbon atom in the heterocycloalkyi base structure has been replaced by a heteroatom.
- Preferred heteroatoms are N, O and S.
- Suitable substituents are the substituents mentioned for the alkyl groups.
- heterocycloalkyi groups which may be unsubstituted or substituted by the radicals mentioned above for the alkyl groups, are radicals derived from the following heterocycles: pyrrolidine, thiolane, tetrahydrofuran, 1 ,2-oxathiolane, oxazolidine, piperidine, thiane, oxane, dioxane, 1 ,3-dithiane, morpholine, piperazine. They may also be polycyclic ring systems. Suitable alkoxy radicals and alkylthio radicals derive correspondingly from the aforementioned alkyl radicals.
- Examples here include OCH 3 , OC 2 H 5 , OC 3 H 7 , OC 4 H 9 and OC 8 H 17 , and also SCH 3 , SC 2 H 5 , SC 3 H 7 , SC 4 H 9 and SC 8 H 17 .
- C 3 H 7 , C 4 H 9 and C 8 H 17 comprise both the n-isomers and branched isomers such as isopropyl, isobutyl, sec-butyl, tert-butyl and 2-ethylhexyl.
- Particularly preferred alkoxy or alkylthio groups are methoxy, ethoxy, n-octyloxy, 2-ethylhexyloxy and SCH 3 .
- Suitable halogen radicals or halogen substituents in the context of the present application are fluorine, chlorine, bromine and iodine, preferably fluorine, chlorine and bromine, more preferably fluorine and chlorine, most preferably fluorine.
- CF 3 CH 2 F, CHF 2 or C 2 F 5 ; amino, preferably dimethylamino, diethylamino or diphenylamino; OH, pseudohalogen radicals, preferably CN, SCN or OCN, more preferably CN, -C(0)OC C 4 -alkyl, preferably -C(0)OMe, P(0)R 2 , preferably P(0)Ph 2 , and S0 2 R 2 , preferably S0 2 Ph .
- Very particularly preferred substituents with donor or acceptor action are selected from the group consisting of methoxy, phenyloxy, halogenated Ci-C 4 -alkyl, preferably CF 3 , CH 2 F, CHF 2 , C 2 F 5 , halogen, preferably F, CN, SiR 32 R 33 R 34 , where suitable R 32 , R 33 and R 34 radicals have been specified above, diphenylamino, -C(0)OCi-C 4 -alkyl, preferably -C(0)OMe, P(0)Ph 2 and S0 2 Ph.
- the aforementioned groups with donor or acceptor action are not intended to rule out the possibility that further radicals and groups among those specified above may also have donor or acceptor action.
- the aforementioned heteroaryl radicals are likewise groups with donor or acceptor action
- the CrC 20 -alkyl radicals are groups with donor action.
- R 32 , R 33 and R 34 radicals mentioned in the aforementioned groups with donor or acceptor action have the definitions already mentioned above, which means that R 32 , R 33 and R 34 are each independently:
- R 32 , R 33 and R 34 radicals are CrC 6 -alkyl, e.g. methyl, ethyl, i-propyl or tert-butyl, or phenyl or pyridyl.
- K in the general formula (I) is an uncharged mono- or bidentate ligand
- L in the general formula (I) is a mono- or dianionic ligand, preferably a monoanionic ligand which may be mono- or bidentate.
- Ligands L with the following general formula (A) are excluded according to the present application:
- Y' is NR 1' , O, S or C(R 10' ) 2 ,
- R 1 is a linear or branched alkyl radical optionally bearing at least one functional group, optionally interrupted by at least one heteroatom and having 1 to 20 carbon atoms, cycloalkyl radical having 3 to 20 carbon atoms, substituted or unsubstituted aryl radical having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical having a total of 5 to 18 carbon atoms and/or heteroatoms,
- R 2' , R 3' , R 4' , R 5' if A 2' , A 3' , A 4' and/or A 5' is N, are each a free electron pair or, if A 2' , A 3' ,
- R 6 and R 7 , R 7 and R 8 or R 8 and R 9 together with the carbon atoms to which they are bonded, form a saturated, unsaturated or aromatic, optionally substituted ring optionally interrupted by at least one heteroatom and having a total of 5 to 18 carbon atoms and/or heteroatoms, and/or if A 5 is C, R 5 and R 6 together form a saturated or unsaturated, linear or branched bridge optionally comprising heteroatoms, aromatic unit, heteroaromatic unit and/or functional groups and having a total of 1 to 30 carbon atoms and/or heteroatoms, to which is optionally fused a substituted or unsubstituted, five- to eight-membered ring comprising carbon atoms and/or heteroatoms,
- R 10 is independently a linear or branched alkyl radical optionally bearing at least one functional group, optionally interrupted by at least one heteroatom and having 1 to 20 carbon atoms, cycloalkyl radical having 3 to 20 carbon atoms, substituted or unsubstituted aryl radical having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical having a total of 5 to 18 carbon atoms and/or heteroatoms.
- a bidentate ligand is understood to mean a ligand coordinated at two sites to the transition metal atom M.
- a monodentate ligand is understood to mean a ligand coordinated at one site on the ligand to the transition metal atom M.
- the n carbene ligands are understood to mean a ligand coordinated at two sites to the transition metal atom M.
- Suitable uncharged mono- or bidentate ligands K are preferably selected from the group consisting of phosphines, both mono- and bisphosphines; phosphonates, both mono- and bisphosphonates, and derivatives thereof, arsenates, both mono- and bisarsenates, and derivatives thereof; phosphites, both mono- and bisphosphites; CO; pyridines, both mono- and bispyridines; nitriles, dinitriles, allyl, diimines, nonconjugated dienes and conjugated dienes which form a ⁇ complex with M 1 .
- Particularly preferred uncharged mono- or bidentate ligands K are selected from the group consisting of phosphines, both mono- and bisphosphines, preferably trialkyl-, triaryl- or alkylarylphosphines, more preferably PAr 3 where Ar is a substituted or unsubstituted aryl radical and the three aryl radicals in PAr 3 may be the same or different, more preferably PPh 3 , PEt 3 , PnBu 3 , PEt 2 Ph, PMe 2 Ph, PnBu 2 Ph; phosphonates and derivatives thereof, arsenates and derivatives thereof, phosphites, CO; pyridines, both mono- and bispyridines, where the pyridines may be substituted by alkyl or aryl groups; nitriles and dienes which form a ⁇ complex with M 1 , preferably n, 4 -diphenyl-1 ,3- butadiene, ⁇ 4 -1 ,3
- Very particularly preferred uncharged monodentate ligands are selected from the group consisting of PPh 3 , P(OPh) 3 , AsPh 3 , CO, pyridine, nitriles and derivatives thereof.
- Suitable uncharged mono- or bidentate ligands are preferably 1 ,4- diphenyl-1 ,3-butadiene, 1 -phenyl-1 ,3-pentadiene, 2,4-hexadiene, n, 4 -cyclooctadiene and r
- Suitable mono- or dianionic ligands L are the ligands typically used as mono- or bidentate mono- or dianionic ligands, excluding ligands of the aforementioned general formula (A).
- Suitable monoanionic monodentate ligands are, for example, halides, especially CI " and Br " , pseudohalides, especially CN “ , cyclopentadienyl (Cp " ), hydride, alkyl radicals joined to the transition metal M via a sigma bond, for example CH 3 , alkylaryl radicals joined to the transition metal M via a sigma bond, for example benzyl.
- Suitable monoanionic bidentate ligands are, for example, ligands of the formula (B)
- R 51 is in each case independently a linear or branched alkyl radical having 1 to 6 carbons atoms, preferably methyl, ethyl, isopropyl, tert-butyl, CF 3 ; substituted or unsubstituted aryl radical having 6 to 20 carbon atoms, preferably unsubstituted phenyl or 2,6-dialkylphenyl; substituted or unsubstituted heteroaryl radical having a total of 5 to 18 carbon atoms and/or heteroatoms,
- R 52 is hydrogen, a linear or branched alkyl radical having 1 to 6 carbon atoms, substituted or unsubstituted aryl radical having 6 to 20 carbon atoms, preferably hydrogen;
- ligand of the formula (B) is, for example, acetylacetonato or hexafluoro- acetylacetonato;
- arylpyridines e.g. phenylpyridine
- arylazoles e.g. 2-arylimidazoles.
- Suitable dianionic bidentate ligands are, for example, dialkoxides, dicarbonates, dicarboxylates, diamides, diimides, dithiolates, biscyclopentadienyls, bisphosphonates, bissulfonates and 3-phenylpyrazole.
- the present invention relates to an inventive metal-carbene complex where L in the general formula (I) is a carbene ligand of the general formula (II)
- a 9 is CR 12 or N
- a 10 is CR 13 or N;
- R 11 is a linear or branched alkyl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyi radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 3 to 20 carbon atoms, substituted or unsubstituted heterocycloalkyl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 3 to 20 carbon atoms and/or heteroatoms, substituted or unsubstituted aryl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having a total of 5 to 18 carbon atoms and/or heteroatoms, R 12 , R 13 are each independently hydrogen, a linear or branched alkyl radical optionally interrupted by
- a 5 is CR 14 or N
- a 6 is CR 15 or N
- a 7 is CR 16 or N
- a 8 is CR 17 or N
- R 16 , R 17 are each independently hydrogen, a linear or branched alkyl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 3 to 20 carbon atoms, substituted or unsubstituted heterocycloalkyl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 3 to 20 carbon atoms and/or heteroatoms, substituted or unsubstituted aryl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having a total of 5 to 18 carbon atoms and/or heteroatoms, group with donor or acceptor action, or
- R 14 and R 15 , R 15 and R 16 or R 16 and R 17 form, together with the carbon atoms to which they are bonded, an unsaturated or aromatic, optionally substituted ring optionally interrupted by at least one heteroatom and having a total of 5 to 18 carbon atoms and/or heteroatoms, and/or
- R 12 and R 13 form, together with A 9 and A 10 to which they are bonded, an unsaturated or aromatic, optionally substituted ring optionally interrupted by exactly one heteroatom or two adjacent heteroatoms and having a total of 5 to 18 ring atoms, and/or if A 9 is CR 12 , R 12 and R 17 together form a saturated or unsaturated, linear or branched bridge optionally comprising heteroatoms, aromatic units, heteroaromatic units and/or functional groups and having a total of 1 to 30 carbon atoms and/or heteroatoms, to which is optionally fused a substituted or unsubstituted, five- to eight-membered ring comprising carbon atoms and/or heteroatoms; q is O or l ; where - when o in formula (I) is 2, the carbene ligands L of the formula (II) may be the same or different.
- the ligands L may each be an identical ligand of the formula (II) or different ligands of the formula (II). It is also possible that one of the ligands L is a ligand of the formula (II) and the second ligand is any ligand L. In a preferred embodiment, in the case that the inventive metal-carbene complex of the formula (I) has two ligands L, the ligands L are each an identical ligand of the formula (II).
- the present invention relates to a metal-carbene complex of the general formula (I) which has exclusively carbene ligands.
- n and o in the metal-carbene complex of the general formula (I) are each 0.
- n is preferably 3 (when M is Ir(lll)) or 2 (when M is Pt(ll)).
- the n azabenzimidazole carbene ligands may each be the same or different in the metal- carbene complexes of the general formula (I). They are preferably the same, which means that, in a preferred embodiment, the present application relates to homoleptic metal-carbene complexes of the general formula (I).
- n is 1 or 2 and o is 1 or 2, where the o ligand(s) L is/are ligand(s) of the general formula (II). If n or o is 2, the particular n azabenzimidazole carbene ligands or o ligands L may be the same or different.
- the complexes are heteroleptic metal-carbene complexes having exclusively carbene ligands. It has been found that metal-carbene complexes of the general formula (I) having exclusively carbene ligands are generally notable for light emission in the deep blue region of the electromagnetic spectrum.
- inventive metal-carbene complexes of the general formula (I) are therefore notable, in a preferred embodiment, for the following CIE values: CIE: y: generally ⁇ 0.40, preferably 0.08 to 0.30, most preferably 0.15 to 0.25; x: generally ⁇ 0.25, preferably 0.10 to 0.20, more preferably 0.14 to 0.20.
- the metal-carbene complexes of the general formula (I) having exclusively carbene ligands are therefore suitable with particular preference as emitter material in OLEDs.
- M in the metal-carbene complexes of the formula (I) having exclusively carbene ligands is Ir.
- the present invention relates to an inventive metal- carbene complex where in the general formula (I), L is selected from the group consisting of a ligand of the formula (B)
- R 51 is in each case independently a linear or branched alkyl radical having 1 to 6 carbons atoms, preferably methyl, ethyl, isopropyl, tert-butyl, CF 3 ; substituted or unsubstituted aryl radical having 6 to 20 carbon atoms, preferably unsubstituted phenyl or 2,6-dialkylphenyl; substituted or unsubstituted heteroaryl radical having a total of 5 to 18 carbon atoms and/or heteroatoms,
- R 52 is hydrogen, a linear or branched alkyl radical having 1 to 6 carbon atoms, substituted or unsubstituted aryl radical having 6 to 20 carbon atoms, preferably hydrogen;
- ligand of the formula (B) is, for example, acetylacetonato or hexafluoro- acetylacetonato;
- D are each independently CR 18 or N, preferably CR 18 ;
- W is C, N, preferably C
- E are each independently CR 19 , N, NR 20 , preferably CR 19 or N;
- G is CR 21 , N, NR 22 , S, O, preferably NR 21
- R 21 are each independently hydrogen, a linear or branched alkyl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 3 to 20 carbon atoms, substituted or unsubstituted heterocycloalkyl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 3 to 20 carbon atoms and/or heteroatoms, substituted or unsubstituted aryl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having a total of 5 to 18 carbon atoms and/or heteroatoms, group with donor or acceptor action, or in each case 2 R 18 , R 19 and R 21
- R 20 , R 22 are each independently a linear or branched alkyl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 3 to 20 carbon atoms, substituted or unsubstituted heterocycloalkyl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 3 to 20 carbon atoms and/or heteroatoms, substituted or unsubstituted aryl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having a total of 5 to 18 carbon atoms and/or heteroatoms, group with donor or acceptor action; preferably ⁇ , ⁇ '-dialkylated
- ligands L are each H, alkyl, aryl, heteroaryl, alkenyl, alkynyl; where - when o in formula (I) is 2, the ligands L may be the same or different.
- R 18 , R 19 and R 21 radicals together with the carbon atoms to which they are bonded, form a saturated, unsaturated or aromatic, optionally substituted ring optionally interrupted by at least one heteroatom and having a total of 5 to 18 carbon atoms and/or heteroatoms, for example, two R 18 radicals, two R 19 radicals or one R 19 radical and one R 21 radical form a corresponding ring.
- the ligands L may each be an identical ligand of the formula (III) or different ligands of the formula (III). It is also possible that one of the ligands L is a ligand of the formula (III) and the second ligand is any ligand L. In a further preferred embodiment, in the case that the inventive metal-carbene complex of the formula (I) has two ligands L, the ligands L are each an identical ligand of the formula (III).
- n is 1 or 2 and o is 1 or 2, where the o ligand(s) L is/are ligand(s) of the general formula (III).
- n or o 2
- the particular n azabenzimidazole carbene ligands or o ligands L may be the same or different.
- the complexes are heteroleptic metal-carbene complexes which, as well as n azabenzimidazole carbene ligands, have o ligands of the general formula (III). It has been found that the aforementioned metal-carbene complexes of the general formula (I) are especially suitable as emitter material in the light-emitting layer of an OLED.
- L is preferably selected from the group consisting of carbene ligands of the general formula (II), ligands of the formula (B), more preferably acetylacetonato or hexafluoroacetylacetonato; picolinato, salicylate 8-hydroxyquinolato and heterocyclic noncarbene ligands of the general formula (III).
- Ligands L which are very particularly preferred in accordance with the invention are
- the number o of monoanionic ligands L in the aforementioned case is 0, 1 , 2.
- the L ligands may be the same or different, and are preferably the same.
- the number m of uncharged ligands K depends on whether the coordination number 6 of the Ir(lll) or 4 of the Pt(ll) has already been attained with the aid of the carbene ligands and of the ligands L.
- m in the aforementioned case is 0.
- Pt(ll) is used - n is two and two monoanionic bidentate carbene ligands are used, m in this case is likewise 0.
- M, n, Y, R 2 , R 3 , R 4 , A 1 , A 2 , A 3 , A 4 , p, K, L, n and o in the general formula (I) are each defined as follows:
- M is Ir or Pt, preferably Ir.
- Ir is present in the inventive complexes preferably in the +3 oxidation state (Ir(lll)).
- Pt is present in the inventive complexes in the +2 oxidation state (Pt(ll)).
- M is Ir(lll), n is preferably 3, where all n carbene ligands
- Suitable ligands L have been specified above, where L in this case is more preferably a ligand of the formula (B).
- Y is NR 1 , O, S or C(R 10 ) 2 , preferably NR 1 .
- R 1 in a preferred embodiment is a linear or branched alkyl radical having 1 to 6 carbon atoms, substituted or unsubstituted cycloalkyl radical having 5 to 20 carbon atoms, substituted or unsubstituted aryl radical having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical having a total of 5 to 18 carbon atoms and/or heteroatoms.
- R 1 is more preferably linear or branched alkyl radical having 1 to 6 carbon atoms, substituted or unsubstituted phenyl radical, substituted or unsubstituted heteroaryl radical having a total of 5 or 6 carbon atoms and/or heteroatoms.
- R 1 is most preferably selected from phenyl, tolyl, mesityl, thiophenyl, furanyl, pyridyl, methyl, isopropyl and neopentyl.
- the present invention therefore relates especially to an inventive metal-carbene complex of the formula (I) in which Y is NR 1 where R 1 is selected from the group consisting of phenyl, tolyl, mesityl, thiophenyl, furanyl, pyridyl, methyl, isopropyl and neopentyl.
- R 2 , R 3 , R 4 are each independently hydrogen, a linear or branched alkyl radical having 1 to 20 carbon atoms, a substituted or unsubstituted cycloalkyl radical having 5 to 20 carbon atoms, a substituted or unsubstituted aryl radical having 6 to 30 carbon atoms, a substituted or unsubstituted heteroaryl radical having 5 to 18 carbon atoms and/or heteroatoms or a group with donor or acceptor action.
- R 2 , R 3 , R 4 are each independently hydrogen, a linear or branched alkyl radical having 1 to 6 carbon atoms, substituted or unsubstituted aryl radical having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical having a total of 5 to 18 carbon atoms and/or heteroatoms or a group with donor or acceptor action selected from halogen radicals, preferably F, CI, more preferably F, CF 3 , CN and SiMe 3 ; or R 3 and R 4 , together with the carbon atoms to which they are bonded, may form an optionally substituted, unsaturated ring which is optionally interrupted by at least one further heteroatom, has a total of 5 to 18 carbon atoms and/or heteroatoms and may optionally be fused to at least one further optionally substituted unsaturated ring interrupted by at least one further heteroatom and having a total of 5 to 18 carbon atoms and/or heteroatoms.
- halogen radicals
- an unsaturated ring is a mono-, di- or polyunsaturated, preferably monounsaturated, ring.
- R 2 is more preferably hydrogen.
- R 3 is more preferably hydrogen or linear or branched alkyl radical having 1 to 20 carbon atoms or optionally substituted, saturated, unsaturated or aromatic ring having a total of 5 to 18 carbon atoms and/or heteroatoms, more preferably branched alkyl radical or ⁇ , ⁇ '-dialkylated phenyl ring.
- R 4 is more preferably hydrogen or linear or branched alkyl radical having 1 to 20 carbon atoms or optionally substituted, saturated, unsaturated or aromatic ring having a total of 5 to 18 carbon atoms and/or heteroatoms, more preferably branched alkyl radical or ⁇ , ⁇ '-dialkylated phenyl ring.
- R 3 and R 4 form, together with the carbon atoms to which they are bonded, an optionally substituted, unsaturated ring having a total of 5 to 18 carbon atoms.
- p in a preferred embodiment is 1 .
- the A 1 group is CR 6 or N, preferably CR 6
- the A 2 group is CR 7 or N, preferably CR 7
- the A 3 group is CR 8 or N, preferably CR 8
- the A 4 group is CR 9 or N, preferably CR 9 .
- 0, 1 or 2 of the A 1 , A 2 , A 3 or A 4 groups are N, more preferably 0 or 1 groups are N, most preferably 0 groups are N.
- R 6 , R 7 , R 8 , R 9 are each independently hydrogen or linear or branched alkyl radical having 1 to 20 carbon atoms, a C 6 - to C-aryl radical, preferably a phenyl radical or an ⁇ , ⁇ '-dialkylated phenyl radical or a group with donor or acceptor action, preferably a group with donor or acceptor action selected from halogen radicals, preferably F, CI, more preferably F, CF 3 , CN and SiMe 3 ; more preferably hydrogen.
- R 6 and R 7 or R 7 and R 8 or R 8 and R 9 form, together with the phenyl ring, i.e. R 6 and R 7 or R 7 and R 8 or R 8 and R 9 form, with the carbon atoms to which the radicals are attached, an unsaturated or aromatic, optionally substituted ring which is optionally interrupted by at least one heteroatom, has a total of 5, 6 or 7 carbon atoms and/or heteroatoms and may optionally be fused to at least one further optionally substituted unsaturated ring interrupted by at least one further heteroatom and having a total of 5 to 18 carbon atoms and/or heteroatoms.
- the two particular radicals more preferably form, together with the phenyl ring, the following heterocycles: dibenzofuran, dibenzothiophene, fluorene, acridane, xanthene, thioxanthene, phenazine or phenoxazine.
- R 10 is, if present, preferably independently in accordance with the invention, a linear or branched alkyl radical having 1 to 20 carbon atoms, a substituted or unsubstituted aryl radical having 6 to 30 carbon atoms, a substituted or unsubstituted heteroaryl radical having 5 to 18 carbon atoms and/or heteroatoms, more preferably a linear alkyl radical or a substituted or unsubstituted phenyl radical;
- the two R 10 radicals form, together with the carbon atom to which they are bonded, a saturated or unsaturated optionally substituted ring optionally interrupted by at least one heteroatom and having a total of 5 to 18 carbon atoms and/or heteroatoms.
- the present invention relates to an inventive metal-carbene complex where M, n, Y, R 2 , R 3 , R 4 , A 1 , A 2 , A 3 , A 4 , p, L, m and o are each defined as follows:
- M is Ir, n is 1 , 2 or 3, preferably 3, the ligand(s)
- Y is NR 1 ,
- R 1 is a linear or branched alkyl radical having 1 to 6 carbon atoms, substituted or unsubstituted cycloalkyl radical having from 5 to 20 carbon atoms, substituted or unsubstituted aryl radical having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical having a total of 5 to 18 carbon atoms and/or heteroatoms,
- R 2 , R 3 , R 4 are independently hydrogen, a linear or branched alkyl radical having
- halogen radicals preferably F, CI, more preferably F; CF 3 , CN and SiMe 3 ; or
- R 2 and R 3 or R 3 and R 4 together with the carbon atoms to which they are bonded, form an optionally substituted, unsaturated, saturated or aromatic ring which is optionally interrupted by at least one further heteroatom, has a total of 5 to 18 carbon atoms and/or heteroatoms, and may optionally be fused to at least one further optionally substituted saturated or unsaturated or aromatic ring optionally interrupted by at least one further heteroatom and having a total of 5 to 18 carbon atoms and/or heteroatoms, p is 1 ; is CR 6
- R 6 , R 7 , R 8 , R 9 are each independently hydrogen, a linear or branched alkyl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 1 to 20 carbon atoms, substituted or unsubstituted aryl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having a total of 5 to 18 carbon atoms and/or heteroatoms, group with donor or acceptor action selected from halogen radicals, preferably F, CI, more preferably F; CF 3 , CN and SiMe 3 ;
- R 8 and R 9 form, together with the carbon atoms to which they are bonded, a saturated, unsaturated or aromatic, optionally substituted ring which is optionally interrupted by at least one heteroatom, has a total of 5 to 18 carbon atoms and/or heteroatoms and may optionally be fused to at least one further optionally substituted saturated or unsaturated or aromatic ring optionally interrupted by at least one further heteroatom and having a total of 5 to 18 carbon atoms and/or heteroatoms, is a monoanionic bidentate ligand, preferably selected from the group consisting of carbene ligands of the general formula (II) according to claim 2,
- R is hydrogen, a linear or branched alkyl radical having 1 to 6 carbon atoms, substituted or unsubstituted aryl radical having 6 to 20 carbon atoms, preferably hydrogen;
- ligand of the formula (B) is, for example, acetylacetonato or hexafluoro- acetylacetonato;
- Y' is NR 1 , O, S or C(R 10 ) 2 ,
- R 2' , R 3' , R 4' , R 5' if A 2' , A 3' , A 4' and/or A 5' is N, are each a free electron pair or, if A 2' , A 3' ,
- a 4 and/or A 5 is C, are each independently hydrogen, a linear or branched alkyl radical optionally bearing at least one functional group, optionally interrupted by at least one heteroatom and having 1 to 20 carbon atoms, cycloalkyl radical having 3 to 20 carbon atoms, substituted or unsubstituted aryl radical having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical having a total of 5 to 18 carbon atoms and/or heteroatoms, group with donor or acceptor action or
- R 3 and R 4 form, together with A 3 and A 4 , an optionally substituted, unsaturated ring optionally interrupted by at least one further heteroatom and having a total of 5 to 18 carbon atoms and/or heteroatoms
- R 6 , R 7 , R 8 , R 9 are each independently hydrogen, a linear or branched alkyl radical optionally bearing at least one functional group, optionally interrupted by at least one heteroatom and having 1 to 20 carbon atoms, cycloalkyl radical having 3 to 20 carbon atoms, cycloheteroalkyl radical having 3 to 20 carbon atoms, substituted or unsubstituted aryl radical having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical having a total of 5 to 18 carbon atoms and/or heteroatoms, group with donor or acceptor action, or
- R 6 and R 7 , R 7 and R 8 or R 8 and R 9 together with the carbon atoms to which they are bonded, form a saturated, unsaturated or aromatic, optionally substituted ring optionally interrupted by at least one heteroatom and having a total of 5 to 18 carbon atoms and/or heteroatoms, and/or if A 5 is C, R 5 and R 6 together form a saturated or unsaturated, linear or branched bridge optionally comprising heteroatoms, aromatic unit, heteroaromatic unit and/or functional groups and having a total of 1 to 30 carbon atoms and/or heteroatoms, to which is optionally fused a substituted or unsubstituted, five- to eight-membered ring comprising carbon atoms and/or heteroatoms, R 10 is independently a linear or branched alkyl radical optionally bearing at least one functional group, optionally interrupted by at least one heteroatom and having 1 to 20 carbon atoms, cycloalkyl radical having 3 to 20 carbon atoms, substituted
- Carbene ligands of the general formula (II) and heterocyclic noncarbene ligands of the general formula (III) have been defined above.
- the present invention more preferably relates to an inventive metal-carbene complex where M, n, Y, R 2 , R 3 , R 4 , A 1 , A 2 , A3 7 , A 48 , p, L, m and o are each defined as follows:
- M is Ir, n is 3, where the ligand(s)
- n ligands are each bidentate ligands, and where all n ligands are more preferably the same;
- Y is NR 1
- R 1 is a linear or branched alkyl radical having 1 to 6 carbon atoms, substituted or unsubstituted cycloalkyl radical having 5 to 20 carbon atoms, substituted or unsubstituted aryl radical having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical having a total of 5 to 18 carbon atoms and/or heteroatoms,
- R 4 are each independently hydrogen, a linear or branched alkyl radical having 1 to 6 carbon atoms, substituted or unsubstituted aryl radical having 6 to 30 carbon atoms, especially ⁇ , ⁇ '-dialkylated or unsubstituted phenyl radical, substituted or unsubstituted heteroaryl radical having a total of 5 to 18 carbon atoms and/or heteroatoms, group with donor or acceptor action selected from halogen radicals, preferably F, CI, more preferably F; CF 3 , CN and SiMe 3 ; or
- R 2 and R 3 or R 3 and R 4 form, together with the carbon atoms to which they are bonded, an optionally substituted unsaturated, saturated or aromatic ring which is optionally interrupted by at least one further heteroatom, has a total of 5 to 7 carbon atoms and/or heteroatoms and may optionally be fused to at least one further optionally substituted saturated or unsaturated or aromatic ring optionally interrupted by at least one further heteroatom and having a total of 5 to 7 carbon atoms and/or heteroatoms,
- a 1 is CR 6 ;
- a 2 is CR 7 ;
- a 3 is CR 8 ;
- a 4 is CR 9 ;
- R 8 , R 9 are each independently hydrogen, a linear or branched alkyl radical having 1 to 20 carbon atoms, aryl radical having 6 to 30 carbon atoms, group with donor or acceptor action selected from halogen radicals, preferably F, CI, more preferably F; CF 3 , CN and SiMe 3 ;
- R 8 and R 9 form, together with the carbon atoms to which they are bonded, an aromatic, optionally substituted ring which is optionally interrupted by one nitrogen or oxygen atom, has a total of 5 to 18 carbon atoms and/or heteroatoms and may optionally be fused to at least one further optionally substituted aromatic ring optionally interrupted by one nitrogen or oxygen atom and having a total of 5 to 18 carbon atoms and/or heteroatoms,
- L is a monoanionic bidentate ligand, selected from the group consisting of carbene ligands of the general formula (II),
- R 51 is in each case independently a linear or branched alkyl radical having 1 to 6 carbons atoms, preferably methyl, ethyl, isopropyl, tert-butyl, CF 3 ; substituted or unsubstituted aryl radical having 6 to 20 carbon atoms, preferably unsubstituted phenyl or 2,6-dialkylphenyl; substituted or unsubstituted heteroaryl radical having a total of 5 to 18 carbon atoms and/or heteroatoms,
- R 52 is hydrogen, a linear or branched alkyl radical having 1 to 6 carbon atoms, substituted or unsubstituted aryl radical having 6 to 20 carbon atoms, preferably hydrogen;
- ligand of the formula (B) is, for example, acetylacetonato or hexafluoro- acetylacetonato;
- inventive homoleptic metal-carbene complexes may be present in the form of facial or meridional isomers.
- the facial isomers can preferably be used as matrix material in the light-emitting layer of an OLED or as charge blockers, and the meridional isomers can preferably be used as emitter materials in OLEDs.
- a particularly preferred embodiment of the present application therefore relates to an OLED comprising at least one homoleptic metal-carbene complex of the general formula (I) as emitter material, the homoleptic metal-carbene complex of the formula (I) preferably being used in the form of the meridional isomer thereof.
- the homoleptic metal-carbene complex of the formula (I) preferably being used in the form of the meridional isomer thereof.
- mixtures of facial and meridional isomers of the formula (I) or facial isomers of the formula (I) are suitable as emitter material in OLEDs.
- heteroleptic metal-carbene complexes four different isomers may be present.
- the heteroleptic complexes are preferably used as emitter materials and/or charge transport material.
- the present invention additionally also relates to a process for preparing the inventive metal-carbene complexes by contacting suitable compounds comprising M with the appropriate ligands or ligand precursors.
- a suitable compound comprising the appropriate metal M, i.e. iridium or platinum, preferably iridium, and appropriate carbene ligands, preferably in deprotonated form as the free carbene or in the form of a protected carbene, for example as the silver-carbene complex, are contacted.
- Suitable precursor compounds comprise the appropriate substituents R 1 to R 4 and R 6 to R 9 and R 10 which should be present in the complexes of the general formula (I).
- the present invention therefore relates more particularly to the process according to the invention wherein the ligand precursor used is a corresponding Ag-carbene complex.
- the ligand precursors used are organic compounds which are reacted with suitable M-comprising compounds.
- the carbene can be released from precursors of the carbene ligands by removing volatile substances, for example lower alcohols such as methanol, ethanol, for example at elevated temperature and/or under reduced pressure and/or using molecular sieves which bind the alcohol molecules eliminated.
- the present invention also relates to a process according to the invention for preparing the metal-carbene complexes of the general formula (I) by contacting suitable M- comprising compounds with compounds of the general formula (IV) or (V)
- R 28 is independently SiR 29 R 30 R 31 , aryl, heteroaryl, alkyl, cycloalkyl or heterocycloalkyl,
- X is F, CI, Br, I, PF 6 , BF 4 ,
- R 28 is alkyl, especially CrC 2 o-alkyl, preferably Ci-Cio-alkyl, more preferably CrC 8 -alkyl, for example methyl, ethyl, propyl such as n-propyl, isopropyl, butyl such as n-butyl, isobutyl, tert-butyl, pentyl, hexyl, heptyl or octyl.
- R 28 in the compound of the general formula (IV) is most preferably methyl or ethyl.
- the compounds of the general formula (IV) are prepared generally at a temperature of 10 to 150°C, preferably 40 to 120°C, more preferably 60 to 1 10°C.
- the reaction time is generally 2 to 48 hours, preferably 6 to 24 hours, more preferably 8 to 16 hours.
- the desired product can be isolated and purified by customary processes known to those skilled in the art, for example filtration, recrystallization, column chromatography, etc.
- Appropriate compounds, especially complexes, comprising the appropriate metal M, preferably iridium, are known to those skilled in the art.
- Particularly suitable compounds comprising platinum or iridium comprise, for example, ligands such as halides, preferably chloride, 1 ,5-cyclooctadiene (COD), cyclooctene (COE), phosphines, cyanides, alkoxides, pseudohalides and/or alkyl.
- the carbene ligand precursors are deprotonated, preferably before the reaction, for example, by basic compounds known to those skilled in the art, for example basic metalates, basic metal acetates, acetylacetonates or alkoxides, or bases such as KO'Bu, NaO'Bu, LiO'Bu, NaH, silylamides, Ag 2 0 and phosphazene bases. Particular preference is given to deprotonating with Ag 2 0 to obtain the corresponding Ag- carbene, which is reacted with the compound comprising M to give the inventive complexes.
- basic compounds known to those skilled in the art for example basic metalates, basic metal acetates, acetylacetonates or alkoxides, or bases such as KO'Bu, NaO'Bu, LiO'Bu, NaH, silylamides, Ag 2 0 and phosphazene bases.
- bases such as KO'Bu, NaO'Bu, LiO'Bu, NaH, silyl
- the process according to the invention for preparing the complexes of the general formula (I) using the compounds of the general formulae (IV) or (V) has the advantage that the compounds of the general formulae (IV) and (V) are stable intermediates which can be handled readily and can be isolated under standard laboratory conditions.
- the compounds of the general formulae (IV) and (V) are soluble in customary organic solvents, such that the preparation of the inventive complexes of the general formula (I) in homogeneous solution is possible, such that a workup of the desired product, i.e. of the complexes of the general formula (I) is more readily possible, for example for isolation and/or purification.
- the contacting is preferably effected in a solvent.
- Suitable solvents are known per se to those skilled in the art and are preferably selected from the group consisting of aromatic or aliphatic solvents, for example benzene, toluene, xylene or mesitylene, cyclic or acyclic ethers, for example dioxane or THF, alcohols, esters, amides, ketones, nitriles, halogenated compounds and mixtures thereof.
- Particularly preferred solvents are toluene, xylenes, mesitylene and dioxane.
- the molar ratio of metal-noncarbene complex used to carbene ligand precursor used is generally 1 :10 to 10:1 , preferably 1 :1 to 1 :6, more preferably 1 :2 to 1 :5.
- the contacting is generally effected at a temperature of 20 to 200°C, preferably 50 to 150°C, more preferably 60 to 130°C.
- the reaction time depends on the desired carbene complex and is generally 0.02 to 50 hours, preferably 0.1 to 24 hours, more preferably 1 to 12 hours.
- the complexes of the general formula (I) obtained after the reaction can optionally be purified by processes known to those skilled in the art, for example washing, crystallization or chromatography, and optionally isomerized under conditions likewise known to those skilled in the art, for example with acid mediation, thermally or photochemically.
- the inventive metal-carbene complexes of the formula (I) can be used in electronic components, for example organic electronic components selected from switching elements such as organic light-emitting diodes (OLEDs), organic photovoltaic cells (OPVs), organic field-effect transistors (OFETs) and light-emitting electrochemical cells (LEECs), preference being given to using the metal-carbene complexes of the formula (I) in OLEDs.
- organic electronic components selected from switching elements such as organic light-emitting diodes (OLEDs), organic photovoltaic cells (OPVs), organic field-effect transistors (OFETs) and light-emitting electrochemical cells (LEECs)
- the organic electronic component is an OLED comprising a light-emitting layer comprising at least one inventive metal-carbene complex of the formula (I).
- the aforementioned metal-carbene complexes of the formula (I) and mixtures thereof are outstandingly suitable as emitter molecules in organic light-emitting diodes (OLEDs). Variations in the ligands make it possible to provide corresponding complexes which exhibit electroluminescence in the red, green and especially in the blue region of the electromagnetic spectrum.
- the inventive metal-carbene complexes of the general formula (I) are therefore outstandingly suitable as emitter substances, since they have emission (electroluminescence) in the visible region of the electromagnetic spectrum, for example at 400 to 800 nm, preferably 400 to 600 nm.
- the inventive complexes make it possible to provide compounds which have electroluminescence in the red, green and in the blue region of the electromagnetic spectrum.
- inventive metal-carbene complexes of the general formula (I) can be used as matrix material, charge transport material, especially hole transport material, and/or charge blocker.
- inventive metal-carbene complexes of the general formula (I) are preferably used as an emitter and/or charge transport material and/or matrix material, more preferably as an emitter.
- inventive metal-carbene complexes of the general formula (I) are particularly good efficiencies, good CIE color loci and long lifetimes when used in OLEDs.
- the present application therefore further provides an OLED comprising at least one inventive metal-carbene complex of the general formula (I).
- inventive metal- carbene complex of the general formula (I) is used in the OLED preferably as an emitter, matrix material, charge transport material, especially hole transport material, and/or charge blocker, more preferably as an emitter and/or hole transport material, most preferably as an emitter.
- the present application also provides for the use of the metal-carbene complexes of the general formula (I) in OLEDs, preferably as an emitter, matrix material, charge transport material, especially hole transport material, and/or charge blocker, more preferably as an emitter and/or hole transport material, most preferably as an emitter.
- Organic light diodes are in principle formed from a plurality of layers, e.g.: anode (1 )
- the OLED does not have all of the layers mentioned; for example, an OLED comprising layers (1 ) (anode), (3) (light-emitting layer) and (5) (cathode) is likewise suitable, in which case the functions of layers (2) (hole- transporting layer) and (4) (electron-transporting layer) are assumed by the adjoining layers. OLEDs having layers (1 ), (2), (3) and (5) or layers (1 ), (3), (4) and (5) are likewise suitable.
- the metal-carbene complexes of the general formula (I) are preferably used as emitter molecules and/or matrix materials in the light-emitting layer (3).
- inventive metal- carbene complexs of the general formula (I) may also - in addition to use as emitter molecules and/or matrix materials in the light-emitting layer (3) or instead of use in the light-emitting layer - also be used as a charge transport material in the hole- transporting layer (2) or in the electron-transporting layer (4) and/or as a charge blocker, preference being given to use as a charge transport material in the hole- transporting layer (2) (hole transport material).
- the present application therefore further provides a light-emitting layer comprising at least one of the inventive metal-carbene complexes of the general formula (I), preferably as emitter material and/or matrix material, more preferably as emitter material.
- Preferred metal-carbene complexes of the general formula (I) have already been specified above.
- the present invention relates to a light-emitting layer consisting of at least one inventive metal-carbene complex of the general formula (I).
- the metal-carbene complexes of the general formula (I) used in accordance with the invention may be present in the light-emitting layer in substance, i.e. without further additions. However, it is also possible that, in addition to the metal-carbene complexes of the general formula (I) used in accordance with the invention, further compounds are present in the light-emitting layer.
- a diluent material matrix material
- This diluent material may be a polymer, for example poly(N-vinylcarbazole) or polysilane.
- the diluent material may, however, likewise be a small molecule, for example 4,4'-N,N'-dicarbazolebiphenyl (CDP) or tertiary aromatic amines.
- CDP 4,4'-N,N'-dicarbazolebiphenyl
- the proportion of the inventive metal-carbene complexes of the general formula (I) in the light-emitting layer is generally less than 40% by weight, preferably 3 to 30% by weight.
- the inventive metal-carbene complexes of the general formula (I) are preferably used in a matrix.
- the light-emitting layer thus preferably comprises at least one inventive metal-carbene complex of the general formula (I) and at least one matrix material.
- Suitable matrix materials are - in addition to the aforementioned dilution materials - in principle the materials specified hereinafter as hole and electron transport materials, and also carbon complexes, for example the carbene complexes of the formula (I) or the carbene complexes mentioned in WO 2005/019373.
- Particularly suitable are carbazole derivatives, for example 4,4'-bis(carbazol-9-yl)-2,2'-dimethylbiphenyl (CDBP), 4,4'-bis(carbazol-9-yl)biphenyl (CBP), 1 ,3-bis(N-carbazolyl)benzene (mCP), and the matrix materials specified in the following applications: WO2008/034758, WO2009/003919.
- WO2007108459 H-1 to H-37
- H-20 to H-22 and H-32 to H-37 most preferably H-20, H-32, H-36, H-37,
- WO2008035571 A1 Host 1 to Host 6
- JP2010135467 compounds 1 to 46 and Host-1 to Host-39 and Host-43
- WO2009008100 compounds No.1 to No.67 preferably No.3, No.4, No.7 to No. 12, No.55, No.59, No. 63 to No.67, more preferably No. 4, No. 8 to No. 12, No. 55, No. 59, No.64, No.65, and No. 67, WO2009008099 compounds No.
- WO20081401 14 compounds 1 -1 to 1 -50, WO2008090912 compounds OC-7 to OC-36 and the polymers of Mo-42 to Mo-51 , JP2008084913 H-1 to H-70, WO2007077810 compounds 1 to 44, preferably 1 , 2, 4-6, 8, 19-22, 26, 28-30, 32, 36, 39-44, WO201001830 the polymers of monomers 1 -1 to 1 -9, preferably of 1 -3, 1 -7, and 1 -9, WO2008029729 the (polymers of) compounds 1 -1 to 1 -36, WO20100443342 HS-1 to HS-101 and BH-1 to BH-17, preferably BH-1 to BH-17, JP2009182298 the (co)polymers based on the monomers 1 to 75, JP2009170764, JP2009135183 the (co)polymers based on the monomers 1 -14, WO2009063757 preferably the (
- one or more compounds of the general formula (X) specified hereinafter are used as matrix material.
- Preferred embodiments of the compounds of the general formula (X) are likewise specified hereinafter.
- the individual layers among the aforementioned layers of the OLED may in turn be formed from two or more layers.
- the hole-transporting layer may be formed from one layer, into which holes are injected from the electrode, and a layer which transports the holes away from the hole-injecting layer into the light-emitting layer.
- the electron-transporting layer may likewise consist of a plurality of layers, for example of a layer in which electrons are injected through the electrode and a layer which receives electrons from the electron-injecting layer and transports them into the light-emitting layer.
- These layers mentioned are each selected according to factors such as energy level, thermal resistance and charge carrier mobility, and also energy difference of the layers mentioned with the organic layers or the metal electrodes.
- the person skilled in the art is capable of selecting the construction of the OLEDs such that it is matched optimally to the heteroleptic complexes according to the present invention used as emitter substances in accordance with the invention.
- the HOMO (highest occupied molecular orbital) of the hole-transporting layer should be aligned to the work function of the anode
- the LUMO (lowest unoccupied molecular orbital) of the electron- transporting layer should be aligned to the work function of the cathode.
- the present application further provides an OLED comprising at least one inventive light-emitting layer.
- the further layers in the OLED may be formed from any material which is typically used in such layers and is known to those skilled in the art.
- Suitable materials for the aforementioned layers are known to those skilled in the art and are specified, for example, in H. Meng, N. Herron, Organic Small Molecule Materials for Organic Light-Emitting Devices in Organic Light-Emitting Materials and Devices, eds: Z. Li, H. Meng, Taylor & Francis, 2007, Chapter 3, pages 295 to 41 1 .
- the anode is an electrode which provides positive charge carriers. It may be composed, for example, of materials which comprise a metal, a mixture of different metals, a metal alloy, a metal oxide or a mixture of different metal oxides. Alternatively, the anode may be a conductive polymer. Suitable metals comprise the metals of groups 1 1 , 4, 5 and 6 of the Periodic Table of the Elements, and also the transition metals of groups 8 to 10. When the anode is to be transparent, mixed metal oxides of groups 12, 13 and 14 of the Periodic Table of the Elements are generally used, for example indium tin oxide (ITO). It is likewise possible that the anode (1 ) comprises an organic material, for example polyaniline, as described, for example, in Nature, Vol. 357, pages 477 to 479 (June 1 1 , 1992). At least either the anode or the cathode should be at least partly transparent in order to be able to emit the light formed.
- ITO indium tin oxide
- Suitable hole transport materials for layer (2) of the inventive OLED are disclosed, for example, in Kirk-Othmer Encyclopedia of Chemical Technology, 4th Edition, Vol. 18, pages 837 to 860, 1996. Either hole-transporting molecules or polymers may be used as the hole transport material.
- Customarily used hole-transporting molecules are selected from the group consisting of 4,4'-bis[N-(1 -naphthyl)-N-phenylamino]biphenyl (a-NPD), N,N'-diphenyl-N,N'-bis(3-methylphenyl)-[1 ,1 '-biphenyl]-4,4'-diamine (TPD), 1 ,1 -bis[(di-4-tolylamino)phenyl]cyclohexane (TAPC), N,N'-bis(4-methylphenyl)-N,N'- bis(4-ethylphenyl)-[1 ,1 '-(3,3'-dimethyl)biphenyl]-4,4'-diamine (ETPD), tetrakis(3- methylphenyl)-N,N,N',N'-2,5-phenylenediamine (PDA), a-phenyl
- Customarily used hole-transporting polymers are selected from the group consisting of polyvinylcarbazoles, (phenylmethyl)polysilanes and polyanilines. It is likewise possible to obtain hole-transporting polymers by doping hole-transporting molecules into polymers such as polystyrene and polycarbonate. Suitable hole-transporting molecules are the molecules already mentioned above. In addition - in one embodiment - it is possible to use carbene complexes as hole conductor materials, in which case the band gap of the at least one hole conductor material is generally greater than the band gap of the emitter material used. In the context of the present application, band gap is understood to mean the triplet energy.
- Suitable carbene complexes are, for example, the inventive carbine complexes of the general formula (I), carbene complexes as described in WO 2005/019373 A2, WO 2006/056418 A2, WO 2005/1 13704, WO 2007/1 15970, WO 2007/1 15981 and WO 2008/000727.
- a suitable carbene complex is lr(DPBIC) 3 with the formula:
- the hole-transporting layer may also be electronically doped in order to improve the transport properties of the materials used, in order firstly to make the layer thicknesses more generous (avoidance of pinholes/short circuits) and in order secondly to minimize the operating voltage of the device.
- Electronic doping is known to those skilled in the art and is disclosed, for example, in W. Gao, A. Kahn, J. Appl. Phys., Vol. 94, No. 1 , 1 July 2003 (p-doped organic layers); A. G. Werner, F. Li, K. Harada, M. Pfeiffer, T. Fritz, K. Leo, Appl. Phys. Lett., Vol. 82, No.
- mixtures may, for example, be the following mixtures: mixtures of the abovementioned hole transport materials with at least one metal oxide, for example Mo0 2 , Mo0 3 , WOx, Re0 3 and/or V 2 0 5 , preferably Mo0 3 and/or Re0 3 , more preferably Re0 3 or mixtures comprising the aforementioned hole transport materials and one or more compounds selected from 7,7,8,8-tetracyanoquinodimethane (TCNQ), 2,3,5,6- tetrafluoro-7,7,8,8-tetracyanoquinodimethane (F 4 -TCNQ), 2,5-bis(2-hydroxyethoxy)- 7,7,8,8-tetracyanoquinodimethane, bis(tetra-n-butylammonium)tetracyanodipheno- quinodimethane, 2,5-dimethyl-7,7,8,8-tetracyanoquinodimethane, tetracyanoethylene, 1 1 ,
- Layer (4) may serve both to ease the electron transport and as a buffer layer or as a barrier layer in order to prevent quenching of the exciton at the interfaces of the layers of the OLED. Layer (4) preferably improves the mobility of the electrons and reduces quenching of the exciton.
- At least one material is electron-conducting.
- at least one phenanthroline compound is used, preferably BCP, or at least one pyridine compound according to the formula (VIII) below, preferably a compound of the formula (Vlllaa) below.
- alkaline earth metal or alkali metal hydroxyquinolate complexes for example Liq, are used. Suitable alkaline earth metal or alkali metal hydroxyquinolate complexes are specified below (formula VII).
- the electron-transporting layer may also be electronically doped in order to improve the transport properties of the materials used, in order firstly to make the layer thicknesses more generous (avoidance of pinholes/short circuits) and in order secondly to minimize the operating voltage of the device.
- Electronic doping is known to those skilled in the art and is disclosed, for example, in W. Gao, A. Kahn, J. Appl. Phys., Vol. 94, No. 1 , 1 July 2003 (p-doped organic layers); A. G. Werner, F. Li, K. Harada, M. Pfeiffer, T. Fritz, K. Leo, Appl. Phys. Lett., Vol. 82, No.
- n-Doping is achieved by the addition of reducing materials.
- mixtures may, for example, be mixtures of the abovementioned electron transport materials with alkali/alkaline earth metals or alkali/alkaline earth metal salts, for example Li, Cs, Ca, Sr, Cs 2 C0 3 , with alkali metal complexes, for example 8-hydroxyquinolatolithium (Liq), and with Y, Ce, Sm, Gd, Tb, Er, Tm, Yb, Li 3 N, Rb 2 C0 3 , dipotassium phthalate, W(hpp) 4 from EP 1786050, or with compounds as described in EP1837926 B1.
- alkali/alkaline earth metals or alkali/alkaline earth metal salts for example Li, Cs, Ca, Sr, Cs 2 C0 3
- alkali metal complexes for example 8-hydroxyquinolatolithium (Liq)
- the present invention therefore also relates to an inventive OLED which comprises an electron-transporting layer comprising at least two different materials, of which at least one material is electron-conducting.
- the electron-transporting layer comprises at least one compound of the general formula
- R 32 and R 33 are each independently F, CrC 8 -alkyl, or C 6 -Ci 4 -aryl, which is optionally substituted by one or more CrC 8 -alkyl groups, or
- R 32 and/or R 33 substituents together form a fused benzene ring which is optionally substituted by one or more CrC 8 -alkyl groups;
- a and b are each independently 0, or 1 , 2 or 3,
- M 1 is an alkaline metal atom or alkaline earth metal atom
- p is 1 when M 1 is an alkali metal atom, p is 2 when M 1 is an alkaline earth metal atom.
- a very particularly preferred compound of the formula (VII) is (Liq), which may be present as a single species, or in other forms such as Li g Q g in which integer, for example Li 6 Q6- Q is an 8-hydroxyquinolate ligand or an 8-hydroxyquinolate derivative.
- the electron-transporting layer comprises at least one compound of the formula (VI I I),
- Ci-Ci 8 -alkyl Ci-Ci 8 -alkyl which is substituted by E and/or interrupted by D
- C 6 -C24-aryl Ci-Ci 8 -alkyl which is substituted by E and/or interrupted by D
- C 6 -C24-aryl Ci-Ci 8 -alkyl which is substituted by E and/or interrupted by D
- C 6 -C24-aryl Ci-C 2 4-aryl which is substituted by G
- D is -CO-; -COO-; -S-; -SO-; -S0 2 -; -0-; -NR 40 -; -SiR 45 R 46 -; -POR 47 -;
- -CR 38 CR 39 -; or -C ⁇ C-;
- E is -OR 44 ; -SR 44 ; -NR 40 R 41 ; -COR 43 ; -COOR 42 ; -CONR 40 R 41 ; -CN ; or F;
- G is E, CrCi 8 -alkyl, Ci-Ci 8 -alkyl which is interrupted by D , Ci-Ci 8 - perfluoroalkyl, Ci-Ci 8 -alkoxy, or Ci-Ci 8 -alkoxy which is substituted by E and/or interrupted by D,
- R 38 and R 39 are each independently H, C 6 -Ci 8 -aryl; C 6 -Ci 8 -aryl which is substituted by
- R 40 and R 41 are each independently C 6 -Ci 8 -aryl; C 6 -Ci 8 -aryl which is substituted by
- R 40 and R 41 together form a 6-membered ring
- R 42 and R 43 are each independently C 6 -Ci 8 -aryl; C 6 -Ci 8 -aryl which is substituted by
- R 44 is C 6 -Ci 8 -aryl; C 6 -Ci 8 -aryl which is substituted by Ci-Ci 8 -alkyl or Ci-Ci 8 - alkoxy; Ci-Ci 8 -alkyl; or Ci-Ci 8 -alkyl which is interrupted by -0-, R and R are each independently Ci-Ci 8 -alkyl, C 6 -Ci 8 -aryl or C 6 -Ci 8 -aryl which is substituted by Ci-Ci 8 -alkyl,
- R 47 is Ci-Ci 8 -alkyl, C 6 -Ci 8 -aryl or C 6 -Ci 8 -aryl which is substituted by C Ci 8 - alkyl.
- Preferred compounds of the formula (VIII) are compounds of the formula (Villa)
- R 4B is H or d-ds-alkyl
- R 48 is H, d-ds-alkyl or or
- the electron-transporting layer comprises a compound of the formula (Liq) and a compound of the formula
- the electron-transporting layer comprises the compound of the formula (VII) in an amount of 99 to 1 % by weight, preferably 75 to 25% by weight, more preferably about 50% by weight, where the amount of the compounds of the formulae (VII) and the amount of the compounds of the formulae (VIII) adds up to a total of 100% by weight.
- the preparation of the compounds of the formula (VIII) is described in J. Kido et al., Chem. Commun. (2008) 5821-5823, J. Kido et al., Chem. Mater. 20 (2008) 5951-5953 and JP2008-127326, or the compounds can be prepared analogously to the processes disclosed in the aforementioned documents.
- the invention relates to an inventive OLED wherein the electron-transporting layer comprises at least one phenanthroline derivative and/or pyridine derivative.
- the invention relates to an inventive OLED wherein the electron-transporting layer comprises at least one phenanthroline derivative and/or pyridine derivative and at least one alkali metal hydroxyquinolate complex.
- the invention relates to an inventive OLED wherein the electron-transporting layer comprises at least one phenanthroline derivative and/or pyridine derivative and 8-hydroxyquinolatolithium.
- the electron-transporting layer comprises at least one phenanthroline derivative and/or pyridine derivative and 8-hydroxyquinolatolithium.
- the cathode (5) is an electrode which serves to introduce electrons or negative charge carriers.
- the cathode may be any metal or nonmetal which has a lower work function than the anode. Suitable materials for the cathode are selected from the group consisting of alkali metals of group 1 , for example Li, Cs, alkaline earth metals of group 2, metals of group 12 of the Periodic Table of the Elements, comprising the rare earth metals and the lanthanides and actinides. In addition, metals such as aluminum, indium, calcium, barium, samarium and magnesium, and combinations thereof, may be used.
- lithium-comprising organometallic compounds such as 8- hydroxyquinolatolithium (Liq), CsF, NaF, KF, Cs 2 C0 3 or LiF may be applied between the organic layer and the cathode as an electron injection layer in order to reduce the operating voltage.
- organometallic compounds such as 8- hydroxyquinolatolithium (Liq), CsF, NaF, KF, Cs 2 C0 3 or LiF may be applied between the organic layer and the cathode as an electron injection layer in order to reduce the operating voltage.
- the OLED of the present invention may additionally comprise further layers which are known to those skilled in the art.
- a layer which eases the transport of the positive charge and/or matches the band gaps of the layers to one another may be applied between the layer (2) and the light-emitting layer (3).
- this further layer may serve as a protective layer.
- additional layers may be present between the light-emitting layer (3) and the layer (4) in order to ease the transport of the negative charge and/or to match the band gaps between the layers to one another.
- this layer may serve as a protective layer.
- the inventive OLED in addition to the layers (1 ) to (5), comprises at least one of the further layers mentioned below: - a hole injection layer between the anode (1 ) and the hole-transporting layer (2); a blocking layer for electrons between the hole-transporting layer (2) and the light- emitting layer (3);
- the OLED does not have all of the layers (1 ) to (5) mentioned; for example, an OLED comprising layers (1 ) (anode), (3) (light-emitting layer) and (5) (cathode) is likewise suitable, in which case the functions of layers (2) (hole-transporting layer) and (4) (electron-transporting layer) are assumed by the adjoining layers. OLEDs having layers (1 ), (2), (3) and (5) or layers (1 ), (3), (4) and (5) are likewise suitable.
- Suitable materials for the individual layers are known to those skilled in the art and disclosed, for example, in WO 00/70655.
- the layers (1 ), (2), (3), (4) and (5) have been surface-treated in order to increase the efficiency of charge carrier transport.
- the selection of the materials for each of the layers mentioned is preferably determined by obtaining an OLED having a high efficiency.
- the inventive OLED can be produced by methods known to those skilled in the art.
- the OLED is produced by successive vapor deposition of the individual layers onto a suitable substrate.
- Suitable substrates are, for example, glass, inorganic materials such as ITO or IZO or polymer films.
- customary techniques may be used, such as thermal evaporation, chemical vapor deposition (CVD), physical vapor deposition (PVD) and others.
- the organic layers may be coated from solutions or dispersions in suitable solvents, in which case coating techniques known to those skilled in the art are employed. Suitable coating techniques are, for example, spin- coating, the casting method, the Langmuir-Blodgett ("LB") method, the inkjet printing method, dip-coating, letterpress printing, screen printing, doctor blade printing, slit- coating, roller printing, reverse roller printing, offset lithography printing, flexographic printing, web printing, spray coating, coating by a brush or pad printing, and the like.
- spin-coating the inkjet printing method and the casting method since they are particularly simple and inexpensive to perform.
- the coating can be obtained using a solution prepared by dissolving the composition in a concentration of 0.0001 to 90% by weight in a suitable organic solvent such as benzene, toluene, xylene, tetrahydrofuran, methyltetrahydrofuran, N,N- dimethylformamide, acetone, acetonitrile, anisole, dichloromethane, dimethyl sulfoxide, water and mixtures thereof.
- a suitable organic solvent such as benzene, toluene, xylene, tetrahydrofuran, methyltetrahydrofuran, N,N- dimethylformamide, acetone, acetonitrile, anisole, dichloromethane, dimethyl sulfoxide, water and mixtures thereof.
- the different layers have the following thicknesses: anode (2) 500 to 5000 A, preferably 1000 to 2000 A (angstrom); hole-transporting layer (3) 50 to 1000 A, preferably 200 to 800 A; light-emitting layer (4) 10 to 1000 A, preferably 100 to 800 A; electron-transporting layer (5) 50 to 1000 A, preferably 200 to 800 A; cathode (6) 200 to 10 000 A, preferably 300 to 5000 A.
- the hole-transporting material can be mixed with the materials of the light-emitting layer and then applied together.
- the position of the recombination zone of holes and electrons in the inventive OLED and thus the emission spectrum of the OLED may be influenced by the relative thickness and concentration ratios of each layer.
- the ratio of the layer thicknesses of the individual layers in the OLED is dependent upon the materials used.
- the layer thicknesses of any additional layers used are known to those skilled in the art.
- the present invention relates to an OLED comprising at least one inventive metal-carbene complex, and at least one compound of the general formula (X)
- T is NR , S, O or PR , preferably S or O, more preferably O;
- R ,57 is aryl, heteroaryl, alkyl, cycloalkyl or heterocycloalkyl;
- Q' is -NR 58 R 59 , -SiR 70 R 71 R 72 , -P(O)R 60 R 61 , -PR 62 R 63 , -S(0) 2 R 64 , -S(0)R 65 , -SR 1 or -OR 67 , preferably -NR 58 R 59 ; more preferably
- R 68 , R 69 are each independently alkyl, cycloalkyl, heterocycloalkyl, aryl or heteroaryl; preferably methyl, carbazolyl, dibenzofuryl or dibenzothienyl;
- y, z are each independently 0, 1 , 2, 3 or 4, preferably 0 or 1 ;
- R 55 , R : 56 are each independently alkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl,
- SiR 70 R 71 R 72 a Q' group or a group with donor or acceptor action; a is 0, 1 , 2, 3 or 4;
- b' is 0, 1 , 2 or 3;
- R 1 59 form, together with the nitrogen atom, a cyclic radical which has 3 to 10 ring atoms and may be unsubstituted or substituted by one or more substituents selected from alkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl and a group with donor or acceptor action, and/or may be fused to one or more further cyclic radicals having 3 to 10 ring atoms, where the fused radicals may be unsubstituted or substituted by one or more substituents selected from alkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl and a group with donor or acceptor action;
- T is S or O, preferably O
- R 68 R 69 are each independently alkyl, cycloalkyi, heterocycloalkyi, aryl or heteroaryl; preferably methyl, carbazolyl, dibenzofuryl or dibenzothienyl;
- y. z are each independently 0, 1 , 2, 3 or 4, preferably 0 or 1.
- T is O or S, preferably O;
- y, z are each independently 0 or 1 ;
- R 68 , R 69 are each independently methyl, carbazolyl, dibenzofuryl or dibenzothienyl
- R 55 is substituted phenyl, carbazolyl, dibenzofuryl or dibenzothienyl.
- formula (Xab) is O or S, preferably O;
- R is substituted phenyl, carbazolyl, dibenzofuryl or dibenzothienyl.
- a very particularly preferred compound of the formula (Xab) is:
- T is O or S, preferably O.
- the compounds of the formula (X) can be prepared, for example, by the processes described in WO2010079051 , WO2007/077810, JP2009267255 or US20090017331 A1 , and WO2009/003898, or analogously to the processes described in the aforementioned documents.
- the compounds of the formula (X) have the formula (XI) or (XI * ):
- T is NR 57 , S, O or PR 57 ;
- R 57 is aryl, heteroaryl, alkyl, cycloalkyl or heterocycloalkyl
- Q' is -NR 58 R 59 , -SiR 70 R 71 R 72 , -P(O)R 60 R 61 , -PR 62 R 63 , -S(0) 2 R 64 ,
- S(0)R 65 , -SR bb or -OR b ' are each independently aryl, heteroaryl, alkyl, cycloalkyl,
- a cyclic radical which has 3 to 10 ring atoms and may be unsubstituted or substituted by one or more substituents selected from alkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl and a group with donor or acceptor action and/or may be fused to one or more further cyclic radicals having 3 to 10 ring atoms, where the fused radicals may be unsubstituted or substituted by one or more substituents selected from alkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl and a group with donor or acceptor action;
- SiR 74 R 75 R 76 are each independently SiR 74 R 75 R 76 , aryl, heteroaryl, alkyl, cycloalkyl or heterocycloalkyl, optionally substituted by an OR 77 group, are each independently SiR 74 R 75 R 76 , aryl, heteroaryl, alkyl, cycloalkyl or heterocycloalkyl,
- the compounds of the general formula (X) can be used as a matrix (diluent material), hole/exciton blocker, electron/exciton blocker, electron transport material or hole transport material in combination with the complexes claimed, which then preferably serve as emitters.
- Inventive OLEDs which include both at least one compound of the formula (X) and a compound of the formula (I) exhibit particularly good efficiencies and lifetimes. Depending on the function in which the compound of the formula (X) is used, it is present in pure form or in different mixing ratios.
- one or more compounds of the formula (X) are used as matrix material in the light-emitting layer.
- aryl radical or group, heteroaryl radical or group, alkyl radical or group, cycloalkyl radical or group, heterocycloalkyl radical or group, alkenyl radical or group, alkynyl radical or group, and groups with donor and/or acceptor action are each defined as follows:
- An aryl radical is understood to mean a radical having a base skeleton of 6 to 30 carbon atoms, preferably 6 to 18 carbon atoms, which is formed from an aromatic ring or a plurality of fused aromatic rings.
- Suitable base skeletons are, for example, phenyl, naphthyl, anthracenyl or phenanthrenyl, indenyl or fluorenyl.
- This base skeleton may be unsubstituted (which means that all carbon atoms which are substitutable bear hydrogen atoms), or may be substituted at one, more than one or all substitutable positions of the base skeleton.
- Suitable substituents are, for example, deuterium, alkoxy radicals, aryloxy radicals, alkylamino groups, arylamino groups, carbazolyl groups, silyl groups, SiR 78 R 79 R 80 , suitable silyl groups SiR 78 R 79 R 80 being specified below, alkyl radicals, preferably alkyl radicals having 1 to 8 carbon atoms, more preferably methyl, ethyl or i-propyl, aryl radicals, preferably C 6 -aryl radicals, which may in turn be substituted or unsubstituted, heteroaryl radicals, preferably heteroaryl radicals which comprise at least one nitrogen atom, more preferably pyridyl radicals and carbazolyl radicals, alkenyl radicals, preferably alkenyl radicals which bear one double bond, more preferably alkenyl radicals having one double bond and 1 to 8 carbon atoms, alkynyl radicals, preferably alkynyl radical
- the substituted aryl radicals most preferably bear substituents selected from the group consisting of methyl, ethyl, isopropyl, alkoxy, heteroaryl, halogen, pseudohalogen and amino, preferably arylamino.
- the aryl radical or the aryl group is preferably a C 6 -Ci 8 -aryl radical, more preferably a C 6 -aryl radical, which is optionally substituted by at least one or more than one of the aforementioned substituents.
- the C 6 -Ci 8 -aryl radical preferably C 6 -aryl radical, more preferably has none, one, two, three or four, most preferably none, one or two, of the aforementioned substituents.
- a heteroaryl radical or a heteroaryl group is understood to mean radicals which differ from the aforementioned aryl radicals in that at least one carbon atom in the base skeleton of the aryl radicals is replaced by a heteroatom, and in that the base skeleton of the heteroaryl radicals preferably has 5 to 18 ring atoms.
- Preferred heteroatoms are N, O and S.
- Heteroaryl radicals suitable with particular preference are nitrogen- containing heteroaryl radicals.
- the base skeleton is especially preferably selected from systems such as pyridine, pyrimidine and five- membered heteroaromatics such as pyrrole, furan, pyrazole, imidazole, thiophene, oxazole, thiazole, triazole.
- the heteroaryl radicals may be fused ring systems, for example benzofuryl, benzothienyl, benzopyrrolyl, dibenzofuryl, dibenzothienyl, phenanthrolinyl, carbazolyl radicals, azacarbazolyl radicals or diazacarbazolyl radicals.
- the base skeleton may be substituted at one, more than one or all substitutable positions of the base skeleton. Suitable substituents are the same as have already been specified for the aryl groups.
- alkyl radical or an alkyl group is understood to mean a radical having 1 to 20 carbon atoms, preferably 1 to 10 carbon atoms, more preferably 1 to 8, most preferably 1 to 4 carbon atoms.
- This alkyl radical may be branched or unbranched and optionally be interrupted by one or more heteroatoms, preferably Si, N, O or S, more preferably N, O or S.
- this alkyl radical may be substituted by one or more of the substituents specified for the aryl groups.
- the alkyl radicals present in accordance with the invention may have at least one halogen atom, for example F, CI, Br or I, especially F.
- the alkyl radicals present in accordance with the invention may be fully fluorinated. It is likewise possible that the alkyl radical bears one or more (hetero)aryl groups. In the context of the present application, for example, benzyl radicals are thus substituted alkyl radicals. In this context, all of the (hetero)aryl groups listed above are suitable.
- the alkyl radicals are more preferably selected from the group consisting of methyl, ethyl, isopropyl, n-propyl, n-butyl, iso- butyl and tert-butyl, very particular preference being given to methyl and ethyl.
- a cycloalkyl radical or a cycloalkyl group is understood to mean a radical having 3 to 20 carbon atoms, preferably 3 to 10 carbon atoms, more preferably 3 to 8 carbon atoms.
- This base skeleton may be unsubstituted (which means that all carbon atoms which are substitutable bear hydrogen atoms) or substituted at one, more than one or all substitutable positions of the base skeleton.
- Suitable substituents are the groups already mentioned above for the aryl radicals. It is likewise possible that the cycloalkyl radical bears one or more (hetero)aryl groups. Examples of suitable cycloalkyl radicals are cyclopropyl, cyclopentyl and cyclohexyl.
- a heterocycloalkyi radical or a heterocycloalkyi group is understood to mean radicals which differ from the aforementioned cycloalkyi radicals in that at least one carbon atom in the base skeleton of the cycloalkyi radicals is replaced by a heteroatom.
- Preferred heteroatoms are N, O and S.
- one or two carbon atoms of the base skeleton of the cycloalkyi radicals are replaced by heteroatoms.
- suitable heterocycloalkyi radicals are radicals derived from pyrrolidine, piperidine, piperazine, tetrahydrofuran, dioxane.
- An alkenyl radical or an alkenyl group is understood to mean a radical which corresponds to the aforementioned alkyl radicals having at least two carbon atoms, with the difference that at least one C-C single bond of the alkyl radical is replaced by a C-C double bond.
- the alkenyl radical preferably has one or two double bonds.
- An alkynyl radical or an alkynyl group is understood to mean a radical which corresponds to the aforementioned alkyl radicals having at least two carbon atoms, with the difference that at least one C-C single bond of the alkyl radical is replaced by a C-C triple bond.
- the alkynyl radical preferably has one or two triple bonds.
- An SiR 78 R 79 R 80 group is understood to mean a silyl radical in which
- R 78 , R 79 and R 80 are each independently alkyl, cycloalkyi, heterocycloalkyi, aryl, heteroaryl or OR 73 .
- An SiR 74 R 75 R 76 group is understood to mean a silyl radical in which
- R 74 , R 75 and R 76 are each independently alkyl, cycloalkyi, heterocycloalkyi, aryl, heteroaryl or OR 73 .
- a group or a substituent with donor or acceptor action is understood to mean the following groups:
- Groups with donor action are understood to mean groups which have a +l and/or +M effect, and groups with acceptor action are understood to mean groups which have a -I and/or -M effect.
- the R 81 , R 82 and R 83 radicals mentioned in the aforementioned groups with donor or acceptor action are each independently: substituted or unsubstituted CrC 20 -alkyl or substituted or unsubstituted C 6 -C 3 o-aryl, or OR 76 , suitable and preferred alkyl and aryl radicals having been specified above.
- the R 81 , R 82 and R 83 radicals are more preferably CrC 6 -alkyl, e.g. methyl, ethyl or i-propyl, or phenyl.
- R 81 R 82 R 83 - R 81 , R 82 and R 83 are preferably each independently substituted or unsubstituted CrC 20 -alkyl or substituted or unsubstituted aryl, preferably phenyl.
- Preferred substituents with donor or acceptor action are selected from the group consisting of:
- CF 3 CH 2 F, CHF 2 or C 2 F 5 ; amino, preferably dimethylamino, diethylamino or diarylamino, more preferably diarylamino; pseudohalogen radicals, preferably CN, - C(0)OC C 4 -alkyl, preferably -C(0)OMe, P(0)R 2 , preferably P(0)Ph 2 .
- Very particularly preferred substituents with donor or acceptor action are selected from the group consisting of methoxy, phenyloxy, halogenated Ci-C 4 -alkyl, preferably CF 3 , CH 2 F, CHF 2 , C 2 F 5 , halogen, preferably F, CN, SiR 81 R 82 R 83 , suitable R 81 , R 82 and R 83 radicals already having been specified, for example SiMe 3 , diarylamino (NR 84 R 85 where R 84 , R 85 are each C 6 -C 30 -aryl), -C(0)OC C 4 -alkyl, preferably -C(0)OMe, P(0)Ph 2 .
- Halogen groups are preferably understood to mean F, CI and Br, more preferably F and CI, most preferably F.
- Pseudohalogen groups are preferably understood to mean CN, SCN and OCN, more preferably CN.
- the aforementioned groups with donor or acceptor action do not rule out the possibility that further radicals and substituents mentioned in the present application, but not included in the above list of groups with donor or acceptor action, have donor or acceptor action.
- aryl radicals or groups, heteroaryl radicals or groups, alkyl radicals or groups, cycloalkyi radicals or groups, heterocycloalkyi radicals or groups, alkenyl radicals or groups and groups with donor and/or acceptor action may - as mentioned above - be substituted or unsubstituted.
- an unsubstituted group is understood to mean a group in which the substitutable atoms of the group bear hydrogen atoms.
- a substituted group is understood to mean a group in which one or more substitutable atom(s) bear(s) a substituent in place of a hydrogen atom at least at one position. Suitable substituents are the substituents specified above for the aryl radicals or groups.
- radicals having the same numbering occur more than once in the compounds according to the present application, these radicals may each independently have the definitions specified.
- the T radical in the compounds of the formula (X) is NR 57 , S, O or PR 57 , preferably NR 57 , S or O, more preferably O or S, most preferably O.
- the R 57 radical is aryl, heteroaryl, alkyl, cycloalkyi or heterocycloalkyi, preferably aryl, heteroaryl or alkyl, more preferably aryl, where the aforementioned radicals may be unsubstituted or substituted. Suitable substituents have been specified above.
- R 65 is more preferably phenyl which may be substituted by the aforementioned substituents or unsubstituted.
- R 57 is most preferably unsubstituted phenyl.
- the Q' group in the compounds of the formula (X) is -NR 58 R 59 , -SiR 70 R 71 R 72 , -P(O)R 60 R 61 , -PR 62 R 63 , -S(0) 2 R 64 , -S(0)R 65 , -SR 66 or -OR 67 ; preferably NR 58 R 59 , - P(O)R 60 R 61 or -OR 67 , more preferably -NR 58 R 59 .
- R 58 to R 67 , R 70 , R 71 , R 72 and R 74 to R 76 radicals are each defined as follows:
- R 58 , R 59 form, together with the nitrogen atom, a cyclic radical which has 3 to 10 ring atoms and may be unsubstituted or substituted by one or more substituents selected from alkyl, cycloalkyi, heterocycloalkyi, aryl, heteroaryl and a group with donor or acceptor action and/or may be fused to one or more further cyclic radicals having 3 to 10 ring atoms, where the fused radicals may be unsubstituted or substituted by one or more substituents selected from alkyl, cycloalkyl, heterocycloalkyi, aryl, heteroaryl and a group with donor or acceptor action;
- R 70 , R 71 , R 72 are each independently aryl, heteroaryl, alkyl, cycloalkyl, heterocycloalkyi or OR 73 ,
- R 73 is independently SiR 74 R 75 R 76 , aryl, heteroaryl, alkyl, cycloalkyl or
- R 77 is independently SiR 74 R 75 R 76 , aryl, heteroaryl, alkyl, cycloalkyl or
- radicals are each independently aryl, heteroaryl, alkyl, cycloalkyl or heterocycloalkyi, preferably aryl or heteroaryl, where the radicals may be unsubstituted or substituted by one or more of the radicals selected from alkyl, cycloalkyl, heterocycloalkyi, aryl, heteroaryl and a group with donor or acceptor action, more preferably unsubstituted or substituted phenyl, suitable substituents having been specified above, for example tolyl or a group of the formula
- T group is as defined for the compounds of the formula (XI) or (XI * ) and the R 70 , R 71 and R 72 radicals are defined above.
- R 60 , R 61 , R 62 , R 63 , R 64 , R 65 , R 66 and R 67 are most preferably each independently phenyl, tolyl or a group of the formula
- T is NPh, S or O.
- Examples of -NR 58 R 59 groups suitable with preference are selected from the group consisting of pyrrolyl, 2,5-dihydro-1 -pyrrolyl, pyrrolidinyl, indolyl, indolinyl, isoindolinyl, carbazolyl, azacarbazolyl, diazacarbazolyl, imidazolyl, imidazolinyl, benzimidazolyl, pyrazolyl, indazolyl, 1 ,2,3-triazolyl, benzotriazolyl, 1 ,2,4-triazolyl, tetrazolyl, 1 ,3- oxazolyl, 1 ,3-thiazolyl, piperidyl, morpholinyl, 9,10-dihydroacridinyl and 1 ,4-oxazinyl, where the aforementioned groups may be unsubstituted or substituted by one or more substituents selected from alkyl, cyclo
- Particularly preferred -NR 58 R 59 groups are:
- R 68 , R 69 are each independently alkyl, cycloalkyi, heterocycloalkyi, aryl or
- heteroaryl preferably methyl, carbazolyl, dibenzofuryl or dibenzothienyl; y, z are each independently 0, 1 , 2, 3 or 4, preferably 0 or 1 ;
- R , R in the compounds of the formula (X) are each independently alkyl, cycloalkyi, heterocycloalkyi, aryl, heteroaryl, a further A group or a group with donor or acceptor action; preferably each independently alkyl, aryl, heteroaryl or a group with donor or acceptor action.
- R 55 or R 56 may each independently be:
- X is NPh, S or O.
- a" R groups and/or b' R groups may be present, where a" and b' are: a" is 0, 1 , 2, 3 or 4; preferably independently 0, 1 or 2;
- b' is 0, 1 , 2 or 3; preferably independently 0, 1 or 2.
- At least a" or b' is 0, very especially preferably a" and b' are each 0 or a" is 1 and b' is 0.
- R 73 in the compounds of the general formula (XI) is generally independently SiR 74 R 75 R 76 , aryl, heteroaryl, alkyl, cycloalkyl or heterocycloalkyl, optionally substituted by an OR 77 group.
- R 77 in compounds of the general formula (XI) is generally independently aryl, heteroaryl, alkyl, cycloalkyl or heterocycloalkyl.
- OR 77 substituent optionally present may generally be present in the radicals mentioned at all sites which appear suitable to the person skilled in the art.
- two units of the general formula (XI) and/or ( ⁇ ) are bridged to one another via a linear or branched, saturated or unsaturated bridge optionally interrupted by at least one heteroatom or via O, where this bridge in the general formula (XI) and/or ( ⁇ ) is in each case attached to the silicon atoms in place of R 71 .
- This bridge is preferably selected from the group consisting of -CH 2 -, -C 2 H 4 -, -C 3 H 6 -, -C4H8-, -C6H-I2-, -C8H-I6-, -C9H18-, -CH(C8H"
- 7 )CH2-, -C2H 4 (CF2)8 C2H4-, -C C-, -1 ,4- (CH 2 )2-phenyl-(CH 2 )2-, 1 ,3-(CH 2 )2-phenyl-(CH 2 )2-, -1 ,4-phenyl-, -1 ,3-phenyl-, -0-, -0-Si(CH 3 ) 2 -0-, -0-Si(CH 3 ) 2 -0- Si(CH 3 ) 2 -0-, -O-
- the compounds of the general formula (X) have the general formula (XIa), (Xlb), (Xlc), (Xld) or (Xle), i.e. they are preferred embodiments of the compounds of the general formula (XI) or (XI * ): in which the Q ⁇ T, R , R , R , R , R radicals and groups, and a' and b', are each as defined above.
- R 70 , R 71 or R 72 in the compounds of the general formula (XI) or ( ⁇ ) are aromatic units of the general formulae (Xli) and/or (Xli * )
- R 55 , R 56 , Q', T, a' and b' are each as defined above.
- the present invention therefore relates, in one embodiment, to an inventive OLED where R 70 , R 71 or R 72 in the compounds of the general formula (XI) or ( ⁇ ) are aromatic units of the general formulae (Xli) and/or (Xli * )
- the present invention relates to an OLED wherein the compound of the general formula (XI) or (XI * ) is selected from the following group:
- T is S or O
- R' isHorCH 3 ;
- R 70 , R 71 , R 72 are each phenyl, carbazolyl, dibenzofuran or dibenzothiophene.
- T is O or S, preferably O.
- Further suitable compounds of the general formula (XI) or ( ⁇ ) correspond to the following formula (XII)
- R , R , R are defined as follows:
- the present invention relates to an OLED comprising at least one inventive metal-carbene complex of the formula (I) and at least one compound of the general formula (X), where the compound of the general formula (X) has the general formula (XIV):
- a further embodiment of the present invention relates to an inventive organic light- emitting diode in which the compound of the general formula VI is a 3,6-disilyl- substituted compound of the general formula Via:
- Ci-C 2 o-alkyl substituted or unsubstituted C 6 - C 30 -aryl or substituted or unsubstituted heteroaryl having 5 to 30 ring atoms; preferably substituted or unsubstituted C 6 -C 3 o-aryl or unsubstituted Ci-C 2 o-alkyl, more preferably substituted or unsubstituted C 6 -Cio-aryl, most preferably substituted or unsubstituted phenyl, suitable substituents having been specified above;
- R 38 , R 39 or R 40 radicals and/or at least one of the R 41 , R 42 or R 43 radicals is substituted or unsubstituted C 6 -C 3 o-aryl, more preferably substituted or unsubstituted C 6 -Ci 0 -aryl, most preferably substituted or unsubstituted phenyl, suitable substituents having been specified above, and/or one of the R 38 , R 39 or R 40 radicals and/or one of the R 41 , R 42 or R 43 radicals is a radical of the structure (c);
- R a and R b are each independently hydrogen or as defined for R a and R b , i.e. each independently substituted or unsubstituted CrC 2 o-alkyl, substituted or unsubstituted C 6 -C 20 -aryl, substituted or unsubstituted heteroaryl having 5 to 30 ring atoms or a substituent with donor or acceptor action, suitable substituents with donor or acceptor action having been specified above; preferably hydrogen, substituted or unsubstituted CrC 6 -alkyl, substituted or unsubstituted C 6 -Ci 0 -aryl or SiR 34 R 35 R 36 ; more preferably hydrogen, methyl, ethyl, phenyl, CF 3 or SiR 34 R 35 R 36' where R 34' , R 35' and R 36' are preferably each independently substituted or unsubstituted CrC 2 o-alkyl or substituted or unsubstituted phenyl; more
- the compounds of the formula (XIV) used in the inventive organic light-emitting diodes have the following definitions for the R 37 to R 43 , R a and R b radicals, and X' group:
- X' is NR 37' ;
- R 37 is substituted or unsubstituted C 6 -C 3 o-aryl, preferably substituted or unsubstituted C 6 -Ci 0 -aryl, more preferably substituted or unsubstituted phenyl, suitable substituents having been specified above;
- R a and R b are each independently hydrogen or as defined for R a and R b , i.e. each independently substituted or unsubstituted Ci-C 2 o-alkyl, substituted or unsubstituted C 6 -C 3 o-aryl, substituted or unsubstituted heteroaryl having 5 to 30 ring atoms or a substituent with donor or acceptor action, suitable substituents with donor or acceptor action already having been specified above; preferably hydrogen, substituted or unsubstituted CrC 6 -alkyl, substituted or unsubstituted C 6 -Ci 0 -aryl or SiR 34 R 35 R 36 ; more preferably hydrogen, methyl, ethyl, phenyl, CF 3 or SiR 34 R 35 R 36' ;
- R 34 , R 35 and R 36 are more preferably each independently substituted or unsubstituted CrC 2 o-alkyl or substituted or unsubstituted phenyl; more preferably, at least one of the R 34 , R 35 or R 36 radicals is substituted or unsubstituted phenyl; most preferably, at least one of the R 34 , R 35 and R 36 radicals is substituted phenyl, suitable substituents having been specified above.
- the present invention relates to an OLED which, as well as at least one metal-carbene complex of the general formula (I), comprises at least one compound of the general formula (X), in which case the compound of the formula (X) is most preferably at least one of the compounds specified below: 85
- T is O or S, preferably O.
- all T groups have the same definition.
- crosslinked or polymeric materials comprising repeat units based on the general formula (X) in crosslinked or polymerized form together with at least one metal-carbene complex of the general formula (I).
- the latter are preferably used as matrix materials.
- the crosslinked or polymeric materials have outstanding solubility in organic solvents, excellent film-forming properties and relatively high glass transition temperatures.
- high charge carrier mobilities, high stabilities of color emission and long operating times of the corresponding components can be observed when crosslinked or polymeric materials according to the present invention are used in organic light- emitting diodes (OLEDs).
- the crosslinked or polymerized materials are particularly suitable as coatings or in thin films since they are thermally and mechanically stable and relatively defect-free.
- the crosslinked or polymerized materials comprising repeat units based on the general formula (X) can be prepared by a process comprising steps (a) and (b): (a) preparation of a crosslinkable or polymerizable compound of the general formula (X) where at least one of the a" R 55 radicals or at least one of the b' R 56 radicals is a crosslinkable or polymerizable group attached via a spacer, and
- step (b) crosslinking or polymerization of the compound of the general formula (X) obtained from step (a).
- the crosslinked or polymerized materials may be homopolymers, which means that exclusively units of the general formula (X) are present in crosslinked or polymerized form. They may also be copolymers, which means that further monomers are present in addition to the units of the general formula (X), for example monomers with hole- conducting and/or electron-conducting properties, in crosslinked or polymerized form.
- inventive OLED comprises an emission layer comprising at least one inventive metal-carbene complex of the general formula (I), at least one matrix material of the formula (X), and optionally at least one further hole-transporting matrix material.
- the inventive OLEDs can be used in all devices in which electroluminescence is useful. Suitable devices are preferably selected from stationary and mobile visual display units and illumination means.
- the present invention therefore also relates to a device selected from the group consisting of stationary visual display units and mobile visual display units and illumination means, comprising an inventive OLED.
- Stationary visual display units are, for example, visual display units of computers, televisions, visual display units in printers, kitchen appliances and advertising panels, illuminations and information panels.
- Mobile visual display units are, for example, visual display units in cellphones, laptops, tablet PCs, digital cameras, mp-3 players, smartphones, vehicles, and destination displays on buses and trains.
- inventive metal-carbene complexes of the general formula (I) can additionally be used in OLEDs with inverse structure.
- the inventive complexes are in turn preferably used in the light-emitting layer.
- the structure of inverse OLEDs and the materials typically used therein are known to those skilled in the art.
- the present invention further provides a white OLED comprising at least one inventive metal-carbene complex of the general formula (I).
- the metal-carbene complex of the general formula (I) is used as emitter material in the white OLED.
- Preferred embodiments of the metal-carbene complex of the general formula (I) have been specified above.
- the white OLED may comprise
- the compounds of the formula (VII) and/or (IX) are preferably used as electron transport material.
- Preferred compounds of the formulae (VII) and (IX) have been specified above.
- the OLED In order to obtain white light, the OLED must generate light which colors the entire visible range of the spectrum.
- organic emitters normally emit only in a limited portion of the visible spectrum - i.e. are colored.
- White light can be generated by the combination of different emitters. Typically, red, green and blue emitters are combined.
- the prior art also discloses other methods for formation of white OLEDs, for example the triplet harvesting approach. Suitable structures for white OLEDs or methods for formation of white OLEDs are known to those skilled in the art.
- a white OLED In one embodiment of a white OLED, several dyes are layered one on top of another in the light-emitting layer of an OLED and hence combined (layered device). This can be achieved by mixing all dyes or by direct series connection of different-colored layers.
- layered OLED and suitable embodiments are known to those skilled in the art.
- the different layers then have the following thicknesses: anode (2) 500 to 5000 A (angstrom), preferably 1000 to 2000 A; hole-transporting layer (3) 50 to 1000 A, preferably 200 to 800 A, either a light-emitting layer comprising a mixture of different emitters (4): 10 to 1000 A, preferably 100 to 800 A, or several light-emitting layers in succession, each individual layer comprising a different emitter (4a, b, c, ...): each 10 to 1000 A, preferably each 50 to 600 A, electron-transporting layer (5) 50 to 1000 A, preferably 200 to 800 A, cathode (6) 200 to 10 000 A, preferably 300 to 5000 A.
- a white OLED In a further embodiment of a white OLED, several different-colored OLEDs are stacked one on top of another (stacked device). For the stacking of two OLEDs, what is called a charge generation layer (CG layer) is used. This CG layer may be formed, for example, from one electrically n-doped and one electrically p-doped transport layer.
- CG layer charge generation layer
- This expression "stacked OLED" and suitable embodiments are known to those skilled in the art.
- the different layers then have the following thicknesses: anode (2) 500 to 5000 A (angstrom), preferably 1000 to 2000 A; first hole-transporting layer (3) 50 to 1000 A, preferably 200 to 800 A, first light-emitting layer (4) 10 to 1000 A, preferably 50 to 600 A, first electron-transporting layer (5) 50 to 1000 A, preferably 200 to 800 A, electrically n-doped layer 50 to 1000 A, preferably 100 to 800 A, electrically p-doped layer 50 to 1000 A, preferably 100 to 800 A, second hole-transporting layer (3) to 50 to 1000 A, preferably 200 to 800 A, second light-emiting layer (4) 10 to 1000 A, preferably 50 to 600 A, second electron-transporting layer (5) 50 to 1000 A, preferably 200 to 800 A, electrically n-doped layer 50 to 1000 A, preferably 100 to 800 A, electrically p- doped layer 50 to 1000 A, preferably 100 to 800 A, third hole-transporting layer (3) to to 1000 A, preferably 200 to 800
- the two concepts mentioned for white light generation can also be combined.
- a single-color OLED for example blue
- a multicolor layered OLED for example red-green
- inventive metal-carbene complex of the formula (I) can be used in any of the layers mentioned above in white OLEDs. In a preferred embodiment, it is used in one or more or all light-emitting layer(s) of the OLED(s), in which case the structure of the invention metal-carbene complex is varied as a function of the use of the complex. Suitable and preferred components for the further layers of the light OLED(s) or materials suitable as matrix material in the light-emitting layer(s) and preferred matrix materials are likewise specified above.
- the present invention also relates to an organic electronic component, preferably an organic light-emitting diode (OLED), organic photovoltaic cell (OPV), organic field-effect transistor (OFET) or light-emitting electrochemical cell (LEEC), comprising at least one inventive metal-carbene complex of the general formula (I).
- OLED organic light-emitting diode
- OPFET organic field-effect transistor
- LEEC light-emitting electrochemical cell
- a suspension of 1 ,3-diphenyl-4-azabenzimidazolium chloride (4.9 g, 16 mmol) and 3A molecular sieve (25 g) in dioxane (250 ml) is admixed with silver(l) oxide (3.0 g, 13 mmol) and stirred at room temperature overnight.
- the mixture is admixed with chloro(1 ,5-cyclooctadien)iridium(l) dimer (1.1 g, 1 .6 mmol) and stirred under reflux overnight. After cooling to room temperature, the precipitate is filtered off with suction and washed with dichloromethane.
- a suspension of 1 -isopropyl-3-phenyl-4-azabenzimidazolium iodide (4.5 g, 16 mmol) and 3A molecular sieve (55 g) in dioxane (380 ml) is admixed with silver(l) oxide (3.1 g, 13 mmol) and stirred at room temperature overnight.
- the mixture is admixed with a solution of chloro-(1 ,5-cyclooctadiene)iridium(l) dimer (1 .1 g, 1 .6 mmol) in o-xylene (500 ml) and stirred at 1 10°C overnight.
- a suspension of 1 -isopropyl-3-(2"-methylbiphen-3'-yl)-4-azabenzimidazolium iodide (400 mg, 0.9 mmol) and 3A molecular sieve (2 g) in dioxane (15 ml) is admixed with silver(l) oxide (163 mg, 0.7 mmol) and stirred at room temperature overnight.
- the mixture is admixed with chloro(1 ,5-cyclooctadiene)iridium(l) dimer (57 mg, 0.08 mmol) and stirred under reflux for three days.
- a suspension of 1 -isopropyl-3-(4-tert-butylphenyl)-4-azabenzimidazolium iodide (8.05 g, 19.2 mmol) and 3A molecular sieve (60 g) in dioxane (400 ml) is admixed with silver(l) oxide (3.35 g, 14.5 mmol) and stirred at room temperature overnight.
- the mixture is admixed with a solution of chloro(1 ,5-cyclooctadiene)iridium(l) dimer (1.28 g, 1.91 mmol) in o-xylene (600 ml) and stirred at 1 10°C overnight.
- a suspension of 1 -isopropyl-3-(4'(-/V-ethylcarbazolyl))-4-azabenzimidazolium iodide (3.99 g, 8.27 mmol) and 3A molecular sieve (50 g) in dioxane (700 ml) is admixed with silver(l) oxide (1 .97 g, 8.50 mmol) and stirred at room temperature for 48 h.
- the mixture is admixed with a solution of chloro(1 ,5-cyclooctadiene)iridium(l) dimer (555 mg, 0.83 mmol) in o-xylene (500 ml) and stirred at 1 10°C overnight.
- K 1 5.00 g (14.0 mmol) of 1 ,3-diphenyl-3H-benzimidazolium tetrafluoroborate are suspended in 80 ml of anhydrous toluene and cooled to -8°C. Then 28 ml of potassium bis(trimethylsilyl)amide (KHMDS, 0.5M in toluene, 14.0 mmol) are added within 10 min. The mixture is stirred at room temperature for one hour and then added dropwise at - 78°C within 15 min to a solution of 4.70 g (7.0 mmol) of [( ⁇ - ⁇ ) ⁇ ( ⁇ 4 -1 ,5-COD)] 2 in 120 ml toluene.
- KHMDS potassium bis(trimethylsilyl)amide
- ⁇ 1 .17 (m, 2H), 1 .34 (m, 4H), 1.61 (m, 2H), 2.43 (m, 2H), 4.31 (m, 2H), 7.18 (m, 2H), 7.25 (m, 2H), 7.51 (m, 6H), 7.96 (m, 4H).
- a suspension of 0.98 g (3.2 mmol) of 1 ,3-diphenyl-4-azabenzimidazolium chloride ZW1 in 75 ml of anhydrous toluene are admixed gradually at 0°C with 6.4 ml of potassium bis(trimethylsilyl)amide (KHMDS, 0.5M in toluene, 3.2 mmol).
- KHMDS potassium bis(trimethylsilyl)amide
- the reaction mixture is allowed to warm up and is stirred at room temperature for 1 h.
- a solution of 0.92 g (1 .5 mmol) of K1 in 125 ml of anhydrous toluene is added dropwise. This is followed by stirring at room temperature for half an hour and at reflux for 18 h.
- Example 11 Complex Em11 -s:
- a suspension of 1 -isopropyl-3-phenyl-4-azabenzimidazolium iodide (synthesis described in stage 3, Example 2; 0.46 g, 1 .3 mmol) in anhydrous dioxane (100 ml) is admixed with molecular sieve (10 g) and silver(l) oxide (0.19 g, 0.81 mmol), and the mixture is stirred at room temperature overnight.
- ⁇ 0.62 (d, 3H), 0.83 (d, 3H), 0.88 (d, 3H), 1.01 (d, 3H), 1.05 (d, 3H), 1.08 (d, 3H), 1.14 (d, 3H), 1.19 (d, 3H), 1.22 (d, 3H), 1.71 (d, 3H), 1.77 (sept, 1H), 2.50 (sept.1H), 2.60 (sept, 1H), 2.78 (sept, 1H), 5.26 (sept, 1H), 6.14 (d, 1H), 6.20 (d, 2H), 6.39-6.48 (m, 3H), 6.54 (m, 2H), 6.62-6.73 (m, 4H), 6.79 (s, 1H), 6.90 (s, 1H), 6.97 (t, 1H), 7.13 (dd, 1H), 7.25 (d, 1H), 7.33-7.37 (m, 3H), 7.49 (t, 1H), 7.54 (t, 1H), 7.75 (d, 1H), 8.35 (d,
- a suspension of 1 -isopropyl-3-phenyl-4-azabenzimidazolium iodide (synthesis described in stage 3, Example 2; 0.46 g, 1 .3 mmol) in anhydrous dioxane (100 ml) is admixed with molecular sieve (10 g) and silver(l) oxide (0.19 g, 0.81 mmol), and stirred at room temperature overnight.
- molecular sieve (10 g) and silver(l) oxide (0.19 g, 0.81 mmol
- a solution of chloro dimer K3 (the preparation of the chloro dimer is described as compound D2 in WO 201 1/051404, 0.57 g, 0.31 mmol) is dissolved in dioxane (100 ml) and added dropwise to the reaction mixture.
- m ax 480 nm, CIE: (0.17;0.24).
- the ITO substrate used as the anode is cleaned first with commercial detergents for LCD production (Deconex ® 20NS, and 250RGAN-ACID ® neutralizing agent) and then in an acetone/isopropanol mixture in an ultrasound bath. To eliminate possible organic residues, the substrate is exposed to a continuous ozone flow in an ozone oven for a further 25 minutes. This treatment also improves the hole injection properties of the ITO. Next, the hole injection layer AJ20-1000 from Plexcore is spun on from solution.
- the hole conductor and exciton blocker applied to the substrate is lr(DPBIC) 3 with a thickness of 45 nm, of which the first 35 nm are doped with MoO x to improve the conductivity.
- a mixture of emitter, in this case Em11 -i (15%), and of the compound Ma1 is applied by vapor deposition with a thickness of 20 nm, the latter compound functioning as a matrix material.
- Compound Ma1 is described as No. 14 in WO 2010/079051 .
- the material lr(DPBIC) 3 is applied by vapor deposition with a thickness of 5 nm as an exciton and hole blocker.
- a mixture of Liq and BCP (2,9-dimethyl-4,7-diphenyl-1 ,10-phenanthroline) is applied by vapor deposition in a thickness of 40 nm, as are a 1 .0 nm-thick liq layer and finally a 100 nm- thick Al electrode. All components are adhesive-bonded to a glass lid in an inert nitrogen atmosphere.
- electroluminescence spectra are recorded at different currents and voltages.
- the current-voltage characteristic is measured in combination with the light output emitted.
- the light output can be converted to photometric parameters by calibration with a photometer.
- the lifetime t 1/2 of the diode is defined by the time taken for the luminance to fall to 50% of its initial value. The lifetime measurement is carried out at a constant current.
- a luminous diode with the following CIE values is obtained: 0.18; 0.26 (voltage in V @ 300 nits: 4.5).
- T1 The synthesis of T1 is described as A1 in European application EP10166507.3 and in US application US61/356057.
- the hole conductor layer was 15 nm, but the hole blocker layer was 5 nm and the electon conductor layer was 40 nm.
- Compound LB1 is described as compound “4g” in WO2009/003898.
- fac-Em2 is, however, still being used as the hole conductor and electron blocker.
- Zink(ll)-chloride-dihydrate (4.39 g, 19.5 mmol) is added to a solution of 2-chloro— 3- nitro-5-(trifluoromethyl)pyridine (1.00 g, 4.41 mmol) in a ethyl acetate (25 ml), and the resultant suspension is stirred for 2 h at 80 °C. After cooling to room temperature, the reaction mixture is slowly added dropwise into an ice cooled saturated sodium hydrogen carbonate solution (100 ml). After warming to room temperature, the resultant suspension is filtered via a celite layer, and the residue is washed four times with ethyl acetate (50 ml each).
- the filtrate and the washing solution are combined and subsequently washed with a saturated sodium hydrogen carbonate solution, water and a saturated aqueous sodium chloride solution.
- the organic phase is dried over magnesium sulfate, filtered and conenctrated to dryness. Yield: 0.78 g (90 %).
- Ammoniumiodide (0.12 g, 0.85 mmol) is added to a solution of 2-N-phenylamino-3-N- isopropylamino-5-(trifluoromethyl)pyridine (0.22 g, 0.74 mmol) in triethylorthoformiate (7.5 ml), and the resultant reaction mixture is stirred at 85 °C for 18 h. After cooling to room temperature, the precipitate formed is filtered, washed with petroleum ether and dried in vacuo. Yield: 0.31 g (97 %).
- Silver(l)oxide (0.50 g, 2.15 mmol) is added to a mixture of 1 -isopropyl-3-phenyl-6- trifluoromethyl-4-azabenzimidazole-iodide (1.25 g, 2.88 mmol), molecular sieve (10 g) and 1 .4-dioxane (150 ml), and the reaction mixture is stirred at room temperature for 16 h. The solvent is removed under reduced pressure and the residue is taken up in o- xylol (200 ml).
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Crystallography & Structural Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Electroluminescent Light Sources (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
The present invention relates to metal-carbene complexes comprising a central atom selected from iridium and platinum, and specific azabenzimidazolocarbeneligands, to OLEDs (Organic Light Emitting Diode, OLED)which comprise such complexes, to a device selected from the group consisting of illuminating elements, stationary visual display units and mobile visual display units comprising such an OLED,to the use of such a metal-carbene complex in OLEDs, for example as emitter, matrix material, charge transport material and/or charge or exciton blocker.
Description
Metal complexes comprising azabenzimidazole carbene ligands and the use thereof in OLEDs
Description
The present invention relates to metal-carbene complexes comprising a central atom selected from iridium and platinum, and specific azabenzimidazole carbene ligands, to OLEDs (Organic Light-Emitting Diodes) which comprise such complexes, to a device selected from the group consisting of illuminating elements, stationary visual display units and mobile visual display units comprising such an OLED, to the use of such a metal-carbene complex in OLEDs, for example as emitter, matrix material, charge transport material and/or charge or exciton blocker.
Organic light-emitting diodes (OLEDs) exploit the propensity of materials to emit light when they are excited by electrical current. OLEDs are of particular interest as an alternative to cathode ray tubes and liquid-crystal displays for production of flat visual display units. Owing to the very compact design and the intrinsically low power consumption, devices comprising OLEDs are suitable especially for mobile applications, for example for applications in cellphones, smartphones, digital cameras, mp3 players, laptops, etc. In addition, white OLEDs give great advantages over the illumination technologies known to date, especially a particularly high efficiency.
The prior art proposes numerous materials which emit light on excitation by electrical current.
WO 2005/019373 discloses the use of transition metal complexes comprising at least one carbene ligand in OLEDs. According to WO2005/019373, a new compound class has been found, which is suitable for electroluminescence in the blue, red and green region of the electromagnetic spectrum, which enables the production of full-color displays.
WO 2006/056418 A2 discloses the use of transition metal-carbene complexes having at least one unsymmetrically substituted carbene ligand in organic light-emitting diodes. The transition metal-carbene complexes are suitable for electroluminescence in the blue, red and green region of the electromagnetic spectrum. Among the disclosed carbene complexes with numerous different carbene ligands, a homoleptic carbene complex with a specific azabenzimidazole carbene ligand is mentioned, though it is not described as advantageous over the further carbene complexes disclosed. However,
this carbene complex differs from the carbene complexes according to the present application.
WO 2005/1 13704 A2 relates to luminescent compounds having carbene ligands. WO 2005/1 13704 A2 discloses numerous different types of carbene ligands. Among the disclosed carbene complexes with numerous different carbene ligands, a homoleptic carbene complex with a specific azabenzimidazole carbene ligand is mentioned, though this is not described as advantageous over the further carbene complexes disclosed. However, this carbene complex differs from the carbene complexes according to the present application.
WO 2009/046266 A1 discloses complexes with tridentate ligands. The tridentate ligands mentioned include tridentate carbene ligands, and these tridentate carbene ligands may bear, for example, two azabenzimidazole substituents. The carbene complexes according to the present application differ from the carbene complexes disclosed in WO 2009/046266 A1 especially in that they do not comprise any tridentate carbene ligands.
Even though there are already known carbene complexes based on azabenzimidazole carbene ligands which are suitable for use in OLEDs, especially as light-emitting substances, it is desirable to provide more stable and/or more efficient compounds which are usable in industry. In addition, the light-emitting substances which emit in the blue region of the electromagnetic spectrum (400 nm to 500 nm), especially in the deep blue region of the electromagnetic spectrum (400 nm to 470 nm), are desirable. In the context of the present invention, electroluminescence is understood to mean both electrofluorescence and electrophosphorescence.
It is therefore an object of the present invention to provide iridium and platinum complexes which are suitable for use in organic electronic components. More particularly, the iridium and platinum complexes shall be suitable for use in OLEDs as emitters, matrix material, charge transport material, or charge blockers. The complexes shall be particularly suitable for electroluminescence in the blue region, more particularly in the deep blue region, of the electromagnetic spectrum, which enables, for example, the production of full-color displays and white OLEDs. It is a further object of the present invention to provide corresponding complexes which can be used as a mixture with a host compound (matrix material) or as a pure layer as a light-emitting layer in OLEDs. More particularly, it is desirable to provide transition metal complexes which exhibit a spectrum of properties improved over known transition metal
complexes, for example improved efficiencies, improved CIE color coordinates and/or improved lifetime/stability.
These objects are achieved in accordance with the invention by the production of metal-carbene complexes of the general formula (I)
(I) where M, n, Y, R2, R3, R4, A1, A2, A3, A4, p, K, L, m and o are each defined as follows:
M is Ir or Pt, n is an integer selected from 1 , 2 and 3, where the ligand(s)
are each bidentate ligands;
Y is NR1, 0, S or C(R10)2,
R1 is a linear or branched alkyl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 1 to 20 carbon
atoms, substituted or unsubstituted cycloalkyi radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 3 to 20 carbon atoms, substituted or unsubstituted aryl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having a total of 5 to 18 carbon atoms and/or heteroatoms,
R2, R3, R4 are each independently hydrogen, a linear or branched alkyl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyi radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 3 to 20 carbon atoms, substituted or unsubstituted aryl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having a total of 5 to 18 carbon atoms and/or heteroatoms, group with donor or acceptor action, or
R2 and R3 or R3 and R4 together with the carbon atoms to which they are bonded form an optionally substituted, saturated or unsaturated or aromatic ring optionally interrupted by at least one further heteroatom and having a total of 5 to 18 carbon atoms and/or heteroatoms, and may optionally be fused to at least one further optionally substituted saturated or unsaturated or aromatic ring optionally interrupted by at least one further heteroatom and having a total of 5 to 18 carbon atoms and/or heteroatoms, A1 is CR6 or N
A2 is CR7 or N
A3 is CR8 or N
A4 is CR9 or N R6, R7, R8, R9 are each independently hydrogen, a linear or branched alkyl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyi radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 3 to 20 carbon atoms, substituted or
unsubstituted heterocycloalkyl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 3 to 20 carbon atoms and/or heteroatoms, substituted or unsubstituted aryl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having a total of 5 to 18 carbon atoms and/or heteroatoms, group with donor or acceptor action, or
R6 and R7, R7 and R8 or R8 and R9, together with the carbon atoms to which they are bonded, form a saturated, unsaturated or aromatic, optionally substituted ring which is optionally interrupted by at least one heteroatom, has a total of 5 to 18 carbon atoms and/or heteroatoms, and may optionally be fused to at least one further optionally substituted saturated or unsaturated or aromatic ring optionally interrupted by at least one further heteroatom and having a total of 5 to 18 carbon atoms and/or heteroatoms, p is O or l ; R10 is independently a linear or branched alkyl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 3 to 20 carbon atoms, substituted or unsubstituted aryl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having a total of 5 to 18 carbon atoms and/or heteroatoms, or
the two R10 radicals form, together with the carbon atom to which they are bonded, a saturated or unsaturated optionally substituted ring optionally interrupted by at least one heteroatom and having a total of 5 to 18 carbon atoms and/or heteroatoms;
K is an uncharged mono- or bidentate ligand,
L is a mono- or dianionic ligand, preferably monoanionic ligand, which may be mono- or bidentate, m is 0, 1 or 2, where, when m is 2, the K ligands may be the same or different,
o is 0, 1 or 2, where, when o is 2, the L ligands may be the same or different, excluding ligands L of the following general formula (A):
(A) where Y', A2', A3', A4', A5', R1', R2', R3', R4', R5', R6', R7', R8', R9' and R10' are each defined as follows:
Y' is NR1 , O, S or C(R10 )2,
A2 , A3 , A4 , A5 are each independently N or C, where 2 A' = nitrogen atoms and at least one carbon atom is present between two nitrogen atoms in the ring, R1 is a linear or branched alkyl radical optionally bearing at least one functional group, optionally interrupted by at least one heteroatom and having 1 to 20 carbon atoms, cycloalkyl radical having 3 to 20 carbon atoms, substituted or unsubstituted aryl radical having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical having a total of 5 to 18 carbon atoms and/or heteroatoms,
R2', R3', R4', R5', if A2', A3', A4' and/or A5' is N, are each a free electron pair or, if A2', A3', A4 and/or A5 is C, are each independently hydrogen, a linear or branched alkyl radical optionally bearing at least one functional group, optionally interrupted by at least one heteroatom and having 1 to 20 carbon atoms, cycloalkyl radical having 3 to 20 carbon atoms, substituted or unsubstituted aryl radical having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical having a total of 5 to 18 carbon atoms and/or heteroatoms, group with donor or acceptor action or
R3 and R4 form, together with A3 and A4 , an optionally substituted, unsaturated ring optionally interrupted by at least one further heteroatom and having a total of 5 to 18 carbon atoms and/or heteroatoms, R6 , R7 , R8 , R9 are each independently hydrogen, a linear or branched alkyl radical optionally bearing at least one functional group, optionally interrupted by at least one heteroatom and having 1 to 20 carbon atoms, cycloalkyl radical having 3 to 20 carbon atoms, cycloheteroalkyl radical having 3 to 20 carbon atoms, substituted or unsubstituted aryl radical having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical having a total of 5 to 18 carbon atoms and/or heteroatoms, group with donor or acceptor action or R6 and R7 , R7 and R8 or R8 and R9 , together with the carbon atoms to which they are bonded, form an unsaturated or aromatic, optionally substituted ring optionally interrupted by at least one heteroatom and having a total of 5 to 18 carbon atoms and/or heteroatoms, and/or if A5 is C, R5 and R6 together form a saturated or unsaturated, linear or branched bridge optionally comprising heteroatoms, aromatic unit, heteroaromatic unit and/or functional groups and having a total of 1 to 30 carbon atoms and/or heteroatoms, to which is optionally fused a substituted or unsubstituted, five- to eight-membered ring comprising carbon atoms and/or heteroatoms,
R10 is independently a linear or branched alkyl radical optionally bearing at least one functional group, optionally interrupted by at least one heteroatom and having 1 to 20 carbon atoms, cycloalkyl radical having 3 to 20 carbon atoms, substituted or unsubstituted aryl radical having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical having a total of 5 to 18 carbon atoms and/or heteroatoms. Preferably, in the metal-carbene complexes of the general formula (I), p is 1 , which means that preferred metal-carbene complexes of the formula (I) have the following formula:
In a particularly preferred embodiment, m and o in formula (I) are each 0 and the n carbene ligands of the formula
in the metal-carbene complex of the general formula (I) are identical, which means that the complexes are homoleptic metal-carbene complexes of the general formula (I). This means that n is 3 in the case when M is Ir, and n is 2 in the case when M is Pt.
In principle - in a preferred embodiment - the n carbene ligands in the metal-carbene complex of the general formula (I) may also be different. In this case, the complex is a heteroleptic pure carbene complex of the formula (I) when m and n are each 0.
In a further preferred embodiment, o is 1 or 2 and L is a carbene ligand, suitable carbene ligands having been specified above. In this case, the complex is likewise a heteroleptic pure carbene complex of the formula (I).
In the context of the present invention, the terms aryl radical, unit or group, heteroaryl radical, unit or group, alkyl radical, unit or group, cycloalkyl radical, unit or group, cycloheteroalkyl radical, unit or group, and groups with donor or acceptor action are each defined as follows - unless stated otherwise:
Aryl radicals or substituted or unsubstituted aryl radicals having 6 to 30 carbon atoms (C6-C30-aryl radicals) refer in the present invention to radicals which are derived from monocyclic, bicyclic or tricyclic aromatics which do not comprise any ring heteroatoms. When the systems are not monocyclic systems, the term "aryl" for the second ring also includes the saturated form (perhydro form) or the partly unsaturated form (for example the dihydro form or tetrahydro form), provided that the particular forms are known and stable. This means that the term "aryl" in the present invention encompasses, for example, also bicyclic or tricyclic radicals in which either both or all three radicals are aromatic, and bicyclic or tricyclic radicals in which only one ring is aromatic, and also tricyclic radicals in which two rings are aromatic. Examples of aryl are: phenyl, naphthyl, indanyl, 1 ,2-dihydronaphthenyl, 1 ,4-dihydronaphthenyl, indenyl, anthracenyl, phenanthrenyl or 1 ,2,3,4-tetrahydronaphthyl. Particular preference is given to C6-Ci0- aryl radicals, for example phenyl or naphthyl, very particular preference to C6-aryl radicals, for example phenyl.
The aryl radicals or C6-C3o-aryl radicals may be unsubstituted or substituted by one or more further radicals. Suitable further radicals are selected from the group consisting of CrC2o-alkyl, C6-C3o-aryl and substituents with donor or acceptor action, suitable substituents with donor or acceptor action having been specified above. The C6-C30- aryl radicals are preferably unsubstituted or substituted by one or more CrC2o-alkyl groups, CrC2o-alkoxy groups, CN, CF3, F or amino groups (NR32R33 where suitable R32 and R33 radicals are specified below).
Heteroaryl radicals or substituted or unsubstituted heteroaryl radicals having a total of 5 to 18 carbon atoms and/or heteroatoms are understood to mean monocyclic, bicyclic or tricyclic heteroaromatics, some of which can be derived from the aforementioned aryl, in which at least one carbon atom in the aryl base structure has been replaced by a heteroatom. Preferred heteroatoms are N, O and S. The heteroaryl radicals more preferably have 5 to 13 ring atoms. The base structure of the heteroaryl radicals is especially preferably selected from systems such as pyridine and five-membered heteroaromatics such as thiophene, pyrrole, imidazole, thiazole, oxazole or furan. These base structures may optionally be fused to one or two six-membered aromatic radicals. Suitable fused heteroaromatics are carbazolyl, benzimidazolyl, benzofuryl, benzothiazole, benzoxazole, dibenzofuryl or dibenzothiophenyl.
The base structure may be substituted at one, more than one or all substitutable positions, suitable substituents being the same as those already specified under the definition of C6-C3o-aryl. However, the heteroaryl radicals are preferably unsubstituted. Suitable heteroaryl radicals are, for example, pyridin-2-yl, pyridin-3-yl, pyridin-4-yl, thiophen-2-yl, thiophen-3-yl, pyrrol-2-yl, pyrrol-3-yl, furan-2-yl, furan-3-yl, thiazol-2-yl, oxazol-2-yl and imidazol-2-yl, and the corresponding benzofused radicals, especially carbazolyl, benzimidazolyl, benzofuryl, benzothiazole, benzoxazole, dibenzofuryl or dibenzothiophenyl.
An alkyl radical in the context of the present application is a linear or branched alkyl radical optionally bearing at least one functional group, optionally interrupted by at least one heteroatom and having 1 to 20 carbon atoms. Preference is given to C to Cio- alkyl radicals, particular preference to C to C6-alkyl radicals. In addition, the alkyl radicals may be substituted by one or more functional groups, preferably selected from the group consisting of CrC2o-alkyl, CrC2o-alkoxy, halogen, preferably F, Ci-C20- haloalkyl, e.g. CF3, and C6-C3o-aryl which may in turn be substituted or unsubstituted. Suitable aryl substituents and suitable alkoxy and halogen substituents are specified below. Examples of suitable alkyl groups are methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl and octyl, and also CrC2o-alkyl-, CrC20-haloalkyl-, C6-C3o-aryl-, CrC20-alkoxy- and/or halogen-substituted, especially F-substituted, derivatives of the alkyl groups mentioned, for example CF3. This comprises both the n-isomers of the radicals mentioned and branched isomers such as isopropyl, isobutyl, isopentyl, sec-butyl, tert- butyl, neopentyl, 3,3-dimethylbutyl, 3-ethylhexyl, etc. Preferred alkyl groups are methyl, ethyl, isopropyl, tert-butyl and CF3.
A cycloalkyi radical or a substituted or unsubstituted cycloalkyi radical having 3 to 20 carbon atoms is understood in the context of the present application to mean a substituted or unsubstituted C3-C20-cycloalkyl radical. Preferred are cycloalkyi radicals having 5 to 20, more preferably 5 to 10 and most preferably 5 to 8 carbon atoms in the base structure (ring) to understand. Suitable substituents are the substituents mentioned for the alkyl groups. Examples of suitable cycloalkyi groups, which may be unsubstituted or substituted by the radicals mentioned above for the alkyl groups, are cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, cyclononyl and cyclodecyl. They may also be polycyclic ring systems such as decalinyl, norbornyl, bornanyl or adamantyl.
A heterocycloalkyl radical or a substituted or unsubstituted heterocycloalkyl radical having 3 to 20 carbon atoms and/or heteroatoms is understood to mean heterocycloalkyl radicals having 3 to 20, preferably 5 to 10 and more preferably 5 to 8 ring atoms,
where at least one carbon atom in the heterocycloalkyi base structure has been replaced by a heteroatom. Preferred heteroatoms are N, O and S. Suitable substituents are the substituents mentioned for the alkyl groups. Examples of suitable heterocycloalkyi groups, which may be unsubstituted or substituted by the radicals mentioned above for the alkyl groups, are radicals derived from the following heterocycles: pyrrolidine, thiolane, tetrahydrofuran, 1 ,2-oxathiolane, oxazolidine, piperidine, thiane, oxane, dioxane, 1 ,3-dithiane, morpholine, piperazine. They may also be polycyclic ring systems. Suitable alkoxy radicals and alkylthio radicals derive correspondingly from the aforementioned alkyl radicals. Examples here include OCH3, OC2H5, OC3H7, OC4H9 and OC8H17, and also SCH3, SC2H5, SC3H7, SC4H9 and SC8H17. In this context, C3H7, C4H9 and C8H17 comprise both the n-isomers and branched isomers such as isopropyl, isobutyl, sec-butyl, tert-butyl and 2-ethylhexyl. Particularly preferred alkoxy or alkylthio groups are methoxy, ethoxy, n-octyloxy, 2-ethylhexyloxy and SCH3.
Suitable halogen radicals or halogen substituents in the context of the present application are fluorine, chlorine, bromine and iodine, preferably fluorine, chlorine and bromine, more preferably fluorine and chlorine, most preferably fluorine.
In the context of the present application, groups with donor or acceptor action are understood to mean the following groups:
Ci-C20-alkoxy, C6-C30-aryloxy, C C2o-alkylthio, C6-C30-arylthio, SiR32R33R34, halogen radicals, halogenated CrC20-alkyl radicals, carbonyl (-CO(R32)), carbonylthio (- C = O (SR32)), carbonyloxy (- C = 0(OR32)), oxycarbonyl (- OC = 0(R32)), thiocarbonyl (- SC = 0(R32)), amino (-NR32R33), OH, pseudohalogen radicals, amido (- C = O (NR32R33)), - NR32C = O (R33), phosphonate (- P(O) (OR32)2, phosphate (-OP(O) (OR32)2), phosphine (-PR32R33), phosphine oxide (-P(0)R32 2), sulfate (-OS(0)2OR32), sulfoxide (- S(0)R32), sulfonate (-S(0)2OR32), sulfonyl (-S(0)2R32), sulfonamide (-S(0)2NR32R33), N02, boronic esters (-OB(OR32)2), imino (-C = NR32R33)), borane radicals, stannate radicals, hydrazine radicals, hydrazone radicals, oxime radicals, nitroso groups, diazo groups, vinyl groups, sulfoximines, alanes, germanes, boroxines and borazines. Preferred substituents with donor or acceptor action are selected from the group consisting of:
C to C20-alkoxy, preferably CrC6-alkoxy, more preferably ethoxy or methoxy; C6-C30- aryloxy, preferably C6-Ci0-aryloxy, more preferably phenyloxy; SiR32R33R34, where R32,
R33 and R34 are preferably each independently substituted or unsubstituted alkyl or substituted or unsubstituted phenyl, suitable substituents having been specified above; halogen radicals, preferably F, CI, Br, more preferably F or CI, most preferably F, halogenated CrC2o-alkyl radicals, preferably halogenated CrC6-alkyl radicals, most preferably fluorinated CrC6-alkyl radicals, e.g. CF3, CH2F, CHF2 or C2F5; amino, preferably dimethylamino, diethylamino or diphenylamino; OH, pseudohalogen radicals, preferably CN, SCN or OCN, more preferably CN, -C(0)OC C4-alkyl, preferably -C(0)OMe, P(0)R2, preferably P(0)Ph2, and S02R2, preferably S02Ph . Very particularly preferred substituents with donor or acceptor action are selected from the group consisting of methoxy, phenyloxy, halogenated Ci-C4-alkyl, preferably CF3, CH2F, CHF2, C2F5, halogen, preferably F, CN, SiR32R33R34, where suitable R32, R33 and R34 radicals have been specified above, diphenylamino, -C(0)OCi-C4-alkyl, preferably -C(0)OMe, P(0)Ph2 and S02Ph.
The aforementioned groups with donor or acceptor action are not intended to rule out the possibility that further radicals and groups among those specified above may also have donor or acceptor action. For example, the aforementioned heteroaryl radicals are likewise groups with donor or acceptor action, and the CrC20-alkyl radicals are groups with donor action.
The R32, R33 and R34 radicals mentioned in the aforementioned groups with donor or acceptor action have the definitions already mentioned above, which means that R32, R33 and R34 are each independently:
Hydrogen, substituted or unsubstituted CrC20-alkyl or substituted or unsubstituted C6- C30-aryl or substituted or unsubstituted heteroaryl having 5 to 30 ring atoms, suitable and preferred alkyl and aryl radicals having been specified above. More preferably, the R32, R33 and R34 radicals are CrC6-alkyl, e.g. methyl, ethyl, i-propyl or tert-butyl, or phenyl or pyridyl.
K in the general formula (I) is an uncharged mono- or bidentate ligand, and L in the general formula (I) is a mono- or dianionic ligand, preferably a monoanionic ligand which may be mono- or bidentate.
Ligands L with the following general formula (A) are excluded according to the present application:
where Y\ A2', A3', A4', A5 , R1', R2', R3', R4', R5 , R6', R7', R8', R9' and R10' are each defined as follows:
Y' is NR1', O, S or C(R10')2,
A2 , A3 , A4 , A5 are each independently N or C, where 2 A' = nitrogen atoms and at least one carbon atom is present between two nitrogen atoms in the ring,
R1 is a linear or branched alkyl radical optionally bearing at least one functional group, optionally interrupted by at least one heteroatom and having 1 to 20 carbon atoms, cycloalkyl radical having 3 to 20 carbon atoms, substituted or unsubstituted aryl radical having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical having a total of 5 to 18 carbon atoms and/or heteroatoms,
R2', R3', R4', R5', if A2', A3', A4' and/or A5' is N, are each a free electron pair or, if A2', A3',
A4 and/or A5 is C, are each independently hydrogen, a linear or branched alkyl radical optionally bearing at least one functional group, optionally interrupted by at least one heteroatom and having 1 to 20 carbon atoms, cycloalkyl radical having 3 to 20 carbon atoms, substituted or unsubstituted aryl radical having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical having a total of 5 to 18 carbon atoms and/or heteroatoms, group with donor or acceptor action or
R3 and R4 form, together with A3 and A4 , an optionally substituted, unsaturated ring optionally interrupted by at least one further heteroatom and having a total of 5 to 18 carbon atoms and/or heteroatoms, R6 , R7 , R8 , R9 are each independently hydrogen, a linear or branched alkyl radical optionally bearing at least one functional group, optionally interrupted by at least one heteroatom and having 1 to 20 carbon atoms, cycloalkyl radical having 3 to 20 carbon atoms, cycloheteroalkyl radical having 3 to 20 carbon atoms, substituted or unsubstituted aryl radical having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical having a total of 5 to 18 carbon atoms and/or heteroatoms, group with donor or acceptor action or
R6 and R7 , R7 and R8 or R8 and R9 , together with the carbon atoms to which they are bonded, form a saturated, unsaturated or aromatic, optionally substituted ring optionally interrupted by at least one heteroatom and having a total of 5 to 18 carbon atoms and/or heteroatoms, and/or if A5 is C, R5 and R6 together form a saturated or unsaturated, linear or branched bridge optionally comprising heteroatoms, aromatic unit, heteroaromatic unit and/or functional groups and having a total of 1 to 30 carbon atoms and/or heteroatoms, to which is optionally fused a substituted or unsubstituted, five- to eight-membered ring comprising carbon atoms and/or heteroatoms,
R10 is independently a linear or branched alkyl radical optionally bearing at least one functional group, optionally interrupted by at least one heteroatom and having 1 to 20 carbon atoms, cycloalkyl radical having 3 to 20 carbon atoms, substituted or unsubstituted aryl radical having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical having a total of 5 to 18 carbon atoms and/or heteroatoms.
A bidentate ligand is understood to mean a ligand coordinated at two sites to the transition metal atom M. A monodentate ligand is understood to mean a ligand coordinated at one site on the ligand to the transition metal atom M.
According to the invention, the n carbene ligands
in the metal-carbene complexes of the formula (I) are bidentate ligands. Suitable uncharged mono- or bidentate ligands K are preferably selected from the group consisting of phosphines, both mono- and bisphosphines; phosphonates, both mono- and bisphosphonates, and derivatives thereof, arsenates, both mono- and bisarsenates, and derivatives thereof; phosphites, both mono- and bisphosphites; CO; pyridines, both mono- and bispyridines; nitriles, dinitriles, allyl, diimines, nonconjugated dienes and conjugated dienes which form a π complex with M1. Particularly preferred uncharged mono- or bidentate ligands K are selected from the group consisting of phosphines, both mono- and bisphosphines, preferably trialkyl-, triaryl- or alkylarylphosphines, more preferably PAr3 where Ar is a substituted or unsubstituted aryl radical and the three aryl radicals in PAr3 may be the same or different, more preferably PPh3, PEt3, PnBu3, PEt2Ph, PMe2Ph, PnBu2Ph; phosphonates and derivatives thereof, arsenates and derivatives thereof, phosphites, CO; pyridines, both mono- and bispyridines, where the pyridines may be substituted by alkyl or aryl groups; nitriles and dienes which form a π complex with M1, preferably n,4-diphenyl-1 ,3- butadiene, η4-1 ,3-pentadiene, n,4-1 -phenyl-1 ,3-pentadiene, η4-1 ,4-dibenzyl-1 ,3- butadiene, n,4-2,4-hexadiene, n,4-3-methyl-1 ,3-pentadiene, η4-1 ,4-ditolyl-1 ,3-butadiene, η4-1 ,4-bis(trimethylsilyl)-1 ,3-butadiene and η2- or n,4-cyclooctadiene (each 1 ,3 and each 1 ,5), more preferably 1 ,4-diphenyl-1 ,3-butadiene, 1 -phenyl-1 ,3-pentadiene, 2,4- hexadiene, butadiene, n,2-cyclooctene, η4-1 ,3-cyclooctadiene and η4-1 ,5- cyclooctadiene. Very particularly preferred uncharged monodentate ligands are selected from the group consisting of PPh3, P(OPh)3, AsPh3, CO, pyridine, nitriles and derivatives thereof. Suitable uncharged mono- or bidentate ligands are preferably 1 ,4- diphenyl-1 ,3-butadiene, 1 -phenyl-1 ,3-pentadiene, 2,4-hexadiene, n,4-cyclooctadiene and r|2-cyclooctadiene (each 1 ,3 and each 1 ,5).
Suitable mono- or dianionic ligands L, preferably monoanionic ligands L which may be mono- or bidentate, are the ligands typically used as mono- or bidentate mono- or dianionic ligands, excluding ligands of the aforementioned general formula (A). Suitable monoanionic monodentate ligands are, for example, halides, especially CI" and Br", pseudohalides, especially CN", cyclopentadienyl (Cp"), hydride, alkyl radicals joined to the transition metal M via a sigma bond, for example CH3, alkylaryl radicals joined to the transition metal M via a sigma bond, for example benzyl. Suitable monoanionic bidentate ligands are, for example, ligands of the formula (B)
in which
R51 is in each case independently a linear or branched alkyl radical having 1 to 6 carbons atoms, preferably methyl, ethyl, isopropyl, tert-butyl, CF3; substituted or unsubstituted aryl radical having 6 to 20 carbon atoms, preferably unsubstituted phenyl or 2,6-dialkylphenyl; substituted or unsubstituted heteroaryl radical having a total of 5 to 18 carbon atoms and/or heteroatoms,
R52 is hydrogen, a linear or branched alkyl radical having 1 to 6 carbon atoms, substituted or unsubstituted aryl radical having 6 to 20 carbon atoms, preferably hydrogen;
where the ligand of the formula (B) is, for example, acetylacetonato or hexafluoro- acetylacetonato;
picolinato, salicylate 8-hydroxyquinolato ligands derived from Schiff bases, ligands derived from amino acids, heterocyclic noncarbene ligands of the general formula (III) specified below, e.g. arylpyridines, e.g. phenylpyridine, and the further bidentate monoanionic ligands specified in WO 02/15645, carbene ligands of the general formula (II) specified below, and also carbene ligands as specified in WO2006056418 and in EP1658343, and arylazoles, e.g. 2-arylimidazoles.
Suitable dianionic bidentate ligands are, for example, dialkoxides, dicarbonates, dicarboxylates, diamides, diimides, dithiolates, biscyclopentadienyls, bisphosphonates, bissulfonates and 3-phenylpyrazole.
In a preferred embodiment, the present invention relates to an inventive metal-carbene complex where L in the general formula (I) is a carbene ligand of the general formula (II)
A9 is CR12 or N;
A10 is CR13 or N;
R11 is a linear or branched alkyl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyi radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 3 to 20 carbon atoms, substituted or unsubstituted heterocycloalkyl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 3 to 20 carbon atoms and/or heteroatoms, substituted or unsubstituted aryl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having a total of 5 to 18 carbon atoms and/or heteroatoms, R12, R13 are each independently hydrogen, a linear or branched alkyl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyi radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 3 to 20 carbon atoms, substituted or unsubstituted heterocycloalkyl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 3 to 20 carbon atoms and/or heteroatoms, substituted or unsubstituted aryl radical optionally interrupted by at least
one heteroatom, optionally bearing at least one functional group and having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having a total of 5 to 18 carbon atoms and/or heteroatoms, group with donor or acceptor action,
A5 is CR14 or N;
A6 is CR15 or N;
A7 is CR16 or N;
A8 is CR17 or N;
R14, R15,
R16, R17 are each independently hydrogen, a linear or branched alkyl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 3 to 20 carbon atoms, substituted or unsubstituted heterocycloalkyl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 3 to 20 carbon atoms and/or heteroatoms, substituted or unsubstituted aryl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having a total of 5 to 18 carbon atoms and/or heteroatoms, group with donor or acceptor action, or
R14 and R15, R15 and R16 or R16 and R17 form, together with the carbon atoms to which they are bonded, an unsaturated or aromatic, optionally substituted ring optionally interrupted by at least one heteroatom and having a total of 5 to 18 carbon atoms and/or heteroatoms, and/or
R12 and R13 form, together with A9 and A10 to which they are bonded, an unsaturated or aromatic, optionally substituted ring optionally interrupted by exactly one heteroatom or two adjacent heteroatoms and having a total of 5 to 18 ring atoms, and/or
if A9 is CR12, R12 and R17 together form a saturated or unsaturated, linear or branched bridge optionally comprising heteroatoms, aromatic units, heteroaromatic units and/or functional groups and having a total of 1 to 30 carbon atoms and/or heteroatoms, to which is optionally fused a substituted or unsubstituted, five- to eight-membered ring comprising carbon atoms and/or heteroatoms; q is O or l ; where - when o in formula (I) is 2, the carbene ligands L of the formula (II) may be the same or different.
In the case that the inventive metal-carbene complex of the formula (I) has two ligands L, the ligands L may each be an identical ligand of the formula (II) or different ligands of the formula (II). It is also possible that one of the ligands L is a ligand of the formula (II) and the second ligand is any ligand L. In a preferred embodiment, in the case that the inventive metal-carbene complex of the formula (I) has two ligands L, the ligands L are each an identical ligand of the formula (II).
In a preferred embodiment, the present invention relates to a metal-carbene complex of the general formula (I) which has exclusively carbene ligands.
In one embodiment, m and o in the metal-carbene complex of the general formula (I) are each 0. In this case, n is preferably 3 (when M is Ir(lll)) or 2 (when M is Pt(ll)). The n azabenzimidazole carbene ligands may each be the same or different in the metal- carbene complexes of the general formula (I). They are preferably the same, which means that, in a preferred embodiment, the present application relates to homoleptic metal-carbene complexes of the general formula (I).
In a further embodiment, m is 0, n is 1 or 2 and o is 1 or 2, where the o ligand(s) L is/are ligand(s) of the general formula (II). If n or o is 2, the particular n azabenzimidazole carbene ligands or o ligands L may be the same or different. In this case, the complexes are heteroleptic metal-carbene complexes having exclusively carbene ligands. It has been found that metal-carbene complexes of the general formula (I) having exclusively carbene ligands are generally notable for light emission in the deep blue region of the electromagnetic spectrum.
The inventive metal-carbene complexes of the general formula (I) are therefore notable, in a preferred embodiment, for the following CIE values: CIE: y: generally < 0.40, preferably 0.08 to 0.30, most preferably 0.15 to 0.25; x: generally < 0.25, preferably 0.10 to 0.20, more preferably 0.14 to 0.20.
The metal-carbene complexes of the general formula (I) having exclusively carbene ligands are therefore suitable with particular preference as emitter material in OLEDs.
More preferably, M in the metal-carbene complexes of the formula (I) having exclusively carbene ligands is Ir.
In a further preferred embodiment, the present invention relates to an inventive metal- carbene complex where in the general formula (I), L is selected from the group consisting of a ligand of the formula (B)
in which
R51 is in each case independently a linear or branched alkyl radical having 1 to 6 carbons atoms, preferably methyl, ethyl, isopropyl, tert-butyl, CF3; substituted or unsubstituted aryl radical having 6 to 20 carbon atoms, preferably unsubstituted phenyl or 2,6-dialkylphenyl; substituted or unsubstituted heteroaryl radical having a total of 5 to 18 carbon atoms and/or heteroatoms,
R52 is hydrogen, a linear or branched alkyl radical having 1 to 6 carbon atoms, substituted or unsubstituted aryl radical having 6 to 20 carbon atoms, preferably hydrogen;
where the ligand of the formula (B) is, for example, acetylacetonato or hexafluoro- acetylacetonato;
picolinato, salicylate 8-hydroxyquinolato and heterocyclic noncarbene ligands of the general formula (III)
in which the symbols in the ligand of the general formula (III) are each defined as follows:
D are each independently CR18 or N, preferably CR18;
W is C, N, preferably C;
E are each independently CR19, N, NR20, preferably CR19 or N;
G is CR21, N, NR22, S, O, preferably NR21
R18, R19
R21 are each independently hydrogen, a linear or branched alkyl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 3 to 20 carbon atoms, substituted or unsubstituted heterocycloalkyl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 3 to 20 carbon atoms and/or heteroatoms, substituted or unsubstituted aryl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having a total of 5 to 18 carbon atoms and/or heteroatoms, group with donor or acceptor action, or in each case 2 R18, R19 and R21 radicals, together with the carbon atoms to which they are bonded, form a saturated, unsaturated or aromatic, optionally substituted ring optionally interrupted by at least one heteroatom and having a total of 5 to 18 carbon atoms and/or heteroatoms,
R20, R22 are each independently a linear or branched alkyl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group
and having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 3 to 20 carbon atoms, substituted or unsubstituted heterocycloalkyl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 3 to 20 carbon atoms and/or heteroatoms, substituted or unsubstituted aryl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having a total of 5 to 18 carbon atoms and/or heteroatoms, group with donor or acceptor action; preferably ο,ο'-dialkylated aryl radical, where the solid curved line is an optional bridge between one of the D groups and the G group; where the bridge may be defined as follows: alkylene, arylene, heteroarylene, alkynylene, alkenylene, NR23, O, S, SiR24R25, CR50=N and (CR26R27)d, where one or more nonadjacent (CR26R27) groups may be replaced by NR23, O, S, SiR24R25, where d is 2 to 10; and
are each H, alkyl, aryl, heteroaryl, alkenyl, alkynyl; where - when o in formula (I) is 2, the ligands L may be the same or different.
For the inventive embodiment wherein in each case 2 R18, R19 and R21 radicals, together with the carbon atoms to which they are bonded, form a saturated, unsaturated or aromatic, optionally substituted ring optionally interrupted by at least one heteroatom and having a total of 5 to 18 carbon atoms and/or heteroatoms, for example, two R18 radicals, two R19 radicals or one R19 radical and one R21 radical form a corresponding ring.
In the case that the inventive metal-carbene complex of the formula (I) has two ligands L (when M = Ir), the ligands L may each be an identical ligand of the formula (III) or different ligands of the formula (III). It is also possible that one of the ligands L is a ligand of the formula (III) and the second ligand is any ligand L. In a further preferred
embodiment, in the case that the inventive metal-carbene complex of the formula (I) has two ligands L, the ligands L are each an identical ligand of the formula (III).
In a further embodiment, m is 0, n is 1 or 2 and o is 1 or 2, where the o ligand(s) L is/are ligand(s) of the general formula (III). If n or o is 2, the particular n azabenzimidazole carbene ligands or o ligands L may be the same or different. In this case, the complexes are heteroleptic metal-carbene complexes which, as well as n azabenzimidazole carbene ligands, have o ligands of the general formula (III). It has been found that the aforementioned metal-carbene complexes of the general formula (I) are especially suitable as emitter material in the light-emitting layer of an OLED.
More preferably, M in the heteroleptic metal-carbene complexes of the formula (I) is Pt, where, in the case that M = Pt, preferably m is 0, n is 1 and o is 1 . Thus, L is preferably selected from the group consisting of carbene ligands of the general formula (II), ligands of the formula (B), more preferably acetylacetonato or hexafluoroacetylacetonato; picolinato, salicylate 8-hydroxyquinolato and heterocyclic noncarbene ligands of the general formula (III). Ligands L which are very particularly preferred in accordance with the invention are
The number o of monoanionic ligands L in the aforementioned case is 0, 1 , 2.
o > 1 , the L ligands may be the same or different, and are preferably the same.
The number m of uncharged ligands K depends on whether the coordination number 6 of the Ir(lll) or 4 of the Pt(ll) has already been attained with the aid of the carbene ligands and of the ligands L. When - in the case that Ir(lll) is used - n is three and three monoanionic bidentate carbene ligands are used, m in the aforementioned case is 0. When - in the case that Pt(ll) is used - n is two and two monoanionic bidentate carbene ligands are used, m in this case is likewise 0.
In a preferred embodiment, M, n, Y, R2, R3, R4, A1, A2, A3, A4, p, K, L, n and o in the general formula (I) are each defined as follows:
According to the invention, M is Ir or Pt, preferably Ir. Ir is present in the inventive complexes preferably in the +3 oxidation state (Ir(lll)). Pt is present in the inventive complexes in the +2 oxidation state (Pt(ll)). M is Ir(lll), n is preferably 3, where all n carbene ligands
are more preferably the same (homoleptic carbene complexes), m and o in this case are preferably each 0.
If M is Pt(ll), n is preferably 1 . In this case, o in formula (I) is preferably likewise 1 and m = 0. Suitable ligands L have been specified above, where L in this case is more preferably a ligand of the formula (B). According to the invention, Y is NR1, O, S or C(R10)2, preferably NR1.
In the preferred case that Y is NR1, R1 in a preferred embodiment is a linear or branched alkyl radical having 1 to 6 carbon atoms, substituted or unsubstituted cycloalkyl radical having 5 to 20 carbon atoms, substituted or unsubstituted aryl radical having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical having a total of 5 to 18 carbon atoms and/or heteroatoms.
R1 is more preferably linear or branched alkyl radical having 1 to 6 carbon atoms, substituted or unsubstituted phenyl radical, substituted or unsubstituted heteroaryl radical having a total of 5 or 6 carbon atoms and/or heteroatoms.
R1 is most preferably selected from phenyl, tolyl, mesityl, thiophenyl, furanyl, pyridyl, methyl, isopropyl and neopentyl. The present invention therefore relates especially to an inventive metal-carbene complex of the formula (I) in which Y is NR1 where R1 is selected from the group consisting of phenyl, tolyl, mesityl, thiophenyl, furanyl, pyridyl, methyl, isopropyl and neopentyl. In a preferred embodiment, R2, R3, R4 are each independently hydrogen, a linear or branched alkyl radical having 1 to 20 carbon atoms, a substituted or unsubstituted cycloalkyl radical having 5 to 20 carbon atoms, a substituted or unsubstituted aryl radical having 6 to 30 carbon atoms, a substituted or unsubstituted heteroaryl radical having 5 to 18 carbon atoms and/or heteroatoms or a group with donor or acceptor action.
In a preferred embodiment, R2, R3, R4 are each independently hydrogen, a linear or branched alkyl radical having 1 to 6 carbon atoms, substituted or unsubstituted aryl radical having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical having a total of 5 to 18 carbon atoms and/or heteroatoms or a group with donor or acceptor action selected from halogen radicals, preferably F, CI, more preferably F, CF3, CN and SiMe3; or
R3 and R4, together with the carbon atoms to which they are bonded, may form an optionally substituted, unsaturated ring which is optionally interrupted by at least one further heteroatom, has a total of 5 to 18 carbon atoms and/or heteroatoms and may optionally be fused to at least one further optionally substituted unsaturated ring interrupted by at least one further heteroatom and having a total of 5 to 18 carbon atoms and/or heteroatoms.
According to the invention, an unsaturated ring is a mono-, di- or polyunsaturated, preferably monounsaturated, ring.
R2 is more preferably hydrogen.
R3 is more preferably hydrogen or linear or branched alkyl radical having 1 to 20 carbon atoms or optionally substituted, saturated, unsaturated or aromatic ring having a total of 5 to 18 carbon atoms and/or heteroatoms, more preferably branched alkyl radical or ο,ο'-dialkylated phenyl ring.
R4 is more preferably hydrogen or linear or branched alkyl radical having 1 to 20 carbon atoms or optionally substituted, saturated, unsaturated or aromatic ring having a total of 5 to 18 carbon atoms and/or heteroatoms, more preferably branched alkyl radical or ο,ο'-dialkylated phenyl ring.
In a further embodiment, R3 and R4 form, together with the carbon atoms to which they are bonded, an optionally substituted, unsaturated ring having a total of 5 to 18 carbon atoms. p in a preferred embodiment is 1 . In one embodiment, the A1 group is CR6 or N, preferably CR6, the A2 group is CR7 or N, preferably CR7, the A3 group is CR8 or N, preferably CR8, and the A4 group is CR9 or N, preferably CR9. In a further embodiment, 0, 1 or 2 of the A1, A2, A3 or A4 groups are N, more preferably 0 or 1 groups are N, most preferably 0 groups are N. In a further preferred embodiment, R6, R7, R8, R9 are each independently hydrogen or linear or branched alkyl radical having 1 to 20 carbon atoms, a C6- to C-aryl radical, preferably a phenyl radical or an ο,ο'-dialkylated phenyl radical or a group with donor or acceptor action, preferably a group with donor or acceptor action selected from
halogen radicals, preferably F, CI, more preferably F, CF3, CN and SiMe3; more preferably hydrogen.
In a further preferred embodiment, R6 and R7 or R7 and R8 or R8 and R9 form, together with the phenyl ring, i.e. R6 and R7 or R7 and R8 or R8 and R9 form, with the carbon atoms to which the radicals are attached, an unsaturated or aromatic, optionally substituted ring which is optionally interrupted by at least one heteroatom, has a total of 5, 6 or 7 carbon atoms and/or heteroatoms and may optionally be fused to at least one further optionally substituted unsaturated ring interrupted by at least one further heteroatom and having a total of 5 to 18 carbon atoms and/or heteroatoms. The two particular radicals more preferably form, together with the phenyl ring, the following heterocycles: dibenzofuran, dibenzothiophene, fluorene, acridane, xanthene, thioxanthene, phenazine or phenoxazine. R10 is, if present, preferably independently in accordance with the invention, a linear or branched alkyl radical having 1 to 20 carbon atoms, a substituted or unsubstituted aryl radical having 6 to 30 carbon atoms, a substituted or unsubstituted heteroaryl radical having 5 to 18 carbon atoms and/or heteroatoms, more preferably a linear alkyl radical or a substituted or unsubstituted phenyl radical;
or
the two R10 radicals form, together with the carbon atom to which they are bonded, a saturated or unsaturated optionally substituted ring optionally interrupted by at least one heteroatom and having a total of 5 to 18 carbon atoms and/or heteroatoms. In a particularly preferred embodiment, the present invention relates to an inventive metal-carbene complex where M, n, Y, R2, R3, R4, A1, A2, A3, A4, p, L, m and o are each defined as follows:
M is Ir, n is 1 , 2 or 3, preferably 3, the ligand(s)
in each case being bidentate ligands; and all n ligands being more preferably the same; Y is NR1,
R1 is a linear or branched alkyl radical having 1 to 6 carbon atoms, substituted or unsubstituted cycloalkyl radical having from 5 to 20 carbon atoms, substituted or unsubstituted aryl radical having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical having a total of 5 to 18 carbon atoms and/or heteroatoms,
R2, R3, R4 are independently hydrogen, a linear or branched alkyl radical having
1 to 6 carbon atoms, substituted or unsubstituted aryl radical having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical having a total of 5 to 18 carbon atoms and/or heteroatoms, group with donor or acceptor action selected from halogen radicals, preferably F, CI, more preferably F; CF3, CN and SiMe3; or
R2 and R3 or R3 and R4, together with the carbon atoms to which they are bonded, form an optionally substituted, unsaturated, saturated or aromatic ring which is optionally interrupted by at least one further heteroatom, has a total of 5 to 18 carbon atoms and/or heteroatoms, and may optionally be fused to at least one further optionally substituted saturated or unsaturated or aromatic ring optionally interrupted by at least one further heteroatom and having a total of 5 to 18 carbon atoms and/or heteroatoms, p is 1 ;
is CR6
is CR7
is CR8
9.
is CR!
R6, R7, R8, R9 are each independently hydrogen, a linear or branched alkyl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 1 to 20 carbon atoms, substituted or unsubstituted aryl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having a total of 5 to 18 carbon atoms and/or heteroatoms, group with donor or acceptor action selected from halogen radicals, preferably F, CI, more preferably F; CF3, CN and SiMe3;
or
R6 and R7,
R7 and R8
or
R8 and R9 form, together with the carbon atoms to which they are bonded, a saturated, unsaturated or aromatic, optionally substituted ring which is optionally interrupted by at least one heteroatom, has a total of 5 to 18 carbon atoms and/or heteroatoms and may optionally be fused to at least one further optionally substituted saturated or unsaturated or aromatic ring optionally interrupted by at least one further heteroatom and having a total of 5 to 18 carbon atoms and/or heteroatoms, is a monoanionic bidentate ligand, preferably selected from the group
consisting of carbene ligands of the general formula (II) according to claim 2,
a ligand of the formula (B)
in which
is in each case independently a linear or branched alkyl radical having 1 to 6 carbons atoms, preferably methyl, ethyl, isopropyl, tert-butyl, CF3; substituted or unsubstituted aryl radical having 6 to 20 carbon atoms, preferably unsubstituted phenyl or 2,6-dialkylphenyl; substituted or unsubstituted heteroaryl radical having a total of 5 to 18 carbon atoms and/or heteroatoms,
R is hydrogen, a linear or branched alkyl radical having 1 to 6 carbon atoms, substituted or unsubstituted aryl radical having 6 to 20 carbon atoms, preferably hydrogen;
where the ligand of the formula (B) is, for example, acetylacetonato or hexafluoro- acetylacetonato;
picolinato, salicylato, 8-hydroxyquinolato and heterocyclic noncarbene ligands of the general formula (III); m is 0, o is 0, 1 or 2, preferably 0; excluding ligands L of the following general formula (A):
where Y', A2', A3', A4', A5', R1', R2', R3', R4', R5', R6', R7', R8', R9' and R10' are each defined as follows:
Y' is NR1 , O, S or C(R10 )2,
A2', A3', A4', A5' are each independently N or C, where 2 A' = nitrogen atoms and at least one carbon atom is present between two nitrogen atoms in the ring,
R1 is a linear or branched alkyl radical optionally bearing at least one functional group, optionally interrupted by at least one heteroatom and having 1 to 20 carbon atoms, cycloalkyl radical having 3 to 20 carbon atoms, substituted or unsubstituted aryl radical having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical having a total of 5 to 18 carbon atoms and/or heteroatoms,
R2', R3', R4', R5', if A2', A3', A4' and/or A5' is N, are each a free electron pair or, if A2', A3',
A4 and/or A5 is C, are each independently hydrogen, a linear or branched alkyl radical optionally bearing at least one functional group, optionally interrupted by at least one heteroatom and having 1 to 20 carbon atoms, cycloalkyl radical having 3 to 20 carbon atoms, substituted or unsubstituted aryl radical having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical having a total of 5 to 18 carbon atoms and/or heteroatoms, group with donor or acceptor action or
R3 and R4 form, together with A3 and A4 , an optionally substituted, unsaturated ring optionally interrupted by at least one further heteroatom and having a total of 5 to 18 carbon atoms and/or heteroatoms, R6 , R7 , R8 , R9 are each independently hydrogen, a linear or branched alkyl radical optionally bearing at least one functional group, optionally interrupted by at least one heteroatom and having 1 to 20 carbon atoms, cycloalkyl radical having 3 to 20 carbon atoms, cycloheteroalkyl radical having 3 to 20 carbon atoms, substituted or unsubstituted aryl radical having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical having a total of 5 to 18 carbon atoms and/or heteroatoms, group with donor or acceptor action, or
R6 and R7 , R7 and R8 or R8 and R9 , together with the carbon atoms to which they are bonded, form a saturated, unsaturated or aromatic, optionally substituted ring optionally interrupted by at least one heteroatom and having a total of 5 to 18 carbon atoms and/or heteroatoms,
and/or if A5 is C, R5 and R6 together form a saturated or unsaturated, linear or branched bridge optionally comprising heteroatoms, aromatic unit, heteroaromatic unit and/or functional groups and having a total of 1 to 30 carbon atoms and/or heteroatoms, to which is optionally fused a substituted or unsubstituted, five- to eight-membered ring comprising carbon atoms and/or heteroatoms, R10 is independently a linear or branched alkyl radical optionally bearing at least one functional group, optionally interrupted by at least one heteroatom and having 1 to 20 carbon atoms, cycloalkyl radical having 3 to 20 carbon atoms, substituted or unsubstituted aryl radical having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical having a total of 5 to 18 carbon atoms and/or heteroatoms.
Carbene ligands of the general formula (II) and heterocyclic noncarbene ligands of the general formula (III) have been defined above.
The present invention more preferably relates to an inventive metal-carbene complex where M, n, Y, R2, R3, R4, A1, A2, A37, A48, p, L, m and o are each defined as follows:
M is Ir, n is 3, where the ligand(s)
are each bidentate ligands, and where all n ligands are more preferably the same;
Y is NR1, R1 is a linear or branched alkyl radical having 1 to 6 carbon atoms, substituted or unsubstituted cycloalkyl radical having 5 to 20 carbon atoms, substituted or
unsubstituted aryl radical having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical having a total of 5 to 18 carbon atoms and/or heteroatoms,
R2, R3,
R4 are each independently hydrogen, a linear or branched alkyl radical having 1 to 6 carbon atoms, substituted or unsubstituted aryl radical having 6 to 30 carbon atoms, especially ο,ο'-dialkylated or unsubstituted phenyl radical, substituted or unsubstituted heteroaryl radical having a total of 5 to 18 carbon atoms and/or heteroatoms, group with donor or acceptor action selected from halogen radicals, preferably F, CI, more preferably F; CF3, CN and SiMe3; or
R2 and R3 or R3 and R4 form, together with the carbon atoms to which they are bonded, an optionally substituted unsaturated, saturated or aromatic ring which is optionally interrupted by at least one further heteroatom, has a total of 5 to 7 carbon atoms and/or heteroatoms and may optionally be fused to at least one further optionally substituted saturated or unsaturated or aromatic ring optionally interrupted by at least one further heteroatom and having a total of 5 to 7 carbon atoms and/or heteroatoms,
P is 1 ;
A1 is CR6;
A2 is CR7;
A3 is CR8;
A4 is CR9;
R6, R7,
R8, R9 are each independently hydrogen, a linear or branched alkyl radical having 1 to 20 carbon atoms, aryl radical having 6 to 30 carbon atoms, group with donor or acceptor action selected from halogen radicals, preferably F, CI, more preferably F; CF3, CN and SiMe3;
or
R6 and R7,
R7 and R8
or
R8 and R9 form, together with the carbon atoms to which they are bonded, an aromatic, optionally substituted ring which is optionally interrupted by one nitrogen or oxygen atom, has a total of 5 to 18 carbon atoms and/or heteroatoms and may
optionally be fused to at least one further optionally substituted aromatic ring optionally interrupted by one nitrogen or oxygen atom and having a total of 5 to 18 carbon atoms and/or heteroatoms,
L is a monoanionic bidentate ligand, selected from the group consisting of carbene ligands of the general formula (II),
a ligand of the formula (B)
in which
R51 is in each case independently a linear or branched alkyl radical having 1 to 6 carbons atoms, preferably methyl, ethyl, isopropyl, tert-butyl, CF3; substituted or unsubstituted aryl radical having 6 to 20 carbon atoms, preferably unsubstituted phenyl or 2,6-dialkylphenyl; substituted or unsubstituted heteroaryl radical having a total of 5 to 18 carbon atoms and/or heteroatoms,
R52 is hydrogen, a linear or branched alkyl radical having 1 to 6 carbon atoms, substituted or unsubstituted aryl radical having 6 to 20 carbon atoms, preferably hydrogen;
where the ligand of the formula (B) is, for example, acetylacetonato or hexafluoro- acetylacetonato;
picolinato, salicylate 8-hydroxyquinolato and heterocyclic noncarbene ligands of the general formula (III); m is 0, o is 0, 1 or 2.
The further abovementioned preferred and particularly preferred embodiments apply correspondingly.
Very particularly preferred inventive metal-carbene complexes of the general formula (I) are shown below.
The inventive homoleptic metal-carbene complexes may be present in the form of facial or meridional isomers.
Especially in the case of the preferred homoleptic metal-carbene complexes (n = 3 where all n carbene ligands are the same) of the general formula (I), the facial isomers can preferably be used as matrix material in the light-emitting layer of an OLED or as charge blockers, and the meridional isomers can preferably be used as emitter materials in OLEDs.
A particularly preferred embodiment of the present application therefore relates to an OLED comprising at least one homoleptic metal-carbene complex of the general formula (I) as emitter material, the homoleptic metal-carbene complex of the formula (I) preferably being used in the form of the meridional isomer thereof. In principle,
however, mixtures of facial and meridional isomers of the formula (I) or facial isomers of the formula (I) are suitable as emitter material in OLEDs.
In the case of the heteroleptic metal-carbene complexes, four different isomers may be present. The heteroleptic complexes are preferably used as emitter materials and/or charge transport material.
The present invention additionally also relates to a process for preparing the inventive metal-carbene complexes by contacting suitable compounds comprising M with the appropriate ligands or ligand precursors.
In a preferred embodiment of the process according to the invention, a suitable compound comprising the appropriate metal M, i.e. iridium or platinum, preferably iridium, and appropriate carbene ligands, preferably in deprotonated form as the free carbene or in the form of a protected carbene, for example as the silver-carbene complex, are contacted. Suitable precursor compounds comprise the appropriate substituents R1 to R4 and R6 to R9 and R10 which should be present in the complexes of the general formula (I). The present invention therefore relates more particularly to the process according to the invention wherein the ligand precursor used is a corresponding Ag-carbene complex.
In a further preferred embodiment of the process according to the invention, the ligand precursors used are organic compounds which are reacted with suitable M-comprising compounds. The carbene can be released from precursors of the carbene ligands by removing volatile substances, for example lower alcohols such as methanol, ethanol, for example at elevated temperature and/or under reduced pressure and/or using molecular sieves which bind the alcohol molecules eliminated.
The present invention also relates to a process according to the invention for preparing the metal-carbene complexes of the general formula (I) by contacting suitable M- comprising compounds with compounds of the general formula (IV) or (V)
(iv) (V)
where Y, R2, R3, R4, A1, A2, A3, A4 and p are each as already defined for the compounds of the general formula (I), and R28 or X are defined as follows: R28 is independently SiR29R30R31, aryl, heteroaryl, alkyl, cycloalkyl or heterocycloalkyl,
X is F, CI, Br, I, PF6, BF4,
are each independently aryl, heteroaryl, alkyl, cycloalkyl or heterocycloalkyl.
The definitions of aryl, heteroaryl, alkyl, cycloalkyl and heterocycloalkyl have been specified above.
In a particularly preferred embodiment, R28 is alkyl, especially CrC2o-alkyl, preferably Ci-Cio-alkyl, more preferably CrC8-alkyl, for example methyl, ethyl, propyl such as n-propyl, isopropyl, butyl such as n-butyl, isobutyl, tert-butyl, pentyl, hexyl, heptyl or octyl.
R28 in the compound of the general formula (IV) is most preferably methyl or ethyl.
Compounds of the general formulae (IV) and (V) are generally obtainable by processes known to those skilled in the art.
In the case, which is particularly preferred in accordance with the invention, that Y is NR1, A1 is R6, A2 is R7, A3 is R8, A4 is R9 and p is 1 , for example, corresponding compounds of the general formula (IV) can be obtained by reacting compounds of the general formula (V)
(V) with compounds of the general formula (VI) HC(0FO3 (VI), where R2, R3, R4, R6, R7, R8, R9 and R28 are each as already defined above for the compounds of the general formula (I) or (IV). This preparation of the compounds of the general formula (IV) can be effected in the presence or in the absence of a solvent. Suitable solvents are specified below. In a preferred embodiment, the compounds of the general formula (IV) are prepared in substance, or the compound of the general formula (VI) is added in an excess, such that it functions as a solvent.
Compounds of the general formulae (V) and (VI) are commercially available and/or obtainable by processes known to those skilled in the art; for example, compounds of the general formula (V) are obtainable by reacting the appropriate chlorides with the appropriate amines.
The compounds of the general formula (IV) are prepared generally at a temperature of 10 to 150°C, preferably 40 to 120°C, more preferably 60 to 1 10°C.
The reaction time is generally 2 to 48 hours, preferably 6 to 24 hours, more preferably 8 to 16 hours.
After the reaction has ended, the desired product can be isolated and purified by customary processes known to those skilled in the art, for example filtration, recrystallization, column chromatography, etc.
Appropriate compounds, especially complexes, comprising the appropriate metal M, preferably iridium, are known to those skilled in the art. Particularly suitable compounds comprising platinum or iridium comprise, for example, ligands such as halides, preferably chloride, 1 ,5-cyclooctadiene (COD), cyclooctene (COE), phosphines, cyanides, alkoxides, pseudohalides and/or alkyl.
Particularly preferred complexes comprising the appropriate metal, especially iridium, are selected from the group consisting of [lr(COD)CI]2, [lr(COE)2CI]2 lrCI3 x H20, lr(acac)3, lr(COD)2BF4, lr(COD)2BARF (BARF = tetrakis[3,5- bis(trifluoromethyl)phenyl]borate)), Pt(COD)CI2, Pt(acac)2, [Pt(C6H10)CI2]2, K2PtCI6 and mixtures thereof.
The carbene ligand precursors are deprotonated, preferably before the reaction, for example, by basic compounds known to those skilled in the art, for example basic metalates, basic metal acetates, acetylacetonates or alkoxides, or bases such as KO'Bu, NaO'Bu, LiO'Bu, NaH, silylamides, Ag20 and phosphazene bases. Particular preference is given to deprotonating with Ag20 to obtain the corresponding Ag- carbene, which is reacted with the compound comprising M to give the inventive complexes.
The process according to the invention for preparing the complexes of the general formula (I) using the compounds of the general formulae (IV) or (V) has the advantage that the compounds of the general formulae (IV) and (V) are stable intermediates which can be handled readily and can be isolated under standard laboratory conditions. In addition, the compounds of the general formulae (IV) and (V) are soluble in customary organic solvents, such that the preparation of the inventive complexes of the general formula (I) in homogeneous solution is possible, such that a workup of the desired product, i.e. of the complexes of the general formula (I) is more readily possible, for example for isolation and/or purification.
The contacting is preferably effected in a solvent. Suitable solvents are known per se to those skilled in the art and are preferably selected from the group consisting of aromatic or aliphatic solvents, for example benzene, toluene, xylene or mesitylene, cyclic or acyclic ethers, for example dioxane or THF, alcohols, esters, amides, ketones, nitriles, halogenated compounds and mixtures thereof. Particularly preferred solvents are toluene, xylenes, mesitylene and dioxane.
The molar ratio of metal-noncarbene complex used to carbene ligand precursor used is generally 1 :10 to 10:1 , preferably 1 :1 to 1 :6, more preferably 1 :2 to 1 :5.
The contacting is generally effected at a temperature of 20 to 200°C, preferably 50 to 150°C, more preferably 60 to 130°C.
The reaction time depends on the desired carbene complex and is generally 0.02 to 50 hours, preferably 0.1 to 24 hours, more preferably 1 to 12 hours. The complexes of the general formula (I) obtained after the reaction can optionally be purified by processes known to those skilled in the art, for example washing, crystallization or chromatography, and optionally isomerized under conditions likewise known to those skilled in the art, for example with acid mediation, thermally or photochemically.
The inventive metal-carbene complexes of the formula (I) can be used in electronic components, for example organic electronic components selected from switching elements such as organic light-emitting diodes (OLEDs), organic photovoltaic cells (OPVs), organic field-effect transistors (OFETs) and light-emitting electrochemical cells (LEECs), preference being given to using the metal-carbene complexes of the formula (I) in OLEDs.
In a preferred embodiment, the organic electronic component is an OLED comprising a light-emitting layer comprising at least one inventive metal-carbene complex of the formula (I).
The aforementioned metal-carbene complexes of the formula (I) and mixtures thereof are outstandingly suitable as emitter molecules in organic light-emitting diodes (OLEDs). Variations in the ligands make it possible to provide corresponding complexes which exhibit electroluminescence in the red, green and especially in the blue region of the electromagnetic spectrum. The inventive metal-carbene complexes of the general formula (I) are therefore outstandingly suitable as emitter substances, since they have emission (electroluminescence) in the visible region of the electromagnetic spectrum, for example at 400 to 800 nm, preferably 400 to 600 nm. The inventive complexes make it possible to provide compounds which have electroluminescence in the red, green and in the blue region of the electromagnetic spectrum. It is thus possible, with the aid of the inventive complexes as emitter substances, to provide industrially usable OLEDs.
In addition, the inventive metal-carbene complexes of the general formula (I) can be used as matrix material, charge transport material, especially hole transport material, and/or charge blocker. The inventive metal-carbene complexes of the general formula (I) are preferably used as an emitter and/or charge transport material and/or matrix material, more preferably as an emitter.
Particular properties of the inventive metal-carbene complexes of the general formula (I) are particularly good efficiencies, good CIE color loci and long lifetimes when used in OLEDs.
The present application therefore further provides an OLED comprising at least one inventive metal-carbene complex of the general formula (I). The inventive metal- carbene complex of the general formula (I) is used in the OLED preferably as an emitter, matrix material, charge transport material, especially hole transport material, and/or charge blocker, more preferably as an emitter and/or hole transport material, most preferably as an emitter. The present application also provides for the use of the metal-carbene complexes of the general formula (I) in OLEDs, preferably as an emitter, matrix material, charge transport material, especially hole transport material, and/or charge blocker, more preferably as an emitter and/or hole transport material, most preferably as an emitter. Organic light diodes are in principle formed from a plurality of layers, e.g.: anode (1 )
hole-transporting layer (2)
light-emitting layer (3)
- electron-transporting layer (4)
cathode (5)
It is, however, also possible that the OLED does not have all of the layers mentioned; for example, an OLED comprising layers (1 ) (anode), (3) (light-emitting layer) and (5) (cathode) is likewise suitable, in which case the functions of layers (2) (hole- transporting layer) and (4) (electron-transporting layer) are assumed by the adjoining layers. OLEDs having layers (1 ), (2), (3) and (5) or layers (1 ), (3), (4) and (5) are likewise suitable.
The metal-carbene complexes of the general formula (I) are preferably used as emitter molecules and/or matrix materials in the light-emitting layer (3). The inventive metal- carbene complexs of the general formula (I) may also - in addition to use as emitter molecules and/or matrix materials in the light-emitting layer (3) or instead of use in the light-emitting layer - also be used as a charge transport material in the hole- transporting layer (2) or in the electron-transporting layer (4) and/or as a charge blocker, preference being given to use as a charge transport material in the hole- transporting layer (2) (hole transport material). The present application therefore further provides a light-emitting layer comprising at least one of the inventive metal-carbene complexes of the general formula (I), preferably as emitter material and/or matrix material, more preferably as emitter material. Preferred metal-carbene complexes of the general formula (I) have already been specified above.
In a further embodiment, the present invention relates to a light-emitting layer consisting of at least one inventive metal-carbene complex of the general formula (I).
The metal-carbene complexes of the general formula (I) used in accordance with the invention may be present in the light-emitting layer in substance, i.e. without further additions. However, it is also possible that, in addition to the metal-carbene complexes of the general formula (I) used in accordance with the invention, further compounds are present in the light-emitting layer. In addition, a diluent material (matrix material) may be used. This diluent material may be a polymer, for example poly(N-vinylcarbazole) or polysilane. The diluent material may, however, likewise be a small molecule, for example 4,4'-N,N'-dicarbazolebiphenyl (CDP) or tertiary aromatic amines. When a diluent material is used, the proportion of the inventive metal-carbene complexes of the general formula (I) in the light-emitting layer is generally less than 40% by weight, preferably 3 to 30% by weight. The inventive metal-carbene complexes of the general formula (I) are preferably used in a matrix. The light-emitting layer thus preferably comprises at least one inventive metal-carbene complex of the general formula (I) and at least one matrix material.
Suitable matrix materials are - in addition to the aforementioned dilution materials - in principle the materials specified hereinafter as hole and electron transport materials, and also carbon complexes, for example the carbene complexes of the formula (I) or the carbene complexes mentioned in WO 2005/019373. Particularly suitable are carbazole derivatives, for example 4,4'-bis(carbazol-9-yl)-2,2'-dimethylbiphenyl (CDBP), 4,4'-bis(carbazol-9-yl)biphenyl (CBP), 1 ,3-bis(N-carbazolyl)benzene (mCP),
and the matrix materials specified in the following applications: WO2008/034758, WO2009/003919.
Further suitable matrix materials, which may be small molecules or (co)polymers of the small molecules mentioned, are specified in the following publications:
WO2007108459 (H-1 to H-37), preferably H-20 to H-22 and H-32 to H-37, most preferably H-20, H-32, H-36, H-37, WO2008035571 A1 (Host 1 to Host 6), JP2010135467 (compounds 1 to 46 and Host-1 to Host-39 and Host-43), WO2009008100 compounds No.1 to No.67, preferably No.3, No.4, No.7 to No. 12, No.55, No.59, No. 63 to No.67, more preferably No. 4, No. 8 to No. 12, No. 55, No. 59, No.64, No.65, and No. 67, WO2009008099 compounds No. 1 to No. 1 10, WO20081401 14 compounds 1 -1 to 1 -50, WO2008090912 compounds OC-7 to OC-36 and the polymers of Mo-42 to Mo-51 , JP2008084913 H-1 to H-70, WO2007077810 compounds 1 to 44, preferably 1 , 2, 4-6, 8, 19-22, 26, 28-30, 32, 36, 39-44, WO201001830 the polymers of monomers 1 -1 to 1 -9, preferably of 1 -3, 1 -7, and 1 -9, WO2008029729 the (polymers of) compounds 1 -1 to 1 -36, WO20100443342 HS-1 to HS-101 and BH-1 to BH-17, preferably BH-1 to BH-17, JP2009182298 the (co)polymers based on the monomers 1 to 75, JP2009170764, JP2009135183 the (co)polymers based on the monomers 1 -14, WO2009063757 preferably the (co)polymers based on the monomers 1 -1 to 1 -26, WO2008146838 the compounds a-1 to a-43 and 1 -1 to 1 -46, JP2008207520 the (co)polymers based on the monomers 1 -1 to 1 -26, JP2008066569 the (co)polymers based on the monomers 1 -1 to 1 -16, WO2008029652 the (co)polymers based on the monomers 1 -1 to 1 -52, WO20071 14244 the (co)polymers based on the monomers 1 -1 to 1 -18, JP2010040830 the compounds HA-1 to HA-20, HB-1 to HB-16, HC-1 to HC-23 and the (co)polymers based on the monomers HD-1 to HD-12, JP2009021336, WO2010090077 the compounds 1 to 55, WO2010079678 the compounds H 1 to H42, WO2010067746, WO2010044342 the compounds HS-1 to HS-101 and Poly-1 to Poly-4, JP20101 14180 the compounds PH-1 to PH-36, US2009284138 the compounds 1 to 1 1 1 and H1 to H71 , WO2008072596 the compounds 1 to 45, JP2010021336 the compounds H-1 to H-38, preferably H-1 , WO2010004877 the compounds H-1 to H-60, JP2009267255 the compounds 1 -1 to 1 -105, WO2009104488 the compounds 1 -1 to 1 -38, WO2009086028, US2009153034, US2009134784, WO2009084413 the compounds 2-1 to 2-56, JP20091 14369 the compounds 2-1 to 2-40, JP20091 14370 the compounds 1 to 67, WO2009060742 the compounds 2-1 to 2-56, WO2009060757 the compounds 1 -1 to 1 -76, WO2009060780 the compounds 1 -1 to 1 -70, WO2009060779 the compounds 1 -1 to 1 -42, WO2008156105 the compounds 1 to 54, JP2009059767
the compounds 1 to 20, JP2008074939 the compounds 1 to 256, JP2008021687 the compounds 1 to 50, WO20071 19816 the compounds 1 to 37, WO2010087222 the compounds H-1 to H-31 , WO2010095564 the compounds HOST-1 to HOST-61 , WO2007108362, WO2009003898, WO2009003919, WO2010040777, US2007224446 and WO06128800.
In a particularly preferred embodiment, one or more compounds of the general formula (X) specified hereinafter are used as matrix material. Preferred embodiments of the compounds of the general formula (X) are likewise specified hereinafter.
The individual layers among the aforementioned layers of the OLED may in turn be formed from two or more layers. For example, the hole-transporting layer may be formed from one layer, into which holes are injected from the electrode, and a layer which transports the holes away from the hole-injecting layer into the light-emitting layer. The electron-transporting layer may likewise consist of a plurality of layers, for example of a layer in which electrons are injected through the electrode and a layer which receives electrons from the electron-injecting layer and transports them into the light-emitting layer. These layers mentioned are each selected according to factors such as energy level, thermal resistance and charge carrier mobility, and also energy difference of the layers mentioned with the organic layers or the metal electrodes. The person skilled in the art is capable of selecting the construction of the OLEDs such that it is matched optimally to the heteroleptic complexes according to the present invention used as emitter substances in accordance with the invention. In order to obtain particularly efficient OLEDs, the HOMO (highest occupied molecular orbital) of the hole-transporting layer should be aligned to the work function of the anode, and the LUMO (lowest unoccupied molecular orbital) of the electron- transporting layer should be aligned to the work function of the cathode. The present application further provides an OLED comprising at least one inventive light-emitting layer. The further layers in the OLED may be formed from any material which is typically used in such layers and is known to those skilled in the art.
Suitable materials for the aforementioned layers (anode, cathode, hole and electron injection materials, hole and electron transport materials and hole and electron blocker materials, matrix materials, fluorescence and phosphorescence emitters) are known to those skilled in the art and are specified, for example, in H. Meng, N. Herron, Organic Small Molecule Materials for Organic Light-Emitting Devices in Organic Light-Emitting
Materials and Devices, eds: Z. Li, H. Meng, Taylor & Francis, 2007, Chapter 3, pages 295 to 41 1 .
The anode is an electrode which provides positive charge carriers. It may be composed, for example, of materials which comprise a metal, a mixture of different metals, a metal alloy, a metal oxide or a mixture of different metal oxides. Alternatively, the anode may be a conductive polymer. Suitable metals comprise the metals of groups 1 1 , 4, 5 and 6 of the Periodic Table of the Elements, and also the transition metals of groups 8 to 10. When the anode is to be transparent, mixed metal oxides of groups 12, 13 and 14 of the Periodic Table of the Elements are generally used, for example indium tin oxide (ITO). It is likewise possible that the anode (1 ) comprises an organic material, for example polyaniline, as described, for example, in Nature, Vol. 357, pages 477 to 479 (June 1 1 , 1992). At least either the anode or the cathode should be at least partly transparent in order to be able to emit the light formed.
Suitable hole transport materials for layer (2) of the inventive OLED are disclosed, for example, in Kirk-Othmer Encyclopedia of Chemical Technology, 4th Edition, Vol. 18, pages 837 to 860, 1996. Either hole-transporting molecules or polymers may be used as the hole transport material. Customarily used hole-transporting molecules are selected from the group consisting of 4,4'-bis[N-(1 -naphthyl)-N-phenylamino]biphenyl (a-NPD), N,N'-diphenyl-N,N'-bis(3-methylphenyl)-[1 ,1 '-biphenyl]-4,4'-diamine (TPD), 1 ,1 -bis[(di-4-tolylamino)phenyl]cyclohexane (TAPC), N,N'-bis(4-methylphenyl)-N,N'- bis(4-ethylphenyl)-[1 ,1 '-(3,3'-dimethyl)biphenyl]-4,4'-diamine (ETPD), tetrakis(3- methylphenyl)-N,N,N',N'-2,5-phenylenediamine (PDA), a-phenyl-4-Ν,Ν- diphenylaminostyrene (TPS), p-(diethylamino)benzaldehyde diphenylhydrazone (DEH), triphenylamine (TPA), bis[4-(N,N-diethylamino)-2-methylphenyl](4- methylphenyl)methane (MPMP), 1 -phenyl-3-[p-(diethylamino)styryl]-5-[p-
(diethylamino)phenyl]pyrazoline (PPR or DEASP), 1 ,2-trans-bis(9H-carbazol-9-yl)- cyclobutane (DCZB), N,N,N',N'-tetrakis(4-methylphenyl)-(1 ,1 '-biphenyl)-4,4'-diamine (TTB), fluorine compounds such as 2,2',7,7'-tetra(N,N-di-tolyl)amino-9,9-spirobifluorene (spiro-TTB), N,N'-bis(naphthalen-1 -yl)-N,N'-bis(phenyl)-9,9-spirobifluorene (spiro-NPB) and 9,9-bis(4-(N,N-bis-biphenyl-4-yl-amino)phenyl-9H-fluorene, benzidine compounds such as N,N'-bis(naphthalen-1 -yl)-N,N'-bis(phenyl)benzidine and porphyrin compounds such as copper phthalocyanines. Customarily used hole-transporting polymers are selected from the group consisting of polyvinylcarbazoles, (phenylmethyl)polysilanes and polyanilines. It is likewise possible to obtain hole-transporting polymers by doping hole-transporting molecules into polymers such as polystyrene and polycarbonate. Suitable hole-transporting molecules are the molecules already mentioned above.
In addition - in one embodiment - it is possible to use carbene complexes as hole conductor materials, in which case the band gap of the at least one hole conductor material is generally greater than the band gap of the emitter material used. In the context of the present application, band gap is understood to mean the triplet energy. Suitable carbene complexes are, for example, the inventive carbine complexes of the general formula (I), carbene complexes as described in WO 2005/019373 A2, WO 2006/056418 A2, WO 2005/1 13704, WO 2007/1 15970, WO 2007/1 15981 and WO 2008/000727. One example of a suitable carbene complex is lr(DPBIC)3 with the formula:
lr(DPBIC)3
The hole-transporting layer may also be electronically doped in order to improve the transport properties of the materials used, in order firstly to make the layer thicknesses more generous (avoidance of pinholes/short circuits) and in order secondly to minimize the operating voltage of the device. Electronic doping is known to those skilled in the art and is disclosed, for example, in W. Gao, A. Kahn, J. Appl. Phys., Vol. 94, No. 1 , 1 July 2003 (p-doped organic layers); A. G. Werner, F. Li, K. Harada, M. Pfeiffer, T. Fritz, K. Leo, Appl. Phys. Lett., Vol. 82, No. 25, 23 June 2003 and Pfeiffer et al., Organic Electronics 2003, 4, 89 - 103 and K. Walzer, B. Maennig, M. Pfeiffer, K. Leo, Chem. Soc. Rev. 2007, 107, 1233. For example it is possible to use mixtures in the hole-transporting layer, in particular mixtures which lead to electrical p-doping of the hole-transporting layer. p-Doping is achieved by the addition of oxidizing materials. These mixtures may, for example, be the following mixtures: mixtures of the abovementioned hole transport materials with at least one metal oxide, for example Mo02, Mo03, WOx, Re03 and/or V205, preferably Mo03 and/or Re03, more preferably Re03 or mixtures comprising the aforementioned hole transport materials and one or more compounds selected from 7,7,8,8-tetracyanoquinodimethane (TCNQ), 2,3,5,6- tetrafluoro-7,7,8,8-tetracyanoquinodimethane (F4-TCNQ), 2,5-bis(2-hydroxyethoxy)-
7,7,8,8-tetracyanoquinodimethane, bis(tetra-n-butylammonium)tetracyanodipheno- quinodimethane, 2,5-dimethyl-7,7,8,8-tetracyanoquinodimethane, tetracyanoethylene, 1 1 ,1 1 ,12,12-tetracyanonaphtho-2,6-quinodimethane, 2-fluoro-7,7,8,8-tetracyanoquino- dimethane, 2,5-difluoro-7,7,8,8-tetracyanoquinodimethane, dicyanomethylene- 1 ,3,4, 5,7, 8-hexafluoro-6H-naphthalen-2-ylidene)malononitrile (F6-TNAP), Mo(tfd)3 (from Kahn et al., J. Am. Chem. Soc. 2009, 131 (35), 12530-12531 ), compounds as described in EP1988587 and in EP2180029 and quinone compounds as mentioned in EP 09153776.1 . Suitable electron-transporting materials for layer (4) of the inventive OLEDs comprise metals chelated with oxinoid compounds, such as tris(8-hydroxyquinolato)aluminum (Alq3), compounds based on phenanthroline such as 2,9-dimethyl-4,7-diphenyl-1 ,10- phenanthroline (DDPA = BCP), 4,7-diphenyl-1 ,10-phenanthroline (Bphen), 2,4,7,9- tetraphenyl-1 ,10-phenanthroline, 4, 7-diphenyl-1 ,10-phenanthroline (DPA) or phenanthroline derivatives disclosed in EP1786050, in EP1970371 , or in EP1097981 , and azole compounds such as 2-(4-biphenylyl)-5-(4-t-butylphenyl)-1 ,3,4-oxadiazole (PBD) and 3-(4-biphenylyl)-4-phenyl-5-(4-t-butylphenyl)-1 ,2,4-triazole (TAZ). Layer (4) may serve both to ease the electron transport and as a buffer layer or as a barrier layer in order to prevent quenching of the exciton at the interfaces of the layers of the OLED. Layer (4) preferably improves the mobility of the electrons and reduces quenching of the exciton.
It is likewise possible to use mixtures of at least two materials in the electron- transporting layer, in which case at least one material is electron-conducting. Preferably, in such mixed electron-transporting layers, at least one phenanthroline compound is used, preferably BCP, or at least one pyridine compound according to the formula (VIII) below, preferably a compound of the formula (Vlllaa) below. More preferably, in mixed electron-transporting layers, in addition to at least one phenanthroline compound, alkaline earth metal or alkali metal hydroxyquinolate complexes, for example Liq, are used. Suitable alkaline earth metal or alkali metal hydroxyquinolate complexes are specified below (formula VII).
The electron-transporting layer may also be electronically doped in order to improve the transport properties of the materials used, in order firstly to make the layer thicknesses more generous (avoidance of pinholes/short circuits) and in order secondly to minimize the operating voltage of the device. Electronic doping is known to those skilled in the art and is disclosed, for example, in W. Gao, A. Kahn, J. Appl. Phys., Vol. 94, No. 1 , 1 July 2003 (p-doped organic layers); A. G. Werner, F. Li, K. Harada, M. Pfeiffer, T. Fritz, K. Leo, Appl. Phys. Lett., Vol. 82, No. 25, 23 June 2003 and Pfeiffer et
al., Organic Electronics 2003, 4, 89 - 103 and K. Walzer, B. Maennig, M. Pfeiffer, K. Leo, Chem. Soc. Rev. 2007, 107, 1233. For example, it is possible to use mixtures which lead to electrical n-doping of the electron-transporting layer. n-Doping is achieved by the addition of reducing materials. These mixtures may, for example, be mixtures of the abovementioned electron transport materials with alkali/alkaline earth metals or alkali/alkaline earth metal salts, for example Li, Cs, Ca, Sr, Cs2C03, with alkali metal complexes, for example 8-hydroxyquinolatolithium (Liq), and with Y, Ce, Sm, Gd, Tb, Er, Tm, Yb, Li3N, Rb2C03, dipotassium phthalate, W(hpp)4 from EP 1786050, or with compounds as described in EP1837926 B1.
The present invention therefore also relates to an inventive OLED which comprises an electron-transporting layer comprising at least two different materials, of which at least one material is electron-conducting. In a preferred embodiment, the electron-transporting layer comprises at least one compound of the general formula
in which
R32 and R33are each independently F, CrC8-alkyl, or C6-Ci4-aryl, which is optionally substituted by one or more CrC8-alkyl groups, or
two R32 and/or R33 substituents together form a fused benzene ring which is optionally substituted by one or more CrC8-alkyl groups;
a and b are each independently 0, or 1 , 2 or 3,
M1 is an alkaline metal atom or alkaline earth metal atom,
p is 1 when M1 is an alkali metal atom, p is 2 when M1 is an alkaline earth metal atom.
A very particularly preferred compound of the formula (VII) is
(Liq), which may be present as a single species, or in other forms such as LigQg in which
integer, for example Li6Q6- Q is an 8-hydroxyquinolate ligand or an 8-hydroxyquinolate derivative.
In a further preferred embodiment, the electron-transporting layer comprises at least one compound of the formula (VI I I),
in which
R34, R35, R36, R37, R34', R35 , R36' and R37'
are each independently H, Ci-Ci8-alkyl, Ci-Ci8-alkyl which is substituted by E and/or interrupted by D, C6-C24-aryl, C6-C24-aryl which is substituted by G,
C2-C2o-heteroaryl or C2-C2o-heteroaryl which is substituted by G, Q is an arylene or heteroarylene group, each of which is optionally substituted by G;
D is -CO-; -COO-; -S-; -SO-; -S02-; -0-; -NR40-; -SiR45R46-; -POR47-;
-CR38=CR39-; or -C≡C-; and
E is -OR44; -SR44; -NR40R41 ; -COR43; -COOR42; -CONR40R41 ; -CN ; or F;
G is E, CrCi8-alkyl, Ci-Ci8-alkyl which is interrupted by D , Ci-Ci8- perfluoroalkyl, Ci-Ci8-alkoxy, or Ci-Ci8-alkoxy which is substituted by E and/or interrupted by D,
in which
R38 and R39 are each independently H, C6-Ci8-aryl; C6-Ci8-aryl which is substituted by
Ci-Cis-alkyl or Ci-Ci8-alkoxy; Ci-Ci8-alkyl; or Ci-Ci8-alkyl which is interrupted by -0-;
R40 and R41 are each independently C6-Ci8-aryl; C6-Ci8-aryl which is substituted by
Ci-Cis-alkyl or Ci-Ci8-alkoxy; Ci-Ci8-alkyl; or Ci-Ci8-alkyl which is interrupted by -0-; or
R40 and R41 together form a 6-membered ring;
R42 and R43are each independently C6-Ci8-aryl; C6-Ci8-aryl which is substituted by
Ci-Cis-alkyl or Ci-Ci8-alkoxy; Ci-Ci8-alkyl; or Ci-Ci8-alkyl which is interrupted by -0-,
R44 is C6-Ci8-aryl; C6-Ci8-aryl which is substituted by Ci-Ci8-alkyl or Ci-Ci8- alkoxy; Ci-Ci8-alkyl; or Ci-Ci8-alkyl which is interrupted by -0-,
R and R are each independently Ci-Ci8-alkyl, C6-Ci8-aryl or C6-Ci8-aryl which is substituted by Ci-Ci8-alkyl,
R47 is Ci-Ci8-alkyl, C6-Ci8-aryl or C6-Ci8-aryl which is substituted by C Ci8- alkyl.
Preferred compounds of the formula (VIII) are compounds of the formula (Villa)
(Villa)
R48 is H, d-ds-alkyl or or
Particular preference is given to a compound of the formula (Vlllaa)
In a further, very particularly preferred embodiment, the electron-transporting layer comprises a compound of the formula
(Liq) and a compound of the formula
Vlllaa.
In a preferred embodiment, the electron-transporting layer comprises the compound of the formula (VII) in an amount of 99 to 1 % by weight, preferably 75 to 25% by weight, more preferably about 50% by weight, where the amount of the compounds of the formulae (VII) and the amount of the compounds of the formulae (VIII) adds up to a total of 100% by weight. The preparation of the compounds of the formula (VIII) is described in J. Kido et al., Chem. Commun. (2008) 5821-5823, J. Kido et al., Chem. Mater. 20 (2008) 5951-5953 and JP2008-127326, or the compounds can be prepared analogously to the processes disclosed in the aforementioned documents. The preparation of the compounds of the formula (VII) is described, for example, in Christoph Schmitz et al. Chem. Mater. 12 (2000) 3012-3019 and WO00/32717, or the compounds can be prepared analogously to the processes disclosed in the aforementioned documents. In a preferred embodiment, the invention relates to an inventive OLED wherein the electron-transporting layer comprises at least one phenanthroline derivative and/or pyridine derivative.
In a further preferred embodiment, the invention relates to an inventive OLED wherein the electron-transporting layer comprises at least one phenanthroline derivative and/or pyridine derivative and at least one alkali metal hydroxyquinolate complex.
In a further preferred embodiment, the invention relates to an inventive OLED wherein the electron-transporting layer comprises at least one phenanthroline derivative and/or pyridine derivative and 8-hydroxyquinolatolithium.
Some of the materials mentioned above as hole transport materials and electron- transporting materials can fulfill several functions. For example, some of the electron- transporting materials are simultaneously hole-blocking materials if they have a low- lying HOMO.
The cathode (5) is an electrode which serves to introduce electrons or negative charge carriers. The cathode may be any metal or nonmetal which has a lower work function than the anode. Suitable materials for the cathode are selected from the group consisting of alkali metals of group 1 , for example Li, Cs, alkaline earth metals of group 2, metals of group 12 of the Periodic Table of the Elements, comprising the rare earth metals and the lanthanides and actinides. In addition, metals such as aluminum, indium, calcium, barium, samarium and magnesium, and combinations thereof, may be used. In addition, lithium-comprising organometallic compounds such as 8- hydroxyquinolatolithium (Liq), CsF, NaF, KF, Cs2C03 or LiF may be applied between the organic layer and the cathode as an electron injection layer in order to reduce the operating voltage.
The OLED of the present invention may additionally comprise further layers which are known to those skilled in the art. For example, a layer which eases the transport of the positive charge and/or matches the band gaps of the layers to one another may be applied between the layer (2) and the light-emitting layer (3). Alternatively, this further layer may serve as a protective layer. In an analogous manner, additional layers may be present between the light-emitting layer (3) and the layer (4) in order to ease the transport of the negative charge and/or to match the band gaps between the layers to one another. Alternatively, this layer may serve as a protective layer.
In a preferred embodiment, the inventive OLED, in addition to the layers (1 ) to (5), comprises at least one of the further layers mentioned below: - a hole injection layer between the anode (1 ) and the hole-transporting layer (2); a blocking layer for electrons between the hole-transporting layer (2) and the light- emitting layer (3);
a blocking layer for holes between the light-emitting layer (3) and the electron- transporting layer (4);
- an electron injection layer between the electron-transporting layer (4) and the cathode (5).
As already mentioned above, however, it is also possible that the OLED does not have all of the layers (1 ) to (5) mentioned; for example, an OLED comprising layers (1 )
(anode), (3) (light-emitting layer) and (5) (cathode) is likewise suitable, in which case the functions of layers (2) (hole-transporting layer) and (4) (electron-transporting layer) are assumed by the adjoining layers. OLEDs having layers (1 ), (2), (3) and (5) or layers (1 ), (3), (4) and (5) are likewise suitable.
Those skilled in the art know how suitable materials have to be selected (for example on the basis of electrochemical investigations). Suitable materials for the individual layers are known to those skilled in the art and disclosed, for example, in WO 00/70655.
In addition, it is possible that some or all of the layers (1 ), (2), (3), (4) and (5) have been surface-treated in order to increase the efficiency of charge carrier transport. The selection of the materials for each of the layers mentioned is preferably determined by obtaining an OLED having a high efficiency.
The inventive OLED can be produced by methods known to those skilled in the art. In general, the OLED is produced by successive vapor deposition of the individual layers onto a suitable substrate. Suitable substrates are, for example, glass, inorganic materials such as ITO or IZO or polymer films. For the vapor deposition, customary techniques may be used, such as thermal evaporation, chemical vapor deposition (CVD), physical vapor deposition (PVD) and others.
In an alternative process, the organic layers may be coated from solutions or dispersions in suitable solvents, in which case coating techniques known to those skilled in the art are employed. Suitable coating techniques are, for example, spin- coating, the casting method, the Langmuir-Blodgett ("LB") method, the inkjet printing method, dip-coating, letterpress printing, screen printing, doctor blade printing, slit- coating, roller printing, reverse roller printing, offset lithography printing, flexographic printing, web printing, spray coating, coating by a brush or pad printing, and the like. Among the processes mentioned, in addition to the aforementioned vapor deposition, preference is given to spin-coating, the inkjet printing method and the casting method since they are particularly simple and inexpensive to perform. In the case that layers of the OLED are obtained by the spin-coating method, the casting method or the inkjet printing method, the coating can be obtained using a solution prepared by dissolving the composition in a concentration of 0.0001 to 90% by weight in a suitable organic solvent such as benzene, toluene, xylene, tetrahydrofuran, methyltetrahydrofuran, N,N- dimethylformamide, acetone, acetonitrile, anisole, dichloromethane, dimethyl sulfoxide, water and mixtures thereof.
It is possible that the layers of the OLED are all produced by the same coating method. Furthermore, it is likewise possible to conduct two or more different coating methods to produce the layers of the OLED. In general, the different layers have the following thicknesses: anode (2) 500 to 5000 A, preferably 1000 to 2000 A (angstrom); hole-transporting layer (3) 50 to 1000 A, preferably 200 to 800 A; light-emitting layer (4) 10 to 1000 A, preferably 100 to 800 A; electron-transporting layer (5) 50 to 1000 A, preferably 200 to 800 A; cathode (6) 200 to 10 000 A, preferably 300 to 5000 A. In addition, it is likewise possible to combine several layers by mixing. For example, the hole-transporting material can be mixed with the materials of the light-emitting layer and then applied together. The position of the recombination zone of holes and electrons in the inventive OLED and thus the emission spectrum of the OLED may be influenced by the relative thickness and concentration ratios of each layer. This means that the thickness of the electron transport layer should preferably be selected such that the electron/hole recombination zone is within the light-emitting layer. The ratio of the layer thicknesses of the individual layers in the OLED is dependent upon the materials used. The layer thicknesses of any additional layers used are known to those skilled in the art. In a preferred embodiment, the present invention relates to an OLED comprising at least one inventive metal-carbene complex, and at least one compound of the general formula (X)
in which
T is NR , S, O or PR , preferably S or O, more preferably O;
R ,57 is aryl, heteroaryl, alkyl, cycloalkyl or heterocycloalkyl;
,66
Q' is -NR58R59, -SiR70R71R72, -P(O)R60R61, -PR62R63, -S(0)2R64, -S(0)R65, -SR1 or -OR67, preferably -NR58R59; more preferably
in which
R68, R69 are each independently alkyl, cycloalkyl, heterocycloalkyl, aryl or heteroaryl; preferably methyl, carbazolyl, dibenzofuryl or dibenzothienyl;
y, z are each independently 0, 1 , 2, 3 or 4, preferably 0 or 1 ;
R55, R: 56 are each independently alkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl,
SiR70R71R72, a Q' group or a group with donor or acceptor action; a is 0, 1 , 2, 3 or 4;
b' is 0, 1 , 2 or 3;
R1 59 form, together with the nitrogen atom, a cyclic radical which has 3 to 10 ring atoms and may be unsubstituted or substituted by one or more substituents selected from alkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl and a group with donor or acceptor action, and/or may be fused to one or more further cyclic radicals having 3 to 10 ring atoms, where the fused radicals may be unsubstituted or substituted by one or more substituents selected from alkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl and a group with donor or acceptor action;
R70, R 71, R>72 o60 o61 o62 D63 D64 D65 066 D67
are each independently aryl, heteroaryl, alkyl, cycloalkyl or
heterocycloalkyl,
or two units of the general formula (X) are bridged to one another via a linear branched, saturated or unsaturated bridge optionally interrupted by at least c heteroatom, via a bond or via O.
in which
R68 R69 are each independently alkyl, cycloalkyi, heterocycloalkyi, aryl or heteroaryl; preferably methyl, carbazolyl, dibenzofuryl or dibenzothienyl;
y. z are each independently 0, 1 , 2, 3 or 4, preferably 0 or 1.
Particularly preferred c lowing formula (Xa):
55 r-,56
in which the symbols and indices Q', T, R , R , a" and b' are each as defined above.
Very particularly preferred compounds of the formula (X) have the formula (Xaa):
In a very particularly preferred embodiment, in formula (Xaa):
T is O or S, preferably O;
a" is 1 ;
b' is 0;
y, z are each independently 0 or 1 ; and
R68, R69 are each independently methyl, carbazolyl, dibenzofuryl or dibenzothienyl R55 is substituted phenyl, carbazolyl, dibenzofuryl or dibenzothienyl.
Further preferred compounds of the formula (X) have the formula (Xab):
in which the symbols and indices each independently R , R y, z, T, R , R , a" and b' are each indepenently as defined above.
In a very particularly preferred embodiment, in formula (Xab): is O or S, preferably O;
is 0;
is 0;
are each independently 0 or 1 ; and
are each independently methyl, carbazolyl, dibenzofuryl or dibenzothienyl
R is substituted phenyl, carbazolyl, dibenzofuryl or dibenzothienyl.
A very particularly preferred compound of the formula (Xab) is:
in which T is O or S, preferably O.
The compounds of the formula (X) can be prepared, for example, by the processes described in WO2010079051 , WO2007/077810, JP2009267255 or US20090017331 A1 , and WO2009/003898, or analogously to the processes described in the aforementioned documents.
In a further preferred embodiment, the compounds of the formula (X) have the formula (XI) or (XI*):
in which
T is NR57, S, O or PR57;
R57 is aryl, heteroaryl, alkyl, cycloalkyl or heterocycloalkyl;
Q' is -NR58R59, -SiR70R71R72, -P(O)R60R61, -PR62R63, -S(0)2R64,
66 j67.
S(0)R65, -SRbb or -ORb';
are each independently aryl, heteroaryl, alkyl, cycloalkyl,
heterocycloalkyl or OR73,
are each independently alkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, a Q' group or a group with donor or acceptor action;
for the compound of the formula (XI): are each independently 0, 1 , 2, 3; for the compound of the formula (XI*), a' is 0, 1 , 2 and b' is 0, 1 , 2, 3, 4;
form, together with the nitrogen atom, a cyclic radical which has 3 to 10 ring atoms and may be unsubstituted or substituted by one or more substituents selected from alkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl and a group with donor or acceptor action and/or may be fused to one or more further cyclic radicals having 3 to 10 ring atoms, where the fused radicals may be unsubstituted or substituted by one or more substituents selected from alkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl and a group with donor or acceptor action;
are each independently SiR74R75R76, aryl, heteroaryl, alkyl, cycloalkyl or heterocycloalkyl, optionally substituted by an OR77 group, are each independently SiR74R75R76, aryl, heteroaryl, alkyl, cycloalkyl or heterocycloalkyl,
R60 D61 D62 D63 D64 D65 D66 D67 D74 D75 D76
are each independently aryl, heteroaryl, alkyl, cycloalkyl or heterocycloalkyl,
or two units of the general formulae (XI) and/or (Χ ) are bridged to one another via a linear or branched, saturated or unsaturated bridge optionally interrupted by at least one heteroatom or via O, where this bridge in the general formulae (XI) and/or (XI*) i in each case attached to the silicon atoms in place of R71.
The compounds of the general formula (X) can be used as a matrix (diluent material), hole/exciton blocker, electron/exciton blocker, electron transport material or hole transport material in combination with the complexes claimed, which then preferably serve as emitters. Inventive OLEDs which include both at least one compound of the formula (X) and a compound of the formula (I) exhibit particularly good efficiencies and lifetimes. Depending on the function in which the compound of the formula (X) is used, it is present in pure form or in different mixing ratios. In a particularly preferred
embodiment, one or more compounds of the formula (X) are used as matrix material in the light-emitting layer.
For the compounds of the general formula (X), especially for the R55 to R77 radicals:
The terms aryl radical or group, heteroaryl radical or group, alkyl radical or group, cycloalkyl radical or group, heterocycloalkyl radical or group, alkenyl radical or group, alkynyl radical or group, and groups with donor and/or acceptor action are each defined as follows:
An aryl radical (or group) is understood to mean a radical having a base skeleton of 6 to 30 carbon atoms, preferably 6 to 18 carbon atoms, which is formed from an aromatic ring or a plurality of fused aromatic rings. Suitable base skeletons are, for example, phenyl, naphthyl, anthracenyl or phenanthrenyl, indenyl or fluorenyl. This base skeleton may be unsubstituted (which means that all carbon atoms which are substitutable bear hydrogen atoms), or may be substituted at one, more than one or all substitutable positions of the base skeleton.
Suitable substituents are, for example, deuterium, alkoxy radicals, aryloxy radicals, alkylamino groups, arylamino groups, carbazolyl groups, silyl groups, SiR78R79R80, suitable silyl groups SiR78R79R80 being specified below, alkyl radicals, preferably alkyl radicals having 1 to 8 carbon atoms, more preferably methyl, ethyl or i-propyl, aryl radicals, preferably C6-aryl radicals, which may in turn be substituted or unsubstituted, heteroaryl radicals, preferably heteroaryl radicals which comprise at least one nitrogen atom, more preferably pyridyl radicals and carbazolyl radicals, alkenyl radicals, preferably alkenyl radicals which bear one double bond, more preferably alkenyl radicals having one double bond and 1 to 8 carbon atoms, alkynyl radicals, preferably alkynyl radicals having one triple bond, more preferably alkynyl radicals having one triple bond and 1 to 8 carbon atoms or groups with donor or acceptor action. Suitable groups with donor or acceptor action are specified below. The substituted aryl radicals most preferably bear substituents selected from the group consisting of methyl, ethyl, isopropyl, alkoxy, heteroaryl, halogen, pseudohalogen and amino, preferably arylamino. The aryl radical or the aryl group is preferably a C6-Ci8-aryl radical, more preferably a C6-aryl radical, which is optionally substituted by at least one or more than one of the aforementioned substituents. The C6-Ci8-aryl radical, preferably C6-aryl radical, more preferably has none, one, two, three or four, most preferably none, one or two, of the aforementioned substituents.
A heteroaryl radical or a heteroaryl group is understood to mean radicals which differ from the aforementioned aryl radicals in that at least one carbon atom in the base skeleton of the aryl radicals is replaced by a heteroatom, and in that the base skeleton of the heteroaryl radicals preferably has 5 to 18 ring atoms. Preferred heteroatoms are N, O and S. Heteroaryl radicals suitable with particular preference are nitrogen- containing heteroaryl radicals. Most preferably, one or two carbon atoms of the base skeleton are replaced by heteroatoms, preferably nitrogen. The base skeleton is especially preferably selected from systems such as pyridine, pyrimidine and five- membered heteroaromatics such as pyrrole, furan, pyrazole, imidazole, thiophene, oxazole, thiazole, triazole. In addition, the heteroaryl radicals may be fused ring systems, for example benzofuryl, benzothienyl, benzopyrrolyl, dibenzofuryl, dibenzothienyl, phenanthrolinyl, carbazolyl radicals, azacarbazolyl radicals or diazacarbazolyl radicals. The base skeleton may be substituted at one, more than one or all substitutable positions of the base skeleton. Suitable substituents are the same as have already been specified for the aryl groups.
An alkyl radical or an alkyl group is understood to mean a radical having 1 to 20 carbon atoms, preferably 1 to 10 carbon atoms, more preferably 1 to 8, most preferably 1 to 4 carbon atoms. This alkyl radical may be branched or unbranched and optionally be interrupted by one or more heteroatoms, preferably Si, N, O or S, more preferably N, O or S. In addition, this alkyl radical may be substituted by one or more of the substituents specified for the aryl groups. In addition, the alkyl radicals present in accordance with the invention may have at least one halogen atom, for example F, CI, Br or I, especially F. In a further embodiment, the alkyl radicals present in accordance with the invention may be fully fluorinated. It is likewise possible that the alkyl radical bears one or more (hetero)aryl groups. In the context of the present application, for example, benzyl radicals are thus substituted alkyl radicals. In this context, all of the (hetero)aryl groups listed above are suitable. The alkyl radicals are more preferably selected from the group consisting of methyl, ethyl, isopropyl, n-propyl, n-butyl, iso- butyl and tert-butyl, very particular preference being given to methyl and ethyl.
A cycloalkyl radical or a cycloalkyl group is understood to mean a radical having 3 to 20 carbon atoms, preferably 3 to 10 carbon atoms, more preferably 3 to 8 carbon atoms. This base skeleton may be unsubstituted (which means that all carbon atoms which are substitutable bear hydrogen atoms) or substituted at one, more than one or all substitutable positions of the base skeleton. Suitable substituents are the groups already mentioned above for the aryl radicals. It is likewise possible that the cycloalkyl radical bears one or more (hetero)aryl groups. Examples of suitable cycloalkyl radicals are cyclopropyl, cyclopentyl and cyclohexyl.
A heterocycloalkyi radical or a heterocycloalkyi group is understood to mean radicals which differ from the aforementioned cycloalkyi radicals in that at least one carbon atom in the base skeleton of the cycloalkyi radicals is replaced by a heteroatom. Preferred heteroatoms are N, O and S. Most preferably, one or two carbon atoms of the base skeleton of the cycloalkyi radicals are replaced by heteroatoms. Examples of suitable heterocycloalkyi radicals are radicals derived from pyrrolidine, piperidine, piperazine, tetrahydrofuran, dioxane. An alkenyl radical or an alkenyl group is understood to mean a radical which corresponds to the aforementioned alkyl radicals having at least two carbon atoms, with the difference that at least one C-C single bond of the alkyl radical is replaced by a C-C double bond. The alkenyl radical preferably has one or two double bonds. An alkynyl radical or an alkynyl group is understood to mean a radical which corresponds to the aforementioned alkyl radicals having at least two carbon atoms, with the difference that at least one C-C single bond of the alkyl radical is replaced by a C-C triple bond. The alkynyl radical preferably has one or two triple bonds. An SiR78R79R80 group is understood to mean a silyl radical in which
R78, R79 and R80 are each independently alkyl, cycloalkyi, heterocycloalkyi, aryl, heteroaryl or OR73. An SiR74R75R76 group is understood to mean a silyl radical in which
R74, R75 and R76 are each independently alkyl, cycloalkyi, heterocycloalkyi, aryl, heteroaryl or OR73. In the context of the present application, a group or a substituent with donor or acceptor action is understood to mean the following groups:
Groups with donor action are understood to mean groups which have a +l and/or +M effect, and groups with acceptor action are understood to mean groups which have a -I and/or -M effect. Preferred suitable groups are selected from CrC2o-alkoxy, C6-C3o- aryloxy, C C2o-alkylthio, C6-C30-arylthio, SiR81R82R83, OR73, halogen radicals, halogenated C C2o-alkyl radicals, carbonyl (-CO(R81)), carbonylthio (- C = O (SR81)), carbonyloxy (- C = 0(OR81)), oxycarbonyl (- OC = 0(R81)), thiocarbonyl (- SC = 0(R81)), amino (-NR81R82), pseudohalogen radicals, amido (- C = O (NR81)), -NR81C = O (R83), phosphonate (- P(O) (OR81)2, phosphate (-OP(O) (OR81)2), phosphine (-PR81R82), phosphine oxide (-P(0)R81 2), sulfate (-OS(0)2OR81), sulfoxide (-S(O)R81), sulfonate
(-S(0)2OR81), sulfonyl (-S(0)2R81, sulfonamide (-S(0)2NR81R82), N02, boronic esters (-OB(OR81)2), imino (-C = NR81R82)), borane radicals, stannane radicals, hydrazine radicals, hydrazone radicals, oxime radicals, nitroso groups, diazo groups, vinyl groups, sulfoximines, alanes, germanes, boroximes and borazines.
The R81, R82 and R83 radicals mentioned in the aforementioned groups with donor or acceptor action are each independently: substituted or unsubstituted CrC20-alkyl or substituted or unsubstituted C6-C3o-aryl, or OR76, suitable and preferred alkyl and aryl radicals having been specified above. The R81, R82 and R83 radicals are more preferably CrC6-alkyl, e.g. methyl, ethyl or i-propyl, or phenyl. In a preferred embodiment - in the case of SiR81R82R83 - R81, R82 and R83 are preferably each independently substituted or unsubstituted CrC20-alkyl or substituted or unsubstituted aryl, preferably phenyl.
Preferred substituents with donor or acceptor action are selected from the group consisting of:
C to C20-alkoxy, preferably CrC6-alkoxy, more preferably ethoxy or methoxy; C6-C30- aryloxy, preferably C6-Cio-aryloxy, more preferably phenyloxy; SiR81R82R83 where R81, R82 and R83 are preferably each independently substituted or unsubstituted alkyl or substituted or unsubstituted aryl, preferably phenyl, for example SiPh3 or SiMe; halogen radicals, preferably F, CI, more preferably F, halogenated CrC20-alkyl radicals, preferably halogenated CrC6-alkyl radicals, most preferably fluorinated CrC6-alkyl radicals, e.g. CF3, CH2F, CHF2 or C2F5; amino, preferably dimethylamino, diethylamino or diarylamino, more preferably diarylamino; pseudohalogen radicals, preferably CN, - C(0)OC C4-alkyl, preferably -C(0)OMe, P(0)R2, preferably P(0)Ph2.
Very particularly preferred substituents with donor or acceptor action are selected from the group consisting of methoxy, phenyloxy, halogenated Ci-C4-alkyl, preferably CF3, CH2F, CHF2, C2F5, halogen, preferably F, CN, SiR81R82R83, suitable R81, R82 and R83 radicals already having been specified, for example SiMe3, diarylamino (NR84R85 where R84, R85 are each C6-C30-aryl), -C(0)OC C4-alkyl, preferably -C(0)OMe, P(0)Ph2. Halogen groups are preferably understood to mean F, CI and Br, more preferably F and CI, most preferably F.
Pseudohalogen groups are preferably understood to mean CN, SCN and OCN, more preferably CN.
The aforementioned groups with donor or acceptor action do not rule out the possibility that further radicals and substituents mentioned in the present application, but not included in the above list of groups with donor or acceptor action, have donor or acceptor action.
The aryl radicals or groups, heteroaryl radicals or groups, alkyl radicals or groups, cycloalkyi radicals or groups, heterocycloalkyi radicals or groups, alkenyl radicals or groups and groups with donor and/or acceptor action may - as mentioned above - be substituted or unsubstituted. In the context of the present application, an unsubstituted group is understood to mean a group in which the substitutable atoms of the group bear hydrogen atoms. In the context of the present application, a substituted group is understood to mean a group in which one or more substitutable atom(s) bear(s) a substituent in place of a hydrogen atom at least at one position. Suitable substituents are the substituents specified above for the aryl radicals or groups.
When radicals having the same numbering occur more than once in the compounds according to the present application, these radicals may each independently have the definitions specified.
The T radical in the compounds of the formula (X) is NR57, S, O or PR57, preferably NR57, S or O, more preferably O or S, most preferably O.
The R57 radical is aryl, heteroaryl, alkyl, cycloalkyi or heterocycloalkyi, preferably aryl, heteroaryl or alkyl, more preferably aryl, where the aforementioned radicals may be unsubstituted or substituted. Suitable substituents have been specified above. R65 is more preferably phenyl which may be substituted by the aforementioned substituents or unsubstituted. R57 is most preferably unsubstituted phenyl. The Q' group in the compounds of the formula (X) is -NR58R59, -SiR70R71R72, -P(O)R60R61, -PR62R63, -S(0)2R64, -S(0)R65, -SR66 or -OR67; preferably NR58R59, - P(O)R60R61 or -OR67, more preferably -NR58R59.
The R58 to R67, R70, R71, R72 and R74 to R76 radicals are each defined as follows:
R58, R59 form, together with the nitrogen atom, a cyclic radical which has 3 to 10 ring atoms and may be unsubstituted or substituted by one or more substituents selected from alkyl, cycloalkyi, heterocycloalkyi, aryl, heteroaryl and a group with donor or acceptor action and/or may be
fused to one or more further cyclic radicals having 3 to 10 ring atoms, where the fused radicals may be unsubstituted or substituted by one or more substituents selected from alkyl, cycloalkyl, heterocycloalkyi, aryl, heteroaryl and a group with donor or acceptor action;
R70, R71, R72 are each independently aryl, heteroaryl, alkyl, cycloalkyl, heterocycloalkyi or OR73,
R73 is independently SiR74R75R76, aryl, heteroaryl, alkyl, cycloalkyl or
heterocycloalkyi, optionally substituted by one OR77 group, R77 is independently SiR74R75R76, aryl, heteroaryl, alkyl, cycloalkyl or
heterocycloalkyi,
R60 D61 D62 D63 D64 D65 D66 D67 D74 D75 D76
, r\ , r\ , r\ , r\ , r\ , r\ , r\ , r\ , r\ , r\
are each independently aryl, heteroaryl, alkyl, cycloalkyl or heterocycloalkyi, preferably aryl or heteroaryl, where the radicals may be unsubstituted or substituted by one or more of the radicals selected from alkyl, cycloalkyl, heterocycloalkyi, aryl, heteroaryl and a group with donor or acceptor action, more preferably unsubstituted or substituted phenyl, suitable substituents having been specified above, for example tolyl or a group of the formula
in which the T group is as defined for the compounds of the formula (XI) or (XI*) and the R70, R71 and R72 radicals are defined above.
R60, R61, R62, R63, R64, R65, R66 and R67 are most preferably each independently phenyl, tolyl or a group of the formula
Examples of -NR58R59 groups suitable with preference are selected from the group consisting of pyrrolyl, 2,5-dihydro-1 -pyrrolyl, pyrrolidinyl, indolyl, indolinyl, isoindolinyl, carbazolyl, azacarbazolyl, diazacarbazolyl, imidazolyl, imidazolinyl, benzimidazolyl, pyrazolyl, indazolyl, 1 ,2,3-triazolyl, benzotriazolyl, 1 ,2,4-triazolyl, tetrazolyl, 1 ,3- oxazolyl, 1 ,3-thiazolyl, piperidyl, morpholinyl, 9,10-dihydroacridinyl and 1 ,4-oxazinyl, where the aforementioned groups may be unsubstituted or substituted by one or more substituents selected from alkyl, cycloalkyi, heterocycloalkyi, aryl, heteroaryl and a group with donor or acceptor action; the -NR58R59 group is preferably selected from carbazolyl, pyrrolyl, indolyl, imidazolyl, benzimidazolyl, azacarbazolyl and diazacarbazolyl, where the aforementioned groups may be unsubstituted or substituted by one or more substituents selected from alkyl, cycloalkyi, heterocycloalkyi, aryl, heteroaryl and a group with donor or acceptor action; the -NR58R59 group is more preferably carbazolyl which may be unsubstituted or substituted by one or more substituents selected from alkyl, cycloalkyi, heterocycloalkyi, aryl, heteroaryl and a group with donor or acceptor action.
Particularly preferred -NR58R59 groups are:
in which
R68, R69 are each independently alkyl, cycloalkyi, heterocycloalkyi, aryl or
heteroaryl; preferably methyl, carbazolyl, dibenzofuryl or dibenzothienyl; y, z are each independently 0, 1 , 2, 3 or 4, preferably 0 or 1 ;
for example:
R , R in the compounds of the formula (X) are each independently alkyl, cycloalkyi, heterocycloalkyi, aryl, heteroaryl, a further A group or a group with donor or acceptor action; preferably each independently alkyl, aryl, heteroaryl or a group with donor or acceptor action. For example, R55 or R56 may each independently be:
in which X is NPh, S or O.
In the compounds of the formula (X) a" R groups and/or b' R groups may be present, where a" and b' are: a" is 0, 1 , 2, 3 or 4; preferably independently 0, 1 or 2;
b' is 0, 1 , 2 or 3; preferably independently 0, 1 or 2.
Most preferably at least a" or b' is 0, very especially preferably a" and b' are each 0 or a" is 1 and b' is 0.
R73 in the compounds of the general formula (XI) is generally independently SiR74R75R76, aryl, heteroaryl, alkyl, cycloalkyl or heterocycloalkyl, optionally substituted by an OR77 group. R77 in compounds of the general formula (XI) is generally independently aryl, heteroaryl, alkyl, cycloalkyl or heterocycloalkyl.
The OR77 substituent optionally present may generally be present in the radicals mentioned at all sites which appear suitable to the person skilled in the art.
In a further embodiment, two units of the general formula (XI) and/or (Χ ) are bridged to one another via a linear or branched, saturated or unsaturated bridge optionally interrupted by at least one heteroatom or via O, where this bridge in the general formula (XI) and/or (Χ ) is in each case attached to the silicon atoms in place of R71.
This bridge is preferably selected from the group consisting of -CH2-, -C2H4-, -C3H6-, -C4H8-, -C6H-I2-, -C8H-I6-, -C9H18-, -CH(C8H"|7)CH2-, -C2H4(CF2)8 C2H4-, -C=C-, -1 ,4- (CH2)2-phenyl-(CH2)2-, 1 ,3-(CH2)2-phenyl-(CH2)2-, -1 ,4-phenyl-, -1 ,3-phenyl-, -0-, -0-Si(CH3)2-0-, -0-Si(CH3)2-0- Si(CH3)2-0-, -O-
In a preferred embodiment of the present application, the compounds of the general formula (X) have the general formula (XIa), (Xlb), (Xlc), (Xld) or (Xle), i.e. they are preferred embodiments of the compounds of the general formula (XI) or (XI*):
in which the Q\ T, R , R , R , R , R radicals and groups, and a' and b', are each as defined above.
In another embodiment preferred in accordance with the invention, R70, R71 or R72 in the compounds of the general formula (XI) or (Χ ) are aromatic units of the general formulae (Xli) and/or (Xli*)
The present invention therefore relates, in one embodiment, to an inventive OLED where R70, R71 or R72 in the compounds of the general formula (XI) or (Χ ) are aromatic units of the general formulae (Xli) and/or (Xli*)
where R , R , Q', T, a' and b' are each as defined above. In a preferred embodiment, the present invention relates to an OLED wherein the compound of the general formula (XI) or (XI*) is selected from the following group:
In these particularly preferred compounds of the general formula (XI) or (Χ ): T is S or O, and
R' isHorCH3;and
R70, R71, R72 are each phenyl, carbazolyl, dibenzofuran or dibenzothiophene.
Further particularly suitable compounds of the general formula (XI) or (Χ ) are:
In these particularly preferred compounds of the general formula (XI) or (Χ ) too, T is O or S, preferably O.
Further suitable compounds of the general formula (XI) or (Χ ) correspond to the following formula (XII)
Each independently linear or branched alkyl radical optionally bearing at least one functional group, optionally interrupted by at least one heteroatom and having 1 to 30 carbon atoms, alkoxy radical having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl radical having 3 to 20 carbon atoms, substituted or unsubstituted aryl radical having 6 to 30 carbon atoms; preferred compounds of the formula (XII) and preferred R70, R71, R72 radicals are specified in European application EP10 187 176.2 and US application 61/391 ,712 and PCT application PCT/EP2010/069541 , all of which were yet to be published at the priority date of the present application. Furthermore, European application EP10 187 176.2 and US application 61/391 ,712 and PCT application PCT/EP2010/069541 , all of which were yet to be published at the priority date of the present application, cite further suitable compounds of the formula (X).
In a further preferred embodiment, the present invention relates to an OLED comprising at least one inventive metal-carbene complex of the formula (I) and at least one compound of the general formula (X), where the compound of the general formula (X) has the general formula (XIV):
A further embodiment of the present invention relates to an inventive organic light- emitting diode in which the compound of the general formula VI is a 3,6-disilyl- substituted compound of the general formula Via:
is S, O; is substituted or unsubstituted Ci-C2o-alkyl, substituted or unsubstituted C6- C30-aryl or substituted or unsubstituted heteroaryl having 5 to 30 ring atoms; preferably substituted or unsubstituted C6-C3o-aryl or unsubstituted Ci-C2o-alkyl, more preferably substituted or unsubstituted C6-Cio-aryl, most preferably substituted or unsubstituted phenyl, suitable substituents having been specified above;
R40', R41', R42', R43'
are each independently substituted or unsubstituted CrC2o-alkyl or substituted or unsubstituted C6-C3o-aryl or a structure of the general formula (c); preferably at least one of the R38 , R39 or R40 radicals and/or at least one of the R41 , R42 or R43 radicals is substituted or unsubstituted C6-C3o-aryl, more preferably substituted or unsubstituted C6-Ci0-aryl, most preferably substituted or unsubstituted phenyl, suitable substituents having been specified above, and/or one of the R38 , R39 or R40 radicals and/or one of the R41 , R42 or R43 radicals is a radical of the structure (c);
R44', R45', R46', R47', R48', R'
are each independently hydrogen or as defined for Ra and Rb , i.e. each independently substituted or unsubstituted CrC2o-alkyl, substituted or unsubstituted C6-C20-aryl, substituted or unsubstituted heteroaryl having 5 to 30 ring atoms or a substituent with donor or acceptor action, suitable
substituents with donor or acceptor action having been specified above; preferably hydrogen, substituted or unsubstituted CrC6-alkyl, substituted or unsubstituted C6-Ci0-aryl or SiR34 R35 R36 ; more preferably hydrogen, methyl, ethyl, phenyl, CF3 or SiR34 R35 R36' where R34', R35' and R36' are preferably each independently substituted or unsubstituted CrC2o-alkyl or substituted or unsubstituted phenyl; more preferably, at least one of the R34 , R35 or R36 radicals is substituted or unsubstituted phenyl; most preferably, at least one of the R34 , R35 and R36 radicals is substituted phenyl, suitable substituents having been specified above; and the further radials and indices R34 , R35 , R36 are each as defined above.
In a particularly preferred embodiment, the compounds of the formula (XIV) used in the inventive organic light-emitting diodes have the following definitions for the R37 to R43 , Ra and Rb radicals, and X' group:
X' is NR37';
R37 is substituted or unsubstituted C6-C3o-aryl, preferably substituted or unsubstituted C6-Ci0-aryl, more preferably substituted or unsubstituted phenyl, suitable substituents having been specified above;
are each independently substituted or unsubstituted CrC2o-alkyl or substituted or unsubstituted C6-C3o-aryl, or a structure of the general formula (c), preferably each independently substituted or unsubstituted d- C6-alkyl or substituted or unsubstituted C6-Ci0-aryl, more preferably substituted or unsubstituted CrC6-alkyl or substituted or unsubstituted phenyl; where, in one embodiment, at least one of the R38 , R39 or R40 radials and/or at least one of the R41 , R42 or R43 radicals is substituted or unsubstituted C6-C3o-aryl, preferably substituted or unsubstituted C6-Ci0- aryl, more preferably substituted or unsubstituted phenyl, preferred substituents having been specified above;
44 R45', R46', R47', R48', R'
are each independently hydrogen or as defined for Ra and Rb , i.e. each independently substituted or unsubstituted Ci-C2o-alkyl, substituted or unsubstituted C6-C3o-aryl, substituted or unsubstituted heteroaryl having 5 to 30 ring atoms or a substituent with donor or acceptor action, suitable substituents with donor or acceptor action already having been specified above; preferably hydrogen, substituted or unsubstituted CrC6-alkyl, substituted or unsubstituted C6-Ci0-aryl or SiR34 R35 R36 ; more preferably hydrogen, methyl, ethyl, phenyl, CF3 or SiR34 R35 R36';
334' ¾35' 36'
are each independently substituted or unsubstituted CrC2o-alkyl or substituted or unsubstituted C6-C3o-aryl, preferably substituted or unsubstituted CrC6-alkyl or substituted or unsubstituted C6-Ci0-aryl, where R34 , R35 and R36 are more preferably each independently substituted or unsubstituted CrC2o-alkyl or substituted or unsubstituted phenyl; more preferably, at least one of the R34 , R35 or R36 radicals is substituted or unsubstituted phenyl; most preferably, at least one of the R34 , R35 and R36 radicals is substituted phenyl, suitable substituents having been specified above.
An example of a particularly suitable compound of the formula (XIV) is
In a very particularly preferred embodiment, the present invention relates to an OLED which, as well as at least one metal-carbene complex of the general formula (I), comprises at least one compound of the general formula (X), in which case the compound of the formula (X) is most preferably at least one of the compounds specified below:
85
In the aforementioned compounds, T is O or S, preferably O. When more than one T occurs in the molecule, all T groups have the same definition.
In addition to the compounds of the formula (X), according to the present invention, it is also possible to use crosslinked or polymeric materials comprising repeat units based on the general formula (X) in crosslinked or polymerized form together with at least one metal-carbene complex of the general formula (I). Like the compounds of the general formula (X), the latter are preferably used as matrix materials.
The crosslinked or polymeric materials have outstanding solubility in organic solvents, excellent film-forming properties and relatively high glass transition temperatures. In addition, high charge carrier mobilities, high stabilities of color emission and long operating times of the corresponding components can be observed when crosslinked or polymeric materials according to the present invention are used in organic light- emitting diodes (OLEDs).
The crosslinked or polymerized materials are particularly suitable as coatings or in thin films since they are thermally and mechanically stable and relatively defect-free.
The crosslinked or polymerized materials comprising repeat units based on the general formula (X) can be prepared by a process comprising steps (a) and (b): (a) preparation of a crosslinkable or polymerizable compound of the general formula (X) where at least one of the a" R55 radicals or at least one of the b' R56 radicals is a crosslinkable or polymerizable group attached via a spacer, and
(b) crosslinking or polymerization of the compound of the general formula (X) obtained from step (a).
The crosslinked or polymerized materials may be homopolymers, which means that exclusively units of the general formula (X) are present in crosslinked or polymerized form. They may also be copolymers, which means that further monomers are present
in addition to the units of the general formula (X), for example monomers with hole- conducting and/or electron-conducting properties, in crosslinked or polymerized form.
In a further preferred embodiment of the inventive OLED, it comprises an emission layer comprising at least one inventive metal-carbene complex of the general formula (I), at least one matrix material of the formula (X), and optionally at least one further hole-transporting matrix material.
The inventive OLEDs can be used in all devices in which electroluminescence is useful. Suitable devices are preferably selected from stationary and mobile visual display units and illumination means. The present invention therefore also relates to a device selected from the group consisting of stationary visual display units and mobile visual display units and illumination means, comprising an inventive OLED. Stationary visual display units are, for example, visual display units of computers, televisions, visual display units in printers, kitchen appliances and advertising panels, illuminations and information panels. Mobile visual display units are, for example, visual display units in cellphones, laptops, tablet PCs, digital cameras, mp-3 players, smartphones, vehicles, and destination displays on buses and trains.
The inventive metal-carbene complexes of the general formula (I) can additionally be used in OLEDs with inverse structure. In these inverse OLEDs, the inventive complexes are in turn preferably used in the light-emitting layer. The structure of inverse OLEDs and the materials typically used therein are known to those skilled in the art.
The present invention further provides a white OLED comprising at least one inventive metal-carbene complex of the general formula (I). In a preferred embodiment, the metal-carbene complex of the general formula (I) is used as emitter material in the white OLED. Preferred embodiments of the metal-carbene complex of the general formula (I) have been specified above. In addition to the at least one metal-carbene complex of the general formula (I), the white OLED may comprise
(i) at least one compound of the formula (X). The compound of the formula (X) is preferably used as matrix material. Preferred compounds of the formula (X) have been specified above; and/or
(ii) at least one compound of the formula (VII) and/or (IX). The compounds of the formula (VII) and/or (IX) are preferably used as electron transport material. Preferred compounds of the formulae (VII) and (IX) have been specified above.
In order to obtain white light, the OLED must generate light which colors the entire visible range of the spectrum. However, organic emitters normally emit only in a limited portion of the visible spectrum - i.e. are colored. White light can be generated by the combination of different emitters. Typically, red, green and blue emitters are combined. However, the prior art also discloses other methods for formation of white OLEDs, for example the triplet harvesting approach. Suitable structures for white OLEDs or methods for formation of white OLEDs are known to those skilled in the art.
In one embodiment of a white OLED, several dyes are layered one on top of another in the light-emitting layer of an OLED and hence combined (layered device). This can be achieved by mixing all dyes or by direct series connection of different-colored layers. The expression "layered OLED" and suitable embodiments are known to those skilled in the art. In general, the different layers then have the following thicknesses: anode (2) 500 to 5000 A (angstrom), preferably 1000 to 2000 A; hole-transporting layer (3) 50 to 1000 A, preferably 200 to 800 A, either a light-emitting layer comprising a mixture of different emitters (4): 10 to 1000 A, preferably 100 to 800 A, or several light-emitting layers in succession, each individual layer comprising a different emitter (4a, b, c, ...): each 10 to 1000 A, preferably each 50 to 600 A, electron-transporting layer (5) 50 to 1000 A, preferably 200 to 800 A, cathode (6) 200 to 10 000 A, preferably 300 to 5000 A.
In a further embodiment of a white OLED, several different-colored OLEDs are stacked one on top of another (stacked device). For the stacking of two OLEDs, what is called a charge generation layer (CG layer) is used. This CG layer may be formed, for example, from one electrically n-doped and one electrically p-doped transport layer. The expression "stacked OLED" and suitable embodiments are known to those skilled in the art. In general, the different layers then have the following thicknesses: anode (2) 500 to 5000 A (angstrom), preferably 1000 to 2000 A; first hole-transporting layer (3) 50 to 1000 A, preferably 200 to 800 A, first light-emitting layer (4) 10 to 1000 A, preferably 50 to 600 A, first electron-transporting layer (5) 50 to 1000 A, preferably 200 to 800 A, electrically n-doped layer 50 to 1000 A, preferably 100 to 800 A, electrically p-doped layer 50 to 1000 A, preferably 100 to 800 A, second hole-transporting layer (3) to 50 to 1000 A, preferably 200 to 800 A, second light-emiting layer (4) 10 to 1000 A, preferably 50 to 600 A, second electron-transporting layer (5) 50 to 1000 A, preferably 200 to 800 A, electrically n-doped layer 50 to 1000 A, preferably 100 to 800 A, electrically p- doped layer 50 to 1000 A, preferably 100 to 800 A, third hole-transporting layer (3) to to
1000 A, preferably 200 to 800 A, third light-emitting layer (4) 10 to 1000 A, preferably 50 to 600 A, third electron-transporting layer (5) to 50 to 1000 A, preferably 200 to 800 A, cathode (6) 200 to 10 000 A, preferably 300 to 5000 A. In further embodiments of this "stacked device concept", it is also possible to stack only two OLEDs or to stack more than three OLEDs.
In a further embodiment of white OLEDs, the two concepts mentioned for white light generation can also be combined. For example, a single-color OLED (for example blue) can be stacked with a multicolor layered OLED (for example red-green). Further combinations of the two concepts are conceivable and known to those skilled in the art.
The inventive metal-carbene complex of the formula (I) can be used in any of the layers mentioned above in white OLEDs. In a preferred embodiment, it is used in one or more or all light-emitting layer(s) of the OLED(s), in which case the structure of the invention metal-carbene complex is varied as a function of the use of the complex. Suitable and preferred components for the further layers of the light OLED(s) or materials suitable as matrix material in the light-emitting layer(s) and preferred matrix materials are likewise specified above.
The present invention also relates to an organic electronic component, preferably an organic light-emitting diode (OLED), organic photovoltaic cell (OPV), organic field-effect transistor (OFET) or light-emitting electrochemical cell (LEEC), comprising at least one inventive metal-carbene complex of the general formula (I).
Examples
The examples which follow, more particularly the methods, materials, conditions, process parameters, apparatus and the like detailed in the examples, are intended to support the present invention, but not to restrict the scope of the present invention.
All experiments are carried out in protective gas atmosphere.
The percentages and ratios mentioned in the examples below - unless stated otherwise - are % by weight and weight ratios.
Synthesis examples
Example 1 : 2,3-Bis(phenylamino ridine (ZW1 )
ZW1
A suspension of 2,3-diaminopyridine (8.9 g, 9 mmol) and iodobenzene (17.8 ml, 18 mmol) in dioxane (270 ml) is admixed with tris(dibenzylideneacetone)dipalladium (Pd2(dba)3, 3838 mg, 0.1 mmol), 9,9-dimethyl-4,5-bis(diphenylphosphin)xanthene (1 -4 g, 0.3 mmol), sodium tert-butoxide (15.4 g, 18 mmol) and water (2.3 g). The mixture is stirred under reflux overnight. After cooling to room temperature, the precipitate is filtered off with suction and washed with dichloromethane. The combined filtrates are concentrated to dryness and the residue is dissolved in dichloromethane (125 ml) and cyclohexane (150 ml) and column-filtered. The product fractions are concentrated and precipitated product is filtered off. Yield: 14.2 g (67%).
1H NMR (CD2CI2, 500 MHz): δ = 5.19 (br s, 1 H), 6.71 -6.76 (m, 3H), 6.84 (dd, 1 H), 6.89- 6.96 (m, 2H), 7.19 (dd, 2H), 7.23 (dd, 2H), 7.39 (d, 1 H), 7.51 (d, 2H), 8.02 (d, 1 H).
1 ,3-Diphenyl-4-azabenzimidazolium chloride:
A suspension of 2,3-bis(/V-phenylamino)pyridine (14.2 g, 54 mmol) in hydrochloric acid (200 ml) is stirred at room temperature overnight. The mixture is concentrated to dryness to obtain 14.0 g of a solid. Triethyl orthoformate (160 ml) is added thereto and the mixture is stirred at 105°C overnight. After cooling to room temperature, the solid is filtered off with suction and washed with triethyl orthoformate. Yield: 10.3 g (62%). 1H NMR (CD2CI2, 500 MHz): δ = 7.55-7.73 (m, 7H), 8.08 (dd, 2H), 8.19 (dd, 1 H), 8.33 (dd, 2H), 8.80 (dd, 1 H), 12.24 (s, 1 H).
Complex fac-Em1 :
A suspension of 1 ,3-diphenyl-4-azabenzimidazolium chloride (4.9 g, 16 mmol) and 3A molecular sieve (25 g) in dioxane (250 ml) is admixed with silver(l) oxide (3.0 g, 13 mmol) and stirred at room temperature overnight. The mixture is admixed with chloro(1 ,5-cyclooctadien)iridium(l) dimer (1.1 g, 1 .6 mmol) and stirred under reflux overnight. After cooling to room temperature, the precipitate is filtered off with suction
and washed with dichloromethane. The combined filtrates are concentrated to dryness and the residue is purified by column filtration (silica gel, dichloromethane). The resulting solid is dissolved in butanone (1 10 ml) and admixed with hydrochloric acid (1 N, 1 1 .8 ml). The mixture is stirred under reflux for 24 hours. After cooling to room temperature, the precipitate is filtered off with suction, washed with cyclohexane and purfied by column chromatography (silica gel, 2:3 dichloromethane/cyclohexane). Yield: 1.02 g (31 %).
1H NMR (CD2CI2, 500 MHz): δ = 6.24 (d, 6H), 6.50 (d, 3H), 6.58 (dd, 3H), 6.68-6.79 (m, 9H), 6.96 (dd, 3H), 7.06 (mc, 3H), 7.27 (dd, 3H), 8.32 (dd, 3H), 8.89 (dd, 3H).
Photoluminescence (2% in a PMMA film):
Xmax = 415 nm, CIE: (0.16;0.07); QY = 41 %
Example 2:
2-Chloro-3-W-isopropylaminopyridine:
A solution of 3-amino-2-chloropyridine (16.0 g, 124 mmol) in dichloromethane (300 ml) and glacial acetic acid (150 ml) is admixed with acetone (25.0 ml, 335 mmol) and, at 0°C, with borane-dimethyl sulfide complex (13.0 ml, 136 mmol), and the mixture is stirred at room temperature overnight. The solution is adjusted to pH 8 with ammonia (25% in water) and diluted with water (100 ml). The organic phase is removed and the aqueous phase is extracted with dichloromethane (3 χ 100 ml). The combined organic phases are dried over sodium sulfate and concentrated to dryness. The crude product is used without further purification. Yield: 21 .4 g (> 100%).
1H NMR (de-DMSO, 500 MHz): 5 = 1 .19 (d, 6H), 3.66 (mc, 1 H), 4.98 (d, 1 H), 7.09 (dd, 1 H), 7.19 (dd, 1 H), 7.59 (dd, 1 H).
2-W-Phenylamino-3-W-isopropylamino ridine:
A mixture of 2-chloro-3-/V-isopropylaminopyridine (21 .4 g, 125 mmol) in aniline (1 1.4 ml, 125 mmol) is stirred at 170°C overnight. After cooling to room temperature, the solid is taken up in water (100 ml) and the solution is adjusted to pH 1 1 with sodium hydroxide solution (1 N). The aqueous phase is extracted with dichloromethane (1 χ 100 ml, 2 x 50 ml). The combined organic phases are concentrated to dryness and the crude product is purified by column chromatography (silica gel, ethyl acetate/n-hexane gradient). Yield: 15.8 g (56%).
1H NMR (de-DMSO, 500 MHz): 5 = 1 .19 (d, 6H), 3.59 (mc, 1 H), 4.91 (d, 1 H), 6.70 (dd, 1 H), 6.76-6.88 (m, 2H), 7.22 (mc, 2H), 7.46 (dd, 1 H), 7.54 (d, 2H), 7.76 (br s, 1 H). 1 -lsopropyl-3-phen l-4-azabenzimidazolium iodide:
A mixture of 2-/V-phenylamino-3-/V-isopropylaminopyridine (5.0 g, 21 mmol) and triethyl orthoformate (20 ml) is admixed with ammonium iodide (3.2 g, 22 mmol) and stirred at 70°C overnight. After cooling to room temperature, the solid is filtered off with suction and washed with petroleum ether and a little dichloromethane. Yield: 6.6 g (89%).
1H NMR (CD2CI2, 500 MHz): δ = 1.90 (d, 6H), 5.43 (sept, 1 H), 7.56-7.72 (m, 4H), 8.15 (mc, 2H), 8.28 (dd, 1 H), 8.77 (dd, 1 H), 1 1 .19 (s, 1 H).
Complex mer-E
mer-Em2
A suspension of 1 -isopropyl-3-phenyl-4-azabenzimidazolium iodide (4.5 g, 16 mmol) and 3A molecular sieve (55 g) in dioxane (380 ml) is admixed with silver(l) oxide (3.1 g, 13 mmol) and stirred at room temperature overnight. The mixture is admixed with a solution of chloro-(1 ,5-cyclooctadiene)iridium(l) dimer (1 .1 g, 1 .6 mmol) in o-xylene (500 ml) and stirred at 1 10°C overnight. After cooling to room temperature, the precipitate is filtered off with suction and stirred with ethyl acetate (400 ml) and dichloromethane (400 ml). The combined filtrates are concentrated to dryness and the residue is column-filtered (silica gel, dichloromethane). The product fractions are concentrated to dryness and stirred with methyl tert-butyl ether. Yield: 2.1 g (72%).
1H NMR (CD2CI2, 500 MHz): δ = 0.59 (d, 3H), 0.66 (d, 3H), 0.80 (d, 3H), 1 .24 (d, 3H), 1.30 (d, 3H), 1 .60 (d, 3H), 4.61 (mc, 2H), 4.80 (sept, 1 H), 6.56 (dd, 1 H), 6.61 -6.70 (m, 4H), 6.91 -7.03 (m, 4H), 7.10-7.18 (m, 3H), 7.67-7.74 (m, 3H), 8.33-8.40 (m, 3H), 8.78 (d, 1 H), 8.81 (d, 1 H), 8.85 (dd, 1 H).
Photoluminescence (2% in a PMMA film):
max = 441 nm, CIE: (0.16;0.1 1 ); QY = 82%
Complex fac-Em2:
mer-Em2 fac-Em2
A solution of mer-Em2 (500 mg, 0.6 mmol) in methanol (50 ml) is admixed with hydrochloric acid (1 N, 5 ml) and stirred under reflux overnight. After cooling to room temperature, the precipitate is filtered off with suction, washed with petroleum ether and stirred with methyl tert-butyl ether overnight. Yield: 338 mg (68%).
1H NMR (CD2CI2, 500 MHz): δ = 0.77 (d, 9H), 1 .51 (d, 9H), 4.66 (sept, 3H), 6.37 (d, 3H), 6.58 (dd, 3H), 6.97 (dd, 3H), 7.10 (dd, 3H), 7.66 (d, 3H), 8.34 (d, 3H), 8.78 (d, 3H).
Photoluminescence (2% in a PMMA film):
max = 418 nm, CIE: (0.16;0.05); QY = 77%
Example 3:
2-W-(2"-methylbiph n-3'-yl)amino-3-yV-isopropylaminopyridine:
A solution of 2-chloro-3-/V-isopropylaminopyridine (3.5 g, 20 mmol) and 2'- methylbiphen-3-ylamine hydrochloride (4.9 g, 23 mmol) in toluene (65 ml) is admixed with tris(dibenzylideneacetone)dipalladium (281 mg, 0.3 mmol), rac-BINAP (585 mg, 0.9 mmol) and sodium fe/t-butoxide (5.1 g, 51 mmol). The mixture is stirred under
reflux overnight. After cooling to room temperature, the precipitate is filtered off with suction and the filtrate is concentrated to dryness. The residue is purified by column chromatography (silica gel, 10:1 toluene/ethyl acetate). Yield: 6.1 g (93%), contaminated with approx. 30% 2'-methylbiphen-3-ylamine.
1H NMR (CD2CI2, 500 MHz): δ = 1 .21 (d, 6H), 3.26 (br s, 1 H), 3.56 (mc, 1 H), 6.31 (br s, 1 H), 6.82 (dd, 1 H), 6.89 (mc, 1 H), 6.97 (dd, 1 H), 7.20-7.34 (m, 7H), 7.70 (dd, 1 H).
1 -lsopropyl-3-(2"-meth lbiphen-3'-yl)-4-azabenzimidazolium iodide:
A mixture of 2-/V-(2"-methylbiphen-3'-yl)amino-3-/V-isopropylaminopyridine (2.0 g, 6.3 mmol) in triethyl orthoformate (8 ml) is admixed with ammonium iodide (281 mg, 6.6 mmol) and stirred at 80°C overnight. After cooling to room temperature, the mixture is diluted with triethyl orthoformate (5 ml) and isopropanol (3.5 ml) and stirred at room temperature overnight. The precipitate is filtered off with suction and washed with n- hexane. Yield: 2.0 g (70%).
1H NMR (de-DMSO, 500 MHz): δ = 1 .94 (d, 6H), 5.50 (sept, 1 H), 7.24-7.34 (m, 3H), 7.39 (dd, 1 H), 7.60 (mc, 1 H), 7.70-7.78 (m, 2H), 8.09 (dd, 1 H), 8.21 (mc, 1 H), 8.40 (dd, 1 H), 8.81 (dd, 1 H), 1 1.21 (s, 1 H).
Complex mer-Em3:
mer-EmZ
A suspension of 1 -isopropyl-3-(2"-methylbiphen-3'-yl)-4-azabenzimidazolium iodide (400 mg, 0.9 mmol) and 3A molecular sieve (2 g) in dioxane (15 ml) is admixed with silver(l) oxide (163 mg, 0.7 mmol) and stirred at room temperature overnight. The mixture is admixed with chloro(1 ,5-cyclooctadiene)iridium(l) dimer (57 mg, 0.08 mmol) and stirred under reflux for three days. After cooling to room temperature, the mixture is diluted with dichloromethane (15 ml), and the precipitate is filtered off with suction and washed with dichloromethane. The combined filtrates are concentrated to dryness and the residue is purified by column chromatography (silica gel, 9:1→4:1 toluene/ethyl acetate). Yield: 176 mg (89%).
1H NMR (CD2CI2, 500 MHz): δ = 0.70 (d, 3H), 0.77 (d, 3H), 0.90 (d, 3H), 1.39 (dd, 6H), 1.70 (d, 3H), 2.31 (s, 3H), 2.39 (s, 3H), 2.42 (s, 3H), 4.77 (mc, 2H), 4.91 (sept, 1 H), 6.70-6.80 (m, 4H), 6.87 (d, 1 H), 7.1 1 -7.31 (m, 14H), 7.33-7.39 (m, 2H), 7.77 (mc, 3H), 8.34-8.40 (m, 3H), 8.93 (dd, 2H), 8.99 (d, 1 H).
Photoluminescence (2% in a PMMA film):
max = 450 nm, CIE: (0.16;0.14); QY = 66%
Complex fac-E Z:
mer-EmZ fac-EmZ
A solution of mer-E Z (127 mg, 0.1 mmol) in butanone (15 ml) is admixed with hydrochloric acid (1 N, 1 .5 ml) and stirred under reflux overnight. After cooling to room temperature, the mixture is diluted with dichloromethane. The organic phase is washed with water and concentrated to dryness. The residue is purified by column chromatography (silica gel, 8: 1 toluene/ethyl acetate). Yield: 50 mg (39%).
1 H N MR (CD2CI2, 500 MHz): δ = 0.87 (d, 9H), 1 .55 (d, 9H), 2.27 (s, 9H), 4.72 (sept, 3H), 6.59 (d, 3H), 6.65 (dd, 3H), 7.08-7.28 (m, 15H), 7.69 (dd, 3H), 8.29 (dd, 3H), 8.86 (d, 3H).
Photoluminescence (2% in a PMMA film):
Xmax = 437 nm, CI E: (0.16;0.12); QY = 65%
Example 4:
A solution of 2,6-dichloro-3-aminopyridine (10.0 g, 61 mmol) in dichloromethane (200 ml) and glacial acetic acid (100 ml) is admixed with acetone (12.0 ml, 166 mmol) and, at 0°C, with borane-dimethyl sulfide complex (6.4 ml, 68 mmol), and the mixture is stirred at room temperature for three hours. The solution is adjusted to pH 9 with
ammonia (25% in water, 150 ml). The organic phase is removed and the aqueous phase is extracted with dichloromethane (2 χ 100 ml). The combined organic phases are concentrated to dryness and the residue is column-filtered (silica gel, 1 :1 dichloromethane/cyclohexane). Yield: 1 1.7 g (93%).
1H NMR (CD2CI2, 500 MHz): δ = 1 .24 (d, 6H), 3.60 (mc, 1 H), 4.20 (br s, 1 H), 6.90 (d, 1 H), 7.1 1 (d, 1 H).
2-yV-Phenylamino-3-yV-iso ropylamino-6-chloropyridine (ZW2):
ZW2
A solution of 2,6-dichloro-3-/V-isopropylaminopyridine (23.2 g, 1 13 mmol) and aniline (1 1.0 ml, 121 mmol) in toluene (500 ml) is admixed with tris(dibenzylideneacetone)- dipalladium (1 .6 g, 1.7 mmol), rac-BINAP (3.2 g, 5.1 mmol) and sodium tert-butoxide (15.2 g, 158 mmol). The mixture is stirred under reflux for 24 hours and, after cooling to room temperature, concentrated to dryness. The residue is purified by column chromatography (silica gel, 3:7 dichloromethane/cyclohexane → dichloromethane). Yield: 19.2 g (65%).
1H NMR (CD2CI2, 500 MHz): 5 = 1 .16 (d, 6H), 3.00 (br s, 1 H), 3.46 (mc, 1 H), 6.44 (br s, 1 H), 6.73 (d, 1 H), 6.90 (d, 1 H), 6.95 (mc, 1 H), 7.22-7.35 (m, 4H).
2-W-Phenylamino-3-yV-isopropylamino-6-(2'-methylphenyl)pyridine:
A solution of 2-/V-phenylamino-3-/V-isopropylamino-6-chloropyridine (5.0 g, 19 mmol) and 2-methylphenylboronic acid (3.1 g, 23 mmol) in dioxane (40 ml) is admixed with bis(tri-tert-butylphosphino)palladium (324 mg, 0.7 mmol) and sodium hydroxide solution (5N, 1 1 .5 mmol), and the mixture is stirred at 85°C overnight. The mixture is diluted with dichloromethane and washed with water. The organic phase is removed and concentrated to dryness. The residue is purified by column chromatography (silica gel, dichloromethane). Yield: 5.6 g (92%).
1H NMR (CD2CI2, 500 MHz): δ = 1 .23 (d, 6H), 2.37 (s, 3H), 3.60 (sept, 1 H),6.39 (br s, 1 H), 6.90 (dd, 1 H), 6.93 (d, 1 H), 7.04 (d, 1 H), 7.16-7.27 (m, 5H), 7.31 -7.39 (m, 3H).
1 -lsoprop l-3-phenyl-5-(2'-methylphenyl)-4-azabenzimidazolium iodide:
A mixture of 2-/V-phenylamino-3-/V-isopropylamino-6-(2'-methylphenyl)pyridine (6.5 g, 21 mmol) in triethyl orthoformate (10 ml) is admixed with ammonium iodide (5.9 mg, 41 mmol) and stirred at 80°C overnight. After cooling to room temperature, the mixture is concentrated to dryness and the residue is taken up in dichloromethane (50 ml). The precipitate is filtered off and washed with dichloromethane. The filtrate is added to methyl tert-butyl ether. The precipitate is filtered off with suction, washed with methyl tert-butyl ether and dried in a vacuum drying cabinet at 70°C. Yield: 8.6 g (92%).
1H NMR (de-DMSO, 500 MHz): δ = 1.72 (d, 6H), 2.35 (s, 3H), 5.20 (sept, 1 H), 7.29-7.41 (m, 3H), 7.48 (d, 1 H), 7.64 (mc, 1 H), 7.71 (mc, 2H), 7.95 (mc, 2H), 8.00 (d, 1 H), 8.84 (d, 1 H), 10.42 (s, 1 H).
Complex roer-Em4:
mer-Em4
A suspension of 1 -isopropyl-3-phenyl-5-(2'-methylphenyl)-4-azabenzimidazolium iodide (330 mg, 0.7 mmol) and 3A molecular sieve (2 g) in dioxane (10 ml) is admixed with silver(l) oxide (167 mg, 0.7 mmol) and stirred at room temperature overnight. The mixture is admixed with chloro(1 ,5-cyclooctadiene)iridium(l) dimer (49 mg, 0.07 mmol) and stirred under reflux overnight. After cooling to room temperature, the precipitate is filtered off with suction and washed with dichloromethane. The combined filtrates are concentrated to dryness and the residue is purified by column chromatography (silica gel, cyclohexane→ ethyl acetate). Yield: 80 mg (47%).
1H NMR (CD2CI2, 500 MHz): δ = 0.69 (d, 3H), 0.76 (d, 3H), 0.91 (d, 3H), 1 .31 (d, 3H), 1.37 (d, 3H), 1.69 (d, 3H), 2.48 (s, 3H), 2.52 (s, 6H), 4.68 (sept, 1 H), 4.74 (sept, 1 H), 4.86 (sept, 1 H), 6.64-6.77 (m, 5H), 6.91 -7.03 (m, 3H), 7.08 (dd, 1 H), 7.26-7.38 (m, 12H), 7.49-7.56 (m, 3H), 7.76-7.82 (m, 3H), 8.83 (d, 1 H), 8.87 (d, 1 H), 8.91 (d, 1 H).
Photoluminescence (2% in a PMMA film):
Xmax = 457 nm, CIE: (0.16; 0.16); QY = 81 %
Complex fac-Em4:
mer-Em4
fac- m
A solution of mer-Em4 (100 mg, 0.09 mmol) in methanol (10 ml) is admixed with hydrochloric acid (1 N, 1 ml) and stirred under reflux overnight. After cooling to room temperature, the precipitate is filtered off with suction and washed with methanol. The solid is stirred with cyclohexane, filtered off with suction and dried in a vacuum drying cabinet at 70°C. Yield: 80 mg (80%). 1H NMR (CD2CI2, 500 MHz): δ = 0.87 (d, 9H), 1 .59 (d, 9H), 2.50 (s, 9H), 4.72 (sept, 3H), 6.43 (dd, 3H), 6.61 (mc, 3H), 6.95 (mc, 3H), 7.24-7.35 (m, 12H), 7.51 (dd, 3H), 7.73 (d, 3H), 8.82 (dd, 3H).
Photoluminescence (2% in a PMMA film):
max = 459 nm, CIE: (0.17;0.19); QY = 76%
Example 5: 2-yV-Phenyla pylamino-6-(2',6'-dimethylphenyl)pyridine
ZW 2
A solution of 2-/V-phenylamino-3-/V-isopropylamino-6-chloropyridine ZW2 (1 .46 g, 5.58 mmol, for preparation see ZW2, Example 4) in dioxane (90 ml) is admixed with sodium hydroxide solution (50% in H20, 0.90 ml, 1 .34 g, 16.8 mmol, 3.0 eq) and degassed, admixed with bis(tri-tert-butylphosphino)palladium (100 mg, 0.19 mmol, 3.5 mol%) and 2,6-dimethylphenylboronic acid (1 .01 g, 6.70 mmol, 1.2 eq) and refluxed for 18 h. The solvent is removed, and the mixture is taken up with dichloromethane and washed with water. The organic phase is removed and concentrated to dryness. The residue is purified by column chromatography (silica gel, CH:EA = 4:1 ). Yield: 1.15 g (62%).
1H NMR (CD2CI2, 500 MHz): δ = 1 .26 (d, J = 6 Hz, 6H), 2.09 (s, 6H), 3.24 (br.s., 1 H), 3.61 (sept., J = 6 Hz, 1 H), 6.37 (br. s, 1 H), 6.73 (d, J = 8 Hz, 1 H), 6.89 (t, J = 7 Hz, 1 H), 7.07 (mc, 3H), 7.12 (dd, J = 7 Hz, J = 9 Hz, 1 H), 7.23 (mc, 2 H), 7.27 - 7.29 (m, 2H). 1 -lsopropy -3-phenyl-5-(2',6'-dimethylphenyl)-4-azabenzimidazolium iodide:
A mixture of 2-/V-phenylamino-3-/V-isopropylamino-6-(2',6'-dimethylphenyl)pyridine (0.95 g, 2.87 mmol) in triethyl orthoformate (25 ml) is admixed with ammonium iodide (1 .86 g, 12.9 mmol, 4.5 eq) and refluxed for 18 h. After cooling, the precipitate formed is filtered off and washed with petroleum ether, and then dried. Yield: 1 .12 g (83%).
1H NMR (CD2CI2, 500 MHz): δ = 2.00 (d, J = 7 Hz, 6H), 2.05 (s, 6H), 5.55 (sept., J = 7 Hz, 1 H), 7.16 (br. d, J = 7 Hz, 2H), 7.26 - 7.29 (m, 1 H), 7.58 - 7.62 (m, 1 H), 7.64 - 7.68 (m, 3H), 8.19 (d, J = 8 Hz, 2H), 8.38 (d, J = 9 Hz, 1 H), 1 1 .30 (s, 1 H).
Complex ro -Em5:
mer-Em5
1 -lsopropyl-3-phenyl-5-(2 6'-dimethylphenyl)-4-azabenzimidazoliurri iodide (1 .12 g, 2.38 mmol) is initially charged in acetonitrile (120 ml) and admixed with silver(l) oxide (276 mg, 1.19 mmol), and stirred at 50°C for 18 h. The solvent is removed and o- xylene (120 ml) is added. The mixture is admixed with chloro(1 ,5-cyclooctadiene)- iridium(l) dimer (160 mg, 0.238 mmol) and stirred at 135°C for 65 h. After cooling, the solvent is removed, and the residue is taken up with ethyl acetate and washed with water. The organic phase is dried and concentrated, and the residue is purified by column chromatography (silica gel, cyclohexane:ethyl acetate = 4:1 ). Yield: 570 mg (quant.).
1H NMR (CD2CI2, 500 MHz): δ = 0.66 (d, 3H), 0.72 (d, 3H), 0.93 (d, 3H), 1.33 (d, 3H), 1 .38 (d, 3H), 1 .72 (d, 3H), 2.05 (br.s, 6H), 2.15 (s, 9H), 2.22 (br.s, 3H), 4.67 (sept, 1 H), 4.81 (sept, 1 H), 4.83 (sept, 1 H), 6.66-6.82 (m, 5H), 6.90-9.97 (m, 3H), 7.06-7.18 (m, 10H), 7.22-7.27 (m, 3H), 7.79 (d, 3H), 8.75 (d, 1 H), 8.80 (d, 1 H), 8.83 (d, 1 H).
MS (Maldi):
m/e = 121 1 (M) +
Photoluminescence (2% in a PMMA film):
max = 444 nm, CIE: (0.16;0.1 1 ); QY = 86%
Example 6:
2-Λ/-Phenylamino-3-Λ/-isopropylamino-6-(2 4,-6,-triisopropylphenyl)pyridine:
A solution of 2-/V-phenylamino-3-/V-isopropylamino-6-chloropyridine ZW2 (2.00 g, 7.64 mmol, for preparation see ZW2, Example 4) in dioxane (100 ml) is admixed with sodium hydroxide solution (50% in H20, 1 .23 ml, 1 .83 g, 22.9, 3.0 eq) and degassed, admixed with bis(tri-tert-butylphosphino)palladium (140 mg, 0.27 mmol, 3.5 mol%) and 2,4,6-triisopropylboronic acid (1.73 g, 6.98 mmol, 0.9 eq) and refluxed for 4 h. A further 40 ml of dioxane are added and the mixture is refluxed over the course of 92 h. The solvent is removed, and the mixture is taken up with dichloromethane and washed with water. The organic phase is removed and concentrated to dryness. The residue is purified by column chromatography (silica gel, CH:EA = 3:2, then 9:1 ). Yield: 420 mg (14%).
1H NMR (CD2CI2, 500 MHz): δ = 1 .08, 1 .09 (2xd, 12H), 1 .26, 1 .28 (2xd, 12H), 2.70 (2xsept, 2H), 2.91 (sept, 1 H), 3.22 (br.s., 1 H), 3.62 (sept, 1 H), 6.35 (br. s, 1 H), 6.75 (d, 1 H), 6.88 (t, 1 H), 7.03 (mc, 3H), 7.22 (mc, 2H), 7.27 - 7.29 (m, 2H). -lsopropyl-3-phenyl-5-(2',4',6'-triisopropylphenyl)-4-azabenzimidazolium iodide:
A mixture of 2-/V-phenylamino-3-/V-isopropylamino-6-(2',4',6'-triisopropylphenyl)pyridine (0.35 g, 0.83 mmol) in triethyl orthoformate (15 ml) is admixed with ammonium iodide
(0.36 g, 2.5 mmol, 3.0 eq) and refluxed for 16 h. After cooling, the precipitate formed is filtered off and washed with petroleum ether and then dried. Yield: 0.34 g (73%).
1H NMR (CD2CI2, 500 MHz): δ = 1 .06 (d, 6H), 1 .12 (d, 6H), 1 .29 (d, 6H), 2.00 (d, 6H), 2.36 (sept, 2H), 2.96 (sept. 1 H), 5.56 (sept, 1 H), 7.12 (s, 2H), 7.59 - 7.68 (m, 4H), 8.18 (d, 2H), 8.33 (d, 1 H), 1 1.32 (s, 1 H).
1 -lsopropyl-3-phenyl-5-(2',4',6'-triisopropylphenyl)-4-azabenzimidazolium iodide (328 mg, 0.579 mmol) is initially charged in acetonitrile (60 ml) and admixed with silver(l) oxide (67 mg, 0.29 mmol), and the mixture is stirred at 50°C for 18 h. The solvent is removed and o-xylene (60 ml) is added. The mixture is admixed with chloro(1 ,5-cyclooctadiene)iridium(l) dimer (39 mg, 0.058 mmol) and stirred at 135°C for 66 h. After cooling, the solvent is removed, taken up with dichloromethane and washed with water. The organic phase is dried and concentrated, and the residue is purified by column chromatography (silica gel, cyclohexane:ethyl acetate = 3:2). Yield: 151 mg (86%). 1H NMR (CD2CI2, 500 MHz): δ = 0.62 (d, 3H), 0.69 (d, 3H), 0.89 (d, 3H), 1 .03 - 1.14 (m, 36 H), 1.30 (d, 21 H), 1.35 (d, 3H), 1 .70 (d, 3H), 2.34 (sept, 1 H), 2.45 (sept. 1 H), 2.50 - 2.64 (m, 3H), 2.75 (sept, 1 H), 2.95 (m, 3H), 4.66 (sept, 1 H), 4.79 (sept, 2H), 6.64 - 6.66 (m, 3H), 6.74 (d, 1 H), 6.64-6.95 (m, 4H), 7.04 -7.14 (m, 10H), 7.73 (d, 3H), 8.73 (d, 1 H), 8.81 (d, 1 H), 8.83 (d, 1 H).
Photoluminescence (2% in a PMMA film):
Xmax = 440 nm, CIE: (0.16;0.10); QY = 72%
Example 7:
2-yV-Phenylamino-3-yV-isopropylamino-6-phenoxypyridine:
ZW2
A mixture of 2-/V-phenylamino-3-/V-isopropylamino-6-chloropyridine ZW2 (2.08 g, 8.00 mmol, for preparation see ZW2, Example 4) phenol (3.76 g + 4.0 g, 40 mmol + 42.5 mmol, 10.3 eq.), Cs2C03 (7.82 g, 24 mmol, 3.0 eq) and copper powder (100 mg, 1 .6 mmol, 0.2 eq) is mixed cautiously and kept at 100°C for 60 h. After cooling, dichloromethane and water are added, the phases are separated and the aqueous phase is extracted with dichloromethane. The combined organic phases are dried and concentrated. Purification is effected by chromatography (silica gel, CH:CH2Cl2 = 2:3). Yield: 720 mg (28%) 1H NMR (CD2CI2, 500 MHz): δ = 1 .17 (d, 6H), 2.56 (br.s, 1 H), 3.36 (m/br.s, 1 H), 6.31 (m/br. s, 1 H), 6.84 (m/t, 1 H), 7.07 - 7.27 (m, 7 H), 7.29 (d, 2H), 7.39 (t, 2H).
1 -lsopropyl-3-phenyl-5-phenoxy-4-azabenzimidazolium iodide:
A mixture of 2-/V-phenylamino-3-/V-isopropylamino-6-phenoxypyridine (0.68 g, 2.1 mmol) in triethyl orthoformate (25 ml) is admixed with ammonium iodide (0.93 g, 6.39 mmol, 3.0 eq) and kept at 80°C overnight. After cooling to 0°C, the precipitate formed is filtered off and washed with cold petroleum ether and then dried. Yield: 760 mg (78%).
1H NMR (CD2CI2, 500 MHz): δ = 1 .91 (d, 6H), 5.55 (sept, 1 H), 7.21 (br. d, 2H), 7.27 - 7.34 (m, 2H), 7.45 (t, 2H), 7.51 (m, 3H), 8.04 (m, 2H), 8.45 (d, 1 H), 1 1 .00 (s, 1 H). Complex mer-Ewl:
mer-Em7
1 -lsopropyl-3-phenyl-5-phenoxy-4-azabenzimidazolium iodide (0.7 g, 1 .53 mmol) is initially charged in acetonitrile (80 ml) and admixed with silver(l) oxide (180 mg, 0.77 mmol), and the mixture is stirred at 50°C for 18 h. The solvent is removed and o- xylene (80 ml) is added. The mixture is admixed with chloro-1 ,5- (cyclooctadiene)iridium(l) dimer (103 mg, 0.153 mmol) and stirred at room temp, for 1 h, then at 135°C for 18 h. After cooling, the solvent is removed and the residue is purified by column chromatography (silica gel, cyclohexane:ethyl acetate = 4:1 ). Yield: 60 mg (5%).
1H NMR (CD2CI2, 500 MHz): δ = 0.63 (d, 3H), 0.67 (d, 3H), 0.83 (d, 3H), 1 .22 (d, 3H), 1.28 (d, 3H), 1.60 (d, 3H), 4.48 (sept, 1 H), 4.57 (sept, 1 H), 4.70 (sept, 1 H), 6.53-6.63 (m, 5H), 6.78 (mc, 6H), 6.93 (d, 1 H), 7.26 (m, 9H), 7.45 (m, 6H), 7.72 (m, 3H), 8.18 (d, 1 H), 8.81 (d, 2H).
Photoluminescence (2% in a PMMA film):
Xmax = 444 nm, CIE: (0.16;0.12); QY = 75%
Example 8:
2-W-(4-ferf-butylphenyl)amino-3-W-isopropylaminopyridine:
A mixture of 2-chloro-3-/V-isopropylaminopyridine (17.9 g, 102 mmol) in 4-(tert- butyl)aniline (17.0 ml, 107 mmol) is stirred at 180°C overnight. After cooling to room temperature, the solid is dissolved in dichloromethane (100 ml) and admixed with water (100 ml). Sodium hydroxide solution (25%) is added to the resulting mixture until a pH of 1 1 has been attained. The phases are separated, and the aqueous phase is extracted with dichloromethane (2 χ 50 ml). The combined organic phases are concentrated to dryness and the crude product is purified by column chromatography (silica gel, ethyl acetate/n-hexane gradient). Yield: 19.9 g (69%).
1H NMR (CD2CI2, 400 MHz): δ = 1 .22 (d, 6H), 1 .31 (s, 9H), 3.19 (br. s, 1 H), 3.57 (mc, 1 H), 6.16 (s, 1 H), 6.79 (dd, 1 H), 6.95 (dd, 1 H), 7.20-7.24 (m, 2H), 7.28-7.32 (m, 2H), 7.68 (dd, 1 H).
1 -lsopropyl-3-(4-tert-butylphenyl)-4-azabenzimidazolium iodide:
A mixture of 2-/V-(4-tert-butylphenyl)amino-3-/V-isopropylaminopyridine (12.1 g,
42.7 mmol) and triethyl orthoformate (90 ml) is admixed with ammonium iodide (6.50 g,
44.8 mmol) and stirred at 80°C overnight. After cooling to room temperature, the solid
is filtered off with suction and washed with petroleum ether and a little ethyl acetate. Yield: 16.1 g (90%).
1H NMR (de-DMSO, 400 MHz): δ = 1.37 (s, 9H), 1.71 (d, 6H), 5.17 (sept, 1 H), 7.73-7.77 (m, 2H), 7.83-7.88 (m, 3H), 8.78-8.82 (m, 2H), 10.37 (s, 1 H).
Complex roer-Em8:
A suspension of 1 -isopropyl-3-(4-tert-butylphenyl)-4-azabenzimidazolium iodide (8.05 g, 19.2 mmol) and 3A molecular sieve (60 g) in dioxane (400 ml) is admixed with silver(l) oxide (3.35 g, 14.5 mmol) and stirred at room temperature overnight. The mixture is admixed with a solution of chloro(1 ,5-cyclooctadiene)iridium(l) dimer (1.28 g, 1.91 mmol) in o-xylene (600 ml) and stirred at 1 10°C overnight. After cooling to room temperature, the precipitate is filtered off with suction and washed with dichloromethane. The combined filtrates are concentrated to dryness. The residue is admixed with methyl tert-butyl ether (50 ml), homogenized in an ultrasound bath and filtered off with suction. The solid is column-filtered (silica gel, dichloromethane). The product fractions are concentrated to dryness. Yield: 2.53 g (61 %). 1H NMR (CD2CI2, 400 MHz): δ = 0.58 (d, 3H), 0.65 (d, 3H), 0.83 (d, 3H), 1 .00 (s, 9H), 1 .04 (s, 9H), 1.14 (s, 9H), 1.26 (d, 3H), 1 .34 (d, 3H), 1.73 (d, 3H), 4.48 (sept, 1 H), 4.79 (sept, 1 H), 4.89 (sept, 1 H), 6.56 (d, 1 H), 6.71 (d, 1 H), 6.93 (dd, 1 H), 7.04-7.18 (m, 6H), 7.69-7.76 (m, 3H), 8.33-8.42 (m, 3H), 8.64 (t, 2H), 8.76 (d, 1 H). Photoluminescence (2% in a PMMA film):
Xmax = 449 nm, CIE: (0.16;0.13); QY = 93%
Example 9:
2-yV-(4'-(yV'-Eth lcarbazolyl))-3-yV-isopropylaminopyridine:
A mixture of 2-chloro-3-/V-isopropylaminopyridine (2.00 g, 1 1.7 mmol) in N-ethyl-4- aminocarbazole (5.2 g, 23.5 mmol) is stirred at 150°C overnight. After cooling to room temperature, the solid is taken up in dichloromethane. The insoluble residue is filtered off and discarded. The filtrate is admixed with water. Sodium hydroxide solution (25%) is added to the resulting mixture until a pH of 1 1 has been attained. The phases are separated, and the aqueous phase is extracted with dichloromethane (2 x 50ml). The combined organic phases are concentrated to dryness and the crude product is purified by column chromatography (alumina, dichloromethane). Yield: 3.65 g (90%).
1H NMR (CD2CI2, 400 MHz): δ = 1 .23 (d, 6H), 1.42 (t, 3H), 3.61 (sept, 1 H), 4.36 (q, 2H), 6.33 (s, 1 H), 6.76-6.80 (m, 1 H), 6.96 (d, 1 H), 7.17 (t, 1 H), 7.35-7.46 (m, 4H), 7.69 (d, 1 H), 8.00 (s, 1 H), 8.02 (d, 1 H).
1 -lsopropyl-3-(4' -A/'-ethylcarbazolyl))-4-azabenzimidazolium iodide:
A mixture of 2-/V-(4'-(/V-ethylcarbazolyl))-3-/V-isopropylaminopyridine (4.04 g, 1 1 .7 mmol) and triethyl orthoformate (50 ml) is admixed with ammonium iodide (1 .70 g, 1 1 .7 mmol) and stirred at 80°C overnight. After cooling to room temperature, the solid is filtered off with suction and washed with cyclohexane. The resulting solid is dissolved in dichloromethane and precipitated by adding cyclohexane. The solid is filtered off with suction and dried under reduced pressure. Yield: 3.01 g (53%).
1H NMR (de-DMSO, 400 MHz): δ = 1 .38 (t, 3H), 1 .75 (d, 6H), 4.58 (q, 2H), 5.22 (sept, 1 H), 7.31 (d, 1 H), 7.56-7.60 (m, 1 H), 7.76 (d, 1 H), 7.86-7.89 (m, 1 H), 7.95-7.99 (m, 2H), 8.22 (d, 1 H), 8.68 (s, 1 H), 8.81-8.85 (m, 2H), 10.47 (s, 1 H).
Complex roer-Em9:
A suspension of 1 -isopropyl-3-(4'(-/V-ethylcarbazolyl))-4-azabenzimidazolium iodide (3.99 g, 8.27 mmol) and 3A molecular sieve (50 g) in dioxane (700 ml) is admixed with silver(l) oxide (1 .97 g, 8.50 mmol) and stirred at room temperature for 48 h. The mixture is admixed with a solution of chloro(1 ,5-cyclooctadiene)iridium(l) dimer (555 mg, 0.83 mmol) in o-xylene (500 ml) and stirred at 1 10°C overnight. After cooling to room temperature, the precipitate is filtered off with suction and washed with ethyl acetate. The combined filtrates are concentrated to dryness. The residue is purified by column chromatography (silica gel, 4:1 n-hexane/ethyl acetate). The resulting solid is recrystallized from hot methyl tert-butyl ether (50 ml), filtered off with suction and dried. Yield: 910 mg (44%).
1H NMR (CD2CI2, 400 MHz): δ = 0.67 (d, 3H), 0.73 (d, 3H), 0.85-0.89 (m, 6H), 0.91 (d, 3H), 1.03 (t, 3H), 1.14 (t, 3H), 1.22-1 .29 (m, 3H), 1 .77 (d, 3H), 3.73 (m, 2H), 3.90 (m, 2H), 4.02 (q, 2H), 4.78 (sept, 1 H), 4.90 (sept, 1 H), 4.99 (sept, 1 H), 6.64 (s, 1 H), 6.73 (s, 1 H), 7.05-7.31 (m, 1 1 H), 7.77 (t, 2H), 7.82 (d, 1 H), 8.08-8.16 (m, 3H), 8.48 (d, 1 H), 8.53 (d, 1 H), 8.59 (d, 1 H), 9.63 (s, 1 H), 9.64 (s, 1 H), 9.72 (s, 1 H).
Photoluminescence (2% in a PMMA film):
max = 458 nm, CIE: (0.15;0.15); QY = 70%;
Example 10:
1 ,3-Diphenyl-3H-benzimidazolium tetrafluoroborate:
The synthesis of this compound is described in WO2005/019373 (compound 3).
Complex K1 :
K 1
5.00 g (14.0 mmol) of 1 ,3-diphenyl-3H-benzimidazolium tetrafluoroborate are suspended in 80 ml of anhydrous toluene and cooled to -8°C. Then 28 ml of potassium bis(trimethylsilyl)amide (KHMDS, 0.5M in toluene, 14.0 mmol) are added within 10 min. The mixture is stirred at room temperature for one hour and then added dropwise at - 78°C within 15 min to a solution of 4.70 g (7.0 mmol) of [(μ-ΟΙ)ΐΓ(η4-1 ,5-COD)]2 in 120 ml toluene. The reaction mixture is stirred at room temperature for 1 .5 h and then heated at reflux for 19 h. After cooling, the precipitate is filtered off and washed with toluene. The combined toluene phases are concentrated to dryness and purified by column chromatography (silica gel, eluent methylene chloride). This gives 5.8 g (68%) of K1 yellow powder.
1H NMR (CD2CI2, 500 MHz):
δ = 1 .17 (m, 2H), 1 .34 (m, 4H), 1.61 (m, 2H), 2.43 (m, 2H), 4.31 (m, 2H), 7.18 (m, 2H), 7.25 (m, 2H), 7.51 (m, 6H), 7.96 (m, 4H).
Complex Em10:
ZW1 Em 10
A suspension of 0.98 g (3.2 mmol) of 1 ,3-diphenyl-4-azabenzimidazolium chloride ZW1 in 75 ml of anhydrous toluene are admixed gradually at 0°C with 6.4 ml of potassium bis(trimethylsilyl)amide (KHMDS, 0.5M in toluene, 3.2 mmol). The reaction mixture is allowed to warm up and is stirred at room temperature for 1 h. Then a solution of 0.92 g (1 .5 mmol) of K1 in 125 ml of anhydrous toluene is added dropwise. This is followed by stirring at room temperature for half an hour and at reflux for 18 h. After removing the solvent under reduced pressure, the residue is purified by column chromatrography
(silica gel, eluent: cyclohexane/acetone with the mass ratio of 4/1 ). This gives 0.17 g of Em10 as a yellow powder (RF = 0.30).
1H NMR (CD2CI2, 500 MHz): δ = 6.23-6.31 (m, 6H), 6.38-6.42 (m, 2H), 6.58-6.68 (m, 5H), 6.72-6.80 (m, 7H), 6.97-7.05 (m, 3H), 7.08-7.14 (m, 3H), 7.26-7.35 (m, 5H), 7.97 (d, 1 H), 8.15 (d, 1 H), 8.34-8.37 (m, 2H), 8.92 (d, 1 H), 8.94 (d, 1 H).
Photoluminescence (2% in a PMMA film):
Xmax = 416 nm, CIE: (0.16;0.06); QY = 45%;
Example 11 : Complex Em11 -s:
Em11-s
A suspension of 1 -isopropyl-3-phenyl-4-azabenzimidazolium iodide (synthesis described in stage 3, Example 2; 0.46 g, 1 .3 mmol) in anhydrous dioxane (100 ml) is admixed with molecular sieve (10 g) and silver(l) oxide (0.19 g, 0.81 mmol), and the mixture is stirred at room temperature overnight. Subsequently, a solution of chloro dimer K2 (the /V-(2,6-diisopropylphenyl)-2-phenylimidazole ligands were synthesized analogously to Exampl 14 in WO2006/12181 1 ; the preparation of the chloro dimer K2 is described as compound D1 in WO 201 1/051404; 0.52 g, 0.31 mmol) is dissolved in dioxane (50 ml) and added dropwise to the reaction mixture. This was followed by dilution with further dioxane (25 ml). Thereafter, the mixture is stirred under reflux for one hour. The reaction mixture is cooled and filtered. The filtrate is freed of the solvent under reduced pressure, washed with methanol. This gives 0.40 g of Em11 -s as a yellow powder (62%).
1H NMR (CD2CI2, 500 MHz):
δ = 0.89 (d, 3H), 0.93 (2d, 6H), 0.96-1.02 (4d, 12H), 1.18 (d, 3H), 1.22 (d, 3H), 1.53 (d, 3H), 2.16 (sept, 1H), 2.49 (m, 1H), 2.70 (sept, 1H), 2.82 (sept, 1H), 5.51 (sept, 1H), 6.15 (d, 1H), 6.23 (d, 1H), 6.39 (d, 1H), 6.45 (t, 1H), 6.48 (t, 1H), 6.54 (d, 1H), 6.58 (d, 1H), 6.65 (2d, 2H), 6.73 (t, 2H), 6.76 (t, 1H), 6.83 (d, 1H), 7.00 (t, 1H), 7.08 (d, 1H), 7.17 (dd, 1H), 7.29 - 7.35 (m, 4H), 7.51 (2t, 2H), 7.81 (dd, 1H), 8.40 (dd, 1H), 8.84 (d, 1H).
MS (Maldi):
m/e = 1034 (M+H) +
Photoluminescence (2% in a PMMAfilm):
max = 488 nm, CIE: (0.18;0.32); Complex Em11-i:
Em11-s Em11_i
The complex Em11-i (isomer of Em11-s) is obtained by irradiating a solution of Em11-s in 3-methoxypropionitrile with a blacklight blue lamp (Osram, L18W/73, max = 370-380 nm) and subsequent column chromatography purification (cyclohexane:acetone = 10:1).
1H NMR (CD2CI2, 500 MHz):
δ = 0.62 (d, 3H), 0.83 (d, 3H), 0.88 (d, 3H), 1.01 (d, 3H), 1.05 (d, 3H), 1.08 (d, 3H), 1.14 (d, 3H), 1.19 (d, 3H), 1.22 (d, 3H), 1.71 (d, 3H), 1.77 (sept, 1H), 2.50 (sept.1H), 2.60 (sept, 1H), 2.78 (sept, 1H), 5.26 (sept, 1H), 6.14 (d, 1H), 6.20 (d, 2H), 6.39-6.48 (m, 3H), 6.54 (m, 2H), 6.62-6.73 (m, 4H), 6.79 (s, 1H), 6.90 (s, 1H), 6.97 (t, 1H), 7.13 (dd, 1H), 7.25 (d, 1H), 7.33-7.37 (m, 3H), 7.49 (t, 1H), 7.54 (t, 1H), 7.75 (d, 1H), 8.35 (d, 1H), 8.74 (d, 1H).
MS (Maldi):
m/e = 1034 (M+H) +
Photoluminescence (2% in a PMMA fil
λ™χ = 484 nm, CIE: (0.18;0.32);
Example 12:
Complex Em12-s
Em12-s
A suspension of 1 -isopropyl-3-phenyl-4-azabenzimidazolium iodide (synthesis described in stage 3, Example 2; 0.46 g, 1 .3 mmol) in anhydrous dioxane (100 ml) is admixed with molecular sieve (10 g) and silver(l) oxide (0.19 g, 0.81 mmol), and stirred at room temperature overnight. Subsequently, a solution of chloro dimer K3 (the preparation of the chloro dimer is described as compound D2 in WO 201 1/051404, 0.57 g, 0.31 mmol) is dissolved in dioxane (100 ml) and added dropwise to the reaction mixture. Thereafter, the mixture is stirred under reflux for three hours. The reaction mixture is cooled and filtered. The filtrate is freed of the solvent under reduced pressure, washed with methanol. This gives, after column chromatography purification (cyclohexane:acetone = 25:1 ), 0.35 g of Em12-s as a lemon yellow powder (49%).
MS (Maldi):
m/e = 1098 (M+H) +
Photoluminescence (2% in a PMMA film):
max = 481 nm, CIE: (0.20;0.29).
Complex Em12-i
Em12-s Em12-i The complex Em12-i (isomer of Em12-s) is obtained by irradiating a solution of Em12-s in 3-methoxypropionitrile with a blacklight blue lamp (Osram, L18W/73, max = 370-380 nm) and subsequent column chromatography purification (cyclohexane:acetone = 10:1 ). MS (Maldi):
m/e = 1098 (M+H) +
Photoluminescence (2% in a PMMA film):
max = 480 nm, CIE: (0.17;0.24).
Example 13 (comparative example noninventive):
lr(DPBIC)3
Preparation and photophysical data of lr(DPBIC)3 are described in WO2005/019373 (see facial Ir complex (7)).
Photoluminescence (in a PMMA film, see Tab. 3 in WO2005/019373, sample 3):
CIE: (0.16;0.05), quantum yield: 17%.
II Device examples
Example 14:
Production of an PLED (using the example of Em11 -i) Use as an emitter The ITO substrate used as the anode is cleaned first with commercial detergents for LCD production (Deconex® 20NS, and 250RGAN-ACID® neutralizing agent) and then in an acetone/isopropanol mixture in an ultrasound bath. To eliminate possible organic residues, the substrate is exposed to a continuous ozone flow in an ozone oven for a further 25 minutes. This treatment also improves the hole injection properties of the ITO. Next, the hole injection layer AJ20-1000 from Plexcore is spun on from solution.
Thereafter, the organic materials specified below are applied by vapor deposition to the cleaned substrate at about 10"7-10"9 mbar at a rate of approx. 0.5-5 nm/min. The hole conductor and exciton blocker applied to the substrate is lr(DPBIC)3 with a thickness of 45 nm, of which the first 35 nm are doped with MoOx to improve the conductivity.
lr(DPBIC)3
(for preparation of lr(DPBIC)3 see Ir complex (7) in the application PCT/EP/04/09269).
Subsequently, a mixture of emitter, in this case Em11 -i (15%), and of the compound Ma1 is applied by vapor deposition with a thickness of 20 nm, the latter compound functioning as a matrix material.
Compound Ma1 is described as No. 14 in WO 2010/079051 .
Subsequently, the material lr(DPBIC)3 is applied by vapor deposition with a thickness of 5 nm as an exciton and hole blocker. Next, as an electron transporter, a mixture of Liq and BCP (2,9-dimethyl-4,7-diphenyl-1 ,10-phenanthroline) is applied by vapor deposition in a thickness of 40 nm, as are a 1 .0 nm-thick liq layer and finally a 100 nm- thick Al electrode. All components are adhesive-bonded to a glass lid in an inert nitrogen atmosphere.
To characterize the OLED, electroluminescence spectra are recorded at different currents and voltages. In addition, the current-voltage characteristic is measured in combination with the light output emitted. The light output can be converted to photometric parameters by calibration with a photometer. The lifetime t1/2 of the diode is defined by the time taken for the luminance to fall to 50% of its initial value. The lifetime measurement is carried out at a constant current. A luminous diode with the following CIE values is obtained: 0.18; 0.26 (voltage in V @ 300 nits: 4.5).
Example 15:
Influence of the matrix materials MM using the example of mer-EM8, or/and use of inventive compounds as matrix material Diode structure:
HIL Plexcore AJ20-1000 - 10 nm lr(DPBIC)3:Re03 (95:5) - 10 nm lr(DPBIC)3 - 20 nm MM:mer-Em8 (80:20) - 5 nm Ma1 - 35 nm T1 :Liq (50:50) - 4 nm KF - 100 nm Al; the diode was produced analogously to Example 14.
Ti
The synthesis of T1 is described as A1 in European application EP10166507.3 and in US application US61/356057.
For the emitter mer-Em8 in various matrix materials (without matrix material) in the above-described OLED structure, the following electrooptical data are obtained:
In this structure, the hole conductor layer was 15 nm, but the hole blocker layer was 5 nm and the electon conductor layer was 40 nm.
2 In this case, 30% mer-Em8 was used as emitter; the hole transporter consisted of
10 nm of lr(DPBIC)3, the hole ;
LB1
Compound LB1 is described as compound "4g" in WO2009/003898.
3 The emitter functioned in this case as the matrix itself; the hole blocker layer case was 10 nm.
Example 16
Use of inventive compounds as hole conductors and electron blockers LL using the example of fac-EM2, and comparative example
Diode structure:
Plexcore AJ20-1000 - 35 nm LL:MoOx (90:10)- 10 nm LL - 20 nm Ma2:AEm (70:30) - 10 nm Ma2 - 20 nm T2 - 4 nm CsF - 100 nm Al; the diode was produced analogously to Example 14. with:
Ma2, described as compound (1 ) in WO 07077810 A1
AEm
AEm, described as compound in fac-Em1 in European application EP10 187 176.2 and US application 61/391 ,712 and also PCT application PCT/EP2010/069541 , and
T2, synthesis described as compound 7 in European application EP 10168921 .4 and US application US61/362314. As hole conductors result in the above-described OLED structure in the following electrooptical data:
Use of inventive compounds as emitters in a mixed matrix using the example of fac-EM2. Diode structure:
Plexcore AJ20-1000 - 35 nm fac-Em2:MoOx (90:10)- 10 nm fac-Em2 - 20 nm Ma2:AEm:fac-Em2- 10 nm Ma2 - 20 nm T2 - 4 nm CsF - 100 nm Al; the diode is produced analogously to Example 14.
The variation of the concentration of the emitters results in the following electrooptical data in the OLED structure described above:
Ma2:AEm:fac-Em2 CIE Voltage at EQE in % LT50 [%]
300 nits at 300 nits
55:30:15 0.17/0.30 93% 132% 450%
40:30:30 0.18/0.32 83% 126% 250%
70:30: 001 0.17/0.29 100% 100% 100%
1 In this case too, fac-Em2 is, however, still being used as the hole conductor and electron blocker.
Example 18
2-Chloro-3-amino-5-(trifluoromethyl)pyridine:
Zink(ll)-chloride-dihydrate (4.39 g, 19.5 mmol) is added to a solution of 2-chloro— 3- nitro-5-(trifluoromethyl)pyridine (1.00 g, 4.41 mmol) in a ethyl acetate (25 ml), and the resultant suspension is stirred for 2 h at 80 °C. After cooling to room temperature, the reaction mixture is slowly added dropwise into an ice cooled saturated sodium hydrogen carbonate solution (100 ml). After warming to room temperature, the resultant suspension is filtered via a celite layer, and the residue is washed four times with ethyl acetate (50 ml each). The filtrate and the washing solution are combined and subsequently washed with a saturated sodium hydrogen carbonate solution, water and a saturated aqueous sodium chloride solution. The organic phase is dried over magnesium sulfate, filtered and conenctrated to dryness. Yield: 0.78 g (90 %).
1H-NMR (CD2CI2, 400 MHZ: δ = 4.4. (br s, 2H), 7.24 (d, 1 H), 8.02 (d, 1 H).
2-Chloro-3-N-isopropylamino-5-(trifluoromethyl)pyridine
To a solution of 2-chloro-3-amino-5(trifluormethyl)pyridine (0.78 g, 3.97 mmol) in dichloromethane (10 ml) are added subsequently at 0°C glacial acetic acid (5 ml), acetone (0.62 g, 10.7 mmol) and borane-dimethyl sulfide (0.33 g, 4.37 mmol). After warming to room temperature the resulting solution is stirred for 16 h. The reaction mixture is cooled to 0 °C, and then a 25 % aqueous ammonia solution is added until a pH of 8 is reached. After addition of water (5 ml) the aqueous phase is removed and extracted three times with dichloromethane (40 ml). The combined organic phases are dried over magnesium sulfate, filtered and concentrated to dryness. Yield: 0.60 g (63 %).
1H-NMR(CD2CI2, 400 MHz: δ = 1.28 (d, 6H), 3.60-3.72 (m,1 H), 4.5 (br s, 1 H), 7.02 (s, 1 H), 7.89 (s, 1 H). 2-N-Phenylamino-3-N-isopropylamine-5-itrifluoromethyl)pyridine:
A mixture of 2-chloro-3-N-isopropylamino-5-(trifluoromethyl)pyridine (0.40 g, 1.68 nmol) and aniline (0.25 g, 2.72 nmol) is stirred at 180 °C for 16 h. After cooling to room temperature subsequently water (10 ml) and dichloromethane are added, and the pH value is then adjusted to 12 with a 50 % aqueous sodium hydroxide solution. The phases are separated, and the aqueous phase is three times extracted with dichloromethane (30 ml). The combined organic phases are dried over magnesium sulfate, filtered and concentrated to dryness. The cooled product is purified by column chromatography with silica gel (eluent, cyclohexane/ethyl acetate 4:1 ). Yield: 0.24 g (49 %).
1H-NMR(CD2CI2, 500 MHz): δ = 1.26 (d, 6h), 3.2 (br s, 1 H), 3.57-3.65 (m, 1 H), 6.55 (s, 1 H), 7.04 (t, 1 H), 7.07 (d, 1 H), 7.32 (t, 2H), 7.41 -7.46 (m, 2H), 7.98 (s, 1 H).
1 -lsopropyl-3-phenyl-6-trifluoromethyl-4-azabenzirriidazole-iodide:
Ammoniumiodide (0.12 g, 0.85 mmol) is added to a solution of 2-N-phenylamino-3-N- isopropylamino-5-(trifluoromethyl)pyridine (0.22 g, 0.74 mmol) in triethylorthoformiate (7.5 ml), and the resultant reaction mixture is stirred at 85 °C for 18 h. After cooling to room temperature, the precipitate formed is filtered, washed with petroleum ether and dried in vacuo. Yield: 0.31 g (97 %). 1H-NMR (CD2CI2, 500 MHz): δ = 1 ,99 (d, 6H), 5.50 (sept, 1 H), 7.66-7.74 (m, 3H), 8.19-8.22 (m, 2H), 8.57 (s, 1 H), 9.08 (s, 1 H), 1 1 .46 (s, 1 H).
Complex mer-EM13;
mer-Em13
Silver(l)oxide (0.50 g, 2.15 mmol) is added to a mixture of 1 -isopropyl-3-phenyl-6- trifluoromethyl-4-azabenzimidazole-iodide (1.25 g, 2.88 mmol), molecular sieve (10 g) and 1 .4-dioxane (150 ml), and the reaction mixture is stirred at room temperature for 16 h. The solvent is removed under reduced pressure and the residue is taken up in o- xylol (200 ml). A solution of lr[(cod)CI]2 (575 mg, 0.86 mmol) in o-xylol (75 ml) is added dropwise in 20 min, and the reaction mixture is stirred under reflux for 48 h. After cooling to room temperature, the insoluble residue is filtered and the filtrate is concentrated to dryness. The cooled product is purified by column chromatography on silica gel (eluent: cyclohexane/acetone 10 : 1 ). Yield 0.30 g (16 %)
1 H-NMR (CD2CI2, 500 MHz) : δ = 0.68 (d, 3H), 0.75 (d, 3H), 0.88 (d, 3H), 1.32 (d, 3H), 1.38 (d, 3H), 1 .69 (d, 3H), 4.61 -4.72 (m, 2H), 4.89 (sept, 1 H), 6.55 (dd, 1 H), 6.70-6.80 (m, 4H), 7.01 -7.12 (m, 4H), 7.93-7.99 (m, 3H), 8.70-8.78 (m, 3H), 8.82-8.88 (m, 2H), 8.91 (dd, 1 H).
Photoluminescence (2% in a PMMA-film):
max = 478 nm, CIE: (0.18; 0.28); QY = 73 % Example 19
Use of mer-EM13 as an emitter
Diode structure 1:
HIL Plexcore AJ20-1000 - 10 nm lr(DPBIC)3: Re03 (95:5) - 10 nm lr(DPBIC)3 - 40 nm Ma1 : mer-EM 13 (80:20) - 5nm Ma1 - 25 nm T1 :Liq (50:50) - 4nm KF - 100nm Al; the diode was produced analogously to example 14. CIE (x:v) = (0.22: 0.39): voltage^,. = 4.1 V: EQE3nnnitg = 14.0%.
Diode structure 2:
HIL Plexcore AJ20-1000 - 10nm lr(DPBIC)3:Re03 (95:5) - 10nm lr(DPBIC)3 - 40nm Ma3:mer-Em13:lr(DPBIC)3 (75:10:15) - 5nm Ma3 - 20nm T1 :Liq (50:50) - 4nm KF - 100nm Al; the diode was produced analogously to example 14.
CIE (x:v) = (0.16: 0.27): voltage^,. = 4.1 V: EQE3nnnitg = 12.1 %.
Claims
Claims
1 . A metal-carbene complex of the general formula (I)
(I) where M, n, Y, R2, R3, R4, A1, A2, A3, A4, p, K, L, m and o are each defined follows:
M is Ir or Pt, integer selected from 1 , 2 and 3, where the ligand(s)
are each bidentate ligands;
Y is NR1, 0, S or C(R10)2,
R1 is a linear or branched alkyl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyi radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 3 to 20 carbon atoms, substituted or unsubstituted aryl radical optionally interrupted by at least one heteroatom,
optionally bearing at least one functional group and having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having a total of 5 to 18 carbon atoms and/or heteroatoms,
R2, R3, R4 are each independently hydrogen, a linear or branched alkyl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 3 to 20 carbon atoms, substituted or unsubstituted aryl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having a total of 5 to 18 carbon atoms and/or heteroatoms, group with donor or acceptor action, or R2 and R3 or R3 and R4 together with the carbon atoms to which they are bonded form an optionally substituted, saturated or unsaturated or aromatic ring optionally interrupted by at least one further heteroatom and having a total of 5 to 18 carbon atoms and/or heteroatoms, and may optionally be fused to at least one further optionally substituted saturated or unsaturated or aromatic ring optionally interrupted by at least one further heteroatom and having a total of 5 to 18 carbon atoms and/or heteroatoms,
A1 is CR6 or N
A2 is CR7 or N
A3 is CR8 or N
A4 is CR9 or N
R6, R7, R8, R9 are each independently hydrogen, a linear or branched alkyl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 3 to 20 carbon atoms, substituted or unsubstituted heterocycloalkyl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 3 to 20 carbon atoms and/or heteroatoms, substituted or unsubstituted aryl radical optionally interrupted by at least one heteroatom, optionally bearing at
least one functional group and having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having a total of 5 to 18 carbon atoms and/or heteroatoms, group with donor or acceptor action, or
R6 and R7, R7 and R8 or R8 and R9, together with the carbon atoms to which they are bonded, form a saturated, unsaturated or aromatic, optionally substituted ring which is optionally interrupted by at least one heteroatom, has a total of 5 to 18 carbon atoms and/or heteroatoms, and may optionally be fused to at least one further optionally substituted saturated or unsaturated or aromatic ring optionally interrupted by at least one further heteroatom and having a total of 5 to 18 carbon atoms and/or heteroatoms, p is 0 or 1 ;
R10 is independently a linear or branched alkyl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 3 to 20 carbon atoms, substituted or unsubstituted aryl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having a total of 5 to 18 carbon atoms and/or heteroatoms,
or
the two R10 radicals form, together with the carbon atom to which they are bonded, a saturated or unsaturated optionally substituted ring optionally interrupted by at least one heteroatom and having a total of 5 to 18 carbon atoms and/or heteroatoms; K is an uncharged mono- or bidentate ligand,
L is a mono- or dianionic ligand, preferably monoanionic ligand, which may be mono- or bidentate, m is 0, 1 or 2, where, when m is 2, the K ligands may be the same or different,
o is 0, 1 or 2, where, when o is 2, the L ligands may be the same or different, excluding ligands L of the following general formula (A):
(A) where Y\ A2', A3', A4', A5', R1 ', R2', R3', R4', R5', R6', R7', R8', R9' and R10' are each defined as follows:
Y' is NR1 , O, S or C(R10 )2,
A2 , A3 , A4 , A5 are each independently N or C, where 2 A' = nitrogen atoms and at least one carbon atom is present between two nitrogen atoms in the ring,
R1 is a linear or branched alkyl radical optionally bearing at least one functional group, optionally interrupted by at least one heteroatom and having 1 to 20 carbon atoms, cycloalkyi radical having 3 to 20 carbon atoms, substituted or unsubstituted aryl radical having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical having a total of 5 to 18 carbon atoms and/or heteroatoms,
R2', R3', R4', R5', if A2', A3', A4' and/or A5' is N, are each a free electron pair or, if A2 , A3 , A4 and/or A5 is C, are each independently hydrogen, a linear or branched alkyl radical optionally bearing at least one functional group, optionally interrupted by at least one heteroatom and having 1 to 20 carbon atoms, cycloalkyi radical having 3 to 20 carbon atoms, substituted or unsubstituted aryl radical having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical having a total of 5 to 18 carbon atoms and/or heteroatoms, group with donor or acceptor action or
R3 and R4 form, together with A3 and A4 , an optionally substituted, unsaturated ring optionally interrupted by at least one further heteroatom and having a total of 5 to 18 carbon atoms and/or heteroatoms, R6 , R7 , R8 , R9 are each independently hydrogen, a linear or branched alkyl radical optionally bearing at least one functional group, optionally interrupted by at least one heteroatom and having 1 to 20 carbon atoms, cycloalkyl radical having 3 to 20 carbon atoms, cycloheteroalkyl radical having 3 to 20 carbon atoms, substituted or unsubstituted aryl radical having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical having a total of 5 to 18 carbon atoms and/or heteroatoms, group with donor or acceptor action, or R6 and R7 , R7 and R8 or R8 and R9 , together with the carbon atoms to which they are bonded, form a saturated, unsaturated or aromatic, optionally substituted ring optionally interrupted by at least one heteroatom and having a total of 5 to 18 carbon atoms and/or heteroatoms, and/or if A5 is C, R5 and R6 together form a saturated or unsaturated, linear or branched bridge optionally comprising heteroatoms, aromatic unit, heteroaromatic unit and/or functional groups and having a total of 1 to 30 carbon atoms and/or heteroatoms, to which is optionally fused a substituted or unsubstituted, five- to eight-membered ring comprising carbon atoms and/or heteroatoms,
R10 is independently a linear or branched alkyl radical optionally bearing at least one functional group, optionally interrupted by at least one heteroatom and having 1 to 20 carbon atoms, cycloalkyl radical having 3 to 20 carbon atoms, substituted or unsubstituted aryl radical having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical having a total of 5 to 18 carbon atoms and/or heteroatoms.
A metal-carbene complex according to claim 1 , wherein, in the general formula (I), L is a carbene ligand of the general formula (II)
A9 is CR12 or N;
A10 is CR13 or N;
R11 is a linear or branched alkyl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyi radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 3 to 20 carbon atoms, substituted or unsubstituted heterocycloalkyl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 3 to 20 carbon atoms and/or heteroatoms, substituted or unsubstituted aryl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having a total of 5 to 18 carbon atoms and/or heteroatoms,
R12, R13 are each independently hydrogen, a linear or branched alkyl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyi radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 3 to 20 carbon atoms, substituted or unsubstituted heterocycloalkyl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 3 to 20 carbon atoms and/or heteroatoms, substituted or unsubstituted aryl radical optionally interrupted by at least
one heteroatom, optionally bearing at least one functional group and having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having a total of 5 to 18 carbon atoms and/or heteroatoms, group with donor or acceptor action, is CR14 or N
is CR15 or N
is CR16 or N
is CR17 or N
R14, R15
R16, R17 are each independently hydrogen, a linear or branched alkyl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 3 to 20 carbon atoms, substituted or unsubstituted heterocycloalkyl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 3 to 20 carbon atoms and/or heteroatoms, substituted or unsubstituted aryl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having a total of 5 to 18 carbon atoms and/or heteroatoms, group with donor or acceptor action, or
R14 and R15, R15 and R16 or R16 and R17 form, together with the carbon atoms to which they are bonded, an unsaturated or aromatic, optionally substituted ring optionally interrupted by at least one heteroatom and having a total of 5 to 18 carbon atoms and/or heteroatoms, and/or
R12 and R13 form, together with A9 and A10 to which they are bonded, an unsaturated or aromatic, optionally substituted ring optionally interrupted by exactly one heteroatom or two adjacent heteroatoms and having a total of 5 to 18 ring atoms,
and/or if A9 is CR12, R12 and R17 together form a saturated or unsaturated, linear or branched bridge optionally comprising heteroatoms, aromatic units,
heteroaromatic units and/or functional groups and having a total of 1 to 30 carbon atoms and/or heteroatoms, to which is optionally fused a substituted or unsubstituted, five- to eight-membered ring comprising carbon atoms and/or heteroatoms; q is O or l ; where - when o in formula (I) is 2, the carbene ligands L of the formula (II) may be the same or different.
A metal-carbene complex according to claim 1 , wherein M, n, m and o are each defined as follows:
M is Ir, n is 3, where the ligand
are each bidentate ligands, where all n ligands are the same; m, o are each 0.
4. A metal-carbene complex according to claim 1 , wherein, in the general formula (I), L is selected from the group consisting of a ligand of the formula (B)
R51 is in each case independently a linear or branched alkyl radical having 1 to 6 carbons atoms, preferably methyl, ethyl, isopropyl, tert-butyl, CF3; substituted or unsubstituted aryl radical having 6 to 20 carbon atoms, preferably unsubstituted phenyl or 2,6-dialkylphenyl; substituted or unsubstituted heteroaryl radical having a total of 5 to 18 carbon atoms and/or heteroatoms,
R52 is hydrogen, a linear or branched alkyl radical having 1 to 6 carbon atoms, substituted or unsubstituted aryl radical having 6 to 20 carbon atoms, preferably hydrogen;
where the ligand of the formula (B) is, for example, acetylacetonato or hexa- fluoroacetylacetonato;
picolinato, salicylate 8-hydroxyquinolato and heterocyclic noncarbene ligands of the general formula
in which the symbols in the ligand of the general formula (III) are each defined as follows:
D are each independently CR18 or N, preferably CR18;
W is C, N, preferably C;
E are each independently CR19, N, NR20
preferably CR19 or N;
G is CR21, N, NR22, S, O, preferably NR21
R18, R19
R21 are each independently hydrogen, a linear or branched alkyl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having
3 to 20 carbon atoms, substituted or unsubstituted heterocycloalkyl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 3 to 20 carbon atoms and/or heteroatoms, substituted or unsubstituted aryl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having a total of 5 to 18 carbon atoms and/or heteroatoms, group with donor or acceptor action, or in each case 2 R18, R19 and R21 radicals, together with the carbon atoms to which they are bonded, form a saturated, unsaturated or aromatic, optionally substituted ring optionally interrupted by at least one heteroatom and having a total of 5 to 18 carbon atoms and/or heteroatoms,
R20, R22 are each independently a linear or branched alkyl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 3 to 20 carbon atoms, substituted or unsubstituted heterocycloalkyl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 3 to 20 carbon atoms and/or heteroatoms, substituted or unsubstituted aryl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical optionally interrupted by at least one heteroatom, optionally bearing at least one functional group and having a total of 5 to 18 carbon atoms and/or heteroatoms, group with donor or acceptor action; preferably ο,ο'-dialkylated aryl radical, where the solid curved line is an optional bridge between one of the D groups and the G group; where the bridge may be defined as follows: alkylene, arylene, heteroarylene, alkynylene, alkenylene, NR23, O, S, SiR24R25, CR50=N and (CR26R27)d, where one or more nonadjacent (CR26R27) groups may be replaced by NR23, O, S, SiR24R25, where d is 2 to 10;
and
are each H, alkyl, aryl, heteroaryl, alkenyl, alkynyl; where - when o in formula (I) is 2, the ligands L may be the same or different. 5. A metal-carbene complex according to any of claims 1 to 4, wherein
M is Ir, is 1 , 2 or 3, preferably 3, where the ligand(s)
are each bidentate ligands; and where all n ligands are more preferably the same;
Y is NR1, R1 is a linear or branched alkyl radical having 1 to 6 carbon atoms, substituted or unsubstituted cycloalkyl radical having 5 to 20 carbon atoms, substituted or unsubstituted aryl radical having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical having a total of 5 to 18 carbon atoms and/or heteroatoms,
R2, R3, R4 are each independently hydrogen, a linear or branched alkyl radical having 1 to 6 carbon atoms, substituted or unsubstituted aryl radical having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical having a total of 5 to 18 carbon atoms and/or heteroatoms, group with donor or acceptor action selected from halogen radicals, preferably F, CI, more preferably F; CF3, CN and SiMe3; or
R2 and R3 or R3 and R4 form, together with the carbon atoms to which they are bonded, an optionally substituted unsaturated, saturated or aromatic ring which is optionally interrupted by at least one further heteroatom, has a total of 5 to 18 carbon atoms and/or heteroatoms and may optionally be fused to at least one further optionally substituted saturated or unsaturated or aromatic ring optionally interrupted by at least one further heteroatom and having a total of 5 to 18 carbon atoms and/or heteroatoms,
P is 1 ;
A1 is CR6;
A2 is CR7;
A3 is CR8;
A4 is CR9;
R6, R7, R8, R9 are each independently hydrogen, a linear or branched alkyl radical optionally bearing at least one functional group, optionally interrupted by at least one heteroatom and having 1 to 20 carbon atoms, substituted or unsubstituted aryl radical having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical having a total of 5 to 18 carbon atoms and/or heteroatoms, group with donor or acceptor action selected from halogen radicals, preferably F, CI, more preferably F; CF3, CN and SiMe3;
or
R6 and R7,
R7 and R8
or
R8 and R9 form, together with the carbon atoms to which they are bonded, a saturated, unsaturated or aromatic, optionally substituted ring which is optionally interrupted by at least one heteroatom, has a total of 5 to 18 carbon atoms and/or heteroatoms and may optionally be fused to at least one further optionally substituted saturated or unsaturated or aromatic ring optionally interrupted by at least one further heteroatom and having a total of 5 to 18 carbon atoms and/or heteroatoms,
L is a monoanionic bidentate ligand, preferably selected from the group consisting of carbene ligands of the general formula (II) according to claim 2,
in which
R ,51 is in each case independently a linear or branched alkyl radical having 1 to 6 carbons atoms, preferably methyl, ethyl, isopropyl, tert-butyl, CF3; substituted or unsubstituted aryl radical having 6 to 20 carbon atoms, preferably unsubstituted phenyl or 2,6-dialkylphenyl; substituted or unsubstituted heteroaryl radical having a total of 5 to 18 carbon atoms and/or heteroatoms,
R52 is hydrogen, a linear or branched alkyl radical having 1 to 6 carbon atoms, substituted or unsubstituted aryl radical having 6 to 20 carbon atoms, preferably hydrogen;
where the ligand of the formula (B) is, for example, acetylacetonato or hexa- fluoroacetylacetonato;
picolinato, salicylato, 8-hydroxyquinolato and heterocyclic noncarbene ligands of the general formula (III) according to claim 4; m is 0, o is 0, 1 or 2, preferably 0.
A metal-carbene complex according to any of claims 1 to 5, wherein M is Ir, n is 3, where the liga
are each bidentate ligands, where all n ligands are more preferably the same;
Y is NR1,
R1 is a linear or branched alkyl radical having 1 to 6 carbon atoms, substituted or unsubstituted cycloalkyl radical having 5 to 20 carbon atoms, substituted or unsubstituted aryl radical having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl radical having a total of 5 to 18 carbon atoms and/or heteroatoms,
R2, R3,
R4 are each independently hydrogen, a linear or branched alkyl radical having 1 to 6 carbon atoms, substituted or unsubstituted aryl radical having 6 to 30 carbon atoms, especially ο,ο'-dialkylated or unsubstituted phenyl radical, substituted or unsubstituted heteroaryl radical having a total of 5 to 18 carbon atoms and/or heteroatoms, group with donor or acceptor action selected from halogen radicals, preferably F, CI, more preferably F; CF3, CN and SiMe3; or
R2 and R3 or R3 and R4 form, together with the carbon atoms to which they are bonded, an optionally substituted unsaturated, saturated or aromatic ring which is optionally interrupted by at least one further heteroatom, has a total of 5 to 7 carbon atoms and/or heteroatoms and may optionally be fused to at least one further optionally substituted saturated or unsaturated or aromatic ring optionally interrupted by at least one further heteroatom and having at total of 5 to 7 carbon atoms and/or heteroatoms,
P is 1 ;
A1 is CR6;
A2 is CR7;
A3 is CR8;
A4 is CR9; R6, R7,
R8, R9 are each independently hydrogen, a linear or branched alkyl radical having 1 to 20 carbon atoms, aryl radical having 6 to 30 carbon atoms, group with donor or acceptor action selected from halogen radicals, preferably F, CI, more preferably F; CF3, CN and SiMe3;
or
R6 and R7,
R7 and R8
or
R8 and R9 form, together with the carbon atoms to which they are bonded, an aromatic, optionally substituted ring which is optionally interrupted by one nitrogen or oxygen atom, has a total of 5 to 18 carbon atoms and/or heteroatoms and may optionally be fused to at least one further optionally substituted aromatic ring optionally interrupted by one nitrogen or oxygen atom and having a total of 5 to 18 carbon atoms and/or heteroatoms,
L is a monoanionic bidentate ligand, selected from the group consisting of carbene ligands of the general formula (II),
a ligand of the formula (B)
in which
R ,51 is in each case independently a linear or branched alkyl radical having 1 to 6 carbons atoms, preferably methyl, ethyl, isopropyl, tert-butyl, CF3; substituted or unsubstituted aryl radical having 6 to 20 carbon atoms, preferably unsubstituted phenyl or 2,6-dialkylphenyl; substituted or unsubstituted heteroaryl radical having a total of 5 to 18 carbon atoms and/or heteroatoms,
R52 is hydrogen, a linear or branched alkyl radical having 1 to 6 carbon atoms, substituted or unsubstituted aryl radical having 6 to 20 carbon atoms, preferably hydrogen;
where the ligand of the formula (B) is, for example, acetylacetonato or hexa- fluoroacetylacetonato;
picolinato, salicylate 8-hydroxyquinolato and heterocyclic noncarbene ligands of the general formula (III); m is 0, o is 0, 1 or 2.
A process for preparing the metal-carbene complexes according to any of claims 1 to 6 by contacting suitable compounds comprising M with compounds of the general formula (IV) or (V)
(IV) (V)
where Y, R2, R3, R4, A1, A2, A3 , A4 und p are each as defined according to claim 1 for the compounds of the general formula (I), and R28 and X are each defined as follows:
28 is independently SiR R R , aryl, heteroaryl, alkyl, cycloalkyl or
heterocycloalkyl,
is F, CI, Br, I, PF6, BF4,
R29,
R31 are each independently aryl, heteroaryl, alkyl, cycloalkyl or
heterocycloalkyl.
An organic electronic component comprising at least one metal-carbene compl according to any of claims 1 to 6.
9. The organic electronic component according to claim 8, wherein the organic electronic component is selected from organic light-emitting diodes (OLEDs), organic photovoltaic cells (OPVs), organic field-effect transistors (OFETs) and light-emitting electrochemical cells (LEECs).
10. The organic electronic component according to claim 9, wherein the organic electronic component is an OLED comprising a light-emitting layer comprising at least one metal-carbene complex according to any of claims 1 to 5.
1 1 . The organic electronic component according to claim 9 or 10, wherein the organic electronic component is an OLED comprising at least one metal-carbene complex according to any of claims 1 to 6, and at least one compound of the formula (X)
in which
T is NR , S, O or PR , preferably S or O, more preferably O;
R57 is aryl, heteroaryl, alkyl, cycloalkyi or heterocycloalkyl;
Q' is -NR58R59, -SiR70R71R72, -P(O)R60R61, -PR62R63, -S(0)2R64, -S(0)R65, -SR66
58D59.
or -OR preferably -NR00R0M; more preferably
in which
R68 R69 are each independently alkyl, cycloalkyi, heterocycloalkyl, aryl or heteroaryl; preferably methyl, carbazolyl, dibenzofuryl or dibenzothienyl;
are each independently 0, 1 , 2, 3 or 4, preferably 0 or 1 ;
R55. R: 56 are each independently alkyl, cycloalkyi, heterocycloalkyl, aryl, heteroaryl, SiR70R71R72, a Q' group or a group with donor or acceptor action;
is 0, 1 , 2, 3 or 4;
is 0, 1 , 2 or 3;
R58. R: 59 form, together with the nitrogen atom, a cyclic radical which has
3 to 10 ring atoms and may be unsubstituted or substituted by one or more substituents selected from alkyl, cycloalkyi, heterocycloalkyl, aryl, heteroaryl and a group with donor or acceptor action, and/or may be fused to one or more further cyclic radicals having 3 to 10 ring atoms, where the fused radicals may be unsubstituted or substituted by one or more
substituents selected from alkyl, cycloalkyi, heterocycloalkyl, aryl, heteroaryl and a group with donor or acceptor action;
R70, R 71, R 72 D60 D61 D62 D63 D64 D65 D66 D67
, r\ , r\ , r\ , r\ , r\ , r\ , r\ , r\
are each independently aryl, heteroaryl, alkyl, cycloalkyi or heterocycloalkyl,
or
two units of the general formula (X) are bridged to one another via a linear or branched, saturated or unsaturated bridge optionally interrupted by at least one heteroatom, via a bond or via O.
The organic electronic component according to claim 1 1 , comprising at least one compound of the formula (XI) or (Χ )
in which
T is NR57, S, O or PR57;
R57 is aryl, heteroaryl, alkyl, cycloalkyl or heterocycloalkyl;
Q is -NR58R59, -SiR70R71R72, -P(O)R60R61, -PR62R63, -S(0)2R64, -
S(0)R65, -SR66 or -OR67;
R70, R71, R72 are each independently aryl, heteroaryl, alkyl, cycloalkyl,
heterocycloalkyl or OR73,
R55, R56 are each independently alkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, a Q group or a group with donor or acceptor action; a', b' for the compound of the formula (XI): are each independently 0,
1 , 2, 3; for the compound of the formula (Χ ), a' is 0, 1 , 2 and b' is 0, 1 , 2, 3, 4;
R58, R59 form, together with the nitrogen atom, a cyclic radical which has
3 to 10 ring atoms and may be unsubstituted or substituted by one or more substituents selected from alkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl and a group with donor or acceptor action and/or may be fused to one or more further cyclic radicals having 3 to 10 ring atoms, where the fused radicals may be unsubstituted or substituted by one or more substituents selected from alkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl and a group with donor or acceptor action;
R ,73
are each independently SiR74R75R76, aryl, heteroaryl, alkyl, cycloalkyl or heterocycloalkyl, optionally substituted by an OR ,77 group;
R ,77
are each independently aryl, heteroaryl, alkyl, cycloalkyl or heterocycloalkyl,
or two units of the general formulae (XI) and/or (Χ ) are bridged to one another via a linear or branched, saturated or unsaturated bridge optionally interrupted by at least one heteroatom or via O, where this bridge in the general formulae (XI) and/or (Χ ) is in each case attached to the silicon atoms in place of R71.
13. The organic electronic component according to claim 1 1 or 12, wherein the
organic electronic component is an OLED which comprises an emission layer comprising at least one metal-carbene complex according to any of claims 1 to 6 and at least one matrix material of the formula (X) and/or (XI) or (Χ ) as defined in either of claims 1 1 and 12.
14. The organic electronic component according to claim 10, wherein the organic electronic component is an OLED which comprises an emission layer consisting of one or more metal-carbene complexes according to one of claims 1 to 6.
15. A device selected from the group consisting of stationary visual display units, mobile visual display units and illumination means, comprising at least one OLED according to any of claims 9 to 14.
16. The use of a metal-carbene complex according to any of claims 1 to 6 in OLEDs. 17. The use according to claim 16, wherein the metal-carbene complexes are used as emitter, matrix material, charge transport material and/or charge blocker.
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201280039588.0A CN103732603B (en) | 2011-06-14 | 2012-06-12 | Metal complex comprising azabenzimidazoles carbene ligands and its purposes in OLED |
EP12800656.6A EP2721043B1 (en) | 2011-06-14 | 2012-06-12 | Metal complexes comprising azabenzimidazole carbene ligands and the use thereof in oleds |
JP2014515323A JP6300722B2 (en) | 2011-06-14 | 2012-06-12 | Metal complexes with azabenzimidazole carbene ligands and their use in organic light-emitting diodes |
EP18187168.2A EP3415521A1 (en) | 2011-06-14 | 2012-06-12 | Metal complexes comprising azabenzimidazole carbene ligands and the use thereof in oleds |
KR1020197004490A KR102090916B1 (en) | 2011-06-14 | 2012-06-12 | Metal complexes comprising azabenzimidazole carbene ligands and the use thereof in oleds |
KR1020147000925A KR101950460B1 (en) | 2011-06-14 | 2012-06-12 | Metal complexes comprising azabenzimidazole carbene ligands and the use thereof in oleds |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11169895.7 | 2011-06-14 | ||
EP11169895 | 2011-06-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2012172482A1 true WO2012172482A1 (en) | 2012-12-20 |
Family
ID=47356605
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2012/052963 WO2012172482A1 (en) | 2011-06-14 | 2012-06-12 | Metal complexes comprising azabenzimidazole carbene ligands and the use thereof in oleds |
Country Status (6)
Country | Link |
---|---|
EP (2) | EP2721043B1 (en) |
JP (2) | JP6300722B2 (en) |
KR (2) | KR101950460B1 (en) |
CN (2) | CN103732603B (en) |
TW (2) | TWI626296B (en) |
WO (1) | WO2012172482A1 (en) |
Cited By (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014088300A1 (en) * | 2012-12-04 | 2014-06-12 | Rohm And Haas Electronic Materials Korea Ltd. | Organic electroluminescence compounds and organic electroluminescence device comprising the same |
WO2014147134A1 (en) | 2013-03-20 | 2014-09-25 | Basf Se | Azabenzimidazole carbene complexes as efficiency booster in oleds |
WO2015000955A1 (en) | 2013-07-02 | 2015-01-08 | Basf Se | Monosubstituted diazabenzimidazole carbene metal complexes for use in organic light emitting diodes |
WO2015014944A1 (en) * | 2013-07-31 | 2015-02-05 | Basf Se | Luminescent diaza- monoaza- and benzimidazole metal carbene complexes for use in electronic devices such as oleds |
WO2015063046A1 (en) | 2013-10-31 | 2015-05-07 | Basf Se | Azadibenzothiophenes for electronic applications |
WO2015150203A1 (en) * | 2014-03-31 | 2015-10-08 | Basf Se | Metal complexes, comprising carbene ligands having an o-substituted non-cyclometalated aryl group and their use in organic light emitting diodes |
WO2016016791A1 (en) | 2014-07-28 | 2016-02-04 | Idemitsu Kosan Co., Ltd (Ikc) | 2,9-functionalized benzimidazolo[1,2-a]benzimidazoles as hosts for organic light emitting diodes (oleds) |
EP2982676A1 (en) | 2014-08-07 | 2016-02-10 | Idemitsu Kosan Co., Ltd. | Benzimidazo[2,1-B]benzoxazoles for electronic applications |
EP2993215A1 (en) | 2014-09-04 | 2016-03-09 | Idemitsu Kosan Co., Ltd. | Azabenzimidazo[2,1-a]benzimidazoles for electronic applications |
EP3015469A1 (en) | 2014-10-30 | 2016-05-04 | Idemitsu Kosan Co., Ltd. | 5-((benz)imidazol-2-yl)benzimidazo[1,2-a]benzimidazoles for electronic applications |
WO2016079667A1 (en) | 2014-11-17 | 2016-05-26 | Idemitsu Kosan Co., Ltd. | Indole derivatives for electronic applications |
WO2016079169A1 (en) | 2014-11-18 | 2016-05-26 | Basf Se | Pt- or pd-carbene complexes for use in organic light emitting diodes |
EP3034507A1 (en) | 2014-12-15 | 2016-06-22 | Idemitsu Kosan Co., Ltd | 1-functionalized dibenzofurans and dibenzothiophenes for organic light emitting diodes (OLEDs) |
EP3034506A1 (en) | 2014-12-15 | 2016-06-22 | Idemitsu Kosan Co., Ltd | 4-functionalized carbazole derivatives for electronic applications |
EP3053918A1 (en) | 2015-02-06 | 2016-08-10 | Idemitsu Kosan Co., Ltd | 2-carbazole substituted benzimidazoles for electronic applications |
EP3054498A1 (en) | 2015-02-06 | 2016-08-10 | Idemitsu Kosan Co., Ltd. | Bisimidazodiazocines |
EP3061759A1 (en) | 2015-02-24 | 2016-08-31 | Idemitsu Kosan Co., Ltd | Nitrile substituted dibenzofurans |
EP3070144A1 (en) | 2015-03-17 | 2016-09-21 | Idemitsu Kosan Co., Ltd. | Seven-membered ring compounds |
EP3072943A1 (en) | 2015-03-26 | 2016-09-28 | Idemitsu Kosan Co., Ltd. | Dibenzofuran/carbazole-substituted benzonitriles |
EP3075737A1 (en) | 2015-03-31 | 2016-10-05 | Idemitsu Kosan Co., Ltd | Benzimidazolo[1,2-a]benzimidazole carrying aryl- or heteroarylnitril groups for organic light emitting diodes |
US9487548B2 (en) | 2009-12-14 | 2016-11-08 | Udc Ireland Limited | Metal complexes comprising diazabenzimidazolocarbene ligands and the use thereof in OLEDs |
WO2016193243A1 (en) | 2015-06-03 | 2016-12-08 | Udc Ireland Limited | Highly efficient oled devices with very short decay times |
US9583719B2 (en) | 2011-08-12 | 2017-02-28 | Basf Se | Carbazolocarbazol-bis(dicarboximides) and their use as semiconductors |
EP3150606A1 (en) | 2015-10-01 | 2017-04-05 | Idemitsu Kosan Co., Ltd. | Benzimidazolo[1,2-a]benzimidazoles carrying benzofurane or benzothiophene groups for organic light emitting diodes |
EP3150604A1 (en) | 2015-10-01 | 2017-04-05 | Idemitsu Kosan Co., Ltd. | Benzimidazolo[1,2-a]benzimidazole carrying benzimidazolo[1,2-a]benzimidazolyl groups, carbazolyl groups, benzofurane groups or benzothiophene groups for organic light emitting diodes |
WO2017056055A1 (en) | 2015-10-01 | 2017-04-06 | Idemitsu Kosan Co., Ltd. | Benzimidazolo[1,2-a]benzimidazole carrying triazine groups for organic light emitting diodes |
WO2017056053A1 (en) | 2015-10-01 | 2017-04-06 | Idemitsu Kosan Co., Ltd. | Benzimidazolo[1,2-a]benzimidazole carrying benzimidazolo[1,2-a]benzimidazolyl groups, carbazolyl groups, benzofurane groups or benzothiophene groups for organic light emitting diodes |
WO2017078182A1 (en) | 2015-11-04 | 2017-05-11 | Idemitsu Kosan Co., Ltd. | Benzimidazole fused heteroaryls |
WO2017093958A1 (en) | 2015-12-04 | 2017-06-08 | Idemitsu Kosan Co., Ltd. | Benzimidazolo[1,2-a]benzimidazole derivatives for organic light emitting diodes |
EP3184534A1 (en) | 2015-12-21 | 2017-06-28 | UDC Ireland Limited | Transition metal complexes with tripodal ligands and the use thereof in oleds |
WO2017109727A1 (en) | 2015-12-21 | 2017-06-29 | Idemitsu Kosan Co., Ltd. | Hetero-condensed phenylquinazolines and their use in electronic devices |
US9780312B2 (en) | 2014-10-17 | 2017-10-03 | Samsung Electronics Co., Ltd. | Carbazole-based compound and organic light emitting device including the same |
WO2017178864A1 (en) | 2016-04-12 | 2017-10-19 | Idemitsu Kosan Co., Ltd. | Seven-membered ring compounds |
WO2017221999A1 (en) | 2016-06-22 | 2017-12-28 | Idemitsu Kosan Co., Ltd. | Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes |
EP3318566A1 (en) | 2012-09-20 | 2018-05-09 | UDC Ireland Limited | Azadibenzofurans for electronic applications |
EP3466954A1 (en) | 2017-10-04 | 2019-04-10 | Idemitsu Kosan Co., Ltd. | Fused phenylquinazolines bridged with a heteroatom |
EP3466957A1 (en) | 2014-08-08 | 2019-04-10 | UDC Ireland Limited | Oled comprising an electroluminescent imidazo-quinoxaline carbene metal complexes |
WO2019084037A1 (en) * | 2017-10-26 | 2019-05-02 | University Of Puerto Rico | Novel carbazole ehop-016 derivatives as anti-cancer and anti-migratory agents |
US10347851B2 (en) | 2013-12-20 | 2019-07-09 | Udc Ireland Limited | Highly efficient OLED devices with very short decay times |
US10400001B2 (en) | 2015-03-10 | 2019-09-03 | National Institute Of Advanced Industrial Science And Technology | Heteroleptic iridium complex, and light-emitting material and organic light-emitting element using compound |
US10418569B2 (en) | 2015-01-25 | 2019-09-17 | Universal Display Corporation | Organic electroluminescent materials and devices |
EP3604477A1 (en) | 2018-07-30 | 2020-02-05 | Idemitsu Kosan Co., Ltd. | Polycyclic compound, organic electroluminescence device, and electronic device |
EP3608319A1 (en) | 2018-08-07 | 2020-02-12 | Idemitsu Kosan Co., Ltd. | Condensed aza cycles as organic light emitting device and materials for use in same |
WO2020053314A1 (en) | 2018-09-12 | 2020-03-19 | Merck Patent Gmbh | Electroluminescent devices |
WO2020053150A1 (en) | 2018-09-12 | 2020-03-19 | Merck Patent Gmbh | Materials for organic electroluminescent devices |
WO2020053315A1 (en) | 2018-09-12 | 2020-03-19 | Merck Patent Gmbh | Electroluminescent devices |
WO2020178230A1 (en) | 2019-03-04 | 2020-09-10 | Merck Patent Gmbh | Ligands for nano-sized materials |
WO2020208051A1 (en) | 2019-04-11 | 2020-10-15 | Merck Patent Gmbh | Materials for organic electroluminescent devices |
WO2021089450A1 (en) | 2019-11-04 | 2021-05-14 | Merck Patent Gmbh | Materials for organic electroluminescent devices |
WO2021094269A1 (en) | 2019-11-12 | 2021-05-20 | Merck Patent Gmbh | Materials for organic electroluminescent devices |
WO2021110741A1 (en) | 2019-12-04 | 2021-06-10 | Merck Patent Gmbh | Materials for organic electroluminescent devices |
WO2021151922A1 (en) | 2020-01-29 | 2021-08-05 | Merck Patent Gmbh | Benzimidazole derivatives |
WO2021191058A1 (en) | 2020-03-23 | 2021-09-30 | Merck Patent Gmbh | Materials for organic electroluminescent devices |
CN114058013A (en) * | 2021-10-12 | 2022-02-18 | 上海工程技术大学 | Preparation method of polybenzimidazole resin |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101950460B1 (en) * | 2011-06-14 | 2019-02-20 | 유디씨 아일랜드 리미티드 | Metal complexes comprising azabenzimidazole carbene ligands and the use thereof in oleds |
GB201421390D0 (en) * | 2014-12-02 | 2015-01-14 | Univ St Andrews | Luminescent complexes for OLEDs |
GB2535476A (en) * | 2015-02-16 | 2016-08-24 | Cambridge Display Tech Ltd | Compound, composition and organic light-emitting device |
KR102188262B1 (en) * | 2019-03-11 | 2020-12-08 | 부산대학교 산학협력단 | Deep Blue Iridium (Ⅲ) Complexes, method for preparaion of Iridium (Ⅲ) Complexes, and Organic Light-Emitting Diodes comprising thereof |
KR20210001240A (en) * | 2019-06-27 | 2021-01-06 | 솔루스첨단소재 주식회사 | Organic electroluminescent device |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005113704A2 (en) * | 2004-05-18 | 2005-12-01 | The University Of Southern California | Luminescent compounds with carbene ligands |
WO2006056418A2 (en) * | 2004-11-25 | 2006-06-01 | Basf Aktiengesellschaft | Use of transition metal carbene complexes in organic light-emitting diodes (oleds) |
WO2009003898A1 (en) * | 2007-07-05 | 2009-01-08 | Basf Se | Organic light-emitting diodes containing carbene transition metal complex emitters and at least one compound selected from disilylcarbazoles, disilyldibenzofurans, disilyldibenzothiophenes, disilyldibenzophospholes, disilyldibenzothiophene s-oxides and disilyldibenzothiophene s,s-dioxides |
WO2010079051A1 (en) * | 2009-01-07 | 2010-07-15 | Basf Se | Silyl and heteroatom substituted compounds selected from carbazoles, dibenzofurans, dibenzothiophenes and dibenzo phospholes and the application thereof in organic electronics |
Family Cites Families (77)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9826406D0 (en) | 1998-12-02 | 1999-01-27 | South Bank Univ Entpr Ltd | Quinolates |
EP1729327B2 (en) | 1999-05-13 | 2022-08-10 | The Trustees Of Princeton University | Use of a phosphorescent iridium compound as emissive molecule in an organic light emitting device |
JP3924648B2 (en) | 1999-11-02 | 2007-06-06 | ソニー株式会社 | Organic electroluminescence device |
EP1325671B1 (en) | 2000-08-11 | 2012-10-24 | The Trustees Of Princeton University | Organometallic compounds and emission-shifting organic electrophosphorescence |
DE10338550A1 (en) | 2003-08-19 | 2005-03-31 | Basf Ag | Transition metal complexes with carbene ligands as emitters for organic light-emitting diodes (OLEDs) |
US7642297B2 (en) | 2003-08-20 | 2010-01-05 | Koninklijke Philips Electronics N.V. | Non-leaching adhesive system and its use in a liquid immersion objective |
US7154114B2 (en) * | 2004-05-18 | 2006-12-26 | Universal Display Corporation | Cyclometallated iridium carbene complexes for use as hosts |
US9051344B2 (en) | 2005-05-06 | 2015-06-09 | Universal Display Corporation | Stability OLED materials and devices |
WO2006128800A1 (en) | 2005-05-30 | 2006-12-07 | Ciba Specialty Chemicals Holding Inc. | Electroluminescent device |
DE502005009802D1 (en) | 2005-11-10 | 2010-08-05 | Novaled Ag | Doped organic semiconductor material |
WO2007077810A1 (en) | 2006-01-05 | 2007-07-12 | Konica Minolta Holdings, Inc. | Organic electroluminescent device, display and illuminating device |
WO2007108362A1 (en) | 2006-03-17 | 2007-09-27 | Konica Minolta Holdings, Inc. | Organic electroluminescent device, display and illuminating device |
EP1837926B1 (en) | 2006-03-21 | 2008-05-07 | Novaled AG | Heterocyclic radicals or diradicals and their dimers, oligomers, polymers, di-spiro and polycyclic derivatives as well as their use in organic semiconductor materials and electronic devices. |
JP5683784B2 (en) | 2006-03-23 | 2015-03-11 | コニカミノルタ株式会社 | Organic electroluminescence element, display device and lighting device |
US20070224446A1 (en) | 2006-03-24 | 2007-09-27 | Idemitsu Kosan Co., Ltd. | Material for organic electroluminescence device and organic electroluminescence device using the same |
WO2007114244A1 (en) | 2006-03-30 | 2007-10-11 | Konica Minolta Holdings, Inc. | Organic electroluminescent device, illuminating device and display device |
JP2009532549A (en) | 2006-04-04 | 2009-09-10 | ビーエーエスエフ ソシエタス・ヨーロピア | Transition metal complexes having one non-carbene ligand and one or two carbene ligands and their use in OLEDs |
KR101431844B1 (en) | 2006-04-05 | 2014-08-25 | 바스프 에스이 | Heteroleptic transition metal-carbene complexes and their use in organic light-emitting diodes (oleds) |
JP5055818B2 (en) | 2006-04-19 | 2012-10-24 | コニカミノルタホールディングス株式会社 | ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE AND LIGHTING DEVICE |
KR20090024300A (en) | 2006-06-26 | 2009-03-06 | 바스프 에스이 | Use of transition metal-carbene complexes which do not comprise any cyclometallation via non-carbenes in oleds |
JP2008021687A (en) | 2006-07-10 | 2008-01-31 | Mitsubishi Chemicals Corp | Material for organic electric field light emitting element, composition for organic electric field light emitting element and organic electric field light emitting element |
WO2008029729A1 (en) | 2006-09-08 | 2008-03-13 | Konica Minolta Holdings, Inc. | Organic electroluminescent device, illuminating device and display |
JP5332614B2 (en) | 2006-09-08 | 2013-11-06 | コニカミノルタ株式会社 | Organic electroluminescence element, lighting device and display device |
JP2008066569A (en) | 2006-09-08 | 2008-03-21 | Konica Minolta Holdings Inc | Organic electroluminescence element, lighting system and display device |
WO2008035571A1 (en) | 2006-09-20 | 2008-03-27 | Konica Minolta Holdings, Inc. | Organic electroluminescence element |
JP2010504634A (en) | 2006-09-21 | 2010-02-12 | ビーエーエスエフ ソシエタス・ヨーロピア | Long-life OLED display |
JP5589251B2 (en) | 2006-09-21 | 2014-09-17 | コニカミノルタ株式会社 | Organic electroluminescence element material |
JP5011908B2 (en) | 2006-09-26 | 2012-08-29 | コニカミノルタホールディングス株式会社 | Organic electroluminescence element, display device and lighting device |
JP5063992B2 (en) | 2006-11-20 | 2012-10-31 | ケミプロ化成株式会社 | Novel di (pyridylphenyl) derivative, electron transport material comprising the same, and organic electroluminescence device including the same |
JP2008147424A (en) * | 2006-12-11 | 2008-06-26 | Idemitsu Kosan Co Ltd | Organic electroluminescence element |
US8541112B2 (en) | 2006-12-13 | 2013-09-24 | Konica Minolta Holdings, Inc. | Organic electroluminescent element, display device and lighting device |
WO2008090912A1 (en) | 2007-01-23 | 2008-07-31 | Konica Minolta Holdings, Inc. | Method for manufacturing organic electroluminescent device, organic electroluminescent device manufactured by the method, display device and illuminating device |
JP2008207520A (en) | 2007-02-28 | 2008-09-11 | Konica Minolta Holdings Inc | Organic thin film, method for producing the same, electronic device, organic luminescence element, display device and lightening equipment |
DE102007012794B3 (en) | 2007-03-16 | 2008-06-19 | Novaled Ag | New pyrido(3,2-h)quinazoline compounds useful to prepare doped organic semi-conductor, which is useful in an organic light-emitting diode, preferably organic solar cells, and modules for an electronic circuits, preferably displays |
EP3076451B1 (en) | 2007-04-30 | 2019-03-06 | Novaled GmbH | Oxocarbon, pseudo oxocarbon and radial compounds and their use |
JP5564942B2 (en) | 2007-05-16 | 2014-08-06 | コニカミノルタ株式会社 | Organic electroluminescence element, display device and lighting device |
WO2008146838A1 (en) | 2007-05-30 | 2008-12-04 | Konica Minolta Holdings, Inc. | Organic electroluminescent device, display device and illuminating device |
JP5540701B2 (en) | 2007-06-21 | 2014-07-02 | コニカミノルタ株式会社 | Organic electroluminescence element material |
JP5804703B2 (en) | 2007-07-05 | 2015-11-04 | ビーエーエスエフ ソシエタス・ヨーロピアBasf Se | Organic light emitting diode comprising at least one disilyl compound selected from disilylcarbazole, disilyldibenzofuran, disilyldibenzothiophene, disilyldibenzophosphole, disilyldibenzothiophene S-oxide and disilyldibenzothiophene S, S-dioxide |
WO2009008100A1 (en) | 2007-07-10 | 2009-01-15 | Idemitsu Kosan Co., Ltd. | Material for organic electroluminescence element, and organic electroluminescence element prepared by using the material |
JP5194596B2 (en) | 2007-07-11 | 2013-05-08 | コニカミノルタホールディングス株式会社 | Organic electroluminescence element, display device and lighting device |
JP5186843B2 (en) | 2007-08-30 | 2013-04-24 | コニカミノルタホールディングス株式会社 | Organic electroluminescence element, lighting device and display device |
US8067100B2 (en) * | 2007-10-04 | 2011-11-29 | Universal Display Corporation | Complexes with tridentate ligands |
JP5691170B2 (en) | 2007-11-08 | 2015-04-01 | コニカミノルタ株式会社 | Method for manufacturing organic electroluminescence element |
WO2009060757A1 (en) | 2007-11-08 | 2009-05-14 | Konica Minolta Holdings, Inc. | Organic electroluminescent device, display device and illuminating device |
JP5018891B2 (en) | 2007-11-08 | 2012-09-05 | コニカミノルタホールディングス株式会社 | ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE AND LIGHTING DEVICE |
JP2009114369A (en) | 2007-11-08 | 2009-05-28 | Konica Minolta Holdings Inc | Organic electroluminescent material, organic electroluminescent element, display and illuminator |
JP2009114370A (en) | 2007-11-08 | 2009-05-28 | Konica Minolta Holdings Inc | Organic electroluminescence element material, organic electroluminescence element, display device, and lighting system |
WO2009060742A1 (en) | 2007-11-08 | 2009-05-14 | Konica Minolta Holdings, Inc. | Organic electroluminescent device, display device, and illuminating device |
US20100276637A1 (en) | 2007-11-14 | 2010-11-04 | Konica Minolta Holdings, Inc. | Organic electroluminescent element material, organic electroluminescent element, method of manufacturing organic electroluminescent element, display device, and illuminating device |
JP2009135183A (en) | 2007-11-29 | 2009-06-18 | Konica Minolta Holdings Inc | Organic electroluminescence element, display, and lighting device |
US20090153034A1 (en) | 2007-12-13 | 2009-06-18 | Universal Display Corporation | Carbazole-containing materials in phosphorescent light emittinig diodes |
JPWO2009084413A1 (en) | 2007-12-28 | 2011-05-19 | コニカミノルタホールディングス株式会社 | ORGANIC ELECTROLUMINESCENT ELEMENT AND METHOD FOR PRODUCING ORGANIC ELECTROLUMINESCENT ELEMENT |
US8221905B2 (en) | 2007-12-28 | 2012-07-17 | Universal Display Corporation | Carbazole-containing materials in phosphorescent light emitting diodes |
JP5549053B2 (en) | 2008-01-18 | 2014-07-16 | コニカミノルタ株式会社 | ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENT ELEMENT, METHOD FOR PRODUCING ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE AND LIGHTING DEVICE |
JP2009182298A (en) | 2008-02-01 | 2009-08-13 | Konica Minolta Holdings Inc | Organic electroluminescence element, lighting device, and display device |
JP5381719B2 (en) | 2008-02-20 | 2014-01-08 | コニカミノルタ株式会社 | White light emitting organic electroluminescence device |
JP2009267255A (en) | 2008-04-28 | 2009-11-12 | Idemitsu Kosan Co Ltd | Material for organic electroluminescent element and organic electroluminescent element using the material |
EP2123733B1 (en) | 2008-05-13 | 2013-07-24 | Konica Minolta Holdings, Inc. | Organic electroluminescent element, display device and lighting device |
US20110084601A1 (en) | 2008-07-01 | 2011-04-14 | Konica Minolta Holdings, Inc. | White light emission organic electroluminescent element, illuminating device and display |
JP2010021336A (en) | 2008-07-10 | 2010-01-28 | Konica Minolta Holdings Inc | Organic electroluminescence device, illuminator, and display device |
JP5609641B2 (en) | 2008-07-10 | 2014-10-22 | コニカミノルタ株式会社 | Organic electroluminescence element, display device and lighting device |
JP5338184B2 (en) | 2008-08-06 | 2013-11-13 | コニカミノルタ株式会社 | Organic electroluminescence element, display device, lighting device |
JP5661635B2 (en) | 2008-10-07 | 2015-01-28 | オスラム オプト セミコンダクターズ ゲゼルシャフト ミット ベシュレンクテル ハフツングOsram Opto Semiconductors GmbH | Siloles substituted with fused ring systems and their use in organic electronics |
JPWO2010044342A1 (en) | 2008-10-15 | 2012-03-15 | コニカミノルタホールディングス株式会社 | ORGANIC ELECTROLUMINESCENT ELEMENT, METHOD FOR PRODUCING ORGANIC ELECTROLUMINESCENT ELEMENT, WHITE ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE AND LIGHTING DEVICE |
EP2180029B1 (en) | 2008-10-23 | 2011-07-27 | Novaled AG | Radialene compounds and their use |
JP5493333B2 (en) | 2008-11-05 | 2014-05-14 | コニカミノルタ株式会社 | ORGANIC ELECTROLUMINESCENT ELEMENT, WHITE ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE AND LIGHTING DEVICE |
JP5707665B2 (en) | 2008-12-03 | 2015-04-30 | コニカミノルタ株式会社 | ORGANIC ELECTROLUMINESCENCE ELEMENT, LIGHTING DEVICE AND DISPLAY DEVICE HAVING THE ELEMENT |
JP5402942B2 (en) | 2008-12-08 | 2014-01-29 | コニカミノルタ株式会社 | Organic electroluminescence element, display device, and lighting device |
WO2010079678A1 (en) | 2009-01-09 | 2010-07-15 | コニカミノルタホールディングス株式会社 | Organic electroluminescent element, display device, and lighting device |
JP5472121B2 (en) | 2009-01-28 | 2014-04-16 | コニカミノルタ株式会社 | ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE AND LIGHTING DEVICE, AND METHOD FOR PRODUCING ORGANIC ELECTROLUMINESCENT ELEMENT |
EP2395573B1 (en) | 2009-02-06 | 2019-02-27 | Konica Minolta Holdings, Inc. | Organic electroluminescent element, and illumination device and display device each comprising the element |
WO2010095564A1 (en) | 2009-02-18 | 2010-08-26 | コニカミノルタホールディングス株式会社 | Organic electroluminescent element, and illuminating device and display device each comprising the element |
US20120205645A1 (en) | 2009-10-28 | 2012-08-16 | Basf Se | Heteroleptic carbene complexes and the use thereof in organic electronics |
PL2513125T3 (en) * | 2009-12-14 | 2015-04-30 | Udc Ireland Ltd | Metal complexes with diazabenzimidazolecarbene ligands and their use in oleds |
US8883322B2 (en) * | 2011-03-08 | 2014-11-11 | Universal Display Corporation | Pyridyl carbene phosphorescent emitters |
KR101950460B1 (en) * | 2011-06-14 | 2019-02-20 | 유디씨 아일랜드 리미티드 | Metal complexes comprising azabenzimidazole carbene ligands and the use thereof in oleds |
-
2012
- 2012-06-12 KR KR1020147000925A patent/KR101950460B1/en active Application Filing
- 2012-06-12 EP EP12800656.6A patent/EP2721043B1/en active Active
- 2012-06-12 CN CN201280039588.0A patent/CN103732603B/en active Active
- 2012-06-12 WO PCT/IB2012/052963 patent/WO2012172482A1/en active Search and Examination
- 2012-06-12 CN CN201710301483.2A patent/CN107501330A/en active Pending
- 2012-06-12 KR KR1020197004490A patent/KR102090916B1/en active IP Right Grant
- 2012-06-12 EP EP18187168.2A patent/EP3415521A1/en active Pending
- 2012-06-12 JP JP2014515323A patent/JP6300722B2/en active Active
- 2012-06-14 TW TW106103305A patent/TWI626296B/en active
- 2012-06-14 TW TW101121395A patent/TWI626243B/en active
-
2017
- 2017-10-26 JP JP2017207114A patent/JP6584474B2/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005113704A2 (en) * | 2004-05-18 | 2005-12-01 | The University Of Southern California | Luminescent compounds with carbene ligands |
WO2006056418A2 (en) * | 2004-11-25 | 2006-06-01 | Basf Aktiengesellschaft | Use of transition metal carbene complexes in organic light-emitting diodes (oleds) |
WO2009003898A1 (en) * | 2007-07-05 | 2009-01-08 | Basf Se | Organic light-emitting diodes containing carbene transition metal complex emitters and at least one compound selected from disilylcarbazoles, disilyldibenzofurans, disilyldibenzothiophenes, disilyldibenzophospholes, disilyldibenzothiophene s-oxides and disilyldibenzothiophene s,s-dioxides |
WO2010079051A1 (en) * | 2009-01-07 | 2010-07-15 | Basf Se | Silyl and heteroatom substituted compounds selected from carbazoles, dibenzofurans, dibenzothiophenes and dibenzo phospholes and the application thereof in organic electronics |
Non-Patent Citations (1)
Title |
---|
See also references of EP2721043A4 * |
Cited By (102)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11444254B2 (en) | 2009-12-14 | 2022-09-13 | Udc Ireland Limited | Metal complexes comprising diazabenzmidazolocarbene ligands and the use thereof in OLEDs |
US10916716B2 (en) | 2009-12-14 | 2021-02-09 | Udc Ireland Limited | Metal complexes comprising diazabenzmidazolocarbene ligands and the use thereof in OLEDS |
US10090476B2 (en) | 2009-12-14 | 2018-10-02 | Udc Ireland Limited | Metal complexes comprising diazabenzmidazolocarbene ligands and the use thereof in OLEDs |
US11839140B2 (en) | 2009-12-14 | 2023-12-05 | Udc Ireland Limited | Metal complexes comprising diazabenzmidazolocarbene ligands and the use thereof in OLEDS |
US9487548B2 (en) | 2009-12-14 | 2016-11-08 | Udc Ireland Limited | Metal complexes comprising diazabenzimidazolocarbene ligands and the use thereof in OLEDs |
US9583719B2 (en) | 2011-08-12 | 2017-02-28 | Basf Se | Carbazolocarbazol-bis(dicarboximides) and their use as semiconductors |
US10249827B2 (en) | 2012-09-20 | 2019-04-02 | Udc Ireland Limited | Azadibenzofurans for electronic applications |
EP3318566A1 (en) | 2012-09-20 | 2018-05-09 | UDC Ireland Limited | Azadibenzofurans for electronic applications |
WO2014088300A1 (en) * | 2012-12-04 | 2014-06-12 | Rohm And Haas Electronic Materials Korea Ltd. | Organic electroluminescence compounds and organic electroluminescence device comprising the same |
KR20150127293A (en) * | 2013-03-20 | 2015-11-16 | 바스프 에스이 | Azabenzimidazole carbene complexes as efficiency booster in oleds |
US10374172B2 (en) | 2013-03-20 | 2019-08-06 | Udc Ireland Limited | Azabenzimidazole carbene complexes as efficiency booster in OLEDs |
JP2016522980A (en) * | 2013-03-20 | 2016-08-04 | ビーエーエスエフ ソシエタス・ヨーロピアBasf Se | Azabenzimidazolecarbene complex as a high efficiency booster in OLED |
CN105051927A (en) * | 2013-03-20 | 2015-11-11 | 巴斯夫欧洲公司 | Azabenzimidazole carbene complexes as efficiency booster in OLEDs |
TWI734860B (en) * | 2013-03-20 | 2021-08-01 | 愛爾蘭商Udc愛爾蘭責任有限公司 | Organic electronic device and apparatus comprising ir metal-carbene complex |
KR102164633B1 (en) * | 2013-03-20 | 2020-10-13 | 유디씨 아일랜드 리미티드 | Azabenzimidazole carbene complexes as efficiency booster in oleds |
CN105051927B (en) * | 2013-03-20 | 2020-10-16 | Udc 爱尔兰有限责任公司 | Azabenzimidazole carbene ligands as efficiency enhancers in OLEDs |
WO2014147134A1 (en) | 2013-03-20 | 2014-09-25 | Basf Se | Azabenzimidazole carbene complexes as efficiency booster in oleds |
TWI609022B (en) * | 2013-03-20 | 2017-12-21 | Udc愛爾蘭責任有限公司 | Azabenzimidazole carbene complexes as efficiency booster in oleds |
CN105518013A (en) * | 2013-07-02 | 2016-04-20 | 巴斯夫欧洲公司 | Monosubstituted diazabenzimidazole carbene metal complexes for use in organic light emitting diodes |
US11605790B2 (en) | 2013-07-02 | 2023-03-14 | Udc Ireland Limited | Monosubstituted diazabenzimidazole carbene metal complexes for use in organic light emitting diodes |
EP3266789A1 (en) | 2013-07-02 | 2018-01-10 | UDC Ireland Limited | Monosubstituted diazabenzimidazole carbene metal complexes for use in organic light emitting diodes |
JP2016532288A (en) * | 2013-07-02 | 2016-10-13 | ビーエーエスエフ ソシエタス・ヨーロピアBasf Se | Monosubstituted diazabenzimidazole carbene metal complexes for use in organic light emitting diodes |
CN105518013B (en) * | 2013-07-02 | 2018-10-26 | Udc 爱尔兰有限责任公司 | For the mono-substituted diaza benzo imidazole carbenes metal complex in organic light emitting diode |
EP3608329A1 (en) | 2013-07-02 | 2020-02-12 | UDC Ireland Limited | Monosubstituted diazabenzimidazole carbene metal complexes for use in organic light emitting diodes |
WO2015000955A1 (en) | 2013-07-02 | 2015-01-08 | Basf Se | Monosubstituted diazabenzimidazole carbene metal complexes for use in organic light emitting diodes |
CN105764911A (en) * | 2013-07-31 | 2016-07-13 | 巴斯夫欧洲公司 | Luminescent diaza- monoaza- and benzimidazole metal carbene complexes for use in electronic devices such as OLEDs |
JP2016534097A (en) * | 2013-07-31 | 2016-11-04 | ユー・ディー・シー アイルランド リミテッド | Luminescent Diazabenzimidazole Carbene Metal Complex |
WO2015014944A1 (en) * | 2013-07-31 | 2015-02-05 | Basf Se | Luminescent diaza- monoaza- and benzimidazole metal carbene complexes for use in electronic devices such as oleds |
EP3239161A1 (en) | 2013-07-31 | 2017-11-01 | UDC Ireland Limited | Luminescent diazabenzimidazole carbene metal complexes |
JP2019094346A (en) * | 2013-07-31 | 2019-06-20 | ユー・ディー・シー アイルランド リミテッド | Luminescent diazabenzimidazole carbene metal complexes |
JP2016531118A (en) * | 2013-07-31 | 2016-10-06 | ビーエーエスエフ ソシエタス・ヨーロピアBasf Se | Luminescent diaza-monoaza- and benzimidazole metal carbene complexes for use in electronic devices such as OLEDs |
CN105431442A (en) * | 2013-07-31 | 2016-03-23 | 巴斯夫欧洲公司 | Luminescent diazabenzimidazole carbene metal complexes |
CN112480177A (en) * | 2013-07-31 | 2021-03-12 | Udc 爱尔兰有限责任公司 | Luminescent diaza-, monoaza-and benzo-imidazole metal carbene complexes for use in electronic devices and methods for their preparation |
CN109021022A (en) * | 2013-07-31 | 2018-12-18 | Udc 爱尔兰有限责任公司 | Luminous diaza benzo imidazole carbene metal complex |
US10290817B2 (en) | 2013-07-31 | 2019-05-14 | Udc Ireland Limited | Luminescent diaza-monoaza-and benzimidazole metal carbene complexes for use in electronic devices such as OLEDs |
WO2015063046A1 (en) | 2013-10-31 | 2015-05-07 | Basf Se | Azadibenzothiophenes for electronic applications |
EP3916822A1 (en) | 2013-12-20 | 2021-12-01 | UDC Ireland Limited | Highly efficient oled devices with very short decay times |
US11075346B2 (en) | 2013-12-20 | 2021-07-27 | Udc Ireland Limited | Highly efficient OLED devices with very short decay times |
US10347851B2 (en) | 2013-12-20 | 2019-07-09 | Udc Ireland Limited | Highly efficient OLED devices with very short decay times |
US11765967B2 (en) | 2013-12-20 | 2023-09-19 | Udc Ireland Limited | Highly efficient OLED devices with very short decay times |
US10370396B2 (en) | 2014-03-31 | 2019-08-06 | Udc Ireland Limited | Metal complexes, comprising carbene ligands having an O-substituted non-cyclometallated aryl group and their use in organic light emitting diodes |
WO2015150203A1 (en) * | 2014-03-31 | 2015-10-08 | Basf Se | Metal complexes, comprising carbene ligands having an o-substituted non-cyclometalated aryl group and their use in organic light emitting diodes |
US10118939B2 (en) | 2014-03-31 | 2018-11-06 | Udc Ireland Limited | Metal complexes, comprising carbene ligands having an o-substituted non-cyclometalated aryl group and their use in organic light emitting diodes |
CN106661068A (en) * | 2014-03-31 | 2017-05-10 | Udc 爱尔兰有限责任公司 | Metal complexes, comprising carbene ligands having an o-substituted non-cyclometalated aryl group and their use in organic light emitting diodes |
US9862739B2 (en) | 2014-03-31 | 2018-01-09 | Udc Ireland Limited | Metal complexes, comprising carbene ligands having an O-substituted non-cyclometalated aryl group and their use in organic light emitting diodes |
WO2016016791A1 (en) | 2014-07-28 | 2016-02-04 | Idemitsu Kosan Co., Ltd (Ikc) | 2,9-functionalized benzimidazolo[1,2-a]benzimidazoles as hosts for organic light emitting diodes (oleds) |
EP2982676A1 (en) | 2014-08-07 | 2016-02-10 | Idemitsu Kosan Co., Ltd. | Benzimidazo[2,1-B]benzoxazoles for electronic applications |
EP3466957A1 (en) | 2014-08-08 | 2019-04-10 | UDC Ireland Limited | Oled comprising an electroluminescent imidazo-quinoxaline carbene metal complexes |
EP2993215A1 (en) | 2014-09-04 | 2016-03-09 | Idemitsu Kosan Co., Ltd. | Azabenzimidazo[2,1-a]benzimidazoles for electronic applications |
US9780312B2 (en) | 2014-10-17 | 2017-10-03 | Samsung Electronics Co., Ltd. | Carbazole-based compound and organic light emitting device including the same |
EP3015469A1 (en) | 2014-10-30 | 2016-05-04 | Idemitsu Kosan Co., Ltd. | 5-((benz)imidazol-2-yl)benzimidazo[1,2-a]benzimidazoles for electronic applications |
WO2016067261A1 (en) | 2014-10-30 | 2016-05-06 | Idemitsu Kosan Co., Ltd. | 5-((benz)imidazol-2-yl)benzimidazo[1,2-a]benzimidazoles for electronic applications |
WO2016079667A1 (en) | 2014-11-17 | 2016-05-26 | Idemitsu Kosan Co., Ltd. | Indole derivatives for electronic applications |
WO2016079169A1 (en) | 2014-11-18 | 2016-05-26 | Basf Se | Pt- or pd-carbene complexes for use in organic light emitting diodes |
EP3034507A1 (en) | 2014-12-15 | 2016-06-22 | Idemitsu Kosan Co., Ltd | 1-functionalized dibenzofurans and dibenzothiophenes for organic light emitting diodes (OLEDs) |
EP3034506A1 (en) | 2014-12-15 | 2016-06-22 | Idemitsu Kosan Co., Ltd | 4-functionalized carbazole derivatives for electronic applications |
WO2016097983A1 (en) | 2014-12-15 | 2016-06-23 | Idemitsu Kosan Co., Ltd. | 1-functionalized dibenzofurans and dibenzothiophenes for organic light emitting diodes (oleds) |
US10418569B2 (en) | 2015-01-25 | 2019-09-17 | Universal Display Corporation | Organic electroluminescent materials and devices |
EP3053918A1 (en) | 2015-02-06 | 2016-08-10 | Idemitsu Kosan Co., Ltd | 2-carbazole substituted benzimidazoles for electronic applications |
EP3054498A1 (en) | 2015-02-06 | 2016-08-10 | Idemitsu Kosan Co., Ltd. | Bisimidazodiazocines |
WO2016125110A1 (en) | 2015-02-06 | 2016-08-11 | Idemitsu Kosan Co., Ltd. | Bisimidazolodiazocines |
EP3061759A1 (en) | 2015-02-24 | 2016-08-31 | Idemitsu Kosan Co., Ltd | Nitrile substituted dibenzofurans |
US10400001B2 (en) | 2015-03-10 | 2019-09-03 | National Institute Of Advanced Industrial Science And Technology | Heteroleptic iridium complex, and light-emitting material and organic light-emitting element using compound |
EP3070144A1 (en) | 2015-03-17 | 2016-09-21 | Idemitsu Kosan Co., Ltd. | Seven-membered ring compounds |
EP3072943A1 (en) | 2015-03-26 | 2016-09-28 | Idemitsu Kosan Co., Ltd. | Dibenzofuran/carbazole-substituted benzonitriles |
EP3075737A1 (en) | 2015-03-31 | 2016-10-05 | Idemitsu Kosan Co., Ltd | Benzimidazolo[1,2-a]benzimidazole carrying aryl- or heteroarylnitril groups for organic light emitting diodes |
WO2016157113A1 (en) | 2015-03-31 | 2016-10-06 | Idemitsu Kosan Co., Ltd. | Benzimidazolo[1,2-a]benzimidazole carrying aryl- or heteroarylnitril groups for organic light emitting diodes |
WO2016193243A1 (en) | 2015-06-03 | 2016-12-08 | Udc Ireland Limited | Highly efficient oled devices with very short decay times |
EP4060757A1 (en) | 2015-06-03 | 2022-09-21 | UDC Ireland Limited | Highly efficient oled devices with very short decay times |
WO2017056053A1 (en) | 2015-10-01 | 2017-04-06 | Idemitsu Kosan Co., Ltd. | Benzimidazolo[1,2-a]benzimidazole carrying benzimidazolo[1,2-a]benzimidazolyl groups, carbazolyl groups, benzofurane groups or benzothiophene groups for organic light emitting diodes |
EP3150606A1 (en) | 2015-10-01 | 2017-04-05 | Idemitsu Kosan Co., Ltd. | Benzimidazolo[1,2-a]benzimidazoles carrying benzofurane or benzothiophene groups for organic light emitting diodes |
WO2017056052A1 (en) | 2015-10-01 | 2017-04-06 | Idemitsu Kosan Co., Ltd. | Benzimidazolo[1,2-a]benzimidazole carrying benzimidazolo[1,2-a]benzimidazolyl groups, carbazolyl groups, benzofurane groups or benzothiophene groups for organic light emitting diodes |
EP3150604A1 (en) | 2015-10-01 | 2017-04-05 | Idemitsu Kosan Co., Ltd. | Benzimidazolo[1,2-a]benzimidazole carrying benzimidazolo[1,2-a]benzimidazolyl groups, carbazolyl groups, benzofurane groups or benzothiophene groups for organic light emitting diodes |
WO2017056055A1 (en) | 2015-10-01 | 2017-04-06 | Idemitsu Kosan Co., Ltd. | Benzimidazolo[1,2-a]benzimidazole carrying triazine groups for organic light emitting diodes |
WO2017078182A1 (en) | 2015-11-04 | 2017-05-11 | Idemitsu Kosan Co., Ltd. | Benzimidazole fused heteroaryls |
WO2017093958A1 (en) | 2015-12-04 | 2017-06-08 | Idemitsu Kosan Co., Ltd. | Benzimidazolo[1,2-a]benzimidazole derivatives for organic light emitting diodes |
WO2017109727A1 (en) | 2015-12-21 | 2017-06-29 | Idemitsu Kosan Co., Ltd. | Hetero-condensed phenylquinazolines and their use in electronic devices |
EP3184534A1 (en) | 2015-12-21 | 2017-06-28 | UDC Ireland Limited | Transition metal complexes with tripodal ligands and the use thereof in oleds |
US10490754B2 (en) | 2015-12-21 | 2019-11-26 | Udc Ireland Limited | Transition metal complexes with tripodal ligands and the use thereof in OLEDs |
WO2017109722A1 (en) | 2015-12-21 | 2017-06-29 | Idemitsu Kosan Co., Ltd. | Nitrogen-containing heterocyclic compounds and organic electroluminescence devices containing them |
WO2017178864A1 (en) | 2016-04-12 | 2017-10-19 | Idemitsu Kosan Co., Ltd. | Seven-membered ring compounds |
WO2017221999A1 (en) | 2016-06-22 | 2017-12-28 | Idemitsu Kosan Co., Ltd. | Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes |
EP3466954A1 (en) | 2017-10-04 | 2019-04-10 | Idemitsu Kosan Co., Ltd. | Fused phenylquinazolines bridged with a heteroatom |
US10729689B2 (en) | 2017-10-26 | 2020-08-04 | University Of Puerto Rico | Carbazole EHop-016 derivatives as anti-cancer and anti-migratory agents |
US11446299B2 (en) | 2017-10-26 | 2022-09-20 | University Of Puerto Rico | Carbazole EHop-016 derivatives as anticancer and anti-migratory agents |
WO2019084037A1 (en) * | 2017-10-26 | 2019-05-02 | University Of Puerto Rico | Novel carbazole ehop-016 derivatives as anti-cancer and anti-migratory agents |
EP3604477A1 (en) | 2018-07-30 | 2020-02-05 | Idemitsu Kosan Co., Ltd. | Polycyclic compound, organic electroluminescence device, and electronic device |
WO2020026133A1 (en) | 2018-07-30 | 2020-02-06 | Idemitsu Kosan Co., Ltd. | Polycyclic compound, organic electroluminescence device, and electronic device |
EP3608319A1 (en) | 2018-08-07 | 2020-02-12 | Idemitsu Kosan Co., Ltd. | Condensed aza cycles as organic light emitting device and materials for use in same |
WO2020053314A1 (en) | 2018-09-12 | 2020-03-19 | Merck Patent Gmbh | Electroluminescent devices |
WO2020053315A1 (en) | 2018-09-12 | 2020-03-19 | Merck Patent Gmbh | Electroluminescent devices |
WO2020053150A1 (en) | 2018-09-12 | 2020-03-19 | Merck Patent Gmbh | Materials for organic electroluminescent devices |
DE202019005924U1 (en) | 2018-09-12 | 2023-05-10 | MERCK Patent Gesellschaft mit beschränkter Haftung | Electroluminescent devices |
DE202019005923U1 (en) | 2018-09-12 | 2023-06-27 | MERCK Patent Gesellschaft mit beschränkter Haftung | Electroluminescent devices |
WO2020178230A1 (en) | 2019-03-04 | 2020-09-10 | Merck Patent Gmbh | Ligands for nano-sized materials |
WO2020208051A1 (en) | 2019-04-11 | 2020-10-15 | Merck Patent Gmbh | Materials for organic electroluminescent devices |
WO2021089450A1 (en) | 2019-11-04 | 2021-05-14 | Merck Patent Gmbh | Materials for organic electroluminescent devices |
WO2021094269A1 (en) | 2019-11-12 | 2021-05-20 | Merck Patent Gmbh | Materials for organic electroluminescent devices |
WO2021110741A1 (en) | 2019-12-04 | 2021-06-10 | Merck Patent Gmbh | Materials for organic electroluminescent devices |
WO2021151922A1 (en) | 2020-01-29 | 2021-08-05 | Merck Patent Gmbh | Benzimidazole derivatives |
WO2021191058A1 (en) | 2020-03-23 | 2021-09-30 | Merck Patent Gmbh | Materials for organic electroluminescent devices |
CN114058013A (en) * | 2021-10-12 | 2022-02-18 | 上海工程技术大学 | Preparation method of polybenzimidazole resin |
Also Published As
Publication number | Publication date |
---|---|
TW201307367A (en) | 2013-02-16 |
TWI626243B (en) | 2018-06-11 |
KR20140041732A (en) | 2014-04-04 |
JP2018024696A (en) | 2018-02-15 |
EP2721043A4 (en) | 2015-02-25 |
JP6584474B2 (en) | 2019-10-02 |
CN103732603B (en) | 2017-05-31 |
EP2721043B1 (en) | 2018-08-29 |
JP2014523874A (en) | 2014-09-18 |
EP2721043A1 (en) | 2014-04-23 |
CN103732603A (en) | 2014-04-16 |
CN107501330A (en) | 2017-12-22 |
KR20190020835A (en) | 2019-03-04 |
EP3415521A1 (en) | 2018-12-19 |
KR102090916B1 (en) | 2020-03-19 |
TW201736572A (en) | 2017-10-16 |
KR101950460B1 (en) | 2019-02-20 |
TWI626296B (en) | 2018-06-11 |
JP6300722B2 (en) | 2018-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11839140B2 (en) | Metal complexes comprising diazabenzmidazolocarbene ligands and the use thereof in OLEDS | |
EP2721043B1 (en) | Metal complexes comprising azabenzimidazole carbene ligands and the use thereof in oleds | |
JP6486451B2 (en) | Dinuclear metal complexes containing carbene ligands and their use in OLEDs | |
US9315724B2 (en) | Metal complexes comprising azabenzimidazole carbene ligands and the use thereof in OLEDs | |
KR102098340B1 (en) | Transition metal complexes with carbene ligands and the use thereof in oleds | |
EP3016960B1 (en) | Monosubstituted diazabenzimidazole carbene metal complexes for use in organic light emitting diodes | |
WO2015014944A1 (en) | Luminescent diaza- monoaza- and benzimidazole metal carbene complexes for use in electronic devices such as oleds | |
KR102128072B1 (en) | Metal complexes comprising diazabenzimidazol carbene-ligands and the use thereof in oleds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12800656 Country of ref document: EP Kind code of ref document: A1 |
|
DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
ENP | Entry into the national phase |
Ref document number: 2014515323 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 20147000925 Country of ref document: KR Kind code of ref document: A |